data_1x32_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1x32 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.412 -0.275 . . . . 2.65 112.412 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.465 ' CA ' HG22 ' A' ' 23' ' ' ILE . 15.0 tt0 61.67 14.05 5.78 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.163 0.506 . . . . 2.17 111.665 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 6' ' ' ASN . 58.0 t -79.67 -42.62 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 O-C-N 121.986 -0.446 . . . . 1.44 111.138 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.434 ' HA ' HG13 ' A' ' 23' ' ' ILE . 20.1 t-20 82.06 44.51 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.697 -0.683 . . . . 2.31 111.999 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 22.9 ptmt -119.76 -143.2 0.35 Allowed 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.179 -1.045 . . . . 2.9 108.179 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.438 ' N ' ' HG3' ' A' ' 7' ' ' LYS . 3.1 tp -45.44 139.26 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 122.219 0.208 . . . . 2.43 111.009 178.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.513 ' HA ' ' CB ' ' A' ' 22' ' ' LEU . 27.6 pt -133.94 129.28 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 114.641 1.349 . . . . 4.33 114.641 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.06 144.41 16.0 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 106.865 -2.494 . . . . 1.14 106.865 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.491 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -152.36 105.42 3.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 118.855 1.328 . . . . 1.95 113.471 -175.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -156.85 102.87 2.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.847 -0.615 . . . . 4.16 110.874 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.484 HG22 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -116.67 -80.82 0.61 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.625 -0.83 . . . . 1.13 113.082 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.3 -58.79 0.19 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.631 0.604 . . . . 1.14 112.631 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.9 -36.37 3.36 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.577 -0.82 . . . . 0.72 111.757 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.19 -31.21 68.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.39 -0.596 . . . . 2.82 109.39 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.402 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -147.35 -58.45 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.029 -0.987 . . . . 0.86 110.847 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.493 ' CB ' HG11 ' A' ' 34' ' ' VAL . . . -106.21 151.45 24.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.523 -0.338 . . . . 1.15 110.662 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.402 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -165.47 26.01 0.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.07 0.767 . . . . 2.5 113.07 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 5.2 mt-10 -146.54 -171.45 3.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.718 -0.845 . . . . 1.28 108.718 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.603 ' CD2' ' CZ3' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -155.17 -53.96 0.09 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 117.965 2.58 . . . . 5.2 117.965 -177.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 9' ' ' ILE . 8.7 mt -88.27 151.69 22.47 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 116.324 1.972 . . . . 5.07 116.324 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.527 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -7.54 -117.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 111.584 -2.553 . . . . 3.21 114.402 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.42 ' CG ' HD11 ' A' ' 9' ' ' ILE . 0.9 OUTLIER 48.88 24.0 0.78 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.623 0.647 . . . . 2.6 110.221 -177.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.527 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -145.81 31.13 1.06 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 113.45 0.907 . . . . 1.71 113.45 -179.302 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.6 mttp 33.54 33.98 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.556 0.576 . . . . 3.74 112.556 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.437 ' HB3' ' CG ' ' A' ' 4' ' ' GLU . 4.1 p-10 46.64 47.81 14.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.886 -0.597 . . . . 2.14 112.194 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.449 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -52.95 -56.11 20.38 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.073 -1.06 . . . . 0.99 111.531 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.487 ' O ' ' O ' ' A' ' 30' ' ' SER . 85.8 m-70 -131.1 94.21 3.54 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 109.337 -0.616 . . . . 3.77 109.337 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 29' ' ' HIS . 13.9 m 40.43 106.68 0.01 OUTLIER Pre-proline 0 C--O 1.223 -0.29 0 N-CA-C 113.468 0.914 . . . . 1.8 113.468 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.437 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 8.2 Cg_exo -33.53 130.63 0.14 Allowed 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 122.479 2.12 . . . . 0.79 110.037 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.556 ' CB ' ' CG2' ' A' ' 34' ' ' VAL . 64.7 m -150.94 156.36 41.02 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 113.94 1.089 . . . . 1.27 113.94 -173.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.603 ' CZ3' ' CD2' ' A' ' 21' ' ' TYR . 3.7 t-105 -86.1 92.26 8.67 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 103.663 -2.717 . . . . 1.48 103.663 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.574 ' CG1' ' CD ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -154.99 -177.8 0.79 Allowed Pre-proline 0 CA--C 1.547 0.855 0 CA-C-N 114.706 -1.133 . . . . 2.35 110.414 -174.607 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.574 ' CD ' ' CG1' ' A' ' 34' ' ' VAL . 30.4 Cg_endo -86.33 103.22 0.66 Allowed 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 124.185 3.257 . . . . 1.52 116.32 -174.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 t 41.2 28.08 0.06 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.108 0.48 . . . . 2.17 111.251 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.502 ' O ' ' CE3' ' A' ' 25' ' ' TRP . 1.5 m -166.23 -131.85 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.444 -0.798 . . . . 1.81 109.913 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -170.45 98.92 0.26 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 105.004 -2.221 . . . . 5.8 105.004 -177.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.48 ' HA ' ' HB2' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -116.59 37.64 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.823 -1.08 . . . . 2.64 111.624 -173.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 41' ' ' ALA . . . -69.82 89.98 0.59 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.188 -0.915 . . . . 1.75 110.904 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 40' ' ' ALA . . . 152.96 42.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.272 -0.876 . . . . 2.67 110.504 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 t70 54.76 88.67 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.72 0.295 . . . . 4.56 110.778 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -169.75 170.6 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.306 -0.628 . . . . 4.12 109.306 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.479 ' N ' ' CG2' ' A' ' 43' ' ' VAL . 7.6 p -128.63 132.99 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 114.079 1.14 . . . . 3.1 114.079 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.43 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 16.6 t 61.83 7.59 2.07 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.669 1.359 . . . . 1.46 114.669 176.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.434 ' O ' ' CG2' ' A' ' 43' ' ' VAL . 3.5 tt0 177.8 -173.04 0.12 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.136 -0.626 . . . . 1.6 112.42 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.48 ' HB2' ' HA ' ' A' ' 39' ' ' ILE . 45.5 t80 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.222 -0.894 . . . . 4.35 110.675 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.414 ' HA2' HG12 ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.242 0 N-CA-C 112.616 -0.194 . . . . 2.65 112.616 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.467 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 0.0 OUTLIER 58.29 12.98 2.16 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.021 0.378 . . . . 2.17 112.021 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.409 ' HB ' ' HG2' ' A' ' 7' ' ' LYS . 23.2 t -89.42 -4.22 10.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 112.274 0.472 . . . . 1.44 112.274 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.402 ' ND2' ' HG3' ' A' ' 24' ' ' GLU . 29.4 t-20 39.09 71.66 0.16 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.007 0.432 . . . . 2.31 111.236 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.415 ' N ' ' OE1' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -150.77 -141.98 0.11 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.874 -0.603 . . . . 2.9 109.389 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.485 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -56.49 106.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.596 0.712 . . . . 2.43 111.537 179.48 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.509 ' CG2' ' CB ' ' A' ' 22' ' ' LEU . 3.0 tp -153.55 171.06 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.845 -0.616 . . . . 4.33 110.763 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.03 169.37 20.45 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 111.824 -0.511 . . . . 1.14 111.824 -175.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.501 ' HA ' ' N ' ' A' ' 21' ' ' TYR . 14.1 p -150.29 103.99 3.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 113.312 0.856 . . . . 1.95 113.312 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.422 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 32.2 ttm180 -159.46 101.36 1.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.481 -0.327 . . . . 4.16 111.845 177.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.477 HG21 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -115.69 -85.42 0.62 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.857 1.058 . . . . 1.13 113.857 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.42 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -146.03 -51.57 0.24 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.421 0.555 . . . . 1.14 112.493 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.06 -35.57 4.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.625 -0.798 . . . . 0.72 112.193 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -59.73 -41.99 92.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.224 0.535 . . . . 2.82 110.01 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -136.03 -40.61 0.14 Allowed Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.397 -0.819 . . . . 0.86 111.697 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.495 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . . . -130.59 150.7 51.67 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.439 -0.578 . . . . 1.15 109.439 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.42 ' HG3' ' C ' ' A' ' 14' ' ' ALA . 2.9 ttt -162.74 24.58 0.1 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.1 0.778 . . . . 2.5 113.1 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 18.5 mt-10 -150.65 178.81 8.74 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.183 -0.673 . . . . 1.28 109.183 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.611 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 2.3 t80 -157.61 9.66 0.18 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.515 0.931 . . . . 5.2 113.515 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.563 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 1.8 pp -83.6 130.3 34.98 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 116.522 2.045 . . . . 5.07 116.522 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.489 HG13 ' HA ' ' A' ' 31' ' ' PRO . 1.4 mp -72.5 10.14 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 CA-C-N 110.016 -3.266 . . . . 3.21 111.1 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.415 ' OE1' ' N ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -78.64 10.86 2.88 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.232 -0.44 . . . . 2.6 110.702 177.411 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.563 ' CD2' ' O ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -86.98 32.57 0.67 Allowed 'General case' 0 C--N 1.347 0.458 0 CA-C-O 120.627 0.251 . . . . 1.71 111.411 178.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 74.6 tttt 48.85 36.3 7.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.626 -0.261 . . . . 3.74 111.212 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.443 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 16.4 t0 57.09 23.08 8.07 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.114 -0.634 . . . . 2.14 109.746 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -43.45 -64.39 1.82 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 120.764 -0.731 . . . . 0.99 111.328 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.509 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -135.16 98.87 4.1 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 109.553 -0.536 . . . . 3.77 109.553 177.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 29' ' ' HIS . 40.6 m 32.43 117.23 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 117.096 2.258 . . . . 1.8 117.096 176.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HA ' HG13 ' A' ' 23' ' ' ILE . 14.8 Cg_exo -31.5 118.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 123.75 2.967 . . . . 0.79 108.427 172.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.529 ' CB ' ' CD2' ' A' ' 38' ' ' TYR . 7.3 t -152.21 154.35 35.62 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.379 1.252 . . . . 1.27 114.379 -172.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.61 ' CE3' ' CD2' ' A' ' 21' ' ' TYR . 8.4 t-105 -91.52 91.23 7.97 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 104.187 -2.523 . . . . 1.48 104.187 175.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -156.77 173.97 4.47 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 114.65 -1.159 . . . . 2.35 110.928 -175.066 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.513 ' HD2' HG22 ' A' ' 39' ' ' ILE . 7.3 Cg_endo -92.38 122.24 0.57 Allowed 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.512 2.808 . . . . 1.52 116.447 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 35' ' ' PRO . 15.6 m 79.9 -51.72 0.38 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.833 -1.076 . . . . 2.17 113.736 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.561 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 57.9 m -144.16 -65.49 0.36 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.538 0.685 . . . . 1.81 111.272 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.866 ' HH ' ' HB2' ' A' ' 40' ' ' ALA . 10.0 t80 178.7 140.88 0.1 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.251 -0.648 . . . . 5.8 109.251 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.513 HG22 ' HD2' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -161.1 30.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 122.801 1.286 . . . . 2.64 109.137 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.866 ' HB2' ' HH ' ' A' ' 38' ' ' TYR . . . -66.23 89.85 0.14 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.748 -1.114 . . . . 1.75 110.507 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 40' ' ' ALA . . . 156.62 41.1 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.438 -0.801 . . . . 2.67 110.573 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 58.18 84.09 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.77 0.319 . . . . 4.56 111.18 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.426 ' HB ' ' CG1' ' A' ' 39' ' ' ILE . 0.6 OUTLIER -157.21 -151.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.43 -0.582 . . . . 4.12 109.43 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -169.05 120.72 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 113.448 0.907 . . . . 3.1 113.448 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.3 t 65.74 7.02 4.23 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 114.089 1.144 . . . . 1.46 114.089 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.496 ' N ' HG23 ' A' ' 39' ' ' ILE . 3.6 tt0 179.05 147.01 0.18 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.571 0.582 . . . . 1.6 112.571 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 38' ' ' TYR . 28.6 p90 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.19 -0.91 . . . . 4.35 111.07 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.492 ' CA ' ' CG2' ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.36 0 CA-C-O 120.468 -0.073 . . . . 2.65 113.034 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.485 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 1.8 tm-20 61.39 26.57 16.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 122.274 1.035 . . . . 2.17 109.275 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -104.32 -19.73 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.129 -0.941 . . . . 1.44 111.505 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.435 ' ND2' ' HA ' ' A' ' 24' ' ' GLU . 7.1 m120 47.5 79.1 0.07 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.946 -0.39 . . . . 2.31 109.946 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -135.68 -98.61 0.23 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.887 0.699 . . . . 2.9 112.887 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.1 tp -135.97 111.63 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 109.839 -0.43 . . . . 2.43 109.839 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.73 ' CG2' ' CE2' ' A' ' 21' ' ' TYR . 6.9 tp -150.97 162.73 3.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 112.622 0.601 . . . . 4.33 112.622 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.486 ' N ' HG13 ' A' ' 9' ' ' ILE . . . -109.85 121.15 5.93 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 110.634 -0.986 . . . . 1.14 110.634 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.793 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -102.55 107.85 18.94 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.698 1.237 . . . . 1.95 113.174 -176.055 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -157.68 112.73 2.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 112.433 -2.167 . . . . 4.16 112.311 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.455 ' CB ' ' HA ' ' A' ' 19' ' ' MET . 1.6 m -116.36 -78.21 0.58 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.408 0.521 . . . . 1.13 112.408 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.96 -54.94 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.731 0.301 . . . . 1.14 111.647 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.12 -35.67 4.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.352 -0.928 . . . . 0.72 112.653 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.3 -27.0 65.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.056 0.455 . . . . 2.82 110.342 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -150.38 -43.64 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.694 -0.685 . . . . 0.86 111.582 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.499 ' CB ' HG11 ' A' ' 34' ' ' VAL . . . -129.98 151.47 50.5 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.862 -0.421 . . . . 1.15 109.862 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.455 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 4.0 ttp -164.23 51.88 0.13 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.618 1.34 . . . . 2.5 114.618 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.695 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 6.7 mt-10 -151.01 -124.39 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 114.886 1.439 . . . . 1.28 114.886 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 1.159 ' HH ' ' CB ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -155.72 -126.78 0.03 OUTLIER 'General case' 0 C--O 1.199 -1.556 0 N-CA-C 117.787 2.514 . . . . 5.2 117.787 -173.323 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.542 ' HA ' ' CZ2' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -151.53 165.19 34.98 Favored 'General case' 0 N--CA 1.432 -1.358 0 O-C-N 121.409 -0.807 . . . . 5.07 111.128 178.517 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.492 ' CG2' ' CA ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER 56.29 63.04 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 124.505 1.122 . . . . 3.21 113.678 179.193 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 1.159 ' CB ' ' HH ' ' A' ' 21' ' ' TYR . 5.0 tt0 178.88 38.67 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.861 0.689 . . . . 2.6 112.861 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.542 ' CZ2' ' HA ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -153.15 32.92 0.47 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.682 0.623 . . . . 1.71 112.682 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp 56.17 20.12 4.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.843 0.354 . . . . 3.74 111.425 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.481 ' HB3' ' CG ' ' A' ' 4' ' ' GLU . 2.6 p-10 47.34 40.16 10.19 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.135 0.791 . . . . 2.14 113.135 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 1.092 ' HA3' ' HH ' ' A' ' 38' ' ' TYR . . . -48.23 -54.89 11.31 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.082 -1.056 . . . . 0.99 112.344 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.591 ' CE1' ' CE2' ' A' ' 47' ' ' TYR . 69.8 t60 -131.69 95.44 3.72 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 117.244 0.522 . . . . 3.77 110.546 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.511 ' O ' ' O ' ' A' ' 29' ' ' HIS . 14.6 m 37.63 107.48 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.402 0 N-CA-C 113.471 0.915 . . . . 1.8 113.471 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 7.1 Cg_exo -33.85 125.67 0.16 Allowed 'Trans proline' 0 C--N 1.366 1.45 0 C-N-CA 122.768 2.312 . . . . 0.79 110.275 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.558 ' O ' ' O ' ' A' ' 21' ' ' TYR . 67.3 m -152.24 143.96 23.58 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 119.422 -0.911 . . . . 1.27 112.879 -173.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.615 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 31.5 t-105 -78.59 92.42 4.7 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 104.051 -2.574 . . . . 1.48 104.051 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.695 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -152.67 173.04 4.88 Favored Pre-proline 0 N--CA 1.442 -0.829 0 CA-C-N 112.308 -2.223 . . . . 2.35 108.533 -176.183 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.514 ' CD ' ' CG1' ' A' ' 34' ' ' VAL . 85.5 Cg_endo -77.46 105.82 2.11 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 123.726 2.95 . . . . 1.52 117.432 -173.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 37' ' ' SER . 46.8 t 43.5 27.25 0.14 Allowed 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.33 -1.305 . . . . 2.17 111.997 176.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.547 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 12.2 m -166.65 -120.16 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.494 -0.775 . . . . 1.81 109.668 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 1.092 ' HH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -175.49 101.21 0.08 Allowed 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 106.45 -1.685 . . . . 5.8 106.45 -177.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.492 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -127.04 33.16 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 114.745 -1.116 . . . . 2.64 109.154 -176.082 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.28 92.79 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.424 -1.262 . . . . 1.75 111.905 -177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 42' ' ' ASP . . . 168.49 -61.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.184 -0.916 . . . . 2.67 110.059 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 9.2 t70 163.29 79.73 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.321 -0.854 . . . . 4.56 109.683 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -148.91 -157.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.959 -0.296 . . . . 4.12 110.401 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.428 ' N ' HD11 ' A' ' 39' ' ' ILE . 4.8 p -155.16 105.9 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.421 0.629 . . . . 3.1 112.531 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.424 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 6.3 p 80.16 2.36 1.98 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.762 -1.108 . . . . 1.46 113.335 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.465 ' CA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER 179.15 140.74 0.11 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.597 0.237 . . . . 1.6 111.311 179.715 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.591 ' CE2' ' CE1' ' A' ' 29' ' ' HIS . 11.0 t80 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.195 -0.907 . . . . 4.35 110.069 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.434 ' HA3' ' CB ' ' A' ' 31' ' ' PRO . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.464 -0.254 . . . . 2.65 112.464 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.49 ' N ' ' CG ' ' A' ' 31' ' ' PRO . 2.1 tm-20 64.36 47.19 3.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.953 0.883 . . . . 2.17 110.137 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.0 t -119.94 -16.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.243 -0.89 . . . . 1.44 111.301 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 24.8 t-20 50.37 38.59 18.35 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 108.529 -0.915 . . . . 2.31 108.529 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.464 ' CG ' HD12 ' A' ' 23' ' ' ILE . 21.7 pttp -93.48 -129.6 0.12 Allowed 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.291 -1.322 . . . . 2.9 111.268 -176.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.429 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -117.02 117.14 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.048 0.452 . . . . 2.43 111.965 -178.402 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.533 HG23 ' CD2' ' A' ' 21' ' ' TYR . 9.7 tp -149.59 161.88 4.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.958 -0.564 . . . . 4.33 110.849 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.447 ' N ' HG13 ' A' ' 9' ' ' ILE . . . -109.34 130.41 9.97 Favored Glycine 0 CA--C 1.505 -0.589 0 N-CA-C 110.363 -1.095 . . . . 1.14 110.363 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.63 ' HB3' ' CG ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -102.16 107.8 19.0 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.562 1.172 . . . . 1.95 113.188 -177.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.34 104.4 2.03 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.547 -2.115 . . . . 4.16 111.285 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.451 ' CB ' ' HA ' ' A' ' 19' ' ' MET . 1.3 m -109.59 -81.51 0.57 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 119.953 -0.699 . . . . 1.13 112.562 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.84 -54.23 0.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.717 0.294 . . . . 1.14 111.417 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.05 -28.37 7.32 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.313 -0.946 . . . . 0.72 112.893 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.28 -33.43 71.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.336 0.589 . . . . 2.82 109.75 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.419 ' HA2' HG11 ' A' ' 44' ' ' VAL . . . -150.32 -46.9 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.785 -0.926 . . . . 0.86 110.785 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.541 ' HB2' ' HA ' ' A' ' 34' ' ' VAL . . . -115.17 152.17 33.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.263 -0.468 . . . . 1.15 110.027 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.451 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -165.94 46.84 0.08 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.105 0.78 . . . . 2.5 113.105 -179.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.721 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 53.3 mt-10 -149.54 -139.77 0.1 Allowed 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 114.621 1.341 . . . . 1.28 114.621 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.63 ' CG ' ' HB3' ' A' ' 11' ' ' SER . 0.1 OUTLIER -123.45 -172.65 2.56 Favored 'General case' 0 C--O 1.191 -2.008 0 N-CA-C 114.728 1.381 . . . . 5.2 114.728 -173.112 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.541 ' HA ' ' CZ2' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -137.88 104.74 5.36 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 114.181 1.178 . . . . 5.07 114.181 173.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.528 ' CG2' ' O ' ' A' ' 22' ' ' LEU . 2.7 pp 136.57 24.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 126.886 2.075 . . . . 3.21 112.436 176.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.565 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 8.9 tp10 -130.57 53.4 1.96 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.786 0.721 . . . . 2.6 111.925 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.576 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -153.83 -169.4 3.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.108 -0.496 . . . . 1.71 109.782 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.59 36.69 1.6 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.08 0.467 . . . . 3.74 109.791 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.437 ' HB2' ' CG ' ' A' ' 4' ' ' GLU . 24.9 t70 53.31 44.82 29.6 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.809 -0.632 . . . . 2.14 110.862 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.509 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -54.04 -64.27 4.41 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.231 -0.985 . . . . 0.99 112.312 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.464 ' O ' ' CB ' ' A' ' 38' ' ' TYR . 47.5 t-80 -134.41 95.94 3.49 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 117.099 0.449 . . . . 3.77 110.386 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 31' ' ' PRO . 17.4 m 39.12 98.01 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 112.573 0.583 . . . . 1.8 112.573 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.49 ' CG ' ' N ' ' A' ' 4' ' ' GLU . 18.0 Cg_exo -27.24 126.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.365 1.395 0 C-N-CA 123.558 2.839 . . . . 0.79 110.407 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.495 ' O ' ' CH2' ' A' ' 25' ' ' TRP . 8.5 t -152.41 144.64 23.93 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 119.038 -1.065 . . . . 1.27 112.959 -171.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.494 ' N ' ' HB3' ' A' ' 22' ' ' LEU . 9.1 t-105 -83.31 96.07 8.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 104.335 -2.469 . . . . 1.48 104.335 175.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.721 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -151.51 -172.24 0.31 Allowed Pre-proline 0 N--CA 1.434 -1.229 0 CA-C-N 112.548 -2.115 . . . . 2.35 106.659 -175.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.511 ' CD ' HG12 ' A' ' 34' ' ' VAL . 44.9 Cg_endo -88.13 102.69 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.676 2.251 . . . . 1.52 116.142 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.42 ' N ' ' OE1' ' A' ' 20' ' ' GLU . 41.9 t 45.41 23.93 0.15 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.725 -0.671 . . . . 2.17 111.989 177.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.548 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 5.4 m -163.59 -122.93 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 116.476 -0.329 . . . . 1.81 110.22 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -174.47 102.15 0.1 Allowed 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 106.282 -1.747 . . . . 5.8 106.282 -177.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.476 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -124.17 34.98 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 114.683 -1.144 . . . . 2.64 110.329 -174.223 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.401 ' O ' ' HB1' ' A' ' 41' ' ' ALA . . . -59.4 91.92 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.346 -1.297 . . . . 1.75 111.695 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.42 ' O ' ' CB ' ' A' ' 42' ' ' ASP . . . 166.72 -60.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.307 -0.86 . . . . 2.67 110.022 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 41' ' ' ALA . 1.6 p30 160.49 78.66 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.567 -0.742 . . . . 4.56 110.398 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.429 ' O ' ' CD1' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -151.44 -166.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 110.067 -0.346 . . . . 4.12 110.067 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.419 HG11 ' HA2' ' A' ' 17' ' ' GLY . 3.1 m -147.22 121.68 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 112.848 0.684 . . . . 3.1 112.848 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.418 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 22.8 t 69.5 5.01 4.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.207 -0.906 . . . . 1.46 113.199 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 45' ' ' SER . 39.1 tt0 179.02 158.62 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.089 0.471 . . . . 1.6 111.863 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.481 ' CD2' ' OXT' ' A' ' 47' ' ' TYR . 37.4 p90 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.176 -0.916 . . . . 4.35 110.997 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.647 -0.181 . . . . 2.65 112.647 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 48.74 26.82 1.36 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.785 0.803 . . . . 2.17 110.348 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.438 ' CG1' ' HG2' ' A' ' 7' ' ' LYS . 5.1 t -105.4 -8.65 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.391 -0.822 . . . . 1.44 112.488 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.493 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 2.0 p30 41.34 74.38 0.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.714 0.293 . . . . 2.31 111.396 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HG2' ' CG1' ' A' ' 5' ' ' VAL . 3.6 pttp -151.44 -107.93 0.06 Allowed 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.963 0.357 . . . . 2.9 111.963 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.496 HG23 HD11 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -82.77 101.46 7.52 Favored 'Isoleucine or valine' 0 C--N 1.345 0.408 0 N-CA-C 109.485 -0.561 . . . . 2.43 109.485 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.667 HD11 ' CE2' ' A' ' 21' ' ' TYR . 2.4 tp -153.29 171.38 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 120.031 -0.667 . . . . 4.33 112.371 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.94 169.74 22.77 Favored Glycine 0 CA--C 1.508 -0.374 0 CA-C-N 116.16 -0.473 . . . . 1.14 111.987 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.478 ' HA ' ' N ' ' A' ' 21' ' ' TYR . 2.5 p -150.35 104.48 3.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.128 0.788 . . . . 1.95 113.128 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.444 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 14.9 tpt180 -157.56 102.2 1.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.015 -0.539 . . . . 4.16 110.829 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.427 ' HB ' ' C ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -117.08 -84.09 0.64 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 114.008 1.114 . . . . 1.13 114.008 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.412 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -150.34 -56.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.428 -0.509 . . . . 1.14 112.305 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.472 ' N ' ' HG3' ' A' ' 19' ' ' MET . . . 119.4 -29.49 6.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.142 -1.028 . . . . 0.72 112.53 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -58.81 -33.7 70.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.471 0.653 . . . . 2.82 109.245 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 43' ' ' VAL . . . -150.83 -46.0 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 114.777 -1.102 . . . . 0.86 111.068 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.534 ' HA ' ' HG3' ' A' ' 35' ' ' PRO . . . -116.19 151.21 36.15 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.208 -0.293 . . . . 1.15 110.208 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.472 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 2.8 ttp -162.61 24.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.433 0.531 . . . . 2.5 112.433 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.563 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 5.7 mt-10 -150.47 -179.91 7.62 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.823 -0.436 . . . . 1.28 109.823 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.768 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 0.4 OUTLIER -155.52 14.09 0.36 Allowed 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 113.702 1.001 . . . . 5.2 113.702 -179.274 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.522 ' O ' ' CE2' ' A' ' 25' ' ' TRP . 0.4 OUTLIER -84.78 135.45 34.11 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 116.003 1.853 . . . . 5.07 116.003 -177.038 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.537 ' CD1' ' HB ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -74.2 16.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 111.505 -2.588 . . . . 3.21 111.126 177.641 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . 24.6 tt0 -80.09 17.25 1.03 Allowed 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.058 0.543 . . . . 2.6 111.082 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.553 ' CD2' ' O ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -91.58 32.28 1.1 Allowed 'General case' 0 C--N 1.342 0.272 0 N-CA-C 109.851 -0.426 . . . . 1.71 109.851 177.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 25' ' ' TRP . 64.4 pttt 46.78 34.44 2.59 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.142 -0.481 . . . . 3.74 111.154 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 0.3 OUTLIER 65.24 23.89 12.23 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.704 -0.399 . . . . 2.14 110.246 179.424 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -44.32 -68.93 0.79 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.848 -0.691 . . . . 0.99 111.798 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.579 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -133.29 99.46 4.54 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.815 -0.439 . . . . 3.77 109.815 178.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.444 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 27.6 t 33.28 113.07 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 116.825 2.157 . . . . 1.8 116.825 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 13.5 Cg_exo -29.2 116.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.982 3.121 . . . . 0.79 110.053 173.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.527 ' HB2' ' CD2' ' A' ' 38' ' ' TYR . 22.8 t -152.72 -177.6 6.35 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 114.093 1.145 . . . . 1.27 114.093 -174.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.6 ' CE3' ' CG ' ' A' ' 21' ' ' TYR . 11.7 t-105 -106.21 92.19 4.03 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.584 -1.189 . . . . 1.48 108.935 178.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.642 ' CG2' HG23 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -159.76 -179.75 1.16 Allowed Pre-proline 0 C--O 1.214 -0.775 0 CA-C-N 115.822 -0.627 . . . . 2.35 110.815 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.57 ' N ' HG11 ' A' ' 34' ' ' VAL . 11.7 Cg_endo -98.53 115.74 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 123.605 2.87 . . . . 1.52 115.778 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t 70.63 -8.75 0.87 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 115.37 1.619 . . . . 2.17 115.37 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.553 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 49.4 m -160.86 -90.27 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 118.707 -1.197 . . . . 1.81 114.102 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 29' ' ' HIS . 12.8 t80 176.75 140.42 0.07 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 110.062 -0.347 . . . . 5.8 110.062 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.642 HG23 ' CG2' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -165.62 31.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 123.182 1.468 . . . . 2.64 108.365 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.481 ' HB1' ' CZ ' ' A' ' 38' ' ' TYR . . . -65.85 91.69 0.15 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.359 -1.292 . . . . 1.75 110.93 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 40' ' ' ALA . . . 160.2 -26.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.367 -0.833 . . . . 2.67 110.421 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -120.84 -92.04 0.55 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.41 0.522 . . . . 4.56 112.41 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.432 ' CA ' HD12 ' A' ' 39' ' ' ILE . 7.1 p 174.98 -30.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.276 0.472 . . . . 4.12 112.276 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.46 ' O ' HG22 ' A' ' 39' ' ' ILE . 32.6 m -54.51 -170.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 112.495 0.554 . . . . 3.1 112.495 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.501 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 11.7 t -107.58 21.8 16.92 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.1 0.778 . . . . 1.46 113.1 -177.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.451 ' N ' HG21 ' A' ' 39' ' ' ILE . 41.4 tt0 -172.86 139.18 0.85 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.565 0.58 . . . . 1.6 112.565 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' A' ' 38' ' ' TYR . 4.1 t80 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.273 -0.87 . . . . 4.35 110.989 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 N-CA-C 112.503 -0.239 . . . . 2.65 112.503 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.486 ' N ' HG23 ' A' ' 23' ' ' ILE . 9.8 tt0 61.46 14.78 6.11 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.303 0.573 . . . . 2.17 111.588 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.444 ' CG1' ' HD2' ' A' ' 7' ' ' LYS . 4.9 t -79.87 -35.39 16.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 122.134 -0.354 . . . . 1.44 111.428 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 58.61 88.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 2.31 110.632 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.444 ' HD2' ' CG1' ' A' ' 5' ' ' VAL . 2.5 ptmm? -150.94 -67.24 0.19 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.176 -0.466 . . . . 2.9 111.73 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.468 HD12 HG22 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -138.76 128.96 33.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.966 -0.561 . . . . 2.43 109.782 -179.22 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.503 ' HA ' ' CB ' ' A' ' 22' ' ' LEU . 13.5 pt -122.1 131.46 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 113.949 1.092 . . . . 4.33 113.949 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.69 102.77 0.23 Allowed Glycine 0 N--CA 1.453 -0.216 0 N-CA-C 109.419 -1.472 . . . . 1.14 109.419 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.585 ' CB ' ' N ' ' A' ' 21' ' ' TYR . 7.0 m -148.99 169.96 19.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.334 1.235 . . . . 1.95 114.334 -176.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -159.89 102.74 1.49 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.522 -1.672 . . . . 4.16 109.91 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.584 ' CG2' ' CD1' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -87.85 -76.97 0.36 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.022 -0.671 . . . . 1.13 112.043 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -150.95 -63.54 0.19 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.683 0.623 . . . . 1.14 112.683 -178.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.471 ' N ' ' HG3' ' A' ' 19' ' ' MET . . . 125.86 -42.05 1.56 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.773 -0.931 . . . . 0.72 110.773 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.408 ' OE2' ' N ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -59.3 -28.16 66.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.576 -0.898 . . . . 2.82 108.576 178.095 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 44' ' ' VAL . . . -142.1 -65.17 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.958 -1.019 . . . . 0.86 111.179 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.6 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -109.19 154.0 22.99 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 119.564 -0.255 . . . . 1.15 111.367 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.471 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 1.6 ttm -157.05 25.09 0.31 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.49 1.293 . . . . 2.5 114.49 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.658 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 18.1 mt-10 -157.73 175.44 13.89 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 107.668 -1.234 . . . . 1.28 107.668 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.585 ' N ' ' CB ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -155.79 -26.69 0.1 Allowed 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 116.047 1.869 . . . . 5.2 116.047 -178.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.544 ' CD2' ' CZ ' ' A' ' 21' ' ' TYR . 2.0 mm? -89.66 138.21 31.67 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 115.308 1.595 . . . . 5.07 115.308 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.56 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -8.17 -119.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 111.363 -2.653 . . . . 3.21 114.969 177.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.463 ' HB2' ' CG2' ' A' ' 9' ' ' ILE . 33.9 tt0 48.23 25.03 0.76 Allowed 'General case' 0 C--N 1.344 0.365 0 O-C-N 121.777 -0.577 . . . . 2.6 109.939 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.703 ' CH2' HG12 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -138.57 32.17 2.28 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 112.764 0.653 . . . . 1.71 112.764 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.2 tptt 37.3 30.41 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.326 0.491 . . . . 3.74 112.326 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.458 ' HB3' ' CB ' ' A' ' 4' ' ' GLU . 4.1 p-10 44.15 35.82 1.32 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.09 0.404 . . . . 2.14 112.09 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 1.017 ' HA3' ' HH ' ' A' ' 38' ' ' TYR . . . -46.69 -53.86 9.63 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.302 -0.952 . . . . 0.99 111.72 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.543 ' CE1' ' CE2' ' A' ' 47' ' ' TYR . 9.6 t60 -132.04 94.57 3.5 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.581 -0.526 . . . . 3.77 109.581 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 29' ' ' HIS . 16.0 t 37.75 112.15 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 115.266 1.58 . . . . 1.8 115.266 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.44 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 17.9 Cg_exo -33.14 122.27 0.11 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.801 2.334 . . . . 0.79 108.768 174.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.492 ' O ' ' CZ2' ' A' ' 25' ' ' TRP . 40.4 m -143.38 174.98 10.26 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 114.201 1.186 . . . . 1.27 114.201 -172.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.584 ' CD1' ' CG2' ' A' ' 13' ' ' THR . 2.1 t90 -97.96 100.97 12.34 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 104.602 -2.37 . . . . 1.48 104.602 174.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.703 HG12 ' CH2' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -151.83 151.62 28.6 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 114.226 -1.352 . . . . 2.35 111.37 -171.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.6 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 40.9 Cg_exo -56.37 -14.15 11.78 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 125.127 3.885 . . . . 1.52 116.588 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.1 t 176.54 -28.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.96 0.726 . . . . 2.17 112.96 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.567 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 49.7 m -114.61 -90.18 0.54 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.0 0.37 . . . . 1.81 112.0 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 1.017 ' HH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -178.94 123.3 0.09 Allowed 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 106.655 -1.609 . . . . 5.8 106.655 -179.349 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.478 HG21 ' CG2' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -135.62 27.89 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.746 0.784 . . . . 2.64 110.305 -175.832 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.424 ' O ' ' CB ' ' A' ' 41' ' ' ALA . . . -59.58 92.04 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.022 -0.99 . . . . 1.75 111.59 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 42' ' ' ASP . . . 160.83 -60.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.232 -0.895 . . . . 2.67 109.948 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 6.7 t70 163.13 80.72 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.435 -0.802 . . . . 4.56 110.13 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.42 -163.34 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.961 -0.296 . . . . 4.12 110.336 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.428 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 15.9 m -141.14 101.74 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 113.073 0.768 . . . . 3.1 113.073 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.516 ' N ' ' HG2' ' A' ' 35' ' ' PRO . 46.9 t 64.39 14.68 8.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.281 -0.872 . . . . 1.46 112.414 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -178.6 133.61 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.487 -0.485 . . . . 1.6 111.822 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.543 ' CE2' ' CE1' ' A' ' 29' ' ' HIS . 90.4 t80 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.228 -0.891 . . . . 4.35 110.927 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.184 -0.366 . . . . 2.65 112.184 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 6.9 tt0 67.52 7.27 5.48 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.771 0.286 . . . . 2.17 111.771 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' A' ' 6' ' ' ASN . 54.9 t -82.53 -43.42 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.035 0.445 . . . . 1.44 110.353 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.488 ' N ' HG23 ' A' ' 23' ' ' ILE . 27.8 t-20 83.56 74.07 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.915 -1.038 . . . . 2.31 110.739 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.445 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 36.4 pttt -151.56 -140.36 0.1 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.302 -1.772 . . . . 2.9 108.093 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.468 ' CD1' ' N ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -38.95 143.54 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 122.565 0.346 . . . . 2.43 110.884 177.231 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.562 ' HA ' ' HB3' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -147.48 126.88 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 114.32 1.23 . . . . 4.33 114.32 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.03 146.71 16.66 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 107.767 -2.133 . . . . 1.14 107.767 175.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.479 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -154.24 104.43 2.61 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 118.51 1.155 . . . . 1.95 112.917 -176.046 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -157.86 102.65 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.822 -0.627 . . . . 4.16 109.849 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 18' ' ' ALA . 1.0 OUTLIER -113.86 -82.98 0.6 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.894 1.072 . . . . 1.13 113.894 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.409 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -145.32 -54.52 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.576 -0.45 . . . . 1.14 112.157 -177.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.438 ' N ' ' HG3' ' A' ' 19' ' ' MET . . . 116.63 -37.27 3.43 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 119.903 -1.142 . . . . 0.72 112.801 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.18 -27.74 64.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.251 0.548 . . . . 2.82 109.522 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -150.02 -53.98 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.33 -0.85 . . . . 0.86 111.123 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.504 ' CA ' ' HD3' ' A' ' 35' ' ' PRO . . . -115.67 146.58 41.72 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 110.034 -0.358 . . . . 1.15 110.034 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.438 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 2.6 ttp -155.68 31.81 0.36 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 111.925 0.343 . . . . 2.5 111.925 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.578 ' CG ' ' HA ' ' A' ' 35' ' ' PRO . 9.3 mt-10 -147.29 -176.39 5.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 119.155 -0.45 . . . . 1.28 109.88 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.646 ' HB2' ' CD2' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -154.28 -62.85 0.13 Allowed 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 119.919 3.303 . . . . 5.2 119.919 -174.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.562 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 10.6 tp -84.18 155.65 22.44 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 114.864 1.431 . . . . 5.07 114.864 -170.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 6' ' ' ASN . 3.4 mp -9.86 -112.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 112.462 -2.154 . . . . 3.21 114.85 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.414 ' N ' HG22 ' A' ' 23' ' ' ILE . 5.9 tt0 70.69 -61.35 0.48 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.728 -1.582 . . . . 2.6 106.728 -175.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.566 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 1.1 p90 -57.76 -173.18 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.021 -0.99 . . . . 1.71 111.033 176.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 3.2 mptp? -116.37 55.2 0.82 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.122 0.487 . . . . 3.74 109.941 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.447 ' HB3' ' CB ' ' A' ' 4' ' ' GLU . 4.0 p30 42.85 33.94 0.55 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.563 -0.744 . . . . 2.14 111.874 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.808 ' H ' ' HH ' ' A' ' 38' ' ' TYR . . . -49.48 -57.54 9.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.534 -0.841 . . . . 0.99 112.722 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.542 ' NE2' ' CE2' ' A' ' 47' ' ' TYR . 54.5 t-80 -131.97 96.29 3.88 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 117.383 0.591 . . . . 3.77 110.694 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 29' ' ' HIS . 23.3 t 39.71 103.24 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 113.761 1.022 . . . . 1.8 113.761 177.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.439 ' C ' ' O ' ' A' ' 30' ' ' SER . 15.1 Cg_exo -31.6 114.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.371 1.723 0 C-N-CA 122.816 2.344 . . . . 0.79 109.699 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 21' ' ' TYR . 10.0 t -133.62 -163.31 1.34 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.712 0.634 . . . . 1.27 112.712 -172.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.646 ' CD2' ' HB2' ' A' ' 21' ' ' TYR . 6.4 t-105 -120.41 91.98 3.66 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.15 -1.796 . . . . 1.48 106.15 175.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.59 HG11 ' N ' ' A' ' 38' ' ' TYR . 1.2 t -158.7 170.65 8.58 Favored Pre-proline 0 N--CA 1.444 -0.751 0 CA-C-N 114.993 -1.003 . . . . 2.35 112.186 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.587 ' CG ' ' HA ' ' A' ' 45' ' ' SER . 59.1 Cg_endo -70.39 108.41 2.19 Favored 'Trans proline' 0 N--CA 1.485 1.003 1 C-N-CA 125.484 4.123 . . . . 1.52 116.253 175.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 t 37.55 30.35 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.813 -0.63 . . . . 2.17 112.13 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.544 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -163.11 -136.14 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 116.024 -0.535 . . . . 1.81 110.464 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.808 ' HH ' ' H ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -174.34 100.68 0.1 Allowed 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.444 -1.688 . . . . 5.8 106.444 -177.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.568 HG23 ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -126.14 31.44 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 122.92 1.343 . . . . 2.64 109.477 -175.106 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.91 92.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.51 -1.223 . . . . 1.75 111.055 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 164.38 -29.46 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.432 -0.804 . . . . 2.67 110.024 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.406 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 23.8 t70 -123.95 -91.46 0.54 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.989 -0.55 . . . . 4.56 112.008 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 18' ' ' ALA . 14.7 p 175.55 -30.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 112.382 0.512 . . . . 4.12 112.382 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.402 HG22 HG13 ' A' ' 39' ' ' ILE . 17.1 m -55.45 -169.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.005 0.372 . . . . 3.1 112.005 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.587 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 26.3 t -106.47 35.09 3.08 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.857 0.688 . . . . 1.46 112.857 -177.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.448 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 34.8 tt0 -179.01 149.21 0.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.81 0.338 . . . . 1.6 110.815 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.542 ' CE2' ' NE2' ' A' ' 29' ' ' HIS . 9.4 t80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.239 -0.886 . . . . 4.35 110.803 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.507 ' HA3' ' HB3' ' A' ' 31' ' ' PRO . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.603 -0.199 . . . . 2.65 112.603 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.475 ' CA ' HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER 62.0 7.92 2.32 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.42 0.526 . . . . 2.17 112.42 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 6' ' ' ASN . 13.9 t -85.31 -50.37 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 120.897 0.379 . . . . 1.44 110.721 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.48 ' HB3' ' O ' ' A' ' 5' ' ' VAL . 34.5 t-20 93.25 69.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.55 -1.205 . . . . 2.31 108.553 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.446 ' HD3' ' CG1' ' A' ' 5' ' ' VAL . 17.0 pttp -150.41 -141.58 0.11 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.002 -0.999 . . . . 2.9 109.932 -177.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.501 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -48.1 102.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 121.486 0.66 . . . . 2.43 111.98 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.637 HD12 ' CE2' ' A' ' 21' ' ' TYR . 5.1 tp -154.06 169.08 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.228 -0.589 . . . . 4.33 111.506 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.91 169.93 20.21 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.542 -0.361 . . . . 1.14 112.524 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.487 ' HA ' ' N ' ' A' ' 21' ' ' TYR . 3.0 p -150.62 104.68 3.22 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 113.264 0.839 . . . . 1.95 113.264 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.428 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 12.6 mmt180 -157.93 103.38 1.87 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.295 -0.411 . . . . 4.16 111.723 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.485 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -125.28 -85.2 0.63 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.207 -0.933 . . . . 1.13 113.488 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.454 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -143.7 -61.36 0.4 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.094 0.405 . . . . 1.14 112.094 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . 124.26 -46.98 1.05 Allowed Glycine 0 C--N 1.329 0.166 0 C-N-CA 120.434 -0.889 . . . . 0.72 112.522 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -59.26 -25.59 64.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.015 0.436 . . . . 2.82 110.517 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -141.43 -54.94 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.802 -0.919 . . . . 0.86 110.802 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.498 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . . . -128.76 150.98 50.06 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.454 -0.573 . . . . 1.15 109.454 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.454 ' HG2' ' N ' ' A' ' 14' ' ' ALA . 2.9 tmm? -162.49 22.61 0.1 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.351 0.871 . . . . 2.5 113.351 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 9.3 mm-40 -148.01 179.75 7.51 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.709 -0.848 . . . . 1.28 108.709 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.75 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 0.4 OUTLIER -156.2 11.72 0.28 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.513 0.931 . . . . 5.2 113.513 -179.394 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.515 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 0.3 OUTLIER -84.99 133.9 34.24 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 117.242 2.312 . . . . 5.07 117.242 -175.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.475 HG21 ' CA ' ' A' ' 4' ' ' GLU . 1.9 mp -64.4 -6.39 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-N 110.248 -3.16 . . . . 3.21 110.151 176.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HA ' ' ND2' ' A' ' 6' ' ' ASN . 30.8 tt0 -47.83 -12.61 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.92 -0.582 . . . . 2.6 112.172 177.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.562 ' CD2' ' O ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -72.56 30.41 0.06 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.776 1.028 . . . . 1.71 113.776 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.6 mttm 46.18 35.57 2.68 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 118.048 0.385 . . . . 3.74 111.916 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 56.4 t0 62.68 25.34 15.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.955 0.407 . . . . 2.14 110.332 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -46.21 -66.57 1.64 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.408 -0.901 . . . . 0.99 111.393 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.546 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -135.35 99.57 4.27 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.934 -0.307 . . . . 3.77 110.612 178.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.454 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 20.1 m 37.18 111.8 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.495 0 N-CA-C 116.469 2.025 . . . . 1.8 116.469 176.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.507 ' HB3' ' HA3' ' A' ' 3' ' ' GLY . 7.3 Cg_exo -33.1 117.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 123.268 2.645 . . . . 0.79 108.935 173.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.541 ' HB2' ' CD2' ' A' ' 38' ' ' TYR . 18.6 t -150.1 176.16 11.07 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.496 0.924 . . . . 1.27 113.496 -173.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.606 ' CE3' ' CG ' ' A' ' 21' ' ' TYR . 12.0 t-105 -104.76 91.3 3.78 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.902 -0.777 . . . . 1.48 108.902 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.61 HG11 HG23 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -159.72 175.05 3.43 Favored Pre-proline 0 C--O 1.217 -0.616 0 CA-C-N 115.468 -0.787 . . . . 2.35 111.124 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.582 ' N ' HG12 ' A' ' 34' ' ' VAL . 26.0 Cg_endo -92.02 142.45 2.59 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.756 2.971 . . . . 1.52 113.118 175.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.8 t 72.91 -57.56 0.63 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.965 -1.016 . . . . 2.17 113.65 176.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.562 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 42.9 m -148.72 -64.32 0.24 Allowed 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 114.937 1.458 . . . . 1.81 114.937 -177.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.546 ' CD2' ' O ' ' A' ' 29' ' ' HIS . 7.9 t80 178.12 149.3 0.19 Allowed 'General case' 0 C--N 1.318 -0.771 0 O-C-N 121.759 -0.588 . . . . 5.8 110.407 -176.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.61 HG23 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER 176.45 74.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.61 0.719 . . . . 2.64 110.019 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.32 92.66 0.06 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.206 -0.906 . . . . 1.75 110.974 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 178.62 -31.9 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.5 -0.773 . . . . 2.67 111.182 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 77.26 25.88 0.74 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.089 -0.505 . . . . 4.56 110.661 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.8 m -121.31 0.5 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 4.12 112.106 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.46 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -159.76 169.23 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-O 120.791 0.329 . . . . 3.1 110.947 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.466 ' CB ' ' HG2' ' A' ' 35' ' ' PRO . 47.4 t -105.32 26.03 9.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.971 -0.559 . . . . 1.46 111.281 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.413 ' N ' HG21 ' A' ' 39' ' ' ILE . 42.2 tt0 -178.8 148.62 0.42 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.028 0.381 . . . . 1.6 112.028 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' TYR . 9.3 t80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.224 -0.893 . . . . 4.35 110.8 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 N-CA-C 112.555 -0.218 . . . . 2.65 112.555 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.438 ' HB3' ' CG ' ' A' ' 31' ' ' PRO . 9.4 pt-20 44.6 27.78 0.27 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.888 0.375 . . . . 2.17 111.006 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -90.07 -8.97 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.16 -0.473 . . . . 1.44 111.846 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.551 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 3.2 t-20 49.14 73.06 0.25 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 110.313 -0.255 . . . . 2.31 110.313 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 ptmm? -140.61 -98.92 0.15 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.298 0.481 . . . . 2.9 112.298 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 tp -137.4 105.34 3.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 CA-C-O 121.034 0.445 . . . . 2.43 110.902 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.504 ' CG2' ' CG1' ' A' ' 23' ' ' ILE . 3.4 tt -151.85 173.77 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.783 -0.644 . . . . 4.33 110.579 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -100.66 167.59 20.05 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.214 -0.517 . . . . 1.14 113.176 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.744 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 13.6 p -153.63 103.9 2.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 1.95 111.896 -177.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -158.99 102.88 1.65 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.608 -0.724 . . . . 4.16 110.043 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 18' ' ' ALA . 1.0 OUTLIER -108.7 -85.2 0.53 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.815 1.043 . . . . 1.13 113.815 -178.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.442 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -145.38 -54.16 0.29 Allowed 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.163 0.431 . . . . 1.14 112.163 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.83 -34.84 4.68 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.291 -0.957 . . . . 0.72 112.268 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.0 -32.82 70.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.532 0.682 . . . . 2.82 109.183 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -141.09 -55.72 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.807 -1.088 . . . . 0.86 110.554 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.543 ' CA ' ' HD3' ' A' ' 35' ' ' PRO . . . -120.28 150.0 41.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.816 -0.192 . . . . 1.15 111.001 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.544 ' H ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -155.46 37.36 0.38 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.032 0.752 . . . . 2.5 113.032 178.088 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 27.8 mt-10 -151.81 -169.45 3.37 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 119.43 -0.319 . . . . 1.28 110.466 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.835 ' O ' ' CH2' ' A' ' 25' ' ' TRP 0.269 2.5 t80 -152.76 -130.77 0.04 OUTLIER 'General case' 0 C--O 1.209 -1.029 0 N-CA-C 116.057 1.873 . . . . 5.2 116.057 -177.46 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.598 ' N ' ' CD1' ' A' ' 21' ' ' TYR . 4.4 mt -78.94 166.67 22.12 Favored 'General case' 0 CA--C 1.491 -1.326 0 O-C-N 120.402 -1.437 . . . . 5.07 114.651 -166.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.551 ' HB ' ' HA ' ' A' ' 6' ' ' ASN . 0.9 OUTLIER 45.5 -166.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 112.848 -1.978 . . . . 3.21 109.679 -179.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.428 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 0.6 OUTLIER 71.08 9.85 6.77 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.721 -0.844 . . . . 2.6 108.721 -177.811 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.835 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -143.48 -173.55 3.98 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 108.694 -0.854 . . . . 1.71 108.694 178.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.417 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 4.0 mppt? -122.29 65.2 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.604 -0.439 . . . . 3.74 111.99 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.437 ' CA ' ' HB2' ' A' ' 4' ' ' GLU . 3.5 p30 40.63 29.01 0.06 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.283 -0.417 . . . . 2.14 112.105 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.758 ' H ' ' HH ' ' A' ' 38' ' ' TYR . . . -46.7 -62.92 3.4 Favored Glycine 0 C--N 1.329 0.16 0 C-N-CA 120.601 -0.809 . . . . 0.99 113.248 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.571 ' CE1' ' CE2' ' A' ' 47' ' ' TYR . 68.4 t60 -133.09 96.3 3.73 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 117.724 0.762 . . . . 3.77 111.153 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 31' ' ' PRO . 13.8 m 40.47 99.98 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 118.575 -0.726 . . . . 1.8 112.874 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.447 ' C ' ' O ' ' A' ' 30' ' ' SER . 17.9 Cg_exo -27.51 124.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.368 2.712 . . . . 0.79 110.789 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.8 t -148.93 -168.81 3.2 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.525 0.935 . . . . 1.27 113.525 -173.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.614 ' CZ3' ' CD2' ' A' ' 21' ' ' TYR . 3.7 t-105 -116.08 95.56 5.15 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.254 -1.387 . . . . 1.48 107.254 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.547 HG11 ' N ' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -157.87 166.3 16.85 Favored Pre-proline 0 C--O 1.221 -0.401 0 CA-C-N 115.872 -0.604 . . . . 2.35 112.469 -178.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.544 ' HD3' ' H ' ' A' ' 19' ' ' MET . 12.1 Cg_endo -56.03 69.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.475 0.438 1 C-N-CA 125.44 4.094 . . . . 1.52 116.129 177.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.4 m 60.94 31.21 19.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.436 0.636 . . . . 2.17 110.794 176.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.577 ' O ' ' CZ3' ' A' ' 25' ' ' TRP . 1.5 m -150.79 -131.57 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.859 -1.064 . . . . 1.81 108.445 177.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.758 ' HH ' ' H ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -174.59 99.91 0.09 Allowed 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 106.374 -1.713 . . . . 5.8 106.374 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.541 HG21 ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -155.2 83.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.184 -1.371 . . . . 2.64 107.691 -175.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.67 91.05 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.585 -1.189 . . . . 1.75 111.504 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 46.41 59.3 3.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.08 -0.964 . . . . 2.67 111.772 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.446 ' O ' ' CG1' ' A' ' 43' ' ' VAL . 25.2 t70 -122.58 -20.95 5.84 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.788 0.662 . . . . 4.56 112.788 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.446 ' CG1' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -179.03 -95.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 112.089 0.403 . . . . 4.12 112.089 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.8 p -179.74 124.93 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 113.159 0.8 . . . . 3.1 113.159 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.447 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 28.8 t 65.87 10.38 6.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.92 -1.037 . . . . 1.46 113.72 176.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 176.98 166.38 0.53 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.773 0.657 . . . . 1.6 112.773 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.571 ' CE2' ' CE1' ' A' ' 29' ' ' HIS . 43.6 t80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.22 -0.895 . . . . 4.35 110.344 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.426 ' O ' ' CG ' ' A' ' 4' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.484 -0.246 . . . . 2.65 112.484 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 27' ' ' ASP . 6.5 pt-20 51.37 21.48 1.19 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.861 0.362 . . . . 2.17 111.6 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.469 ' N ' HG21 ' A' ' 23' ' ' ILE . 18.6 t -78.62 -6.05 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 113.271 0.841 . . . . 1.44 113.271 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.465 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 26.0 t-20 38.28 85.79 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.843 0.292 . . . . 2.31 110.594 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.443 ' HD3' ' CG1' ' A' ' 5' ' ' VAL . 22.2 pttp -150.99 -135.04 0.06 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 121.098 -0.241 . . . . 2.9 110.563 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.408 ' CG2' ' O ' ' A' ' 8' ' ' ILE . 0.9 OUTLIER -105.49 97.92 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 112.874 0.694 . . . . 2.43 112.874 -178.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.645 HD13 ' CE2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -133.46 172.93 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 116.171 -0.468 . . . . 4.33 111.925 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.562 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -99.86 165.38 19.9 Favored Glycine 0 C--O 1.219 -0.815 0 N-CA-C 110.138 -1.185 . . . . 1.14 110.138 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.512 ' HA ' ' HB2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -155.55 109.37 2.82 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 117.916 0.858 . . . . 1.95 113.077 -176.466 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 11' ' ' SER . 2.1 mpt_? -154.63 103.21 2.44 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.38 -0.373 . . . . 4.16 111.196 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.484 HG22 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -106.24 -82.72 0.53 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.397 0.888 . . . . 1.13 113.397 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.402 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -146.31 -53.25 0.25 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.072 0.397 . . . . 1.14 112.072 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.49 -35.91 4.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.291 -0.957 . . . . 0.72 112.839 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -58.69 -30.09 67.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.325 0.583 . . . . 2.82 109.762 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.495 ' HA3' ' CG2' ' A' ' 43' ' ' VAL . . . -150.39 -46.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.236 -0.893 . . . . 0.86 110.899 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.567 ' CA ' ' HD3' ' A' ' 35' ' ' PRO . . . -121.53 142.12 50.38 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 121.034 -0.266 . . . . 1.15 111.045 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.469 ' H ' ' HD3' ' A' ' 35' ' ' PRO . 0.8 OUTLIER -153.49 39.14 0.49 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.66 0.615 . . . . 2.5 112.66 178.38 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 27.9 mt-10 -145.79 -151.4 0.37 Allowed 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 118.371 -0.823 . . . . 1.28 111.378 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.767 ' CE1' ' HB2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -153.24 -97.19 0.05 OUTLIER 'General case' 0 C--O 1.203 -1.345 0 N-CA-C 119.725 3.231 . . . . 5.2 119.725 -174.228 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.767 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 13.2 tp -120.57 168.6 11.19 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 113.035 0.754 . . . . 5.07 113.035 -174.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.61 HG12 ' CG2' ' A' ' 9' ' ' ILE . 0.0 OUTLIER 38.5 -142.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.579 -1.191 . . . . 3.21 110.435 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 53.29 19.32 1.51 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.609 1.095 . . . . 2.6 109.464 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.637 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -152.77 -173.19 4.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.731 -0.668 . . . . 1.71 109.756 -179.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -122.52 62.75 0.97 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.792 0.664 . . . . 3.74 112.792 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . 31.2 t70 46.22 26.11 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.187 0.44 . . . . 2.14 112.187 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.566 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -47.52 -61.04 4.9 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 119.707 -1.235 . . . . 0.99 111.884 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.479 ' O ' ' CB ' ' A' ' 38' ' ' TYR . 58.3 t-80 -134.05 95.8 3.5 Favored 'General case' 0 C--O 1.215 -0.721 0 C-N-CA 119.966 -0.694 . . . . 3.77 111.575 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 29' ' ' HIS . 14.8 m 37.88 105.63 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 114.215 1.191 . . . . 1.8 114.215 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' SER . 23.7 Cg_exo -30.55 116.86 0.06 OUTLIER 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 123.038 2.492 . . . . 0.79 110.31 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 21' ' ' TYR . 8.5 t -135.94 -150.44 0.37 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.36 0.874 . . . . 1.27 113.36 -173.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.595 ' CZ3' ' CD2' ' A' ' 21' ' ' TYR . 6.8 t-105 -135.0 95.08 3.24 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 106.141 -1.8 . . . . 1.48 106.141 174.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.623 HG13 HG21 ' A' ' 39' ' ' ILE . 1.4 t -156.75 162.04 28.36 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 115.132 -0.94 . . . . 2.35 113.092 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.6 ' CG ' ' HA ' ' A' ' 45' ' ' SER . 18.6 Cg_endo -55.31 72.5 0.03 OUTLIER 'Trans proline' 0 N--CA 1.477 0.502 1 C-N-CA 126.784 4.989 . . . . 1.52 115.488 177.24 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 35.3 t 65.04 23.7 12.5 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.748 -0.381 . . . . 2.17 111.742 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.547 ' O ' ' CZ3' ' A' ' 25' ' ' TRP . 7.3 m -149.06 -123.06 0.05 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.23 -0.441 . . . . 1.81 110.262 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.566 ' CZ ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -176.83 107.79 0.07 Allowed 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.81 -1.552 . . . . 5.8 106.81 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.623 HG21 HG13 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -174.9 39.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 122.937 1.351 . . . . 2.64 108.51 -175.426 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.04 90.14 3.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.862 -1.517 . . . . 1.75 110.596 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.41 -34.87 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.391 -1.277 . . . . 2.67 109.923 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.431 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 32.0 t70 -102.03 -99.48 0.27 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.889 -0.596 . . . . 4.56 111.895 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.495 ' CG2' ' HA3' ' A' ' 17' ' ' GLY . 7.2 p 174.09 68.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 119.841 -0.123 . . . . 4.12 110.971 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.447 ' CG2' HG12 ' A' ' 39' ' ' ILE . 25.2 m -156.81 169.99 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 113.995 1.109 . . . . 3.1 113.995 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.6 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 28.2 t -83.44 10.8 7.99 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.607 -1.178 . . . . 1.46 112.487 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 36.8 tt0 179.16 161.13 0.74 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.113 0.483 . . . . 1.6 111.963 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.481 ' CD2' ' OXT' ' A' ' 47' ' ' TYR . 38.1 p90 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.265 -0.874 . . . . 4.35 110.917 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 112.657 -0.177 . . . . 2.65 112.657 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.463 ' HB2' ' CB ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 56.11 18.09 3.03 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.863 0.363 . . . . 2.17 111.072 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.408 ' HB ' ' HG2' ' A' ' 7' ' ' LYS . 12.7 t -106.79 -4.14 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.33 . . . . 1.44 111.429 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.501 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 9.7 p30 45.28 79.73 0.05 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.33 0.586 . . . . 2.31 110.886 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 6.2 pttp -143.99 -104.71 0.12 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.138 -0.937 . . . . 2.9 110.442 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.459 HD12 HG22 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -87.06 103.67 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 108.354 -0.98 . . . . 2.43 108.354 178.458 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.483 ' CG2' ' HB2' ' A' ' 22' ' ' LEU . 21.9 pt -104.2 165.73 3.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.917 0.865 . . . . 4.33 113.082 -177.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.4 138.83 9.29 Favored Glycine 0 CA--C 1.498 -0.983 0 N-CA-C 107.454 -2.258 . . . . 1.14 107.454 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.498 ' HA ' ' N ' ' A' ' 21' ' ' TYR . 12.4 p -144.59 104.45 4.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 119.062 1.431 . . . . 1.95 113.415 -176.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.418 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 31.2 ttm180 -159.94 101.09 1.44 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.452 -1.249 . . . . 4.16 111.091 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.504 ' HB ' ' C ' ' A' ' 18' ' ' ALA . 2.9 m -116.68 -87.99 0.6 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 113.981 1.104 . . . . 1.13 113.981 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.63 -60.0 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.218 -0.593 . . . . 1.14 112.581 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . 125.24 -34.98 3.22 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.327 -0.94 . . . . 0.72 112.13 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -30.28 66.74 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.256 -0.646 . . . . 2.82 109.256 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 44' ' ' VAL . . . -146.43 -47.38 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.137 -0.938 . . . . 0.86 110.931 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.517 ' CA ' ' HD3' ' A' ' 35' ' ' PRO . . . -127.02 151.78 48.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 111.488 0.181 . . . . 1.15 111.488 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.449 ' H ' ' HD3' ' A' ' 35' ' ' PRO . 1.6 ttm -151.66 22.0 0.7 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.891 0.33 . . . . 2.5 111.891 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.555 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 18.9 mt-10 -148.36 177.85 9.09 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 122.287 -0.258 . . . . 1.28 111.407 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.67 ' CG ' ' O ' ' A' ' 21' ' ' TYR . 1.0 OUTLIER -159.09 50.91 0.37 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.514 0.673 . . . . 5.2 111.701 -179.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.612 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 2.0 pp -110.15 114.05 27.24 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 116.266 1.95 . . . . 5.07 116.266 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.608 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 8.2 pt -53.89 -16.92 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 113.195 -1.821 . . . . 3.21 112.376 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.501 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . 35.1 tt0 -67.3 65.51 0.07 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.242 0.544 . . . . 2.6 111.212 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.612 ' CD2' ' O ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -142.97 31.69 1.4 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.568 -0.742 . . . . 1.71 110.225 178.439 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 60.06 34.17 21.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.288 -0.869 . . . . 3.74 111.908 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.463 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 4.2 p30 44.77 29.17 0.41 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.88 0.371 . . . . 2.14 111.282 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.469 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -47.63 -61.95 4.37 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.676 -0.774 . . . . 0.99 112.338 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.55 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 35.8 t60 -135.26 93.71 3.02 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 110.01 -0.367 . . . . 3.77 110.01 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 32' ' ' SER . 28.9 m 39.57 116.39 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 116.3 1.963 . . . . 1.8 116.3 177.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.49 ' HB3' ' CG2' ' A' ' 23' ' ' ILE . 14.2 Cg_exo -32.08 92.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 124.138 3.226 . . . . 0.79 107.749 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 30' ' ' SER . 33.8 t -111.72 166.32 11.28 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.334 -1.303 . . . . 1.27 113.849 -172.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.626 ' CZ3' ' CD2' ' A' ' 21' ' ' TYR . 15.0 t-105 -97.87 91.23 5.24 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 105.656 -1.979 . . . . 1.48 105.656 176.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.669 HG13 ' N ' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -156.36 165.55 18.39 Favored Pre-proline 0 N--CA 1.441 -0.882 0 N-CA-C 113.887 1.069 . . . . 2.35 113.887 -178.376 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.549 ' CD ' HG11 ' A' ' 34' ' ' VAL . 38.2 Cg_endo -67.58 78.05 0.51 Allowed 'Trans proline' 0 C--N 1.352 0.728 1 C-N-CA 125.791 4.327 . . . . 1.52 117.609 177.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 35' ' ' PRO . 13.8 m 76.09 14.5 2.52 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.641 0.978 . . . . 2.17 113.641 173.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.547 ' O ' ' CE3' ' A' ' 25' ' ' TRP . 1.8 m -162.54 -110.6 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 120.571 -0.451 . . . . 1.81 112.029 176.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.669 ' N ' HG13 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -174.49 132.82 0.37 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.997 -1.853 . . . . 5.8 105.997 -176.774 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.569 HG22 ' CG1' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -149.68 28.98 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 119.377 -0.929 . . . . 2.64 111.118 -174.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 41' ' ' ALA . . . -60.86 89.43 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.574 -0.739 . . . . 1.75 110.25 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . 153.69 38.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.839 -1.073 . . . . 2.67 110.705 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 55.83 87.51 0.05 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.429 0.529 . . . . 4.56 112.429 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -151.59 -156.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 110.05 -0.352 . . . . 4.12 110.05 178.547 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 17' ' ' GLY . 8.3 p -159.29 120.59 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 113.702 1.001 . . . . 3.1 113.702 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.487 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 28.8 t 63.44 8.71 3.68 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.202 0.816 . . . . 1.46 113.202 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 45' ' ' SER . 38.0 tt0 179.23 154.99 0.47 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.912 0.387 . . . . 1.6 111.931 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 39' ' ' ILE . 35.4 t80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.2 -0.905 . . . . 4.35 110.833 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.424 ' C ' ' HG3' ' A' ' 31' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.495 -0.242 . . . . 2.65 112.495 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.47 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 0.0 OUTLIER 64.97 3.78 2.23 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 112.179 0.437 . . . . 2.17 112.179 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.454 ' HB ' ' HG2' ' A' ' 7' ' ' LYS . 24.1 t -79.74 -41.21 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 CA-C-O 121.317 0.579 . . . . 1.44 110.807 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 25' ' ' TRP . 0.3 OUTLIER 81.68 71.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.821 -1.081 . . . . 2.31 108.421 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.454 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 5.3 ptpt -152.41 -107.12 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 112.986 0.736 . . . . 2.9 112.986 -176.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.482 HG21 HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -79.49 97.95 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 C-N-CA 123.217 0.607 . . . . 2.43 110.105 -179.22 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.509 ' CG2' ' CB ' ' A' ' 22' ' ' LEU . 3.2 tp -153.42 170.49 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 C-N-CA 120.008 -0.677 . . . . 4.33 111.615 -178.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.24 169.18 20.63 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 121.276 -0.487 . . . . 1.14 111.982 -175.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.5 ' HB2' ' CB ' ' A' ' 20' ' ' GLU . 11.8 p -151.14 102.41 2.94 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 113.403 0.89 . . . . 1.95 113.403 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -163.3 97.32 0.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 119.176 -0.44 . . . . 4.16 111.255 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.528 ' CG2' ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -105.02 -81.12 0.54 Allowed 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 119.022 -1.071 . . . . 1.13 113.742 177.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -150.81 -55.85 0.16 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.824 0.675 . . . . 1.14 112.824 -177.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . 122.49 -45.35 1.21 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.483 -0.865 . . . . 0.72 111.656 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -59.17 -32.17 69.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.036 -0.727 . . . . 2.82 109.036 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.46 -68.52 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.03 -0.986 . . . . 0.86 110.948 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.615 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -111.48 155.65 22.9 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 119.774 -0.155 . . . . 1.15 110.845 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.455 ' HG2' ' N ' ' A' ' 15' ' ' GLY . 0.9 OUTLIER -153.85 16.07 0.5 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.75 1.018 . . . . 2.5 113.75 179.209 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.647 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 18.2 mt-10 -152.69 178.91 9.11 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 119.367 -0.349 . . . . 1.28 110.131 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.604 ' HB2' ' CG ' ' A' ' 33' ' ' TRP . 1.1 t80 -160.05 12.94 0.12 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.445 1.276 . . . . 5.2 114.445 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.509 ' CB ' ' CG2' ' A' ' 9' ' ' ILE . 0.3 OUTLIER -85.43 125.64 33.17 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 117.916 2.561 . . . . 5.07 117.916 -175.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.61 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 5.7 mt -48.56 -22.48 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-N 111.266 -2.697 . . . . 3.21 110.868 174.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.417 ' HB3' HD11 ' A' ' 22' ' ' LEU . 23.6 tt0 -29.34 -32.19 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.839 0.856 . . . . 2.6 112.517 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.676 ' CZ3' ' CG1' ' A' ' 34' ' ' VAL . 0.4 OUTLIER -55.96 -163.4 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.26 -0.645 . . . . 1.71 109.26 177.014 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.43 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -114.62 54.61 0.77 Allowed 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.513 -0.742 . . . . 3.74 111.104 -178.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.433 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 4.2 p30 44.36 28.41 0.29 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.918 -0.583 . . . . 2.14 111.256 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.505 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -49.54 -65.63 2.69 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.471 -0.871 . . . . 0.99 112.087 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.447 ' O ' ' O ' ' A' ' 30' ' ' SER . 41.5 m-70 -134.56 94.85 3.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.706 -0.398 . . . . 3.77 110.432 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 29' ' ' HIS . 29.5 t 41.26 114.47 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 116.058 1.873 . . . . 1.8 116.058 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.46 ' HB3' HG12 ' A' ' 23' ' ' ILE . 8.0 Cg_exo -30.96 95.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 124.022 3.148 . . . . 0.79 108.167 172.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 30' ' ' SER . 33.5 t -119.43 176.67 5.24 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-N 114.462 -1.245 . . . . 1.27 113.782 -172.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.604 ' CG ' ' HB2' ' A' ' 21' ' ' TYR . 4.3 t-105 -104.79 99.83 9.47 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.326 -1.761 . . . . 1.48 107.18 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.676 ' CG1' ' CZ3' ' A' ' 25' ' ' TRP . 7.4 p -152.42 155.44 32.92 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 115.166 -0.925 . . . . 2.35 111.591 -175.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.66 ' HD2' ' CG2' ' A' ' 34' ' ' VAL . 53.5 Cg_exo -55.03 -12.75 5.41 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 124.17 3.247 . . . . 1.52 115.789 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 19.4 p 174.07 -19.32 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.328 0.862 . . . . 2.17 113.328 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.589 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -115.32 -95.39 0.47 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.179 0.445 . . . . 1.81 111.7 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.64 ' HA ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -178.44 122.98 0.1 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.296 -1.372 . . . . 5.8 107.296 -178.336 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.613 HG22 ' CG2' ' A' ' 34' ' ' VAL . 5.1 pt -145.64 32.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 119.904 -0.718 . . . . 2.64 111.139 -176.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.22 90.57 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.944 -1.026 . . . . 1.75 110.489 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 42' ' ' ASP . . . 162.5 -61.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.888 -1.051 . . . . 2.67 109.736 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 13.5 t70 165.71 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.918 -0.583 . . . . 4.56 111.406 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.45 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -147.58 -159.51 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 110.083 -0.34 . . . . 4.12 110.083 178.708 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.414 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 13.0 m -146.91 109.78 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 113.426 0.898 . . . . 3.1 113.426 -178.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.48 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . 47.2 t 54.26 16.17 1.14 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.816 -0.629 . . . . 1.46 112.481 178.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 178.36 132.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.566 -0.453 . . . . 1.6 111.703 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 38' ' ' TYR . 91.7 t80 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.244 -0.884 . . . . 4.35 110.67 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.487 -0.245 . . . . 2.65 112.487 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.453 ' CB ' ' HB3' ' A' ' 27' ' ' ASP . 1.2 pp20? 44.88 26.15 0.19 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.925 0.393 . . . . 2.17 111.996 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.436 ' CG1' ' HD3' ' A' ' 7' ' ' LYS . 38.8 t -79.8 -11.91 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.042 -0.527 . . . . 1.44 112.357 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.554 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 10.3 t-20 43.22 81.53 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.496 0.665 . . . . 2.31 109.871 -178.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.436 ' HD3' ' CG1' ' A' ' 5' ' ' VAL . 62.3 pttt -150.95 -134.02 0.06 Allowed 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.667 -1.151 . . . . 2.9 109.499 -177.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.486 HG22 HD11 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -96.52 113.69 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 120.989 0.423 . . . . 2.43 110.512 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.648 HG23 HG13 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -151.06 167.92 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 119.524 -0.87 . . . . 4.33 112.221 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -104.12 168.21 16.59 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.75 -0.659 . . . . 1.14 112.703 -178.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.644 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 1.2 p -153.94 103.96 2.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 1.95 111.589 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -157.8 102.15 1.83 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.239 -0.437 . . . . 4.16 110.956 178.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.512 ' CG2' ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -110.76 -82.66 0.58 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 119.243 -0.983 . . . . 1.13 113.642 179.686 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.05 -56.72 0.2 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.194 0.442 . . . . 1.14 112.194 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.51 -40.72 2.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.408 -0.901 . . . . 0.72 112.422 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.53 -25.25 64.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.975 0.417 . . . . 2.82 110.301 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -149.12 -45.92 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.511 -0.636 . . . . 0.86 111.511 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.503 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . . . -131.07 152.59 50.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.767 -0.457 . . . . 1.15 109.767 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.454 ' N ' ' HG3' ' A' ' 35' ' ' PRO . 2.8 ttt -163.01 31.68 0.1 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.202 1.186 . . . . 2.5 114.202 -178.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 35.5 mt-10 -150.64 -160.55 1.18 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 117.508 -1.234 . . . . 1.28 108.618 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.888 ' OH ' HD23 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -153.45 -79.35 0.1 Allowed 'General case' 0 C--O 1.204 -1.327 1 N-CA-C 122.151 4.13 . . . . 5.2 122.151 -175.797 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.888 HD23 ' OH ' ' A' ' 21' ' ' TYR . 3.9 tp -114.22 166.59 11.49 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 115.401 1.63 . . . . 5.07 115.401 -173.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.648 HG13 HG23 ' A' ' 9' ' ' ILE . 1.3 pp 23.75 -150.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 111.956 -2.383 . . . . 3.21 113.03 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.495 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER 63.07 16.56 9.42 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.038 -0.727 . . . . 2.6 109.038 -178.722 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.614 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.3 OUTLIER -152.24 31.14 0.54 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.154 0.502 . . . . 1.71 111.401 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt 17.08 74.55 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.332 1.605 . . . . 3.74 115.332 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.453 ' HB3' ' CB ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 39.16 67.58 0.43 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.6 0.963 . . . . 2.14 113.6 176.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.563 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -88.18 -62.24 1.44 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.524 -1.322 . . . . 0.99 109.953 177.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.549 ' CD2' ' CD2' ' A' ' 47' ' ' TYR . 48.3 t-80 -133.2 94.78 3.4 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 109.544 -0.539 . . . . 3.77 109.544 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 31' ' ' PRO . 18.1 t 37.52 98.14 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 113.873 1.064 . . . . 1.8 113.873 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.432 ' C ' ' O ' ' A' ' 30' ' ' SER . 52.9 Cg_exo -27.08 106.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.349 2.7 . . . . 0.79 110.896 176.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 21' ' ' TYR . 8.7 t -122.18 -149.85 0.44 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.421 -0.809 . . . . 1.27 112.309 -173.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.59 ' CE3' ' CG ' ' A' ' 21' ' ' TYR . 6.9 t-105 -137.87 94.48 2.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.069 -1.826 . . . . 1.48 106.069 174.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.584 ' CG1' ' HD2' ' A' ' 35' ' ' PRO . 1.4 t -156.26 165.25 19.02 Favored Pre-proline 0 C--O 1.218 -0.553 0 CA-C-N 116.053 -0.521 . . . . 2.35 111.759 -176.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.584 ' HD2' ' CG1' ' A' ' 34' ' ' VAL . 14.5 Cg_exo -63.81 81.3 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.286 2.657 . . . . 1.52 116.039 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.3 t 63.73 28.27 14.86 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.019 0.438 . . . . 2.17 111.365 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.592 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 5.6 t -151.78 -127.31 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.802 -0.635 . . . . 1.81 110.563 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.592 ' CG ' ' C ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -175.8 102.34 0.07 Allowed 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.317 -1.364 . . . . 5.8 107.317 -177.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.515 HG21 HG13 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -158.98 72.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.978 1.371 . . . . 2.64 108.679 -176.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.96 91.31 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.461 -1.7 . . . . 1.75 110.821 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 42' ' ' ASP . . . -166.36 -35.19 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.551 -1.204 . . . . 2.67 110.921 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 15.2 t70 80.86 30.19 0.17 Allowed 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.183 -0.462 . . . . 4.56 110.31 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.85 -3.53 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 112.885 0.698 . . . . 4.12 112.885 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' N ' HD11 ' A' ' 39' ' ' ILE . 3.6 t -158.32 153.38 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.253 0.549 . . . . 3.1 111.787 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.532 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 18.6 p -93.57 21.67 6.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.343 -0.844 . . . . 1.46 111.179 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.481 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 12.4 tt0 -178.99 141.15 0.17 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 120.424 -0.51 . . . . 1.6 112.153 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.549 ' CD2' ' CD2' ' A' ' 29' ' ' HIS . 75.4 t80 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.268 -0.873 . . . . 4.35 110.762 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.462 ' HA2' ' CD1' ' A' ' 23' ' ' ILE . . . . . . . . 0 CA--C 1.521 0.449 0 N-CA-C 112.557 -0.217 . . . . 2.65 112.557 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 61.48 18.66 9.61 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.431 0.634 . . . . 2.17 111.583 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 t -107.08 -9.51 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.046 -0.524 . . . . 1.44 111.621 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 44.1 t-20 50.72 88.33 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.021 0.439 . . . . 2.31 110.177 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.41 ' HG2' HG12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -138.36 -147.77 0.24 Allowed 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.876 -0.787 . . . . 2.9 108.876 -178.295 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.3 OUTLIER -65.08 117.44 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 109.824 -0.435 . . . . 2.43 109.824 178.347 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.724 ' CG1' ' CE2' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -129.25 136.25 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 114.096 1.147 . . . . 4.33 114.096 -178.125 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.51 106.97 1.55 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 107.693 -2.163 . . . . 1.14 107.693 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.667 ' CB ' ' CD2' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -102.76 108.34 19.53 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 114.736 1.384 . . . . 1.95 114.736 -174.722 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -158.18 102.69 1.79 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 112.91 -1.95 . . . . 4.16 112.39 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.464 ' CB ' ' HA ' ' A' ' 19' ' ' MET . 0.2 OUTLIER -111.74 -82.29 0.58 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.25 -0.906 . . . . 1.13 112.478 178.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.428 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -140.61 -50.82 0.46 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.689 0.281 . . . . 1.14 111.416 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.441 ' CA ' ' HG3' ' A' ' 19' ' ' MET . . . 110.74 -44.41 1.51 Allowed Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.312 -0.947 . . . . 0.72 112.732 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.41 ' HG3' HG11 ' A' ' 43' ' ' VAL . 9.8 pt-20 -58.62 -24.98 62.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.229 0.538 . . . . 2.82 109.811 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.487 ' HA3' ' CB ' ' A' ' 43' ' ' VAL . . . -145.14 -69.32 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.519 -1.032 . . . . 0.86 110.519 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.586 ' HB2' ' HA ' ' A' ' 34' ' ' VAL . . . -105.18 150.46 25.06 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.407 -0.59 . . . . 1.15 109.407 178.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.464 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 2.4 tmm? -165.01 42.48 0.08 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 114.218 1.192 . . . . 2.5 114.218 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 32.0 mt-10 -143.47 -147.8 0.22 Allowed 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 114.398 1.259 . . . . 1.28 114.398 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.724 ' CE2' ' CG1' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -113.27 -174.41 2.45 Favored 'General case' 0 CA--C 1.456 -2.659 0 C-N-CA 124.837 1.255 . . . . 5.2 112.097 -173.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.549 ' HB3' ' N ' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -127.39 78.64 1.83 Allowed 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 115.823 1.786 . . . . 5.07 115.823 175.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.529 ' CB ' ' O ' ' A' ' 22' ' ' LEU . 4.6 tt 152.41 71.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.136 0 N-CA-C 113.75 1.019 . . . . 3.21 113.75 171.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.718 ' OE1' ' OH ' ' A' ' 21' ' ' TYR . 14.2 tt0 178.58 59.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.154 -0.475 . . . . 2.6 111.96 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.539 ' CD1' ' N ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -154.22 29.86 0.44 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.854 0.359 . . . . 1.71 110.898 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.446 ' N ' ' CD ' ' A' ' 26' ' ' LYS . 9.6 mptt 55.17 22.54 4.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.217 -0.447 . . . . 3.74 110.816 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.418 ' HB2' ' HG3' ' A' ' 4' ' ' GLU . 16.1 t70 59.29 109.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.588 0.709 . . . . 2.14 111.617 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.565 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -121.08 -62.52 0.24 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 109.857 -1.297 . . . . 0.99 109.857 178.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.473 ' O ' ' CB ' ' A' ' 38' ' ' TYR . 39.7 m80 -135.17 94.45 3.13 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.605 -0.517 . . . . 3.77 109.605 177.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 29' ' ' HIS . 15.5 m 39.99 102.69 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 113.338 0.866 . . . . 1.8 113.338 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.451 ' C ' ' O ' ' A' ' 30' ' ' SER . 14.8 Cg_exo -25.69 125.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.877 3.052 . . . . 0.79 109.705 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.512 ' O ' ' CH2' ' A' ' 25' ' ' TRP . 3.8 t -154.19 138.95 17.05 Favored 'General case' 0 C--O 1.21 -0.989 0 N-CA-C 114.62 1.341 . . . . 1.27 114.62 -171.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.549 ' N ' ' HB3' ' A' ' 22' ' ' LEU . 5.5 t-105 -83.6 96.58 8.69 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.593 -2.373 . . . . 1.48 104.593 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.594 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -150.88 -159.73 0.04 OUTLIER Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-N 113.271 -1.786 . . . . 2.35 107.631 -175.613 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.527 ' HD3' ' CG1' ' A' ' 34' ' ' VAL . 60.5 Cg_endo -95.25 99.01 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 122.708 2.003 . . . . 1.52 116.683 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.0 t 55.18 16.79 1.74 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.709 -0.678 . . . . 2.17 112.223 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.557 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 50.4 m -162.76 -109.65 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 120.402 -0.519 . . . . 1.81 111.48 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.565 ' OH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -177.71 102.07 0.05 OUTLIER 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 106.645 -1.613 . . . . 5.8 106.645 -176.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -159.05 71.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.418 -0.81 . . . . 2.64 110.199 -176.078 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.65 91.6 5.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.974 -1.012 . . . . 1.75 110.676 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.8 -43.74 0.15 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.999 -1.001 . . . . 2.67 109.964 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.437 ' O ' ' CG1' ' A' ' 43' ' ' VAL . 7.8 m-20 -142.53 -74.14 0.29 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.841 -0.618 . . . . 4.56 111.242 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.487 ' CB ' ' HA3' ' A' ' 17' ' ' GLY . 0.0 OUTLIER 175.46 74.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.234 -0.439 . . . . 4.12 111.354 -178.375 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.463 ' O ' ' HG3' ' A' ' 35' ' ' PRO . 24.0 t -133.84 150.33 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 120.957 -0.297 . . . . 3.1 111.757 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.501 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 45.4 t -68.07 1.79 2.53 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.372 1.249 . . . . 1.46 114.372 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.492 ' N ' HG23 ' A' ' 39' ' ' ILE . 38.0 tt0 -179.59 155.67 0.67 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.607 0.242 . . . . 1.6 110.695 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.423 ' N ' ' HB ' ' A' ' 39' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.186 -0.911 . . . . 4.35 110.47 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' A' ' 31' ' ' PRO . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.671 -0.172 . . . . 2.65 112.671 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 1.1 tm-20 51.16 54.27 11.48 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 122.549 1.166 . . . . 2.17 109.268 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.443 ' CG1' ' HG2' ' A' ' 7' ' ' LYS . 12.0 t -131.42 -24.25 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.033 -0.985 . . . . 1.44 112.49 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 9.7 t-20 50.96 78.26 0.11 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.188 -0.671 . . . . 2.31 109.188 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.443 ' HG2' ' CG1' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -138.39 -98.16 0.18 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.844 0.683 . . . . 2.9 112.844 -176.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.3 tp -137.69 114.03 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 109.765 -0.457 . . . . 2.43 109.765 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.538 HG23 ' CD2' ' A' ' 21' ' ' TYR . 6.4 tp -150.03 165.06 3.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.315 -0.402 . . . . 4.33 111.987 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.484 ' N ' HG13 ' A' ' 9' ' ' ILE . . . -111.57 115.99 4.05 Favored Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.0 -1.24 . . . . 1.14 110.0 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.79 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -101.11 106.36 17.61 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 123.063 1.411 . . . . 1.95 112.819 -174.497 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -157.93 109.02 2.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 111.723 -2.49 . . . . 4.16 111.987 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.484 ' HB ' ' C ' ' A' ' 18' ' ' ALA . 3.2 m -115.24 -80.92 0.6 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.703 0.631 . . . . 1.13 112.703 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.69 -59.92 0.33 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.341 0.497 . . . . 1.14 112.341 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.11 -41.53 1.77 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.64 -0.791 . . . . 0.72 112.472 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.19 -26.67 65.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.025 0.44 . . . . 2.82 110.138 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -150.77 -50.75 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.75 -0.659 . . . . 0.86 111.577 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.601 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -117.52 152.33 35.3 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.153 -0.684 . . . . 1.15 109.153 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.542 ' N ' ' HG3' ' A' ' 35' ' ' PRO . 3.4 ttt -169.74 34.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 115.387 1.625 . . . . 2.5 115.387 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.77 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 7.2 mt-10 -141.09 -122.25 0.1 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 119.198 -1.001 . . . . 1.28 111.982 176.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.79 ' HB3' ' HA ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -154.74 -117.47 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 117.996 2.591 . . . . 5.2 117.996 -175.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.544 ' HA ' ' CZ2' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -152.67 168.89 24.15 Favored 'General case' 0 N--CA 1.424 -1.774 0 O-C-N 121.398 -0.814 . . . . 5.07 110.497 -178.591 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.517 HG12 HG22 ' A' ' 9' ' ' ILE . 0.2 OUTLIER 47.43 58.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.874 -0.603 . . . . 3.21 111.38 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 0.3 OUTLIER -168.03 28.72 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.088 -0.506 . . . . 2.6 112.23 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.585 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -142.86 31.24 1.43 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.862 0.363 . . . . 1.71 110.245 177.32 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.406 ' O ' ' OD2' ' A' ' 27' ' ' ASP . 7.4 mtpm? 47.85 38.8 9.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 3.74 110.183 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.491 ' HB3' ' CG ' ' A' ' 4' ' ' GLU . 1.3 p30 53.88 38.83 29.56 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.554 -0.748 . . . . 2.14 110.985 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -43.41 -70.13 0.57 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.838 -0.696 . . . . 0.99 111.659 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.497 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -132.9 100.23 4.84 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 120.877 -0.329 . . . . 3.77 110.349 178.175 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.47 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 19.5 m 38.83 103.32 0.02 OUTLIER Pre-proline 0 C--O 1.218 -0.562 0 N-CA-C 114.095 1.146 . . . . 1.8 114.095 176.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.447 ' HB3' ' CA ' ' A' ' 3' ' ' GLY . 25.6 Cg_exo -25.21 138.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.966 3.111 . . . . 0.79 112.518 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.619 ' HB2' ' CD2' ' A' ' 38' ' ' TYR . 43.7 t -152.36 -155.85 0.65 Allowed 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 113.362 0.875 . . . . 1.27 113.362 -175.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.605 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 48.6 t-105 -139.3 95.0 2.86 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 101.524 -3.51 . . . . 1.48 101.524 172.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.77 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -154.42 163.73 23.22 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 114.086 -1.415 . . . . 2.35 109.745 -171.336 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.682 ' HA ' ' HG3' ' A' ' 20' ' ' GLU . 24.0 Cg_exo -62.81 -11.12 22.57 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.542 2.828 . . . . 1.52 118.379 -175.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 35' ' ' PRO . 1.9 m 157.98 31.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 114.051 1.13 . . . . 2.17 114.051 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.524 ' N ' ' CE3' ' A' ' 25' ' ' TRP . 37.8 m -176.55 -85.86 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.02 0.438 . . . . 1.81 110.126 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.99 ' HH ' ' HB2' ' A' ' 40' ' ' ALA . 29.4 t80 -177.96 152.75 0.77 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.757 -0.656 . . . . 5.8 110.602 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.624 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 0.6 OUTLIER 175.55 73.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.869 0.366 . . . . 2.64 110.197 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.99 ' HB2' ' HH ' ' A' ' 38' ' ' TYR . . . -66.46 91.94 0.19 Allowed 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.98 -0.688 . . . . 1.75 110.618 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 42' ' ' ASP . . . 172.06 -31.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.51 -0.768 . . . . 2.67 110.95 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 17.7 t70 75.9 28.92 0.84 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.043 -0.526 . . . . 4.56 110.963 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.71 -9.15 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.222 -0.444 . . . . 4.12 112.142 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.474 ' O ' HG22 ' A' ' 39' ' ' ILE . 11.2 t -145.41 162.97 12.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.389 0.138 . . . . 3.1 110.899 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.602 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 78.1 p -97.64 17.39 17.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.397 -0.365 . . . . 1.46 111.761 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 178.39 140.46 0.09 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 120.696 -0.402 . . . . 1.6 111.632 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 38' ' ' TYR . 7.5 t80 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.234 -0.888 . . . . 4.35 111.052 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.489 -0.244 . . . . 2.65 112.489 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.539 ' HA ' ' CD1' ' A' ' 23' ' ' ILE . 1.6 tt0 60.27 14.71 4.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.281 0.562 . . . . 2.17 111.404 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -91.18 -21.77 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.648 -0.501 . . . . 1.44 109.648 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.455 ' ND2' ' HA ' ' A' ' 24' ' ' GLU . 34.5 t-20 58.45 80.23 0.19 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.881 -0.6 . . . . 2.31 109.476 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.453 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 17.8 pttp -147.75 -140.39 0.1 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.037 -0.983 . . . . 2.9 108.423 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.421 ' N ' ' HG3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -67.79 132.34 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.467 -0.938 . . . . 2.43 108.467 177.195 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.58 ' HB ' ' CB ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -148.7 173.19 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 113.965 1.098 . . . . 4.33 113.965 -176.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.68 159.51 21.55 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 113.545 -1.661 . . . . 1.14 110.388 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.506 ' HB2' ' CB ' ' A' ' 20' ' ' GLU . 2.8 p -154.79 103.71 2.45 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.319 0.859 . . . . 1.95 113.319 -177.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.1 ttp-105 -161.68 98.41 1.1 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.504 0.928 . . . . 4.16 113.504 176.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.517 ' CG2' ' CD1' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -110.54 -81.3 0.58 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 119.031 -1.068 . . . . 1.13 113.521 176.005 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -151.16 -57.44 0.16 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.645 0.609 . . . . 1.14 112.645 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . 125.14 -41.6 1.66 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.0 -0.619 . . . . 0.72 111.771 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -72.76 -9.39 58.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.767 0.318 . . . . 2.82 111.26 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -151.55 -55.47 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.216 -1.154 . . . . 0.86 110.216 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.653 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -131.52 153.04 50.22 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 108.774 -0.825 . . . . 1.15 108.774 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.521 ' N ' ' HG3' ' A' ' 35' ' ' PRO . 2.6 ttt -154.33 11.06 0.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.969 1.1 . . . . 2.5 113.969 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.711 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 14.8 mt-10 -151.55 -177.82 6.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.484 -0.932 . . . . 1.28 108.484 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.718 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -157.87 9.35 0.17 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.258 0.836 . . . . 5.2 113.258 178.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.58 ' CB ' ' HB ' ' A' ' 9' ' ' ILE . 3.6 pp -87.23 128.5 35.15 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 115.343 1.609 . . . . 5.07 115.343 -175.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.667 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 0.4 OUTLIER -42.02 -104.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 112.508 -2.133 . . . . 3.21 108.522 173.704 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.455 ' HA ' ' ND2' ' A' ' 6' ' ' ASN . 7.4 tp10 34.72 30.15 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.609 1.095 . . . . 2.6 112.561 177.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.667 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -134.53 32.29 3.35 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.068 -0.515 . . . . 1.71 111.052 -178.284 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 50.95 29.4 4.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.873 -0.603 . . . . 3.74 111.167 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.434 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 4.2 p30 43.64 38.07 1.79 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.524 . . . . 2.14 111.696 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.801 ' HA3' ' HH ' ' A' ' 38' ' ' TYR . . . -47.94 -57.4 7.83 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.547 -0.835 . . . . 0.99 112.287 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.568 ' HB2' ' CD1' ' A' ' 38' ' ' TYR . 76.2 m80 -133.65 92.17 2.94 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.245 -0.65 . . . . 3.77 109.245 178.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 29' ' ' HIS . 22.7 t 39.62 117.71 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 116.082 1.882 . . . . 1.8 116.082 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' A' ' 4' ' ' GLU . 11.1 Cg_exo -32.88 95.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.95 3.1 . . . . 0.79 107.953 172.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 30' ' ' SER . 18.3 m -117.21 173.34 6.74 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 114.463 1.283 . . . . 1.27 114.463 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.6 ' CE3' ' CG ' ' A' ' 21' ' ' TYR . 7.4 t-105 -104.08 100.49 10.24 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 105.314 -2.106 . . . . 1.48 105.314 176.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.711 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 4.4 p -151.39 158.98 34.15 Favored Pre-proline 0 C--O 1.204 -1.309 0 CA-C-N 114.19 -1.368 . . . . 2.35 111.417 -173.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.653 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 50.3 Cg_exo -61.48 -6.43 7.0 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 124.07 3.18 . . . . 1.52 115.712 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m 172.2 -12.91 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.182 1.179 . . . . 2.17 114.182 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.557 ' O ' ' CE3' ' A' ' 25' ' ' TRP . 73.9 m -138.75 -87.49 0.23 Allowed 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 118.816 0.734 . . . . 1.81 112.138 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.801 ' HH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -177.05 102.47 0.05 Allowed 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.223 -1.029 . . . . 5.8 108.223 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.54 ' CG2' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -127.68 59.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 122.746 1.26 . . . . 2.64 110.583 -174.578 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.0 92.63 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 113.852 -1.522 . . . . 1.75 110.934 -178.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . 164.95 -29.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 113.966 -1.47 . . . . 2.67 109.177 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 77.15 54.82 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.434 -0.803 . . . . 4.56 111.856 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.405 ' C ' ' CG2' ' A' ' 44' ' ' VAL . 3.4 t -154.76 23.77 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 112.643 0.608 . . . . 4.12 112.643 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 39' ' ' ILE . 2.4 t -157.88 152.32 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 113.083 0.771 . . . . 3.1 113.083 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.623 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 39.0 t -82.44 -2.71 54.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.747 -0.66 . . . . 1.46 111.409 177.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.449 ' HG2' ' CB ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 176.51 153.71 0.2 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.233 0.457 . . . . 1.6 112.233 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.487 ' CB ' ' O ' ' A' ' 38' ' ' TYR . 36.6 t80 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.26 -0.876 . . . . 4.35 110.754 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.456 0 N-CA-C 112.554 -0.218 . . . . 2.65 112.554 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.476 ' HB2' ' CB ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 53.66 20.57 2.24 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.66 0.743 . . . . 2.17 109.536 -178.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.414 ' HB ' ' HD2' ' A' ' 7' ' ' LYS . 17.4 t -98.61 -19.55 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.656 -0.702 . . . . 1.44 111.0 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.544 ' ND2' ' HA ' ' A' ' 24' ' ' GLU . 30.7 t-20 62.88 62.35 1.06 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.929 0.871 . . . . 2.31 108.851 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.414 ' HD2' ' HB ' ' A' ' 5' ' ' VAL . 18.1 ptmt -134.99 -133.34 0.16 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.13 -1.395 . . . . 2.9 108.272 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.446 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 6.8 tp -45.45 105.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.341 0 N-CA-C 109.213 -0.662 . . . . 2.43 109.213 177.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.582 ' CB ' ' HB2' ' A' ' 22' ' ' LEU . 1.4 pt -104.03 109.63 27.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 113.757 1.021 . . . . 4.33 113.757 -176.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.61 139.01 14.85 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 108.685 -1.766 . . . . 1.14 108.685 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.499 ' HA ' ' H ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -153.53 109.34 3.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 114.66 1.356 . . . . 1.95 114.66 -175.07 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.486 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 15.0 tpt180 -158.61 100.0 1.6 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.029 -0.668 . . . . 4.16 112.361 177.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.469 ' CB ' ' HA ' ' A' ' 19' ' ' MET . 0.2 OUTLIER -117.24 -79.48 0.59 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 119.406 -0.918 . . . . 1.13 113.326 178.688 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.435 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -149.15 -59.35 0.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.721 -0.392 . . . . 1.14 112.022 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 19' ' ' MET . . . 118.33 -50.55 0.8 Allowed Glycine 0 C--N 1.329 0.162 0 C-N-CA 119.906 -1.14 . . . . 0.72 112.617 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -58.38 -21.1 49.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.047 0.451 . . . . 2.82 109.971 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.44 ' HA3' ' CG2' ' A' ' 43' ' ' VAL . . . -143.71 -57.2 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.862 -0.608 . . . . 0.86 111.875 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.613 ' HA ' ' HB3' ' A' ' 35' ' ' PRO . . . -129.21 149.82 50.85 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.616 -0.883 . . . . 1.15 108.616 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.469 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -167.51 20.7 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 116.629 2.085 . . . . 2.5 116.629 -178.277 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 34' ' ' VAL . 2.8 mt-10 -154.68 98.67 2.09 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 118.928 0.786 . . . . 1.28 112.044 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.643 ' HB2' ' CG ' ' A' ' 33' ' ' TRP . 3.0 t80 -79.13 8.1 6.38 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 113.486 0.921 . . . . 5.2 113.486 -177.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.582 ' HB2' ' CB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -89.16 130.37 35.6 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 116.095 1.887 . . . . 5.07 116.095 -176.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.68 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -47.77 -137.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 111.758 -2.473 . . . . 3.21 112.118 174.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.544 ' HA ' ' ND2' ' A' ' 6' ' ' ASN . 33.1 tt0 60.27 16.5 6.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 120.934 -1.104 . . . . 2.6 109.698 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.68 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -112.15 31.26 6.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.287 0.565 . . . . 1.71 110.423 179.486 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.463 ' N ' ' CD ' ' A' ' 26' ' ' LYS . 0.5 OUTLIER 57.95 28.38 16.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.384 -0.826 . . . . 3.74 111.941 177.698 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.476 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 4.6 p-10 44.87 32.15 0.78 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.751 0.31 . . . . 2.14 111.346 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 1.128 ' HA3' ' HH ' ' A' ' 38' ' ' TYR . . . -47.82 -59.94 5.78 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.498 -0.858 . . . . 0.99 112.285 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.586 ' HB2' ' CD1' ' A' ' 38' ' ' TYR . 99.2 m-70 -134.89 91.3 2.74 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 119.897 -0.721 . . . . 3.77 109.618 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 29' ' ' HIS . 24.2 t 42.22 120.16 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 115.68 1.733 . . . . 1.8 115.68 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.454 ' HD3' ' CB ' ' A' ' 4' ' ' GLU . 2.9 Cg_exo -38.05 101.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 122.86 2.374 . . . . 0.79 107.425 172.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.557 ' CB ' ' CG2' ' A' ' 34' ' ' VAL . 68.7 m -124.0 155.82 37.56 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-N 115.176 -0.92 . . . . 1.27 112.81 -172.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.643 ' CG ' ' HB2' ' A' ' 21' ' ' TYR . 6.8 t-105 -90.29 92.81 9.08 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.43 -2.433 . . . . 1.48 104.43 176.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.588 HG13 HG21 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -155.05 -166.46 0.15 Allowed Pre-proline 0 C--O 1.186 -2.272 0 CA-C-N 115.354 -0.839 . . . . 2.35 112.258 -173.115 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.613 ' HB3' ' HA ' ' A' ' 18' ' ' ALA . 65.6 Cg_endo -95.67 105.78 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.108 0 CA-C-N 122.566 1.952 . . . . 1.52 116.278 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.4 t 37.48 30.08 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.293 0.568 . . . . 2.17 111.359 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.539 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 1.3 m -168.4 -130.31 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.059 -0.973 . . . . 1.81 108.922 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 1.128 ' HH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -173.17 100.9 0.12 Allowed 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 106.562 -1.644 . . . . 5.8 106.562 -178.006 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.647 ' CD1' ' HA ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -121.95 31.8 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.526 -0.761 . . . . 2.64 112.245 -174.137 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.69 93.05 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.743 -0.783 . . . . 1.75 111.415 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . 163.08 -30.1 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 114.192 -1.367 . . . . 2.67 109.404 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.487 ' O ' HG12 ' A' ' 39' ' ' ILE . 4.8 p-10 -177.3 104.19 0.05 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.863 -0.608 . . . . 4.56 111.009 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.647 ' HA ' ' CD1' ' A' ' 39' ' ' ILE . 23.0 m -51.05 126.82 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.098 -0.501 . . . . 4.12 112.276 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.1 p -173.66 34.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.519 0 N-CA-C 114.615 1.339 . . . . 3.1 114.615 -178.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.521 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 30.1 t 68.41 2.9 3.52 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 114.373 1.249 . . . . 1.46 114.373 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 45' ' ' SER . 36.4 tt0 179.37 153.01 0.42 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.827 0.677 . . . . 1.6 112.827 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.433 ' CD2' ' CE1' ' A' ' 29' ' ' HIS . 17.3 t80 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.23 -0.89 . . . . 4.35 110.939 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.417 ' C ' ' HG3' ' A' ' 31' ' ' PRO . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.222 -0.351 . . . . 2.65 112.222 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.494 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER 51.65 22.2 1.54 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.638 0.732 . . . . 2.17 110.044 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.45 ' CG1' ' HD3' ' A' ' 7' ' ' LYS . 2.9 t -104.54 -17.14 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.72 -0.673 . . . . 1.44 111.137 -179.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 24' ' ' GLU . 31.4 t-20 61.17 66.17 0.91 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.998 -0.742 . . . . 2.31 108.998 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.45 ' HD3' ' CG1' ' A' ' 5' ' ' VAL . 19.8 pttp -150.72 -146.96 0.21 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.05 -0.523 . . . . 2.9 109.65 -178.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.494 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -47.59 98.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 121.956 0.884 . . . . 2.43 111.525 178.669 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.586 ' CG2' ' HB2' ' A' ' 22' ' ' LEU . 3.4 tp -152.85 170.07 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.659 -0.701 . . . . 4.33 110.177 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -130.76 168.6 21.76 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.88 -0.676 . . . . 1.14 112.113 -175.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.498 ' HA ' ' N ' ' A' ' 21' ' ' TYR . 35.4 p -148.24 103.57 3.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 113.398 0.888 . . . . 1.95 113.398 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.431 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 51.0 ttp180 -159.96 101.6 1.45 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.003 -0.544 . . . . 4.16 111.254 176.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.474 HG22 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -115.45 -84.81 0.62 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.532 0.938 . . . . 1.13 113.532 179.237 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.6 -55.72 0.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.425 -0.51 . . . . 1.14 112.357 -178.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.81 -34.14 4.48 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.342 -0.933 . . . . 0.72 112.489 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.19 -29.38 67.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.206 0.527 . . . . 2.82 109.763 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.408 ' O ' ' HG3' ' A' ' 35' ' ' PRO . . . -150.44 -41.23 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.422 -0.808 . . . . 0.86 111.879 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.517 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . . . -130.54 151.2 51.27 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.449 -0.575 . . . . 1.15 109.449 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.439 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 4.7 ttp -163.17 27.71 0.09 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.705 1.002 . . . . 2.5 113.705 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.541 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 20.4 mt-10 -151.4 -179.71 7.61 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.516 -0.55 . . . . 1.28 109.516 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.64 ' CD2' ' CE3' ' A' ' 33' ' ' TRP . 2.8 t80 -159.66 11.09 0.12 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.57 0.952 . . . . 5.2 113.57 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.586 ' HB2' ' CG2' ' A' ' 9' ' ' ILE . 2.4 pt? -86.66 120.76 28.31 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 117.327 2.343 . . . . 5.07 117.327 -176.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.702 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 5.7 pt -55.49 -15.02 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 111.967 -2.379 . . . . 3.21 110.497 174.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.468 ' O ' ' ND2' ' A' ' 6' ' ' ASN . 29.4 tp10 -39.14 -27.57 0.02 OUTLIER 'General case' 0 C--N 1.344 0.332 0 CA-C-N 116.065 -0.516 . . . . 2.6 110.682 177.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.702 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -57.58 -163.19 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.803 -0.814 . . . . 1.71 108.803 176.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -107.41 44.76 1.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.449 -0.782 . . . . 3.74 111.379 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.46 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 3.5 p30 42.01 28.51 0.1 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.268 -0.424 . . . . 2.14 111.585 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 1.031 ' HA3' ' HH ' ' A' ' 38' ' ' TYR . . . -53.57 -55.53 24.59 Favored Glycine 0 CA--C 1.507 -0.422 0 C-N-CA 120.202 -0.999 . . . . 0.99 111.797 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.594 ' HB2' ' CD1' ' A' ' 38' ' ' TYR . 72.8 m80 -134.1 92.8 2.99 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 119.882 -0.727 . . . . 3.77 110.322 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.491 ' O ' ' OG ' ' A' ' 32' ' ' SER . 17.0 m 41.62 119.45 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 116.54 2.052 . . . . 1.8 116.54 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.497 ' HB3' ' CG2' ' A' ' 23' ' ' ILE . 12.5 Cg_exo -34.25 97.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 123.493 2.795 . . . . 0.79 107.856 170.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.559 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 67.2 m -121.06 155.16 35.01 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 114.263 1.209 . . . . 1.27 114.263 -172.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.64 ' CE3' ' CD2' ' A' ' 21' ' ' TYR . 6.7 t-105 -90.75 91.37 8.35 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 104.107 -2.553 . . . . 1.48 104.107 175.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.559 ' CG2' ' HB3' ' A' ' 32' ' ' SER . 0.0 OUTLIER -155.76 177.79 1.91 Allowed Pre-proline 0 C--O 1.215 -0.74 0 CA-C-N 114.896 -1.047 . . . . 2.35 110.974 -174.736 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.533 ' CD ' ' CG1' ' A' ' 34' ' ' VAL . 28.8 Cg_endo -86.34 111.86 1.07 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.879 2.386 . . . . 1.52 116.651 -174.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.7 t 49.69 19.37 0.4 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.555 -1.202 . . . . 2.17 113.079 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.553 ' N ' ' CE3' ' A' ' 25' ' ' TRP . 11.7 t -173.4 -108.15 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.205 -0.598 . . . . 1.81 111.597 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 1.031 ' HH ' ' HA3' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -176.3 116.59 0.12 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.446 -1.687 . . . . 5.8 106.446 -177.578 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.501 HG21 HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -141.51 31.42 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.772 0.796 . . . . 2.64 111.008 -174.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 41' ' ' ALA . . . -59.59 89.82 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.069 -0.969 . . . . 1.75 110.636 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 40' ' ' ALA . . . 157.02 39.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.138 -0.937 . . . . 2.67 110.763 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 t70 56.67 85.41 0.08 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.816 0.302 . . . . 4.56 111.816 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.473 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -153.94 -159.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 110.083 -0.34 . . . . 4.12 110.083 179.113 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.44 ' CA ' HD12 ' A' ' 39' ' ' ILE . 7.4 p -157.27 118.58 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 113.557 0.947 . . . . 3.1 113.557 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 54.5 p 65.99 4.77 3.17 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 114.696 -1.138 . . . . 1.46 113.757 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 45' ' ' SER . 39.0 tt0 179.38 154.03 0.46 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.099 0.476 . . . . 1.6 111.671 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 t80 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.243 -0.884 . . . . 4.35 110.991 -179.753 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.427 -0.269 . . . . 2.65 112.427 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.474 ' HA ' ' CD1' ' A' ' 23' ' ' ILE . 2.7 tm-20 65.46 9.03 5.45 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.868 0.366 . . . . 2.17 111.891 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.1 t -91.39 -36.18 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 122.017 0.913 . . . . 1.44 108.85 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.442 ' N ' HG12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER 68.65 87.45 0.12 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.678 -1.601 . . . . 2.31 111.329 179.014 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -150.31 -144.4 0.15 Allowed 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.995 -1.113 . . . . 2.9 107.995 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.431 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -55.03 118.44 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.006 -0.368 . . . . 2.43 110.006 178.57 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.487 ' HA ' ' CB ' ' A' ' 22' ' ' LEU . 36.6 pt -111.27 136.79 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 114.751 1.389 . . . . 4.33 114.751 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.8 146.43 16.67 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 106.86 -2.496 . . . . 1.14 106.86 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.515 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.6 OUTLIER -153.13 105.94 2.95 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 118.781 1.291 . . . . 1.95 113.408 -175.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -156.3 102.82 2.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.995 -0.548 . . . . 4.16 111.104 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.487 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -121.97 -80.74 0.63 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 119.599 -0.84 . . . . 1.13 112.993 179.402 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -150.05 -57.75 0.19 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.437 -0.505 . . . . 1.14 112.172 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.04 -42.34 1.8 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.538 -0.839 . . . . 0.72 112.158 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -59.38 -33.89 71.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.169 0.509 . . . . 2.82 110.135 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.45 -48.72 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.568 -0.742 . . . . 0.86 111.493 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.49 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -130.55 150.13 51.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.86 -0.422 . . . . 1.15 109.86 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.454 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -163.9 30.08 0.08 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.062 1.134 . . . . 2.5 114.062 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 11.1 mt-10 -148.79 -171.9 3.98 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.287 -1.005 . . . . 1.28 108.287 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.617 ' CD2' ' CZ3' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -154.02 -57.5 0.12 Allowed 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 119.217 3.043 . . . . 5.2 119.217 -176.056 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.488 HD21 ' CE1' ' A' ' 21' ' ' TYR . 8.4 mt -81.24 148.04 29.67 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 118.034 -1.466 . . . . 5.07 114.705 -171.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.51 HD13 ' CD1' ' A' ' 25' ' ' TRP . 3.2 tp -13.23 -105.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 110.818 -2.901 . . . . 3.21 114.07 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.491 ' N ' HG13 ' A' ' 23' ' ' ILE . 8.1 mm-40 42.82 25.85 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 119.39 0.996 . . . . 2.6 111.349 -177.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.536 ' CE3' ' HA ' ' A' ' 37' ' ' SER . 0.5 OUTLIER -136.53 29.01 2.98 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 116.133 -0.485 . . . . 1.71 111.289 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 40.35 30.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 3.74 112.133 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.43 ' HB2' ' CG ' ' A' ' 4' ' ' GLU . 23.8 t70 63.51 34.11 12.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.008 0.432 . . . . 2.14 110.312 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 25' ' ' TRP . . . -45.37 -63.76 2.57 Favored Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 111.045 -0.822 . . . . 0.99 111.045 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.514 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -133.44 109.12 9.09 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 109.047 -0.723 . . . . 3.77 109.047 177.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.446 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 48.1 m 31.0 103.3 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 114.994 1.479 . . . . 1.8 114.994 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.438 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 13.4 Cg_exo -29.87 120.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.257 0 C-N-CA 123.093 2.529 . . . . 0.79 111.372 176.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.601 ' HB2' ' CD2' ' A' ' 38' ' ' TYR . 17.9 t -143.34 -163.72 1.71 Allowed 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 114.345 1.239 . . . . 1.27 114.345 -174.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.617 ' CZ3' ' CD2' ' A' ' 21' ' ' TYR . 4.5 t-105 -123.11 93.11 3.85 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 106.349 -1.722 . . . . 1.48 106.349 175.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.691 HG12 HG22 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -159.85 178.27 1.74 Allowed Pre-proline 0 C--O 1.22 -0.47 0 CA-C-N 115.356 -0.838 . . . . 2.35 111.01 -177.72 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.581 ' N ' HG13 ' A' ' 34' ' ' VAL . 6.4 Cg_endo -95.51 137.27 0.72 Allowed 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.939 3.093 . . . . 1.52 112.444 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 10.7 t 79.83 -62.17 0.27 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.454 0.909 . . . . 2.17 113.454 177.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.536 ' HA ' ' CE3' ' A' ' 25' ' ' TRP . 47.5 t -150.54 -56.89 0.17 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.556 1.317 . . . . 1.81 114.556 -177.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.855 ' HH ' ' CB ' ' A' ' 40' ' ' ALA . 14.4 t80 176.97 152.04 0.19 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.799 -0.445 . . . . 5.8 109.799 -176.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.691 HG22 HG12 ' A' ' 34' ' ' VAL . 0.6 OUTLIER 175.86 67.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.9 0.857 . . . . 2.64 108.851 -179.621 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.855 ' CB ' ' HH ' ' A' ' 38' ' ' TYR . . . -59.66 92.76 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.151 -0.931 . . . . 1.75 111.082 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 174.14 -31.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.337 -0.847 . . . . 2.67 110.983 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 74.08 23.94 2.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.075 -0.511 . . . . 4.56 110.807 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.82 -25.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 4.12 111.211 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.446 ' HB ' HG12 ' A' ' 39' ' ' ILE . 3.5 t -136.07 165.02 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.955 0.407 . . . . 3.1 111.118 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.499 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 29.6 t -96.38 25.46 4.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.873 -0.603 . . . . 1.46 110.689 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -179.72 149.05 0.35 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.437 -0.347 . . . . 1.6 110.996 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.499 ' HB3' ' CD2' ' A' ' 29' ' ' HIS . 10.3 t80 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.212 -0.899 . . . . 4.35 110.944 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.48 ' CA ' ' CD1' ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.404 0 N-CA-C 112.424 -0.27 . . . . 2.65 112.424 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.454 ' HB3' ' HG3' ' A' ' 31' ' ' PRO . 0.0 OUTLIER 78.0 -13.49 0.95 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.144 0.794 . . . . 2.17 113.144 179.484 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 6' ' ' ASN . 11.3 t -77.71 -51.29 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 121.454 0.645 . . . . 1.44 111.12 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.475 ' CA ' HG23 ' A' ' 23' ' ' ILE . 1.1 m-20 99.11 82.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.362 -1.29 . . . . 2.31 109.669 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.9 pttp -150.61 -131.23 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.42 -1.264 . . . . 2.9 108.75 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.481 HG21 HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -47.06 113.83 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 118.306 0.503 . . . . 2.43 109.824 177.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.47 ' HA ' ' CB ' ' A' ' 22' ' ' LEU . 3.1 pt -124.8 116.49 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 114.793 1.405 . . . . 4.33 114.793 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.447 ' H ' ' HB2' ' A' ' 22' ' ' LEU . . . -101.72 144.54 16.43 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 107.055 -2.418 . . . . 1.14 107.055 174.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.589 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 15.9 p -155.11 104.38 2.45 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.934 1.087 . . . . 1.95 113.934 -175.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.27 98.22 1.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.944 -0.571 . . . . 4.16 109.881 176.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.484 HG22 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -102.89 -82.16 0.49 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 119.385 -0.926 . . . . 1.13 112.901 179.533 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -142.69 -65.78 0.39 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.692 0.627 . . . . 1.14 112.692 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . 126.19 -35.05 3.07 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.099 -0.8 . . . . 0.72 111.099 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -66.78 -30.52 70.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.27 0.557 . . . . 2.82 109.61 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.418 ' HA2' HG11 ' A' ' 44' ' ' VAL . . . -145.47 -49.1 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.272 -0.876 . . . . 0.86 111.686 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.553 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -118.49 151.55 37.62 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 119.701 -0.19 . . . . 1.15 110.597 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.43 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -160.36 27.03 0.16 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.886 1.439 . . . . 2.5 114.886 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.646 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 12.3 mt-10 -151.1 -174.4 4.79 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.56 -0.533 . . . . 1.28 109.56 177.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.614 ' CD2' ' CZ3' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -153.08 -72.55 0.14 Allowed 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 118.815 2.894 . . . . 5.2 118.815 -177.185 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.529 ' HG ' ' CE2' ' A' ' 21' ' ' TYR . 33.7 mt -82.92 143.09 30.96 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 114.749 1.389 . . . . 5.07 114.749 -172.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.48 ' CD1' ' CA ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER 17.37 -148.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 111.522 -2.581 . . . . 3.21 113.751 -179.297 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER 83.15 -5.88 1.23 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.902 -0.407 . . . . 2.6 109.902 -178.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.574 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 1.3 p90 -121.98 28.57 7.49 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 120.861 -0.336 . . . . 1.71 111.023 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.8 tttt 29.18 62.93 0.14 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.223 0.823 . . . . 3.74 113.223 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.433 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 3.9 p30 45.61 27.4 0.42 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.753 0.311 . . . . 2.14 111.631 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -49.48 -65.9 2.54 Favored Glycine 0 CA--C 1.508 -0.356 0 N-CA-C 110.776 -0.929 . . . . 0.99 110.776 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.566 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -132.56 100.72 5.05 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 108.752 -0.833 . . . . 3.77 108.752 177.374 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.417 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 70.2 m 37.08 109.53 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 N-CA-C 116.24 1.941 . . . . 1.8 116.24 176.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.454 ' HG3' ' HB3' ' A' ' 4' ' ' GLU . 2.8 Cg_exo -34.92 102.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.938 2.425 . . . . 0.79 110.027 174.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.544 ' HB2' ' CD2' ' A' ' 38' ' ' TYR . 28.7 t -124.2 -177.54 3.81 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 114.166 1.173 . . . . 1.27 114.166 -174.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.614 ' CZ3' ' CD2' ' A' ' 21' ' ' TYR . 3.7 t-105 -109.33 100.13 9.28 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 103.235 -2.876 . . . . 1.48 103.235 173.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.646 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -153.07 154.79 31.4 Favored Pre-proline 0 N--CA 1.444 -0.761 0 CA-C-N 115.267 -0.879 . . . . 2.35 112.63 -171.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.553 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 21.2 Cg_endo -59.45 -13.74 22.15 Favored 'Trans proline' 0 N--CA 1.491 1.344 1 C-N-CA 126.35 4.7 . . . . 1.52 117.817 -176.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 18.6 p 178.51 -23.59 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 119.572 1.078 . . . . 2.17 113.764 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.521 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 48.2 t -141.21 -73.23 0.33 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.514 0.673 . . . . 1.81 110.663 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.929 ' HH ' ' HB3' ' A' ' 40' ' ' ALA . 11.7 t80 177.8 131.84 0.06 Allowed 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 115.536 -0.756 . . . . 5.8 109.84 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.492 HG21 HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -146.67 26.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.503 -0.879 . . . . 2.64 110.852 -179.216 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.929 ' HB3' ' HH ' ' A' ' 38' ' ' TYR . . . -64.81 88.7 0.07 Allowed 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.144 -1.022 . . . . 1.75 109.955 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 40' ' ' ALA . . . 151.8 37.84 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.538 -1.21 . . . . 2.67 110.522 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 61.19 88.72 0.08 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.057 0.391 . . . . 4.56 112.057 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.417 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -162.99 -169.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 110.25 -0.278 . . . . 4.12 110.25 178.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.418 HG11 ' HA2' ' A' ' 17' ' ' GLY . 11.4 m -144.59 124.1 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 113.216 0.821 . . . . 3.1 113.216 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.437 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 28.9 t 53.8 16.25 0.99 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.249 -0.887 . . . . 1.46 113.084 178.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 179.84 148.01 0.27 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.724 -0.39 . . . . 1.6 111.925 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.546 ' N ' ' O ' ' A' ' 38' ' ' TYR . 14.4 t80 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.211 -0.899 . . . . 4.35 111.094 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.544 -0.222 . . . . 6.49 112.544 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.2 m 56.0 54.24 8.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.908 0.385 . . . . 4.66 110.852 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.75 144.59 8.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.782 -0.723 . . . . 2.65 112.412 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.465 ' CA ' HG22 ' A' ' 23' ' ' ILE . 15.0 tt0 61.67 14.05 5.78 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.163 0.506 . . . . 2.17 111.665 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 6' ' ' ASN . 58.0 t -79.67 -42.62 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 O-C-N 121.986 -0.446 . . . . 1.44 111.138 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.434 ' HA ' HG13 ' A' ' 23' ' ' ILE . 20.1 t-20 82.06 44.51 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.697 -0.683 . . . . 2.31 111.999 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 22.9 ptmt -119.76 -143.2 0.35 Allowed 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.179 -1.045 . . . . 2.9 108.179 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.438 ' N ' ' HG3' ' A' ' 7' ' ' LYS . 3.1 tp -45.44 139.26 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 122.219 0.208 . . . . 2.43 111.009 178.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.513 ' HA ' ' CB ' ' A' ' 22' ' ' LEU . 27.6 pt -133.94 129.28 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 114.641 1.349 . . . . 4.33 114.641 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.06 144.41 16.0 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 106.865 -2.494 . . . . 1.14 106.865 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.491 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -152.36 105.42 3.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 118.855 1.328 . . . . 1.95 113.471 -175.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -156.85 102.87 2.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.847 -0.615 . . . . 4.16 110.874 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.484 HG22 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -116.67 -80.82 0.61 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.625 -0.83 . . . . 1.13 113.082 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.3 -58.79 0.19 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.631 0.604 . . . . 1.14 112.631 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.9 -36.37 3.36 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.577 -0.82 . . . . 0.72 111.757 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.19 -31.21 68.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.39 -0.596 . . . . 2.82 109.39 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.402 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -147.35 -58.45 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.029 -0.987 . . . . 0.86 110.847 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.493 ' CB ' HG11 ' A' ' 34' ' ' VAL . . . -106.21 151.45 24.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.523 -0.338 . . . . 1.15 110.662 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.402 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -165.47 26.01 0.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.07 0.767 . . . . 2.5 113.07 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 5.2 mt-10 -146.54 -171.45 3.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.718 -0.845 . . . . 1.28 108.718 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.603 ' CD2' ' CZ3' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -155.17 -53.96 0.09 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 117.965 2.58 . . . . 5.2 117.965 -177.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 9' ' ' ILE . 8.7 mt -88.27 151.69 22.47 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 116.324 1.972 . . . . 5.07 116.324 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.527 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -7.54 -117.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 111.584 -2.553 . . . . 3.21 114.402 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.42 ' CG ' HD11 ' A' ' 9' ' ' ILE . 0.9 OUTLIER 48.88 24.0 0.78 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.623 0.647 . . . . 2.6 110.221 -177.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.527 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -145.81 31.13 1.06 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 113.45 0.907 . . . . 1.71 113.45 -179.302 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.6 mttp 33.54 33.98 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.556 0.576 . . . . 3.74 112.556 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.437 ' HB3' ' CG ' ' A' ' 4' ' ' GLU . 4.1 p-10 46.64 47.81 14.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.886 -0.597 . . . . 2.14 112.194 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.449 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -52.95 -56.11 20.38 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.073 -1.06 . . . . 0.99 111.531 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.487 ' O ' ' O ' ' A' ' 30' ' ' SER . 85.8 m-70 -131.1 94.21 3.54 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 109.337 -0.616 . . . . 3.77 109.337 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 29' ' ' HIS . 13.9 m 40.43 106.68 0.01 OUTLIER Pre-proline 0 C--O 1.223 -0.29 0 N-CA-C 113.468 0.914 . . . . 1.8 113.468 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.437 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 8.2 Cg_exo -33.53 130.63 0.14 Allowed 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 122.479 2.12 . . . . 0.79 110.037 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.556 ' CB ' ' CG2' ' A' ' 34' ' ' VAL . 64.7 m -150.94 156.36 41.02 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 113.94 1.089 . . . . 1.27 113.94 -173.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.603 ' CZ3' ' CD2' ' A' ' 21' ' ' TYR . 3.7 t-105 -86.1 92.26 8.67 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 103.663 -2.717 . . . . 1.48 103.663 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.574 ' CG1' ' CD ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -154.99 -177.8 0.79 Allowed Pre-proline 0 CA--C 1.547 0.855 0 CA-C-N 114.706 -1.133 . . . . 2.35 110.414 -174.607 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.574 ' CD ' ' CG1' ' A' ' 34' ' ' VAL . 30.4 Cg_endo -86.33 103.22 0.66 Allowed 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 124.185 3.257 . . . . 1.52 116.32 -174.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 t 41.2 28.08 0.06 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.108 0.48 . . . . 2.17 111.251 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.502 ' O ' ' CE3' ' A' ' 25' ' ' TRP . 1.5 m -166.23 -131.85 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.444 -0.798 . . . . 1.81 109.913 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -170.45 98.92 0.26 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 105.004 -2.221 . . . . 5.8 105.004 -177.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.48 ' HA ' ' HB2' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -116.59 37.64 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.823 -1.08 . . . . 2.64 111.624 -173.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 41' ' ' ALA . . . -69.82 89.98 0.59 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.188 -0.915 . . . . 1.75 110.904 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 40' ' ' ALA . . . 152.96 42.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.272 -0.876 . . . . 2.67 110.504 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 t70 54.76 88.67 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.72 0.295 . . . . 4.56 110.778 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -169.75 170.6 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.306 -0.628 . . . . 4.12 109.306 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.479 ' N ' ' CG2' ' A' ' 43' ' ' VAL . 7.6 p -128.63 132.99 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 114.079 1.14 . . . . 3.1 114.079 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.43 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 16.6 t 61.83 7.59 2.07 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.669 1.359 . . . . 1.46 114.669 176.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' O ' ' CG2' ' A' ' 43' ' ' VAL . 3.5 tt0 177.8 -173.04 0.12 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.136 -0.626 . . . . 1.6 112.42 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.48 ' HB2' ' HA ' ' A' ' 39' ' ' ILE . 45.5 t80 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.222 -0.894 . . . . 4.35 110.675 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.503 -0.239 . . . . 6.49 112.503 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.5 t 63.16 45.18 5.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.851 0.358 . . . . 4.66 111.055 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.414 ' HA2' HG12 ' A' ' 23' ' ' ILE . . . -168.91 146.75 10.54 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.678 -0.772 . . . . 2.65 112.616 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.467 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 0.0 OUTLIER 58.29 12.98 2.16 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.021 0.378 . . . . 2.17 112.021 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.409 ' HB ' ' HG2' ' A' ' 7' ' ' LYS . 23.2 t -89.42 -4.22 10.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 112.274 0.472 . . . . 1.44 112.274 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.402 ' ND2' ' HG3' ' A' ' 24' ' ' GLU . 29.4 t-20 39.09 71.66 0.16 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.007 0.432 . . . . 2.31 111.236 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.415 ' N ' ' OE1' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -150.77 -141.98 0.11 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.874 -0.603 . . . . 2.9 109.389 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.485 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -56.49 106.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.596 0.712 . . . . 2.43 111.537 179.48 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.509 ' CG2' ' CB ' ' A' ' 22' ' ' LEU . 3.0 tp -153.55 171.06 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.845 -0.616 . . . . 4.33 110.763 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.03 169.37 20.45 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 111.824 -0.511 . . . . 1.14 111.824 -175.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.501 ' HA ' ' N ' ' A' ' 21' ' ' TYR . 14.1 p -150.29 103.99 3.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 113.312 0.856 . . . . 1.95 113.312 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.422 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 32.2 ttm180 -159.46 101.36 1.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.481 -0.327 . . . . 4.16 111.845 177.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.477 HG21 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -115.69 -85.42 0.62 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.857 1.058 . . . . 1.13 113.857 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.42 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -146.03 -51.57 0.24 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.421 0.555 . . . . 1.14 112.493 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.06 -35.57 4.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.625 -0.798 . . . . 0.72 112.193 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -59.73 -41.99 92.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.224 0.535 . . . . 2.82 110.01 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -136.03 -40.61 0.14 Allowed Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.397 -0.819 . . . . 0.86 111.697 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.495 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . . . -130.59 150.7 51.67 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.439 -0.578 . . . . 1.15 109.439 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.42 ' HG3' ' C ' ' A' ' 14' ' ' ALA . 2.9 ttt -162.74 24.58 0.1 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.1 0.778 . . . . 2.5 113.1 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 18.5 mt-10 -150.65 178.81 8.74 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.183 -0.673 . . . . 1.28 109.183 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.611 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 2.3 t80 -157.61 9.66 0.18 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.515 0.931 . . . . 5.2 113.515 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.563 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 1.8 pp -83.6 130.3 34.98 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 116.522 2.045 . . . . 5.07 116.522 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.489 HG13 ' HA ' ' A' ' 31' ' ' PRO . 1.4 mp -72.5 10.14 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 CA-C-N 110.016 -3.266 . . . . 3.21 111.1 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.415 ' OE1' ' N ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -78.64 10.86 2.88 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.232 -0.44 . . . . 2.6 110.702 177.411 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.563 ' CD2' ' O ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -86.98 32.57 0.67 Allowed 'General case' 0 C--N 1.347 0.458 0 CA-C-O 120.627 0.251 . . . . 1.71 111.411 178.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 74.6 tttt 48.85 36.3 7.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.626 -0.261 . . . . 3.74 111.212 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.443 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 16.4 t0 57.09 23.08 8.07 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.114 -0.634 . . . . 2.14 109.746 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -43.45 -64.39 1.82 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 120.764 -0.731 . . . . 0.99 111.328 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.509 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -135.16 98.87 4.1 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 109.553 -0.536 . . . . 3.77 109.553 177.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 29' ' ' HIS . 40.6 m 32.43 117.23 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 117.096 2.258 . . . . 1.8 117.096 176.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HA ' HG13 ' A' ' 23' ' ' ILE . 14.8 Cg_exo -31.5 118.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 123.75 2.967 . . . . 0.79 108.427 172.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.529 ' CB ' ' CD2' ' A' ' 38' ' ' TYR . 7.3 t -152.21 154.35 35.62 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.379 1.252 . . . . 1.27 114.379 -172.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.61 ' CE3' ' CD2' ' A' ' 21' ' ' TYR . 8.4 t-105 -91.52 91.23 7.97 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 104.187 -2.523 . . . . 1.48 104.187 175.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -156.77 173.97 4.47 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 114.65 -1.159 . . . . 2.35 110.928 -175.066 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.513 ' HD2' HG22 ' A' ' 39' ' ' ILE . 7.3 Cg_endo -92.38 122.24 0.57 Allowed 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.512 2.808 . . . . 1.52 116.447 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 35' ' ' PRO . 15.6 m 79.9 -51.72 0.38 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.833 -1.076 . . . . 2.17 113.736 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.561 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 57.9 m -144.16 -65.49 0.36 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.538 0.685 . . . . 1.81 111.272 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.866 ' HH ' ' HB2' ' A' ' 40' ' ' ALA . 10.0 t80 178.7 140.88 0.1 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.251 -0.648 . . . . 5.8 109.251 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.513 HG22 ' HD2' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -161.1 30.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 122.801 1.286 . . . . 2.64 109.137 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.866 ' HB2' ' HH ' ' A' ' 38' ' ' TYR . . . -66.23 89.85 0.14 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.748 -1.114 . . . . 1.75 110.507 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 40' ' ' ALA . . . 156.62 41.1 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.438 -0.801 . . . . 2.67 110.573 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 58.18 84.09 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.77 0.319 . . . . 4.56 111.18 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.426 ' HB ' ' CG1' ' A' ' 39' ' ' ILE . 0.6 OUTLIER -157.21 -151.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.43 -0.582 . . . . 4.12 109.43 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -169.05 120.72 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 113.448 0.907 . . . . 3.1 113.448 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.3 t 65.74 7.02 4.23 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 114.089 1.144 . . . . 1.46 114.089 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.496 ' N ' HG23 ' A' ' 39' ' ' ILE . 3.6 tt0 179.05 147.01 0.18 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.571 0.582 . . . . 1.6 112.571 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 38' ' ' TYR . 28.6 p90 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.19 -0.91 . . . . 4.35 111.07 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.567 -0.213 . . . . 6.49 112.567 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.6 t -110.18 -30.89 7.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 4.66 110.857 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.492 ' CA ' ' CG2' ' A' ' 23' ' ' ILE . . . -127.55 -116.59 2.0 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.657 -0.782 . . . . 2.65 113.034 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.485 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 1.8 tm-20 61.39 26.57 16.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 122.274 1.035 . . . . 2.17 109.275 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -104.32 -19.73 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.129 -0.941 . . . . 1.44 111.505 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.435 ' ND2' ' HA ' ' A' ' 24' ' ' GLU . 7.1 m120 47.5 79.1 0.07 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.946 -0.39 . . . . 2.31 109.946 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -135.68 -98.61 0.23 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.887 0.699 . . . . 2.9 112.887 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.1 tp -135.97 111.63 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 109.839 -0.43 . . . . 2.43 109.839 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.73 ' CG2' ' CE2' ' A' ' 21' ' ' TYR . 6.9 tp -150.97 162.73 3.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 112.622 0.601 . . . . 4.33 112.622 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.486 ' N ' HG13 ' A' ' 9' ' ' ILE . . . -109.85 121.15 5.93 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 110.634 -0.986 . . . . 1.14 110.634 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.793 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -102.55 107.85 18.94 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.698 1.237 . . . . 1.95 113.174 -176.055 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -157.68 112.73 2.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 112.433 -2.167 . . . . 4.16 112.311 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.455 ' CB ' ' HA ' ' A' ' 19' ' ' MET . 1.6 m -116.36 -78.21 0.58 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.408 0.521 . . . . 1.13 112.408 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.96 -54.94 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.731 0.301 . . . . 1.14 111.647 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.12 -35.67 4.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.352 -0.928 . . . . 0.72 112.653 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.3 -27.0 65.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.056 0.455 . . . . 2.82 110.342 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -150.38 -43.64 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.694 -0.685 . . . . 0.86 111.582 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.499 ' CB ' HG11 ' A' ' 34' ' ' VAL . . . -129.98 151.47 50.5 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.862 -0.421 . . . . 1.15 109.862 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.455 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 4.0 ttp -164.23 51.88 0.13 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.618 1.34 . . . . 2.5 114.618 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.695 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 6.7 mt-10 -151.01 -124.39 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 114.886 1.439 . . . . 1.28 114.886 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 1.159 ' HH ' ' CB ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -155.72 -126.78 0.03 OUTLIER 'General case' 0 C--O 1.199 -1.556 0 N-CA-C 117.787 2.514 . . . . 5.2 117.787 -173.323 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.542 ' HA ' ' CZ2' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -151.53 165.19 34.98 Favored 'General case' 0 N--CA 1.432 -1.358 0 O-C-N 121.409 -0.807 . . . . 5.07 111.128 178.517 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.492 ' CG2' ' CA ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER 56.29 63.04 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 124.505 1.122 . . . . 3.21 113.678 179.193 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 1.159 ' CB ' ' HH ' ' A' ' 21' ' ' TYR . 5.0 tt0 178.88 38.67 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.861 0.689 . . . . 2.6 112.861 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.542 ' CZ2' ' HA ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -153.15 32.92 0.47 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.682 0.623 . . . . 1.71 112.682 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp 56.17 20.12 4.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.843 0.354 . . . . 3.74 111.425 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.481 ' HB3' ' CG ' ' A' ' 4' ' ' GLU . 2.6 p-10 47.34 40.16 10.19 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.135 0.791 . . . . 2.14 113.135 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 1.092 ' HA3' ' HH ' ' A' ' 38' ' ' TYR . . . -48.23 -54.89 11.31 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.082 -1.056 . . . . 0.99 112.344 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.591 ' CE1' ' CE2' ' A' ' 47' ' ' TYR . 69.8 t60 -131.69 95.44 3.72 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 117.244 0.522 . . . . 3.77 110.546 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.511 ' O ' ' O ' ' A' ' 29' ' ' HIS . 14.6 m 37.63 107.48 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.402 0 N-CA-C 113.471 0.915 . . . . 1.8 113.471 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 7.1 Cg_exo -33.85 125.67 0.16 Allowed 'Trans proline' 0 C--N 1.366 1.45 0 C-N-CA 122.768 2.312 . . . . 0.79 110.275 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.558 ' O ' ' O ' ' A' ' 21' ' ' TYR . 67.3 m -152.24 143.96 23.58 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 119.422 -0.911 . . . . 1.27 112.879 -173.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.615 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 31.5 t-105 -78.59 92.42 4.7 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 104.051 -2.574 . . . . 1.48 104.051 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.695 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -152.67 173.04 4.88 Favored Pre-proline 0 N--CA 1.442 -0.829 0 CA-C-N 112.308 -2.223 . . . . 2.35 108.533 -176.183 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.514 ' CD ' ' CG1' ' A' ' 34' ' ' VAL . 85.5 Cg_endo -77.46 105.82 2.11 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 123.726 2.95 . . . . 1.52 117.432 -173.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 37' ' ' SER . 46.8 t 43.5 27.25 0.14 Allowed 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.33 -1.305 . . . . 2.17 111.997 176.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.547 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 12.2 m -166.65 -120.16 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.494 -0.775 . . . . 1.81 109.668 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 1.092 ' HH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -175.49 101.21 0.08 Allowed 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 106.45 -1.685 . . . . 5.8 106.45 -177.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.492 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -127.04 33.16 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 114.745 -1.116 . . . . 2.64 109.154 -176.082 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.28 92.79 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.424 -1.262 . . . . 1.75 111.905 -177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 42' ' ' ASP . . . 168.49 -61.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.184 -0.916 . . . . 2.67 110.059 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 9.2 t70 163.29 79.73 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.321 -0.854 . . . . 4.56 109.683 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -148.91 -157.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.959 -0.296 . . . . 4.12 110.401 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.428 ' N ' HD11 ' A' ' 39' ' ' ILE . 4.8 p -155.16 105.9 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.421 0.629 . . . . 3.1 112.531 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.424 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 6.3 p 80.16 2.36 1.98 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.762 -1.108 . . . . 1.46 113.335 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.465 ' CA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER 179.15 140.74 0.11 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.597 0.237 . . . . 1.6 111.311 179.715 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.591 ' CE2' ' CE1' ' A' ' 29' ' ' HIS . 11.0 t80 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.195 -0.907 . . . . 4.35 110.069 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.519 -0.232 . . . . 6.49 112.519 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.6 p -87.97 94.7 9.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 4.66 110.917 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.434 ' HA3' ' CB ' ' A' ' 31' ' ' PRO . . . -151.25 -143.66 3.76 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.791 -0.718 . . . . 2.65 112.464 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.49 ' N ' ' CG ' ' A' ' 31' ' ' PRO . 2.1 tm-20 64.36 47.19 3.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.953 0.883 . . . . 2.17 110.137 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.0 t -119.94 -16.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.243 -0.89 . . . . 1.44 111.301 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 24.8 t-20 50.37 38.59 18.35 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 108.529 -0.915 . . . . 2.31 108.529 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.464 ' CG ' HD12 ' A' ' 23' ' ' ILE . 21.7 pttp -93.48 -129.6 0.12 Allowed 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.291 -1.322 . . . . 2.9 111.268 -176.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.429 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -117.02 117.14 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.048 0.452 . . . . 2.43 111.965 -178.402 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.533 HG23 ' CD2' ' A' ' 21' ' ' TYR . 9.7 tp -149.59 161.88 4.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.958 -0.564 . . . . 4.33 110.849 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' N ' HG13 ' A' ' 9' ' ' ILE . . . -109.34 130.41 9.97 Favored Glycine 0 CA--C 1.505 -0.589 0 N-CA-C 110.363 -1.095 . . . . 1.14 110.363 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.63 ' HB3' ' CG ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -102.16 107.8 19.0 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.562 1.172 . . . . 1.95 113.188 -177.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.34 104.4 2.03 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.547 -2.115 . . . . 4.16 111.285 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.451 ' CB ' ' HA ' ' A' ' 19' ' ' MET . 1.3 m -109.59 -81.51 0.57 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 119.953 -0.699 . . . . 1.13 112.562 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.84 -54.23 0.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.717 0.294 . . . . 1.14 111.417 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.05 -28.37 7.32 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.313 -0.946 . . . . 0.72 112.893 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.28 -33.43 71.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.336 0.589 . . . . 2.82 109.75 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.419 ' HA2' HG11 ' A' ' 44' ' ' VAL . . . -150.32 -46.9 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.785 -0.926 . . . . 0.86 110.785 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.541 ' HB2' ' HA ' ' A' ' 34' ' ' VAL . . . -115.17 152.17 33.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.263 -0.468 . . . . 1.15 110.027 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.451 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -165.94 46.84 0.08 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.105 0.78 . . . . 2.5 113.105 -179.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.721 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 53.3 mt-10 -149.54 -139.77 0.1 Allowed 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 114.621 1.341 . . . . 1.28 114.621 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.63 ' CG ' ' HB3' ' A' ' 11' ' ' SER . 0.1 OUTLIER -123.45 -172.65 2.56 Favored 'General case' 0 C--O 1.191 -2.008 0 N-CA-C 114.728 1.381 . . . . 5.2 114.728 -173.112 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.541 ' HA ' ' CZ2' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -137.88 104.74 5.36 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 114.181 1.178 . . . . 5.07 114.181 173.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.528 ' CG2' ' O ' ' A' ' 22' ' ' LEU . 2.7 pp 136.57 24.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 126.886 2.075 . . . . 3.21 112.436 176.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.565 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 8.9 tp10 -130.57 53.4 1.96 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.786 0.721 . . . . 2.6 111.925 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.576 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -153.83 -169.4 3.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.108 -0.496 . . . . 1.71 109.782 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.59 36.69 1.6 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.08 0.467 . . . . 3.74 109.791 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.437 ' HB2' ' CG ' ' A' ' 4' ' ' GLU . 24.9 t70 53.31 44.82 29.6 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.809 -0.632 . . . . 2.14 110.862 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.509 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -54.04 -64.27 4.41 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.231 -0.985 . . . . 0.99 112.312 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.464 ' O ' ' CB ' ' A' ' 38' ' ' TYR . 47.5 t-80 -134.41 95.94 3.49 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 117.099 0.449 . . . . 3.77 110.386 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 31' ' ' PRO . 17.4 m 39.12 98.01 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 112.573 0.583 . . . . 1.8 112.573 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.49 ' CG ' ' N ' ' A' ' 4' ' ' GLU . 18.0 Cg_exo -27.24 126.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.365 1.395 0 C-N-CA 123.558 2.839 . . . . 0.79 110.407 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.495 ' O ' ' CH2' ' A' ' 25' ' ' TRP . 8.5 t -152.41 144.64 23.93 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 119.038 -1.065 . . . . 1.27 112.959 -171.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.494 ' N ' ' HB3' ' A' ' 22' ' ' LEU . 9.1 t-105 -83.31 96.07 8.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 104.335 -2.469 . . . . 1.48 104.335 175.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.721 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -151.51 -172.24 0.31 Allowed Pre-proline 0 N--CA 1.434 -1.229 0 CA-C-N 112.548 -2.115 . . . . 2.35 106.659 -175.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.511 ' CD ' HG12 ' A' ' 34' ' ' VAL . 44.9 Cg_endo -88.13 102.69 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.676 2.251 . . . . 1.52 116.142 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.42 ' N ' ' OE1' ' A' ' 20' ' ' GLU . 41.9 t 45.41 23.93 0.15 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.725 -0.671 . . . . 2.17 111.989 177.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.548 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 5.4 m -163.59 -122.93 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 116.476 -0.329 . . . . 1.81 110.22 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -174.47 102.15 0.1 Allowed 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 106.282 -1.747 . . . . 5.8 106.282 -177.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.476 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -124.17 34.98 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 114.683 -1.144 . . . . 2.64 110.329 -174.223 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.401 ' O ' ' HB1' ' A' ' 41' ' ' ALA . . . -59.4 91.92 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.346 -1.297 . . . . 1.75 111.695 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.42 ' O ' ' CB ' ' A' ' 42' ' ' ASP . . . 166.72 -60.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.307 -0.86 . . . . 2.67 110.022 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 41' ' ' ALA . 1.6 p30 160.49 78.66 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.567 -0.742 . . . . 4.56 110.398 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.429 ' O ' ' CD1' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -151.44 -166.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 110.067 -0.346 . . . . 4.12 110.067 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.419 HG11 ' HA2' ' A' ' 17' ' ' GLY . 3.1 m -147.22 121.68 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 112.848 0.684 . . . . 3.1 112.848 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.418 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 22.8 t 69.5 5.01 4.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.207 -0.906 . . . . 1.46 113.199 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 45' ' ' SER . 39.1 tt0 179.02 158.62 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.089 0.471 . . . . 1.6 111.863 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.481 ' CD2' ' OXT' ' A' ' 47' ' ' TYR . 37.4 p90 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.176 -0.916 . . . . 4.35 110.997 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.529 -0.229 . . . . 6.49 112.529 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.1 p -94.05 173.6 7.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.765 0.317 . . . . 4.66 110.908 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 5' ' ' VAL . . . 81.56 144.84 4.57 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.724 -0.751 . . . . 2.65 112.647 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 48.74 26.82 1.36 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.785 0.803 . . . . 2.17 110.348 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.438 ' CG1' ' HG2' ' A' ' 7' ' ' LYS . 5.1 t -105.4 -8.65 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.391 -0.822 . . . . 1.44 112.488 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.493 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 2.0 p30 41.34 74.38 0.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.714 0.293 . . . . 2.31 111.396 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HG2' ' CG1' ' A' ' 5' ' ' VAL . 3.6 pttp -151.44 -107.93 0.06 Allowed 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.963 0.357 . . . . 2.9 111.963 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.496 HG23 HD11 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -82.77 101.46 7.52 Favored 'Isoleucine or valine' 0 C--N 1.345 0.408 0 N-CA-C 109.485 -0.561 . . . . 2.43 109.485 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.667 HD11 ' CE2' ' A' ' 21' ' ' TYR . 2.4 tp -153.29 171.38 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 120.031 -0.667 . . . . 4.33 112.371 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.94 169.74 22.77 Favored Glycine 0 CA--C 1.508 -0.374 0 CA-C-N 116.16 -0.473 . . . . 1.14 111.987 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.478 ' HA ' ' N ' ' A' ' 21' ' ' TYR . 2.5 p -150.35 104.48 3.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.128 0.788 . . . . 1.95 113.128 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.444 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 14.9 tpt180 -157.56 102.2 1.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.015 -0.539 . . . . 4.16 110.829 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.427 ' HB ' ' C ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -117.08 -84.09 0.64 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 114.008 1.114 . . . . 1.13 114.008 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.412 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -150.34 -56.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.428 -0.509 . . . . 1.14 112.305 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.472 ' N ' ' HG3' ' A' ' 19' ' ' MET . . . 119.4 -29.49 6.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.142 -1.028 . . . . 0.72 112.53 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -58.81 -33.7 70.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.471 0.653 . . . . 2.82 109.245 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 43' ' ' VAL . . . -150.83 -46.0 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 114.777 -1.102 . . . . 0.86 111.068 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.534 ' HA ' ' HG3' ' A' ' 35' ' ' PRO . . . -116.19 151.21 36.15 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.208 -0.293 . . . . 1.15 110.208 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.472 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 2.8 ttp -162.61 24.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.433 0.531 . . . . 2.5 112.433 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.563 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 5.7 mt-10 -150.47 -179.91 7.62 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.823 -0.436 . . . . 1.28 109.823 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.768 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 0.4 OUTLIER -155.52 14.09 0.36 Allowed 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 113.702 1.001 . . . . 5.2 113.702 -179.274 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.522 ' O ' ' CE2' ' A' ' 25' ' ' TRP . 0.4 OUTLIER -84.78 135.45 34.11 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 116.003 1.853 . . . . 5.07 116.003 -177.038 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.537 ' CD1' ' HB ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -74.2 16.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 111.505 -2.588 . . . . 3.21 111.126 177.641 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . 24.6 tt0 -80.09 17.25 1.03 Allowed 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.058 0.543 . . . . 2.6 111.082 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.553 ' CD2' ' O ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -91.58 32.28 1.1 Allowed 'General case' 0 C--N 1.342 0.272 0 N-CA-C 109.851 -0.426 . . . . 1.71 109.851 177.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 25' ' ' TRP . 64.4 pttt 46.78 34.44 2.59 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.142 -0.481 . . . . 3.74 111.154 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 0.3 OUTLIER 65.24 23.89 12.23 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.704 -0.399 . . . . 2.14 110.246 179.424 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -44.32 -68.93 0.79 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.848 -0.691 . . . . 0.99 111.798 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.579 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -133.29 99.46 4.54 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.815 -0.439 . . . . 3.77 109.815 178.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.444 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 27.6 t 33.28 113.07 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 116.825 2.157 . . . . 1.8 116.825 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 13.5 Cg_exo -29.2 116.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.982 3.121 . . . . 0.79 110.053 173.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.527 ' HB2' ' CD2' ' A' ' 38' ' ' TYR . 22.8 t -152.72 -177.6 6.35 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 114.093 1.145 . . . . 1.27 114.093 -174.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.6 ' CE3' ' CG ' ' A' ' 21' ' ' TYR . 11.7 t-105 -106.21 92.19 4.03 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.584 -1.189 . . . . 1.48 108.935 178.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.642 ' CG2' HG23 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -159.76 -179.75 1.16 Allowed Pre-proline 0 C--O 1.214 -0.775 0 CA-C-N 115.822 -0.627 . . . . 2.35 110.815 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.57 ' N ' HG11 ' A' ' 34' ' ' VAL . 11.7 Cg_endo -98.53 115.74 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 123.605 2.87 . . . . 1.52 115.778 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t 70.63 -8.75 0.87 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 115.37 1.619 . . . . 2.17 115.37 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.553 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 49.4 m -160.86 -90.27 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 118.707 -1.197 . . . . 1.81 114.102 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 29' ' ' HIS . 12.8 t80 176.75 140.42 0.07 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 110.062 -0.347 . . . . 5.8 110.062 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.642 HG23 ' CG2' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -165.62 31.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 123.182 1.468 . . . . 2.64 108.365 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.481 ' HB1' ' CZ ' ' A' ' 38' ' ' TYR . . . -65.85 91.69 0.15 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.359 -1.292 . . . . 1.75 110.93 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 40' ' ' ALA . . . 160.2 -26.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.367 -0.833 . . . . 2.67 110.421 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -120.84 -92.04 0.55 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.41 0.522 . . . . 4.56 112.41 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.432 ' CA ' HD12 ' A' ' 39' ' ' ILE . 7.1 p 174.98 -30.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.276 0.472 . . . . 4.12 112.276 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.46 ' O ' HG22 ' A' ' 39' ' ' ILE . 32.6 m -54.51 -170.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 112.495 0.554 . . . . 3.1 112.495 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.501 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 11.7 t -107.58 21.8 16.92 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.1 0.778 . . . . 1.46 113.1 -177.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.451 ' N ' HG21 ' A' ' 39' ' ' ILE . 41.4 tt0 -172.86 139.18 0.85 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.565 0.58 . . . . 1.6 112.565 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' A' ' 38' ' ' TYR . 4.1 t80 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.273 -0.87 . . . . 4.35 110.989 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.511 -0.236 . . . . 6.49 112.511 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.3 m -153.96 144.08 22.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 4.66 110.919 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 70.18 162.67 4.0 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.704 -0.76 . . . . 2.65 112.503 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.486 ' N ' HG23 ' A' ' 23' ' ' ILE . 9.8 tt0 61.46 14.78 6.11 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.303 0.573 . . . . 2.17 111.588 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.444 ' CG1' ' HD2' ' A' ' 7' ' ' LYS . 4.9 t -79.87 -35.39 16.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 122.134 -0.354 . . . . 1.44 111.428 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 58.61 88.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 2.31 110.632 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.444 ' HD2' ' CG1' ' A' ' 5' ' ' VAL . 2.5 ptmm? -150.94 -67.24 0.19 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.176 -0.466 . . . . 2.9 111.73 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.468 HD12 HG22 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -138.76 128.96 33.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.966 -0.561 . . . . 2.43 109.782 -179.22 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.503 ' HA ' ' CB ' ' A' ' 22' ' ' LEU . 13.5 pt -122.1 131.46 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 113.949 1.092 . . . . 4.33 113.949 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.69 102.77 0.23 Allowed Glycine 0 N--CA 1.453 -0.216 0 N-CA-C 109.419 -1.472 . . . . 1.14 109.419 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.585 ' CB ' ' N ' ' A' ' 21' ' ' TYR . 7.0 m -148.99 169.96 19.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.334 1.235 . . . . 1.95 114.334 -176.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -159.89 102.74 1.49 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.522 -1.672 . . . . 4.16 109.91 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.584 ' CG2' ' CD1' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -87.85 -76.97 0.36 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.022 -0.671 . . . . 1.13 112.043 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -150.95 -63.54 0.19 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.683 0.623 . . . . 1.14 112.683 -178.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.471 ' N ' ' HG3' ' A' ' 19' ' ' MET . . . 125.86 -42.05 1.56 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.773 -0.931 . . . . 0.72 110.773 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.408 ' OE2' ' N ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -59.3 -28.16 66.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.576 -0.898 . . . . 2.82 108.576 178.095 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 44' ' ' VAL . . . -142.1 -65.17 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.958 -1.019 . . . . 0.86 111.179 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.6 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -109.19 154.0 22.99 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 119.564 -0.255 . . . . 1.15 111.367 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.471 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 1.6 ttm -157.05 25.09 0.31 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.49 1.293 . . . . 2.5 114.49 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.658 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 18.1 mt-10 -157.73 175.44 13.89 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 107.668 -1.234 . . . . 1.28 107.668 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.585 ' N ' ' CB ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -155.79 -26.69 0.1 Allowed 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 116.047 1.869 . . . . 5.2 116.047 -178.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.544 ' CD2' ' CZ ' ' A' ' 21' ' ' TYR . 2.0 mm? -89.66 138.21 31.67 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 115.308 1.595 . . . . 5.07 115.308 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.56 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -8.17 -119.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 111.363 -2.653 . . . . 3.21 114.969 177.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.463 ' HB2' ' CG2' ' A' ' 9' ' ' ILE . 33.9 tt0 48.23 25.03 0.76 Allowed 'General case' 0 C--N 1.344 0.365 0 O-C-N 121.777 -0.577 . . . . 2.6 109.939 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.703 ' CH2' HG12 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -138.57 32.17 2.28 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 112.764 0.653 . . . . 1.71 112.764 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.2 tptt 37.3 30.41 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.326 0.491 . . . . 3.74 112.326 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.458 ' HB3' ' CB ' ' A' ' 4' ' ' GLU . 4.1 p-10 44.15 35.82 1.32 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.09 0.404 . . . . 2.14 112.09 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 1.017 ' HA3' ' HH ' ' A' ' 38' ' ' TYR . . . -46.69 -53.86 9.63 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.302 -0.952 . . . . 0.99 111.72 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.543 ' CE1' ' CE2' ' A' ' 47' ' ' TYR . 9.6 t60 -132.04 94.57 3.5 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.581 -0.526 . . . . 3.77 109.581 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 29' ' ' HIS . 16.0 t 37.75 112.15 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 115.266 1.58 . . . . 1.8 115.266 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.44 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 17.9 Cg_exo -33.14 122.27 0.11 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.801 2.334 . . . . 0.79 108.768 174.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.492 ' O ' ' CZ2' ' A' ' 25' ' ' TRP . 40.4 m -143.38 174.98 10.26 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 114.201 1.186 . . . . 1.27 114.201 -172.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.584 ' CD1' ' CG2' ' A' ' 13' ' ' THR . 2.1 t90 -97.96 100.97 12.34 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 104.602 -2.37 . . . . 1.48 104.602 174.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.703 HG12 ' CH2' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -151.83 151.62 28.6 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 114.226 -1.352 . . . . 2.35 111.37 -171.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.6 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 40.9 Cg_exo -56.37 -14.15 11.78 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 125.127 3.885 . . . . 1.52 116.588 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.1 t 176.54 -28.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.96 0.726 . . . . 2.17 112.96 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.567 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 49.7 m -114.61 -90.18 0.54 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.0 0.37 . . . . 1.81 112.0 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 1.017 ' HH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -178.94 123.3 0.09 Allowed 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 106.655 -1.609 . . . . 5.8 106.655 -179.349 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.478 HG21 ' CG2' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -135.62 27.89 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.746 0.784 . . . . 2.64 110.305 -175.832 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.424 ' O ' ' CB ' ' A' ' 41' ' ' ALA . . . -59.58 92.04 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.022 -0.99 . . . . 1.75 111.59 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 42' ' ' ASP . . . 160.83 -60.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.232 -0.895 . . . . 2.67 109.948 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 6.7 t70 163.13 80.72 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.435 -0.802 . . . . 4.56 110.13 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.42 -163.34 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.961 -0.296 . . . . 4.12 110.336 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.428 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 15.9 m -141.14 101.74 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 113.073 0.768 . . . . 3.1 113.073 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.516 ' N ' ' HG2' ' A' ' 35' ' ' PRO . 46.9 t 64.39 14.68 8.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.281 -0.872 . . . . 1.46 112.414 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -178.6 133.61 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.487 -0.485 . . . . 1.6 111.822 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.543 ' CE2' ' CE1' ' A' ' 29' ' ' HIS . 90.4 t80 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.228 -0.891 . . . . 4.35 110.927 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 112.545 -0.222 . . . . 6.49 112.545 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 81.3 p 51.27 -173.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.938 0.399 . . . . 4.66 110.945 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 146.32 158.5 7.79 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.882 -0.675 . . . . 2.65 112.184 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 6.9 tt0 67.52 7.27 5.48 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.771 0.286 . . . . 2.17 111.771 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' A' ' 6' ' ' ASN . 54.9 t -82.53 -43.42 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.035 0.445 . . . . 1.44 110.353 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.488 ' N ' HG23 ' A' ' 23' ' ' ILE . 27.8 t-20 83.56 74.07 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.915 -1.038 . . . . 2.31 110.739 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.445 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 36.4 pttt -151.56 -140.36 0.1 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.302 -1.772 . . . . 2.9 108.093 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.468 ' CD1' ' N ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -38.95 143.54 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 122.565 0.346 . . . . 2.43 110.884 177.231 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.562 ' HA ' ' HB3' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -147.48 126.88 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 114.32 1.23 . . . . 4.33 114.32 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.03 146.71 16.66 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 107.767 -2.133 . . . . 1.14 107.767 175.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.479 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -154.24 104.43 2.61 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 118.51 1.155 . . . . 1.95 112.917 -176.046 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -157.86 102.65 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.822 -0.627 . . . . 4.16 109.849 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 18' ' ' ALA . 1.0 OUTLIER -113.86 -82.98 0.6 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.894 1.072 . . . . 1.13 113.894 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.409 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -145.32 -54.52 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.576 -0.45 . . . . 1.14 112.157 -177.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.438 ' N ' ' HG3' ' A' ' 19' ' ' MET . . . 116.63 -37.27 3.43 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 119.903 -1.142 . . . . 0.72 112.801 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.18 -27.74 64.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.251 0.548 . . . . 2.82 109.522 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -150.02 -53.98 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.33 -0.85 . . . . 0.86 111.123 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.504 ' CA ' ' HD3' ' A' ' 35' ' ' PRO . . . -115.67 146.58 41.72 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 110.034 -0.358 . . . . 1.15 110.034 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.438 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 2.6 ttp -155.68 31.81 0.36 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 111.925 0.343 . . . . 2.5 111.925 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.578 ' CG ' ' HA ' ' A' ' 35' ' ' PRO . 9.3 mt-10 -147.29 -176.39 5.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 119.155 -0.45 . . . . 1.28 109.88 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.646 ' HB2' ' CD2' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -154.28 -62.85 0.13 Allowed 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 119.919 3.303 . . . . 5.2 119.919 -174.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.562 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 10.6 tp -84.18 155.65 22.44 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 114.864 1.431 . . . . 5.07 114.864 -170.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 6' ' ' ASN . 3.4 mp -9.86 -112.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 112.462 -2.154 . . . . 3.21 114.85 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.414 ' N ' HG22 ' A' ' 23' ' ' ILE . 5.9 tt0 70.69 -61.35 0.48 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.728 -1.582 . . . . 2.6 106.728 -175.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.566 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 1.1 p90 -57.76 -173.18 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.021 -0.99 . . . . 1.71 111.033 176.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 3.2 mptp? -116.37 55.2 0.82 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.122 0.487 . . . . 3.74 109.941 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.447 ' HB3' ' CB ' ' A' ' 4' ' ' GLU . 4.0 p30 42.85 33.94 0.55 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.563 -0.744 . . . . 2.14 111.874 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.808 ' H ' ' HH ' ' A' ' 38' ' ' TYR . . . -49.48 -57.54 9.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.534 -0.841 . . . . 0.99 112.722 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.542 ' NE2' ' CE2' ' A' ' 47' ' ' TYR . 54.5 t-80 -131.97 96.29 3.88 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 117.383 0.591 . . . . 3.77 110.694 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 29' ' ' HIS . 23.3 t 39.71 103.24 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 113.761 1.022 . . . . 1.8 113.761 177.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.439 ' C ' ' O ' ' A' ' 30' ' ' SER . 15.1 Cg_exo -31.6 114.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.371 1.723 0 C-N-CA 122.816 2.344 . . . . 0.79 109.699 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 21' ' ' TYR . 10.0 t -133.62 -163.31 1.34 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.712 0.634 . . . . 1.27 112.712 -172.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.646 ' CD2' ' HB2' ' A' ' 21' ' ' TYR . 6.4 t-105 -120.41 91.98 3.66 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.15 -1.796 . . . . 1.48 106.15 175.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.59 HG11 ' N ' ' A' ' 38' ' ' TYR . 1.2 t -158.7 170.65 8.58 Favored Pre-proline 0 N--CA 1.444 -0.751 0 CA-C-N 114.993 -1.003 . . . . 2.35 112.186 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.587 ' CG ' ' HA ' ' A' ' 45' ' ' SER . 59.1 Cg_endo -70.39 108.41 2.19 Favored 'Trans proline' 0 N--CA 1.485 1.003 1 C-N-CA 125.484 4.123 . . . . 1.52 116.253 175.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 t 37.55 30.35 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.813 -0.63 . . . . 2.17 112.13 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.544 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -163.11 -136.14 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 116.024 -0.535 . . . . 1.81 110.464 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.808 ' HH ' ' H ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -174.34 100.68 0.1 Allowed 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.444 -1.688 . . . . 5.8 106.444 -177.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.568 HG23 ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -126.14 31.44 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 122.92 1.343 . . . . 2.64 109.477 -175.106 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.91 92.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.51 -1.223 . . . . 1.75 111.055 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 164.38 -29.46 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.432 -0.804 . . . . 2.67 110.024 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.406 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 23.8 t70 -123.95 -91.46 0.54 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.989 -0.55 . . . . 4.56 112.008 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 18' ' ' ALA . 14.7 p 175.55 -30.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 112.382 0.512 . . . . 4.12 112.382 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.402 HG22 HG13 ' A' ' 39' ' ' ILE . 17.1 m -55.45 -169.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.005 0.372 . . . . 3.1 112.005 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.587 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 26.3 t -106.47 35.09 3.08 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.857 0.688 . . . . 1.46 112.857 -177.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.448 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 34.8 tt0 -179.01 149.21 0.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.81 0.338 . . . . 1.6 110.815 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.542 ' CE2' ' NE2' ' A' ' 29' ' ' HIS . 9.4 t80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.239 -0.886 . . . . 4.35 110.803 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.501 -0.24 . . . . 6.49 112.501 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.5 p -72.41 -177.72 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.747 0.308 . . . . 4.66 110.73 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.507 ' HA3' ' HB3' ' A' ' 31' ' ' PRO . . . 148.25 -158.47 27.7 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.482 -0.866 . . . . 2.65 112.603 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.475 ' CA ' HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER 62.0 7.92 2.32 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.42 0.526 . . . . 2.17 112.42 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 6' ' ' ASN . 13.9 t -85.31 -50.37 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 120.897 0.379 . . . . 1.44 110.721 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.48 ' HB3' ' O ' ' A' ' 5' ' ' VAL . 34.5 t-20 93.25 69.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.55 -1.205 . . . . 2.31 108.553 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.446 ' HD3' ' CG1' ' A' ' 5' ' ' VAL . 17.0 pttp -150.41 -141.58 0.11 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.002 -0.999 . . . . 2.9 109.932 -177.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.501 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -48.1 102.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 121.486 0.66 . . . . 2.43 111.98 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.637 HD12 ' CE2' ' A' ' 21' ' ' TYR . 5.1 tp -154.06 169.08 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.228 -0.589 . . . . 4.33 111.506 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.91 169.93 20.21 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.542 -0.361 . . . . 1.14 112.524 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.487 ' HA ' ' N ' ' A' ' 21' ' ' TYR . 3.0 p -150.62 104.68 3.22 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 113.264 0.839 . . . . 1.95 113.264 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.428 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 12.6 mmt180 -157.93 103.38 1.87 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.295 -0.411 . . . . 4.16 111.723 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.485 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -125.28 -85.2 0.63 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.207 -0.933 . . . . 1.13 113.488 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.454 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -143.7 -61.36 0.4 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.094 0.405 . . . . 1.14 112.094 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . 124.26 -46.98 1.05 Allowed Glycine 0 C--N 1.329 0.166 0 C-N-CA 120.434 -0.889 . . . . 0.72 112.522 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -59.26 -25.59 64.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.015 0.436 . . . . 2.82 110.517 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -141.43 -54.94 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.802 -0.919 . . . . 0.86 110.802 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.498 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . . . -128.76 150.98 50.06 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.454 -0.573 . . . . 1.15 109.454 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.454 ' HG2' ' N ' ' A' ' 14' ' ' ALA . 2.9 tmm? -162.49 22.61 0.1 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.351 0.871 . . . . 2.5 113.351 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 9.3 mm-40 -148.01 179.75 7.51 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.709 -0.848 . . . . 1.28 108.709 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.75 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 0.4 OUTLIER -156.2 11.72 0.28 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.513 0.931 . . . . 5.2 113.513 -179.394 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.515 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 0.3 OUTLIER -84.99 133.9 34.24 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 117.242 2.312 . . . . 5.07 117.242 -175.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.475 HG21 ' CA ' ' A' ' 4' ' ' GLU . 1.9 mp -64.4 -6.39 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-N 110.248 -3.16 . . . . 3.21 110.151 176.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HA ' ' ND2' ' A' ' 6' ' ' ASN . 30.8 tt0 -47.83 -12.61 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.92 -0.582 . . . . 2.6 112.172 177.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.562 ' CD2' ' O ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -72.56 30.41 0.06 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.776 1.028 . . . . 1.71 113.776 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.6 mttm 46.18 35.57 2.68 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 118.048 0.385 . . . . 3.74 111.916 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 56.4 t0 62.68 25.34 15.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.955 0.407 . . . . 2.14 110.332 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -46.21 -66.57 1.64 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.408 -0.901 . . . . 0.99 111.393 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.546 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -135.35 99.57 4.27 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.934 -0.307 . . . . 3.77 110.612 178.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.454 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 20.1 m 37.18 111.8 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.495 0 N-CA-C 116.469 2.025 . . . . 1.8 116.469 176.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.507 ' HB3' ' HA3' ' A' ' 3' ' ' GLY . 7.3 Cg_exo -33.1 117.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 123.268 2.645 . . . . 0.79 108.935 173.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.541 ' HB2' ' CD2' ' A' ' 38' ' ' TYR . 18.6 t -150.1 176.16 11.07 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.496 0.924 . . . . 1.27 113.496 -173.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.606 ' CE3' ' CG ' ' A' ' 21' ' ' TYR . 12.0 t-105 -104.76 91.3 3.78 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.902 -0.777 . . . . 1.48 108.902 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.61 HG11 HG23 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -159.72 175.05 3.43 Favored Pre-proline 0 C--O 1.217 -0.616 0 CA-C-N 115.468 -0.787 . . . . 2.35 111.124 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.582 ' N ' HG12 ' A' ' 34' ' ' VAL . 26.0 Cg_endo -92.02 142.45 2.59 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.756 2.971 . . . . 1.52 113.118 175.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.8 t 72.91 -57.56 0.63 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.965 -1.016 . . . . 2.17 113.65 176.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.562 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 42.9 m -148.72 -64.32 0.24 Allowed 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 114.937 1.458 . . . . 1.81 114.937 -177.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.546 ' CD2' ' O ' ' A' ' 29' ' ' HIS . 7.9 t80 178.12 149.3 0.19 Allowed 'General case' 0 C--N 1.318 -0.771 0 O-C-N 121.759 -0.588 . . . . 5.8 110.407 -176.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.61 HG23 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER 176.45 74.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.61 0.719 . . . . 2.64 110.019 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.32 92.66 0.06 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.206 -0.906 . . . . 1.75 110.974 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 178.62 -31.9 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.5 -0.773 . . . . 2.67 111.182 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 77.26 25.88 0.74 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.089 -0.505 . . . . 4.56 110.661 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.8 m -121.31 0.5 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 4.12 112.106 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.46 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -159.76 169.23 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-O 120.791 0.329 . . . . 3.1 110.947 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.466 ' CB ' ' HG2' ' A' ' 35' ' ' PRO . 47.4 t -105.32 26.03 9.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.971 -0.559 . . . . 1.46 111.281 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.413 ' N ' HG21 ' A' ' 39' ' ' ILE . 42.2 tt0 -178.8 148.62 0.42 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.028 0.381 . . . . 1.6 112.028 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' TYR . 9.3 t80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.224 -0.893 . . . . 4.35 110.8 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 112.612 -0.195 . . . . 6.49 112.612 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m -121.12 -57.07 1.89 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.321 . . . . 4.66 110.85 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -121.07 -102.47 1.82 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.678 -0.773 . . . . 2.65 112.555 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.438 ' HB3' ' CG ' ' A' ' 31' ' ' PRO . 9.4 pt-20 44.6 27.78 0.27 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.888 0.375 . . . . 2.17 111.006 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -90.07 -8.97 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.16 -0.473 . . . . 1.44 111.846 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.551 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 3.2 t-20 49.14 73.06 0.25 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 110.313 -0.255 . . . . 2.31 110.313 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 ptmm? -140.61 -98.92 0.15 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.298 0.481 . . . . 2.9 112.298 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 tp -137.4 105.34 3.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 CA-C-O 121.034 0.445 . . . . 2.43 110.902 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.504 ' CG2' ' CG1' ' A' ' 23' ' ' ILE . 3.4 tt -151.85 173.77 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.783 -0.644 . . . . 4.33 110.579 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -100.66 167.59 20.05 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.214 -0.517 . . . . 1.14 113.176 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.744 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 13.6 p -153.63 103.9 2.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 1.95 111.896 -177.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -158.99 102.88 1.65 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.608 -0.724 . . . . 4.16 110.043 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 18' ' ' ALA . 1.0 OUTLIER -108.7 -85.2 0.53 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.815 1.043 . . . . 1.13 113.815 -178.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.442 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -145.38 -54.16 0.29 Allowed 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.163 0.431 . . . . 1.14 112.163 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.83 -34.84 4.68 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.291 -0.957 . . . . 0.72 112.268 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.0 -32.82 70.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.532 0.682 . . . . 2.82 109.183 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -141.09 -55.72 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.807 -1.088 . . . . 0.86 110.554 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.543 ' CA ' ' HD3' ' A' ' 35' ' ' PRO . . . -120.28 150.0 41.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.816 -0.192 . . . . 1.15 111.001 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.544 ' H ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -155.46 37.36 0.38 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.032 0.752 . . . . 2.5 113.032 178.088 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 27.8 mt-10 -151.81 -169.45 3.37 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 119.43 -0.319 . . . . 1.28 110.466 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.835 ' O ' ' CH2' ' A' ' 25' ' ' TRP 0.269 2.5 t80 -152.76 -130.77 0.04 OUTLIER 'General case' 0 C--O 1.209 -1.029 0 N-CA-C 116.057 1.873 . . . . 5.2 116.057 -177.46 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.598 ' N ' ' CD1' ' A' ' 21' ' ' TYR . 4.4 mt -78.94 166.67 22.12 Favored 'General case' 0 CA--C 1.491 -1.326 0 O-C-N 120.402 -1.437 . . . . 5.07 114.651 -166.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.551 ' HB ' ' HA ' ' A' ' 6' ' ' ASN . 0.9 OUTLIER 45.5 -166.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 112.848 -1.978 . . . . 3.21 109.679 -179.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.428 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 0.6 OUTLIER 71.08 9.85 6.77 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.721 -0.844 . . . . 2.6 108.721 -177.811 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.835 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -143.48 -173.55 3.98 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 108.694 -0.854 . . . . 1.71 108.694 178.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 4.0 mppt? -122.29 65.2 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.604 -0.439 . . . . 3.74 111.99 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.437 ' CA ' ' HB2' ' A' ' 4' ' ' GLU . 3.5 p30 40.63 29.01 0.06 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.283 -0.417 . . . . 2.14 112.105 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.758 ' H ' ' HH ' ' A' ' 38' ' ' TYR . . . -46.7 -62.92 3.4 Favored Glycine 0 C--N 1.329 0.16 0 C-N-CA 120.601 -0.809 . . . . 0.99 113.248 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.571 ' CE1' ' CE2' ' A' ' 47' ' ' TYR . 68.4 t60 -133.09 96.3 3.73 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 117.724 0.762 . . . . 3.77 111.153 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 31' ' ' PRO . 13.8 m 40.47 99.98 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 118.575 -0.726 . . . . 1.8 112.874 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.447 ' C ' ' O ' ' A' ' 30' ' ' SER . 17.9 Cg_exo -27.51 124.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.368 2.712 . . . . 0.79 110.789 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.8 t -148.93 -168.81 3.2 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.525 0.935 . . . . 1.27 113.525 -173.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.614 ' CZ3' ' CD2' ' A' ' 21' ' ' TYR . 3.7 t-105 -116.08 95.56 5.15 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.254 -1.387 . . . . 1.48 107.254 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.547 HG11 ' N ' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -157.87 166.3 16.85 Favored Pre-proline 0 C--O 1.221 -0.401 0 CA-C-N 115.872 -0.604 . . . . 2.35 112.469 -178.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.544 ' HD3' ' H ' ' A' ' 19' ' ' MET . 12.1 Cg_endo -56.03 69.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.475 0.438 1 C-N-CA 125.44 4.094 . . . . 1.52 116.129 177.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.4 m 60.94 31.21 19.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.436 0.636 . . . . 2.17 110.794 176.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.577 ' O ' ' CZ3' ' A' ' 25' ' ' TRP . 1.5 m -150.79 -131.57 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.859 -1.064 . . . . 1.81 108.445 177.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.758 ' HH ' ' H ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -174.59 99.91 0.09 Allowed 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 106.374 -1.713 . . . . 5.8 106.374 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.541 HG21 ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -155.2 83.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.184 -1.371 . . . . 2.64 107.691 -175.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.67 91.05 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.585 -1.189 . . . . 1.75 111.504 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 46.41 59.3 3.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.08 -0.964 . . . . 2.67 111.772 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.446 ' O ' ' CG1' ' A' ' 43' ' ' VAL . 25.2 t70 -122.58 -20.95 5.84 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.788 0.662 . . . . 4.56 112.788 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.446 ' CG1' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -179.03 -95.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 112.089 0.403 . . . . 4.12 112.089 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.8 p -179.74 124.93 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 113.159 0.8 . . . . 3.1 113.159 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.447 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 28.8 t 65.87 10.38 6.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.92 -1.037 . . . . 1.46 113.72 176.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 176.98 166.38 0.53 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.773 0.657 . . . . 1.6 112.773 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.571 ' CE2' ' CE1' ' A' ' 29' ' ' HIS . 43.6 t80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.22 -0.895 . . . . 4.35 110.344 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 112.589 -0.204 . . . . 6.49 112.589 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.0 m 61.57 170.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.796 0.331 . . . . 4.66 110.873 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.426 ' O ' ' CG ' ' A' ' 4' ' ' GLU . . . 106.39 134.73 7.81 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 2.65 112.484 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 27' ' ' ASP . 6.5 pt-20 51.37 21.48 1.19 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.861 0.362 . . . . 2.17 111.6 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.469 ' N ' HG21 ' A' ' 23' ' ' ILE . 18.6 t -78.62 -6.05 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 113.271 0.841 . . . . 1.44 113.271 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.465 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 26.0 t-20 38.28 85.79 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.843 0.292 . . . . 2.31 110.594 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.443 ' HD3' ' CG1' ' A' ' 5' ' ' VAL . 22.2 pttp -150.99 -135.04 0.06 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 121.098 -0.241 . . . . 2.9 110.563 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.408 ' CG2' ' O ' ' A' ' 8' ' ' ILE . 0.9 OUTLIER -105.49 97.92 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 112.874 0.694 . . . . 2.43 112.874 -178.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.645 HD13 ' CE2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -133.46 172.93 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 116.171 -0.468 . . . . 4.33 111.925 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.562 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -99.86 165.38 19.9 Favored Glycine 0 C--O 1.219 -0.815 0 N-CA-C 110.138 -1.185 . . . . 1.14 110.138 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.512 ' HA ' ' HB2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -155.55 109.37 2.82 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 117.916 0.858 . . . . 1.95 113.077 -176.466 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 11' ' ' SER . 2.1 mpt_? -154.63 103.21 2.44 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.38 -0.373 . . . . 4.16 111.196 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.484 HG22 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -106.24 -82.72 0.53 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.397 0.888 . . . . 1.13 113.397 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.402 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -146.31 -53.25 0.25 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.072 0.397 . . . . 1.14 112.072 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.49 -35.91 4.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.291 -0.957 . . . . 0.72 112.839 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -58.69 -30.09 67.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.325 0.583 . . . . 2.82 109.762 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.495 ' HA3' ' CG2' ' A' ' 43' ' ' VAL . . . -150.39 -46.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.236 -0.893 . . . . 0.86 110.899 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.567 ' CA ' ' HD3' ' A' ' 35' ' ' PRO . . . -121.53 142.12 50.38 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 121.034 -0.266 . . . . 1.15 111.045 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.469 ' H ' ' HD3' ' A' ' 35' ' ' PRO . 0.8 OUTLIER -153.49 39.14 0.49 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.66 0.615 . . . . 2.5 112.66 178.38 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 27.9 mt-10 -145.79 -151.4 0.37 Allowed 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 118.371 -0.823 . . . . 1.28 111.378 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.767 ' CE1' ' HB2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -153.24 -97.19 0.05 OUTLIER 'General case' 0 C--O 1.203 -1.345 0 N-CA-C 119.725 3.231 . . . . 5.2 119.725 -174.228 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.767 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 13.2 tp -120.57 168.6 11.19 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 113.035 0.754 . . . . 5.07 113.035 -174.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.61 HG12 ' CG2' ' A' ' 9' ' ' ILE . 0.0 OUTLIER 38.5 -142.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.579 -1.191 . . . . 3.21 110.435 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 53.29 19.32 1.51 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.609 1.095 . . . . 2.6 109.464 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.637 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -152.77 -173.19 4.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.731 -0.668 . . . . 1.71 109.756 -179.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -122.52 62.75 0.97 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.792 0.664 . . . . 3.74 112.792 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . 31.2 t70 46.22 26.11 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.187 0.44 . . . . 2.14 112.187 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.566 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -47.52 -61.04 4.9 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 119.707 -1.235 . . . . 0.99 111.884 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.479 ' O ' ' CB ' ' A' ' 38' ' ' TYR . 58.3 t-80 -134.05 95.8 3.5 Favored 'General case' 0 C--O 1.215 -0.721 0 C-N-CA 119.966 -0.694 . . . . 3.77 111.575 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 29' ' ' HIS . 14.8 m 37.88 105.63 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 114.215 1.191 . . . . 1.8 114.215 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.443 ' C ' ' O ' ' A' ' 30' ' ' SER . 23.7 Cg_exo -30.55 116.86 0.06 OUTLIER 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 123.038 2.492 . . . . 0.79 110.31 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 21' ' ' TYR . 8.5 t -135.94 -150.44 0.37 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.36 0.874 . . . . 1.27 113.36 -173.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.595 ' CZ3' ' CD2' ' A' ' 21' ' ' TYR . 6.8 t-105 -135.0 95.08 3.24 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 106.141 -1.8 . . . . 1.48 106.141 174.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.623 HG13 HG21 ' A' ' 39' ' ' ILE . 1.4 t -156.75 162.04 28.36 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 115.132 -0.94 . . . . 2.35 113.092 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.6 ' CG ' ' HA ' ' A' ' 45' ' ' SER . 18.6 Cg_endo -55.31 72.5 0.03 OUTLIER 'Trans proline' 0 N--CA 1.477 0.502 1 C-N-CA 126.784 4.989 . . . . 1.52 115.488 177.24 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 35.3 t 65.04 23.7 12.5 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.748 -0.381 . . . . 2.17 111.742 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.547 ' O ' ' CZ3' ' A' ' 25' ' ' TRP . 7.3 m -149.06 -123.06 0.05 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.23 -0.441 . . . . 1.81 110.262 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.566 ' CZ ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -176.83 107.79 0.07 Allowed 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.81 -1.552 . . . . 5.8 106.81 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.623 HG21 HG13 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -174.9 39.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 122.937 1.351 . . . . 2.64 108.51 -175.426 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.04 90.14 3.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.862 -1.517 . . . . 1.75 110.596 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.41 -34.87 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.391 -1.277 . . . . 2.67 109.923 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.431 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 32.0 t70 -102.03 -99.48 0.27 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.889 -0.596 . . . . 4.56 111.895 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.495 ' CG2' ' HA3' ' A' ' 17' ' ' GLY . 7.2 p 174.09 68.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 119.841 -0.123 . . . . 4.12 110.971 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.447 ' CG2' HG12 ' A' ' 39' ' ' ILE . 25.2 m -156.81 169.99 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 113.995 1.109 . . . . 3.1 113.995 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.6 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 28.2 t -83.44 10.8 7.99 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.607 -1.178 . . . . 1.46 112.487 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 36.8 tt0 179.16 161.13 0.74 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.113 0.483 . . . . 1.6 111.963 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.481 ' CD2' ' OXT' ' A' ' 47' ' ' TYR . 38.1 p90 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.265 -0.874 . . . . 4.35 110.917 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.463 -0.255 . . . . 6.49 112.463 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.2 p -155.63 60.57 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.738 0.304 . . . . 4.66 110.824 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 129.47 176.91 14.61 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.6 -0.81 . . . . 2.65 112.657 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.463 ' HB2' ' CB ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 56.11 18.09 3.03 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.863 0.363 . . . . 2.17 111.072 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.408 ' HB ' ' HG2' ' A' ' 7' ' ' LYS . 12.7 t -106.79 -4.14 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.33 . . . . 1.44 111.429 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.501 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 9.7 p30 45.28 79.73 0.05 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.33 0.586 . . . . 2.31 110.886 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 6.2 pttp -143.99 -104.71 0.12 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.138 -0.937 . . . . 2.9 110.442 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.459 HD12 HG22 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -87.06 103.67 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 108.354 -0.98 . . . . 2.43 108.354 178.458 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.483 ' CG2' ' HB2' ' A' ' 22' ' ' LEU . 21.9 pt -104.2 165.73 3.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.917 0.865 . . . . 4.33 113.082 -177.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.4 138.83 9.29 Favored Glycine 0 CA--C 1.498 -0.983 0 N-CA-C 107.454 -2.258 . . . . 1.14 107.454 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.498 ' HA ' ' N ' ' A' ' 21' ' ' TYR . 12.4 p -144.59 104.45 4.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 119.062 1.431 . . . . 1.95 113.415 -176.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.418 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 31.2 ttm180 -159.94 101.09 1.44 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.452 -1.249 . . . . 4.16 111.091 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.504 ' HB ' ' C ' ' A' ' 18' ' ' ALA . 2.9 m -116.68 -87.99 0.6 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 113.981 1.104 . . . . 1.13 113.981 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.63 -60.0 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.218 -0.593 . . . . 1.14 112.581 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . 125.24 -34.98 3.22 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.327 -0.94 . . . . 0.72 112.13 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -30.28 66.74 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.256 -0.646 . . . . 2.82 109.256 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 44' ' ' VAL . . . -146.43 -47.38 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.137 -0.938 . . . . 0.86 110.931 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.517 ' CA ' ' HD3' ' A' ' 35' ' ' PRO . . . -127.02 151.78 48.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 111.488 0.181 . . . . 1.15 111.488 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.449 ' H ' ' HD3' ' A' ' 35' ' ' PRO . 1.6 ttm -151.66 22.0 0.7 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.891 0.33 . . . . 2.5 111.891 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.555 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 18.9 mt-10 -148.36 177.85 9.09 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 122.287 -0.258 . . . . 1.28 111.407 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.67 ' CG ' ' O ' ' A' ' 21' ' ' TYR . 1.0 OUTLIER -159.09 50.91 0.37 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.514 0.673 . . . . 5.2 111.701 -179.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.612 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 2.0 pp -110.15 114.05 27.24 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 116.266 1.95 . . . . 5.07 116.266 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.608 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 8.2 pt -53.89 -16.92 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 113.195 -1.821 . . . . 3.21 112.376 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.501 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . 35.1 tt0 -67.3 65.51 0.07 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.242 0.544 . . . . 2.6 111.212 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.612 ' CD2' ' O ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -142.97 31.69 1.4 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.568 -0.742 . . . . 1.71 110.225 178.439 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 60.06 34.17 21.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.288 -0.869 . . . . 3.74 111.908 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.463 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 4.2 p30 44.77 29.17 0.41 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.88 0.371 . . . . 2.14 111.282 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.469 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -47.63 -61.95 4.37 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.676 -0.774 . . . . 0.99 112.338 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.55 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 35.8 t60 -135.26 93.71 3.02 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 110.01 -0.367 . . . . 3.77 110.01 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 32' ' ' SER . 28.9 m 39.57 116.39 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 116.3 1.963 . . . . 1.8 116.3 177.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.49 ' HB3' ' CG2' ' A' ' 23' ' ' ILE . 14.2 Cg_exo -32.08 92.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 124.138 3.226 . . . . 0.79 107.749 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 30' ' ' SER . 33.8 t -111.72 166.32 11.28 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.334 -1.303 . . . . 1.27 113.849 -172.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.626 ' CZ3' ' CD2' ' A' ' 21' ' ' TYR . 15.0 t-105 -97.87 91.23 5.24 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 105.656 -1.979 . . . . 1.48 105.656 176.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.669 HG13 ' N ' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -156.36 165.55 18.39 Favored Pre-proline 0 N--CA 1.441 -0.882 0 N-CA-C 113.887 1.069 . . . . 2.35 113.887 -178.376 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.549 ' CD ' HG11 ' A' ' 34' ' ' VAL . 38.2 Cg_endo -67.58 78.05 0.51 Allowed 'Trans proline' 0 C--N 1.352 0.728 1 C-N-CA 125.791 4.327 . . . . 1.52 117.609 177.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 35' ' ' PRO . 13.8 m 76.09 14.5 2.52 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.641 0.978 . . . . 2.17 113.641 173.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.547 ' O ' ' CE3' ' A' ' 25' ' ' TRP . 1.8 m -162.54 -110.6 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 120.571 -0.451 . . . . 1.81 112.029 176.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.669 ' N ' HG13 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -174.49 132.82 0.37 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.997 -1.853 . . . . 5.8 105.997 -176.774 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.569 HG22 ' CG1' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -149.68 28.98 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 119.377 -0.929 . . . . 2.64 111.118 -174.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 41' ' ' ALA . . . -60.86 89.43 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.574 -0.739 . . . . 1.75 110.25 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . 153.69 38.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.839 -1.073 . . . . 2.67 110.705 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 55.83 87.51 0.05 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.429 0.529 . . . . 4.56 112.429 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -151.59 -156.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 110.05 -0.352 . . . . 4.12 110.05 178.547 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 17' ' ' GLY . 8.3 p -159.29 120.59 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 113.702 1.001 . . . . 3.1 113.702 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.487 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 28.8 t 63.44 8.71 3.68 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.202 0.816 . . . . 1.46 113.202 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 45' ' ' SER . 38.0 tt0 179.23 154.99 0.47 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.912 0.387 . . . . 1.6 111.931 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 39' ' ' ILE . 35.4 t80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.2 -0.905 . . . . 4.35 110.833 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 112.501 -0.24 . . . . 6.49 112.501 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.2 t -139.44 135.76 33.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.783 0.325 . . . . 4.66 110.878 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.424 ' C ' ' HG3' ' A' ' 31' ' ' PRO . . . 143.53 154.03 6.03 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.686 -0.769 . . . . 2.65 112.495 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.47 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 0.0 OUTLIER 64.97 3.78 2.23 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 112.179 0.437 . . . . 2.17 112.179 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.454 ' HB ' ' HG2' ' A' ' 7' ' ' LYS . 24.1 t -79.74 -41.21 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 CA-C-O 121.317 0.579 . . . . 1.44 110.807 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 25' ' ' TRP . 0.3 OUTLIER 81.68 71.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.821 -1.081 . . . . 2.31 108.421 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.454 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 5.3 ptpt -152.41 -107.12 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 112.986 0.736 . . . . 2.9 112.986 -176.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.482 HG21 HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -79.49 97.95 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 C-N-CA 123.217 0.607 . . . . 2.43 110.105 -179.22 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.509 ' CG2' ' CB ' ' A' ' 22' ' ' LEU . 3.2 tp -153.42 170.49 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 C-N-CA 120.008 -0.677 . . . . 4.33 111.615 -178.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.24 169.18 20.63 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 121.276 -0.487 . . . . 1.14 111.982 -175.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.5 ' HB2' ' CB ' ' A' ' 20' ' ' GLU . 11.8 p -151.14 102.41 2.94 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 113.403 0.89 . . . . 1.95 113.403 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -163.3 97.32 0.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 119.176 -0.44 . . . . 4.16 111.255 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.528 ' CG2' ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -105.02 -81.12 0.54 Allowed 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 119.022 -1.071 . . . . 1.13 113.742 177.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -150.81 -55.85 0.16 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.824 0.675 . . . . 1.14 112.824 -177.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . 122.49 -45.35 1.21 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.483 -0.865 . . . . 0.72 111.656 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -59.17 -32.17 69.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.036 -0.727 . . . . 2.82 109.036 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.46 -68.52 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.03 -0.986 . . . . 0.86 110.948 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.615 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -111.48 155.65 22.9 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 119.774 -0.155 . . . . 1.15 110.845 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.455 ' HG2' ' N ' ' A' ' 15' ' ' GLY . 0.9 OUTLIER -153.85 16.07 0.5 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.75 1.018 . . . . 2.5 113.75 179.209 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.647 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 18.2 mt-10 -152.69 178.91 9.11 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 119.367 -0.349 . . . . 1.28 110.131 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.604 ' HB2' ' CG ' ' A' ' 33' ' ' TRP . 1.1 t80 -160.05 12.94 0.12 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.445 1.276 . . . . 5.2 114.445 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.509 ' CB ' ' CG2' ' A' ' 9' ' ' ILE . 0.3 OUTLIER -85.43 125.64 33.17 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 117.916 2.561 . . . . 5.07 117.916 -175.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.61 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 5.7 mt -48.56 -22.48 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-N 111.266 -2.697 . . . . 3.21 110.868 174.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.417 ' HB3' HD11 ' A' ' 22' ' ' LEU . 23.6 tt0 -29.34 -32.19 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.839 0.856 . . . . 2.6 112.517 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.676 ' CZ3' ' CG1' ' A' ' 34' ' ' VAL . 0.4 OUTLIER -55.96 -163.4 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.26 -0.645 . . . . 1.71 109.26 177.014 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.43 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -114.62 54.61 0.77 Allowed 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.513 -0.742 . . . . 3.74 111.104 -178.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.433 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 4.2 p30 44.36 28.41 0.29 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.918 -0.583 . . . . 2.14 111.256 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.505 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -49.54 -65.63 2.69 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.471 -0.871 . . . . 0.99 112.087 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.447 ' O ' ' O ' ' A' ' 30' ' ' SER . 41.5 m-70 -134.56 94.85 3.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.706 -0.398 . . . . 3.77 110.432 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 29' ' ' HIS . 29.5 t 41.26 114.47 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 116.058 1.873 . . . . 1.8 116.058 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.46 ' HB3' HG12 ' A' ' 23' ' ' ILE . 8.0 Cg_exo -30.96 95.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 124.022 3.148 . . . . 0.79 108.167 172.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 30' ' ' SER . 33.5 t -119.43 176.67 5.24 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-N 114.462 -1.245 . . . . 1.27 113.782 -172.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.604 ' CG ' ' HB2' ' A' ' 21' ' ' TYR . 4.3 t-105 -104.79 99.83 9.47 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.326 -1.761 . . . . 1.48 107.18 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.676 ' CG1' ' CZ3' ' A' ' 25' ' ' TRP . 7.4 p -152.42 155.44 32.92 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 115.166 -0.925 . . . . 2.35 111.591 -175.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.66 ' HD2' ' CG2' ' A' ' 34' ' ' VAL . 53.5 Cg_exo -55.03 -12.75 5.41 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 124.17 3.247 . . . . 1.52 115.789 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 19.4 p 174.07 -19.32 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.328 0.862 . . . . 2.17 113.328 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.589 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -115.32 -95.39 0.47 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.179 0.445 . . . . 1.81 111.7 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.64 ' HA ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -178.44 122.98 0.1 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.296 -1.372 . . . . 5.8 107.296 -178.336 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.613 HG22 ' CG2' ' A' ' 34' ' ' VAL . 5.1 pt -145.64 32.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 119.904 -0.718 . . . . 2.64 111.139 -176.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.22 90.57 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.944 -1.026 . . . . 1.75 110.489 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 42' ' ' ASP . . . 162.5 -61.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.888 -1.051 . . . . 2.67 109.736 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 13.5 t70 165.71 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.918 -0.583 . . . . 4.56 111.406 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.45 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -147.58 -159.51 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 110.083 -0.34 . . . . 4.12 110.083 178.708 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.414 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 13.0 m -146.91 109.78 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 113.426 0.898 . . . . 3.1 113.426 -178.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.48 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . 47.2 t 54.26 16.17 1.14 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.816 -0.629 . . . . 1.46 112.481 178.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 178.36 132.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.566 -0.453 . . . . 1.6 111.703 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 38' ' ' TYR . 91.7 t80 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.244 -0.884 . . . . 4.35 110.67 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.557 -0.217 . . . . 6.49 112.557 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.8 t -122.36 -52.14 1.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.766 0.317 . . . . 4.66 110.921 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 175.55 -151.38 11.86 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.692 -0.766 . . . . 2.65 112.487 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.453 ' CB ' ' HB3' ' A' ' 27' ' ' ASP . 1.2 pp20? 44.88 26.15 0.19 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.925 0.393 . . . . 2.17 111.996 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.436 ' CG1' ' HD3' ' A' ' 7' ' ' LYS . 38.8 t -79.8 -11.91 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.042 -0.527 . . . . 1.44 112.357 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.554 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 10.3 t-20 43.22 81.53 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.496 0.665 . . . . 2.31 109.871 -178.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.436 ' HD3' ' CG1' ' A' ' 5' ' ' VAL . 62.3 pttt -150.95 -134.02 0.06 Allowed 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.667 -1.151 . . . . 2.9 109.499 -177.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.486 HG22 HD11 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -96.52 113.69 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 120.989 0.423 . . . . 2.43 110.512 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.648 HG23 HG13 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -151.06 167.92 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 119.524 -0.87 . . . . 4.33 112.221 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -104.12 168.21 16.59 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.75 -0.659 . . . . 1.14 112.703 -178.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.644 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 1.2 p -153.94 103.96 2.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 1.95 111.589 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -157.8 102.15 1.83 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.239 -0.437 . . . . 4.16 110.956 178.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.512 ' CG2' ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -110.76 -82.66 0.58 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 119.243 -0.983 . . . . 1.13 113.642 179.686 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.05 -56.72 0.2 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.194 0.442 . . . . 1.14 112.194 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.51 -40.72 2.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.408 -0.901 . . . . 0.72 112.422 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.53 -25.25 64.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.975 0.417 . . . . 2.82 110.301 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -149.12 -45.92 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.511 -0.636 . . . . 0.86 111.511 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.503 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . . . -131.07 152.59 50.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.767 -0.457 . . . . 1.15 109.767 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.454 ' N ' ' HG3' ' A' ' 35' ' ' PRO . 2.8 ttt -163.01 31.68 0.1 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.202 1.186 . . . . 2.5 114.202 -178.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 35.5 mt-10 -150.64 -160.55 1.18 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 117.508 -1.234 . . . . 1.28 108.618 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.888 ' OH ' HD23 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -153.45 -79.35 0.1 Allowed 'General case' 0 C--O 1.204 -1.327 1 N-CA-C 122.151 4.13 . . . . 5.2 122.151 -175.797 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.888 HD23 ' OH ' ' A' ' 21' ' ' TYR . 3.9 tp -114.22 166.59 11.49 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 115.401 1.63 . . . . 5.07 115.401 -173.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.648 HG13 HG23 ' A' ' 9' ' ' ILE . 1.3 pp 23.75 -150.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 111.956 -2.383 . . . . 3.21 113.03 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.495 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER 63.07 16.56 9.42 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.038 -0.727 . . . . 2.6 109.038 -178.722 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.614 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.3 OUTLIER -152.24 31.14 0.54 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.154 0.502 . . . . 1.71 111.401 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt 17.08 74.55 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.332 1.605 . . . . 3.74 115.332 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.453 ' HB3' ' CB ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 39.16 67.58 0.43 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.6 0.963 . . . . 2.14 113.6 176.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.563 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -88.18 -62.24 1.44 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.524 -1.322 . . . . 0.99 109.953 177.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.549 ' CD2' ' CD2' ' A' ' 47' ' ' TYR . 48.3 t-80 -133.2 94.78 3.4 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 109.544 -0.539 . . . . 3.77 109.544 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 31' ' ' PRO . 18.1 t 37.52 98.14 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 113.873 1.064 . . . . 1.8 113.873 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.432 ' C ' ' O ' ' A' ' 30' ' ' SER . 52.9 Cg_exo -27.08 106.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.349 2.7 . . . . 0.79 110.896 176.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 21' ' ' TYR . 8.7 t -122.18 -149.85 0.44 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.421 -0.809 . . . . 1.27 112.309 -173.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.59 ' CE3' ' CG ' ' A' ' 21' ' ' TYR . 6.9 t-105 -137.87 94.48 2.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.069 -1.826 . . . . 1.48 106.069 174.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.584 ' CG1' ' HD2' ' A' ' 35' ' ' PRO . 1.4 t -156.26 165.25 19.02 Favored Pre-proline 0 C--O 1.218 -0.553 0 CA-C-N 116.053 -0.521 . . . . 2.35 111.759 -176.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.584 ' HD2' ' CG1' ' A' ' 34' ' ' VAL . 14.5 Cg_exo -63.81 81.3 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.286 2.657 . . . . 1.52 116.039 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.3 t 63.73 28.27 14.86 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.019 0.438 . . . . 2.17 111.365 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.592 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 5.6 t -151.78 -127.31 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.802 -0.635 . . . . 1.81 110.563 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.592 ' CG ' ' C ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -175.8 102.34 0.07 Allowed 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.317 -1.364 . . . . 5.8 107.317 -177.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.515 HG21 HG13 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -158.98 72.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.978 1.371 . . . . 2.64 108.679 -176.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.96 91.31 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.461 -1.7 . . . . 1.75 110.821 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 42' ' ' ASP . . . -166.36 -35.19 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.551 -1.204 . . . . 2.67 110.921 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 15.2 t70 80.86 30.19 0.17 Allowed 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.183 -0.462 . . . . 4.56 110.31 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.85 -3.53 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 112.885 0.698 . . . . 4.12 112.885 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' N ' HD11 ' A' ' 39' ' ' ILE . 3.6 t -158.32 153.38 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.253 0.549 . . . . 3.1 111.787 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.532 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 18.6 p -93.57 21.67 6.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.343 -0.844 . . . . 1.46 111.179 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.481 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 12.4 tt0 -178.99 141.15 0.17 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 120.424 -0.51 . . . . 1.6 112.153 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.549 ' CD2' ' CD2' ' A' ' 29' ' ' HIS . 75.4 t80 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.268 -0.873 . . . . 4.35 110.762 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.448 -0.261 . . . . 6.49 112.448 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.1 t -120.21 -57.27 1.94 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.715 0.293 . . . . 4.66 110.934 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.462 ' HA2' ' CD1' ' A' ' 23' ' ' ILE . . . -103.26 -125.56 5.66 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.531 -0.842 . . . . 2.65 112.557 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 61.48 18.66 9.61 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.431 0.634 . . . . 2.17 111.583 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 t -107.08 -9.51 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.046 -0.524 . . . . 1.44 111.621 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 44.1 t-20 50.72 88.33 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.021 0.439 . . . . 2.31 110.177 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.41 ' HG2' HG12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -138.36 -147.77 0.24 Allowed 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.876 -0.787 . . . . 2.9 108.876 -178.295 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.3 OUTLIER -65.08 117.44 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 109.824 -0.435 . . . . 2.43 109.824 178.347 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.724 ' CG1' ' CE2' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -129.25 136.25 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 114.096 1.147 . . . . 4.33 114.096 -178.125 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.51 106.97 1.55 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 107.693 -2.163 . . . . 1.14 107.693 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.667 ' CB ' ' CD2' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -102.76 108.34 19.53 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 114.736 1.384 . . . . 1.95 114.736 -174.722 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -158.18 102.69 1.79 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 112.91 -1.95 . . . . 4.16 112.39 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.464 ' CB ' ' HA ' ' A' ' 19' ' ' MET . 0.2 OUTLIER -111.74 -82.29 0.58 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.25 -0.906 . . . . 1.13 112.478 178.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.428 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -140.61 -50.82 0.46 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.689 0.281 . . . . 1.14 111.416 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.441 ' CA ' ' HG3' ' A' ' 19' ' ' MET . . . 110.74 -44.41 1.51 Allowed Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.312 -0.947 . . . . 0.72 112.732 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.41 ' HG3' HG11 ' A' ' 43' ' ' VAL . 9.8 pt-20 -58.62 -24.98 62.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.229 0.538 . . . . 2.82 109.811 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.487 ' HA3' ' CB ' ' A' ' 43' ' ' VAL . . . -145.14 -69.32 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.519 -1.032 . . . . 0.86 110.519 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.586 ' HB2' ' HA ' ' A' ' 34' ' ' VAL . . . -105.18 150.46 25.06 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.407 -0.59 . . . . 1.15 109.407 178.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.464 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 2.4 tmm? -165.01 42.48 0.08 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 114.218 1.192 . . . . 2.5 114.218 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 32.0 mt-10 -143.47 -147.8 0.22 Allowed 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 114.398 1.259 . . . . 1.28 114.398 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.724 ' CE2' ' CG1' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -113.27 -174.41 2.45 Favored 'General case' 0 CA--C 1.456 -2.659 0 C-N-CA 124.837 1.255 . . . . 5.2 112.097 -173.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.549 ' HB3' ' N ' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -127.39 78.64 1.83 Allowed 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 115.823 1.786 . . . . 5.07 115.823 175.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.529 ' CB ' ' O ' ' A' ' 22' ' ' LEU . 4.6 tt 152.41 71.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.136 0 N-CA-C 113.75 1.019 . . . . 3.21 113.75 171.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.718 ' OE1' ' OH ' ' A' ' 21' ' ' TYR . 14.2 tt0 178.58 59.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.154 -0.475 . . . . 2.6 111.96 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.539 ' CD1' ' N ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -154.22 29.86 0.44 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.854 0.359 . . . . 1.71 110.898 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.446 ' N ' ' CD ' ' A' ' 26' ' ' LYS . 9.6 mptt 55.17 22.54 4.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.217 -0.447 . . . . 3.74 110.816 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.418 ' HB2' ' HG3' ' A' ' 4' ' ' GLU . 16.1 t70 59.29 109.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.588 0.709 . . . . 2.14 111.617 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.565 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -121.08 -62.52 0.24 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 109.857 -1.297 . . . . 0.99 109.857 178.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.473 ' O ' ' CB ' ' A' ' 38' ' ' TYR . 39.7 m80 -135.17 94.45 3.13 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.605 -0.517 . . . . 3.77 109.605 177.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 29' ' ' HIS . 15.5 m 39.99 102.69 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 113.338 0.866 . . . . 1.8 113.338 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.451 ' C ' ' O ' ' A' ' 30' ' ' SER . 14.8 Cg_exo -25.69 125.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.877 3.052 . . . . 0.79 109.705 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.512 ' O ' ' CH2' ' A' ' 25' ' ' TRP . 3.8 t -154.19 138.95 17.05 Favored 'General case' 0 C--O 1.21 -0.989 0 N-CA-C 114.62 1.341 . . . . 1.27 114.62 -171.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.549 ' N ' ' HB3' ' A' ' 22' ' ' LEU . 5.5 t-105 -83.6 96.58 8.69 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.593 -2.373 . . . . 1.48 104.593 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.594 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -150.88 -159.73 0.04 OUTLIER Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-N 113.271 -1.786 . . . . 2.35 107.631 -175.613 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.527 ' HD3' ' CG1' ' A' ' 34' ' ' VAL . 60.5 Cg_endo -95.25 99.01 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 122.708 2.003 . . . . 1.52 116.683 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.0 t 55.18 16.79 1.74 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.709 -0.678 . . . . 2.17 112.223 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.557 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 50.4 m -162.76 -109.65 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 120.402 -0.519 . . . . 1.81 111.48 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.565 ' OH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -177.71 102.07 0.05 OUTLIER 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 106.645 -1.613 . . . . 5.8 106.645 -176.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -159.05 71.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.418 -0.81 . . . . 2.64 110.199 -176.078 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.65 91.6 5.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.974 -1.012 . . . . 1.75 110.676 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.8 -43.74 0.15 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.999 -1.001 . . . . 2.67 109.964 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.437 ' O ' ' CG1' ' A' ' 43' ' ' VAL . 7.8 m-20 -142.53 -74.14 0.29 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.841 -0.618 . . . . 4.56 111.242 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.487 ' CB ' ' HA3' ' A' ' 17' ' ' GLY . 0.0 OUTLIER 175.46 74.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.234 -0.439 . . . . 4.12 111.354 -178.375 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.463 ' O ' ' HG3' ' A' ' 35' ' ' PRO . 24.0 t -133.84 150.33 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 120.957 -0.297 . . . . 3.1 111.757 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.501 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 45.4 t -68.07 1.79 2.53 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.372 1.249 . . . . 1.46 114.372 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.492 ' N ' HG23 ' A' ' 39' ' ' ILE . 38.0 tt0 -179.59 155.67 0.67 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.607 0.242 . . . . 1.6 110.695 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.423 ' N ' ' HB ' ' A' ' 39' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.186 -0.911 . . . . 4.35 110.47 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 112.487 -0.245 . . . . 6.49 112.487 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m -101.36 -62.15 1.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.756 0.312 . . . . 4.66 110.731 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' A' ' 31' ' ' PRO . . . 93.97 155.14 31.56 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.634 -0.793 . . . . 2.65 112.671 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 1.1 tm-20 51.16 54.27 11.48 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 122.549 1.166 . . . . 2.17 109.268 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.443 ' CG1' ' HG2' ' A' ' 7' ' ' LYS . 12.0 t -131.42 -24.25 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.033 -0.985 . . . . 1.44 112.49 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 9.7 t-20 50.96 78.26 0.11 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.188 -0.671 . . . . 2.31 109.188 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.443 ' HG2' ' CG1' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -138.39 -98.16 0.18 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.844 0.683 . . . . 2.9 112.844 -176.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.3 tp -137.69 114.03 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 109.765 -0.457 . . . . 2.43 109.765 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.538 HG23 ' CD2' ' A' ' 21' ' ' TYR . 6.4 tp -150.03 165.06 3.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.315 -0.402 . . . . 4.33 111.987 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.484 ' N ' HG13 ' A' ' 9' ' ' ILE . . . -111.57 115.99 4.05 Favored Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.0 -1.24 . . . . 1.14 110.0 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.79 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -101.11 106.36 17.61 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 123.063 1.411 . . . . 1.95 112.819 -174.497 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -157.93 109.02 2.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 111.723 -2.49 . . . . 4.16 111.987 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.484 ' HB ' ' C ' ' A' ' 18' ' ' ALA . 3.2 m -115.24 -80.92 0.6 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.703 0.631 . . . . 1.13 112.703 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.69 -59.92 0.33 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.341 0.497 . . . . 1.14 112.341 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.11 -41.53 1.77 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.64 -0.791 . . . . 0.72 112.472 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.19 -26.67 65.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.025 0.44 . . . . 2.82 110.138 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -150.77 -50.75 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.75 -0.659 . . . . 0.86 111.577 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.601 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -117.52 152.33 35.3 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.153 -0.684 . . . . 1.15 109.153 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.542 ' N ' ' HG3' ' A' ' 35' ' ' PRO . 3.4 ttt -169.74 34.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 115.387 1.625 . . . . 2.5 115.387 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.77 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 7.2 mt-10 -141.09 -122.25 0.1 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 119.198 -1.001 . . . . 1.28 111.982 176.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.79 ' HB3' ' HA ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -154.74 -117.47 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 117.996 2.591 . . . . 5.2 117.996 -175.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.544 ' HA ' ' CZ2' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -152.67 168.89 24.15 Favored 'General case' 0 N--CA 1.424 -1.774 0 O-C-N 121.398 -0.814 . . . . 5.07 110.497 -178.591 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.517 HG12 HG22 ' A' ' 9' ' ' ILE . 0.2 OUTLIER 47.43 58.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.874 -0.603 . . . . 3.21 111.38 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 0.3 OUTLIER -168.03 28.72 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.088 -0.506 . . . . 2.6 112.23 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.585 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -142.86 31.24 1.43 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.862 0.363 . . . . 1.71 110.245 177.32 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.406 ' O ' ' OD2' ' A' ' 27' ' ' ASP . 7.4 mtpm? 47.85 38.8 9.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 3.74 110.183 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.491 ' HB3' ' CG ' ' A' ' 4' ' ' GLU . 1.3 p30 53.88 38.83 29.56 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.554 -0.748 . . . . 2.14 110.985 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -43.41 -70.13 0.57 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.838 -0.696 . . . . 0.99 111.659 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.497 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -132.9 100.23 4.84 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 120.877 -0.329 . . . . 3.77 110.349 178.175 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.47 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 19.5 m 38.83 103.32 0.02 OUTLIER Pre-proline 0 C--O 1.218 -0.562 0 N-CA-C 114.095 1.146 . . . . 1.8 114.095 176.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.447 ' HB3' ' CA ' ' A' ' 3' ' ' GLY . 25.6 Cg_exo -25.21 138.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.966 3.111 . . . . 0.79 112.518 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.619 ' HB2' ' CD2' ' A' ' 38' ' ' TYR . 43.7 t -152.36 -155.85 0.65 Allowed 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 113.362 0.875 . . . . 1.27 113.362 -175.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.605 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 48.6 t-105 -139.3 95.0 2.86 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 101.524 -3.51 . . . . 1.48 101.524 172.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.77 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -154.42 163.73 23.22 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 114.086 -1.415 . . . . 2.35 109.745 -171.336 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.682 ' HA ' ' HG3' ' A' ' 20' ' ' GLU . 24.0 Cg_exo -62.81 -11.12 22.57 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.542 2.828 . . . . 1.52 118.379 -175.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 35' ' ' PRO . 1.9 m 157.98 31.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 114.051 1.13 . . . . 2.17 114.051 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.524 ' N ' ' CE3' ' A' ' 25' ' ' TRP . 37.8 m -176.55 -85.86 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.02 0.438 . . . . 1.81 110.126 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.99 ' HH ' ' HB2' ' A' ' 40' ' ' ALA . 29.4 t80 -177.96 152.75 0.77 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.757 -0.656 . . . . 5.8 110.602 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.624 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 0.6 OUTLIER 175.55 73.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.869 0.366 . . . . 2.64 110.197 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.99 ' HB2' ' HH ' ' A' ' 38' ' ' TYR . . . -66.46 91.94 0.19 Allowed 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.98 -0.688 . . . . 1.75 110.618 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 42' ' ' ASP . . . 172.06 -31.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.51 -0.768 . . . . 2.67 110.95 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 17.7 t70 75.9 28.92 0.84 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.043 -0.526 . . . . 4.56 110.963 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.71 -9.15 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.222 -0.444 . . . . 4.12 112.142 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.474 ' O ' HG22 ' A' ' 39' ' ' ILE . 11.2 t -145.41 162.97 12.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.389 0.138 . . . . 3.1 110.899 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.602 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 78.1 p -97.64 17.39 17.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.397 -0.365 . . . . 1.46 111.761 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 178.39 140.46 0.09 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 120.696 -0.402 . . . . 1.6 111.632 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 38' ' ' TYR . 7.5 t80 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.234 -0.888 . . . . 4.35 111.052 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.491 -0.244 . . . . 6.49 112.491 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.7 p 50.48 45.83 26.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.864 0.364 . . . . 4.66 110.922 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.22 163.24 29.4 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.756 -0.735 . . . . 2.65 112.489 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.539 ' HA ' ' CD1' ' A' ' 23' ' ' ILE . 1.6 tt0 60.27 14.71 4.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.281 0.562 . . . . 2.17 111.404 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -91.18 -21.77 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.648 -0.501 . . . . 1.44 109.648 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.455 ' ND2' ' HA ' ' A' ' 24' ' ' GLU . 34.5 t-20 58.45 80.23 0.19 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.881 -0.6 . . . . 2.31 109.476 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.453 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 17.8 pttp -147.75 -140.39 0.1 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.037 -0.983 . . . . 2.9 108.423 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.421 ' N ' ' HG3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -67.79 132.34 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.467 -0.938 . . . . 2.43 108.467 177.195 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.58 ' HB ' ' CB ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -148.7 173.19 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 113.965 1.098 . . . . 4.33 113.965 -176.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.68 159.51 21.55 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 113.545 -1.661 . . . . 1.14 110.388 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.506 ' HB2' ' CB ' ' A' ' 20' ' ' GLU . 2.8 p -154.79 103.71 2.45 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.319 0.859 . . . . 1.95 113.319 -177.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.1 ttp-105 -161.68 98.41 1.1 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.504 0.928 . . . . 4.16 113.504 176.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.517 ' CG2' ' CD1' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -110.54 -81.3 0.58 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 119.031 -1.068 . . . . 1.13 113.521 176.005 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -151.16 -57.44 0.16 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.645 0.609 . . . . 1.14 112.645 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . 125.14 -41.6 1.66 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.0 -0.619 . . . . 0.72 111.771 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -72.76 -9.39 58.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.767 0.318 . . . . 2.82 111.26 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -151.55 -55.47 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.216 -1.154 . . . . 0.86 110.216 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.653 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -131.52 153.04 50.22 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 108.774 -0.825 . . . . 1.15 108.774 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.521 ' N ' ' HG3' ' A' ' 35' ' ' PRO . 2.6 ttt -154.33 11.06 0.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.969 1.1 . . . . 2.5 113.969 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.711 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 14.8 mt-10 -151.55 -177.82 6.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.484 -0.932 . . . . 1.28 108.484 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.718 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -157.87 9.35 0.17 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.258 0.836 . . . . 5.2 113.258 178.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.58 ' CB ' ' HB ' ' A' ' 9' ' ' ILE . 3.6 pp -87.23 128.5 35.15 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 115.343 1.609 . . . . 5.07 115.343 -175.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.667 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 0.4 OUTLIER -42.02 -104.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 112.508 -2.133 . . . . 3.21 108.522 173.704 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.455 ' HA ' ' ND2' ' A' ' 6' ' ' ASN . 7.4 tp10 34.72 30.15 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.609 1.095 . . . . 2.6 112.561 177.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.667 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -134.53 32.29 3.35 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.068 -0.515 . . . . 1.71 111.052 -178.284 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 50.95 29.4 4.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.873 -0.603 . . . . 3.74 111.167 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.434 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 4.2 p30 43.64 38.07 1.79 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.524 . . . . 2.14 111.696 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.801 ' HA3' ' HH ' ' A' ' 38' ' ' TYR . . . -47.94 -57.4 7.83 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.547 -0.835 . . . . 0.99 112.287 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.568 ' HB2' ' CD1' ' A' ' 38' ' ' TYR . 76.2 m80 -133.65 92.17 2.94 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.245 -0.65 . . . . 3.77 109.245 178.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 29' ' ' HIS . 22.7 t 39.62 117.71 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 116.082 1.882 . . . . 1.8 116.082 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' A' ' 4' ' ' GLU . 11.1 Cg_exo -32.88 95.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.95 3.1 . . . . 0.79 107.953 172.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 30' ' ' SER . 18.3 m -117.21 173.34 6.74 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 114.463 1.283 . . . . 1.27 114.463 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.6 ' CE3' ' CG ' ' A' ' 21' ' ' TYR . 7.4 t-105 -104.08 100.49 10.24 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 105.314 -2.106 . . . . 1.48 105.314 176.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.711 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 4.4 p -151.39 158.98 34.15 Favored Pre-proline 0 C--O 1.204 -1.309 0 CA-C-N 114.19 -1.368 . . . . 2.35 111.417 -173.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.653 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 50.3 Cg_exo -61.48 -6.43 7.0 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 124.07 3.18 . . . . 1.52 115.712 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m 172.2 -12.91 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.182 1.179 . . . . 2.17 114.182 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.557 ' O ' ' CE3' ' A' ' 25' ' ' TRP . 73.9 m -138.75 -87.49 0.23 Allowed 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 118.816 0.734 . . . . 1.81 112.138 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.801 ' HH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -177.05 102.47 0.05 Allowed 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.223 -1.029 . . . . 5.8 108.223 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.54 ' CG2' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -127.68 59.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 122.746 1.26 . . . . 2.64 110.583 -174.578 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.0 92.63 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 113.852 -1.522 . . . . 1.75 110.934 -178.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . 164.95 -29.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 113.966 -1.47 . . . . 2.67 109.177 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 77.15 54.82 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.434 -0.803 . . . . 4.56 111.856 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.405 ' C ' ' CG2' ' A' ' 44' ' ' VAL . 3.4 t -154.76 23.77 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 112.643 0.608 . . . . 4.12 112.643 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 39' ' ' ILE . 2.4 t -157.88 152.32 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 113.083 0.771 . . . . 3.1 113.083 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.623 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 39.0 t -82.44 -2.71 54.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.747 -0.66 . . . . 1.46 111.409 177.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.449 ' HG2' ' CB ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 176.51 153.71 0.2 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.233 0.457 . . . . 1.6 112.233 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.487 ' CB ' ' O ' ' A' ' 38' ' ' TYR . 36.6 t80 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.26 -0.876 . . . . 4.35 110.754 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.771 -0.132 . . . . 6.49 112.771 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.5 p -101.26 -77.49 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.976 0.417 . . . . 4.66 110.691 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 131.95 -116.68 1.91 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.834 -0.698 . . . . 2.65 112.554 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.476 ' HB2' ' CB ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 53.66 20.57 2.24 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.66 0.743 . . . . 2.17 109.536 -178.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.414 ' HB ' ' HD2' ' A' ' 7' ' ' LYS . 17.4 t -98.61 -19.55 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.656 -0.702 . . . . 1.44 111.0 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.544 ' ND2' ' HA ' ' A' ' 24' ' ' GLU . 30.7 t-20 62.88 62.35 1.06 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.929 0.871 . . . . 2.31 108.851 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.414 ' HD2' ' HB ' ' A' ' 5' ' ' VAL . 18.1 ptmt -134.99 -133.34 0.16 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.13 -1.395 . . . . 2.9 108.272 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.446 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 6.8 tp -45.45 105.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.341 0 N-CA-C 109.213 -0.662 . . . . 2.43 109.213 177.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.582 ' CB ' ' HB2' ' A' ' 22' ' ' LEU . 1.4 pt -104.03 109.63 27.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 113.757 1.021 . . . . 4.33 113.757 -176.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.61 139.01 14.85 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 108.685 -1.766 . . . . 1.14 108.685 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.499 ' HA ' ' H ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -153.53 109.34 3.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 114.66 1.356 . . . . 1.95 114.66 -175.07 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.486 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 15.0 tpt180 -158.61 100.0 1.6 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.029 -0.668 . . . . 4.16 112.361 177.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.469 ' CB ' ' HA ' ' A' ' 19' ' ' MET . 0.2 OUTLIER -117.24 -79.48 0.59 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 119.406 -0.918 . . . . 1.13 113.326 178.688 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.435 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -149.15 -59.35 0.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.721 -0.392 . . . . 1.14 112.022 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 19' ' ' MET . . . 118.33 -50.55 0.8 Allowed Glycine 0 C--N 1.329 0.162 0 C-N-CA 119.906 -1.14 . . . . 0.72 112.617 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -58.38 -21.1 49.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.047 0.451 . . . . 2.82 109.971 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.44 ' HA3' ' CG2' ' A' ' 43' ' ' VAL . . . -143.71 -57.2 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.862 -0.608 . . . . 0.86 111.875 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.613 ' HA ' ' HB3' ' A' ' 35' ' ' PRO . . . -129.21 149.82 50.85 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.616 -0.883 . . . . 1.15 108.616 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.469 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -167.51 20.7 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 116.629 2.085 . . . . 2.5 116.629 -178.277 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 34' ' ' VAL . 2.8 mt-10 -154.68 98.67 2.09 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 118.928 0.786 . . . . 1.28 112.044 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.643 ' HB2' ' CG ' ' A' ' 33' ' ' TRP . 3.0 t80 -79.13 8.1 6.38 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 113.486 0.921 . . . . 5.2 113.486 -177.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.582 ' HB2' ' CB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -89.16 130.37 35.6 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 116.095 1.887 . . . . 5.07 116.095 -176.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.68 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -47.77 -137.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 111.758 -2.473 . . . . 3.21 112.118 174.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.544 ' HA ' ' ND2' ' A' ' 6' ' ' ASN . 33.1 tt0 60.27 16.5 6.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 120.934 -1.104 . . . . 2.6 109.698 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.68 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -112.15 31.26 6.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.287 0.565 . . . . 1.71 110.423 179.486 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.463 ' N ' ' CD ' ' A' ' 26' ' ' LYS . 0.5 OUTLIER 57.95 28.38 16.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.384 -0.826 . . . . 3.74 111.941 177.698 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.476 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 4.6 p-10 44.87 32.15 0.78 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.751 0.31 . . . . 2.14 111.346 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 1.128 ' HA3' ' HH ' ' A' ' 38' ' ' TYR . . . -47.82 -59.94 5.78 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.498 -0.858 . . . . 0.99 112.285 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.586 ' HB2' ' CD1' ' A' ' 38' ' ' TYR . 99.2 m-70 -134.89 91.3 2.74 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 119.897 -0.721 . . . . 3.77 109.618 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 29' ' ' HIS . 24.2 t 42.22 120.16 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 115.68 1.733 . . . . 1.8 115.68 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.454 ' HD3' ' CB ' ' A' ' 4' ' ' GLU . 2.9 Cg_exo -38.05 101.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 122.86 2.374 . . . . 0.79 107.425 172.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.557 ' CB ' ' CG2' ' A' ' 34' ' ' VAL . 68.7 m -124.0 155.82 37.56 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-N 115.176 -0.92 . . . . 1.27 112.81 -172.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.643 ' CG ' ' HB2' ' A' ' 21' ' ' TYR . 6.8 t-105 -90.29 92.81 9.08 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.43 -2.433 . . . . 1.48 104.43 176.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.588 HG13 HG21 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -155.05 -166.46 0.15 Allowed Pre-proline 0 C--O 1.186 -2.272 0 CA-C-N 115.354 -0.839 . . . . 2.35 112.258 -173.115 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.613 ' HB3' ' HA ' ' A' ' 18' ' ' ALA . 65.6 Cg_endo -95.67 105.78 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.108 0 CA-C-N 122.566 1.952 . . . . 1.52 116.278 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.4 t 37.48 30.08 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.293 0.568 . . . . 2.17 111.359 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.539 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 1.3 m -168.4 -130.31 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.059 -0.973 . . . . 1.81 108.922 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 1.128 ' HH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -173.17 100.9 0.12 Allowed 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 106.562 -1.644 . . . . 5.8 106.562 -178.006 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.647 ' CD1' ' HA ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -121.95 31.8 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.526 -0.761 . . . . 2.64 112.245 -174.137 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.69 93.05 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.743 -0.783 . . . . 1.75 111.415 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . 163.08 -30.1 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 114.192 -1.367 . . . . 2.67 109.404 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.487 ' O ' HG12 ' A' ' 39' ' ' ILE . 4.8 p-10 -177.3 104.19 0.05 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.863 -0.608 . . . . 4.56 111.009 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.647 ' HA ' ' CD1' ' A' ' 39' ' ' ILE . 23.0 m -51.05 126.82 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.098 -0.501 . . . . 4.12 112.276 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.1 p -173.66 34.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.519 0 N-CA-C 114.615 1.339 . . . . 3.1 114.615 -178.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.521 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 30.1 t 68.41 2.9 3.52 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 114.373 1.249 . . . . 1.46 114.373 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 45' ' ' SER . 36.4 tt0 179.37 153.01 0.42 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.827 0.677 . . . . 1.6 112.827 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.433 ' CD2' ' CE1' ' A' ' 29' ' ' HIS . 17.3 t80 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.23 -0.89 . . . . 4.35 110.939 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.436 -0.266 . . . . 6.49 112.436 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.0 t -177.33 39.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.918 0.389 . . . . 4.66 110.718 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.417 ' C ' ' HG3' ' A' ' 31' ' ' PRO . . . 113.32 -176.08 17.07 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.912 -0.661 . . . . 2.65 112.222 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.494 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER 51.65 22.2 1.54 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.638 0.732 . . . . 2.17 110.044 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.45 ' CG1' ' HD3' ' A' ' 7' ' ' LYS . 2.9 t -104.54 -17.14 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.72 -0.673 . . . . 1.44 111.137 -179.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 24' ' ' GLU . 31.4 t-20 61.17 66.17 0.91 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.998 -0.742 . . . . 2.31 108.998 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.45 ' HD3' ' CG1' ' A' ' 5' ' ' VAL . 19.8 pttp -150.72 -146.96 0.21 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.05 -0.523 . . . . 2.9 109.65 -178.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.494 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -47.59 98.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 121.956 0.884 . . . . 2.43 111.525 178.669 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.586 ' CG2' ' HB2' ' A' ' 22' ' ' LEU . 3.4 tp -152.85 170.07 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.659 -0.701 . . . . 4.33 110.177 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -130.76 168.6 21.76 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.88 -0.676 . . . . 1.14 112.113 -175.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.498 ' HA ' ' N ' ' A' ' 21' ' ' TYR . 35.4 p -148.24 103.57 3.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 113.398 0.888 . . . . 1.95 113.398 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.431 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 51.0 ttp180 -159.96 101.6 1.45 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.003 -0.544 . . . . 4.16 111.254 176.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.474 HG22 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -115.45 -84.81 0.62 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.532 0.938 . . . . 1.13 113.532 179.237 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.6 -55.72 0.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.425 -0.51 . . . . 1.14 112.357 -178.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.81 -34.14 4.48 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.342 -0.933 . . . . 0.72 112.489 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.19 -29.38 67.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.206 0.527 . . . . 2.82 109.763 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.408 ' O ' ' HG3' ' A' ' 35' ' ' PRO . . . -150.44 -41.23 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.422 -0.808 . . . . 0.86 111.879 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.517 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . . . -130.54 151.2 51.27 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.449 -0.575 . . . . 1.15 109.449 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.439 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 4.7 ttp -163.17 27.71 0.09 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.705 1.002 . . . . 2.5 113.705 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.541 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 20.4 mt-10 -151.4 -179.71 7.61 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.516 -0.55 . . . . 1.28 109.516 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.64 ' CD2' ' CE3' ' A' ' 33' ' ' TRP . 2.8 t80 -159.66 11.09 0.12 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.57 0.952 . . . . 5.2 113.57 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.586 ' HB2' ' CG2' ' A' ' 9' ' ' ILE . 2.4 pt? -86.66 120.76 28.31 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 117.327 2.343 . . . . 5.07 117.327 -176.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.702 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 5.7 pt -55.49 -15.02 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 111.967 -2.379 . . . . 3.21 110.497 174.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.468 ' O ' ' ND2' ' A' ' 6' ' ' ASN . 29.4 tp10 -39.14 -27.57 0.02 OUTLIER 'General case' 0 C--N 1.344 0.332 0 CA-C-N 116.065 -0.516 . . . . 2.6 110.682 177.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.702 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -57.58 -163.19 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.803 -0.814 . . . . 1.71 108.803 176.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -107.41 44.76 1.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.449 -0.782 . . . . 3.74 111.379 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.46 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 3.5 p30 42.01 28.51 0.1 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.268 -0.424 . . . . 2.14 111.585 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 1.031 ' HA3' ' HH ' ' A' ' 38' ' ' TYR . . . -53.57 -55.53 24.59 Favored Glycine 0 CA--C 1.507 -0.422 0 C-N-CA 120.202 -0.999 . . . . 0.99 111.797 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.594 ' HB2' ' CD1' ' A' ' 38' ' ' TYR . 72.8 m80 -134.1 92.8 2.99 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 119.882 -0.727 . . . . 3.77 110.322 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.491 ' O ' ' OG ' ' A' ' 32' ' ' SER . 17.0 m 41.62 119.45 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 116.54 2.052 . . . . 1.8 116.54 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.497 ' HB3' ' CG2' ' A' ' 23' ' ' ILE . 12.5 Cg_exo -34.25 97.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 123.493 2.795 . . . . 0.79 107.856 170.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.559 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 67.2 m -121.06 155.16 35.01 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 114.263 1.209 . . . . 1.27 114.263 -172.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.64 ' CE3' ' CD2' ' A' ' 21' ' ' TYR . 6.7 t-105 -90.75 91.37 8.35 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 104.107 -2.553 . . . . 1.48 104.107 175.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.559 ' CG2' ' HB3' ' A' ' 32' ' ' SER . 0.0 OUTLIER -155.76 177.79 1.91 Allowed Pre-proline 0 C--O 1.215 -0.74 0 CA-C-N 114.896 -1.047 . . . . 2.35 110.974 -174.736 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.533 ' CD ' ' CG1' ' A' ' 34' ' ' VAL . 28.8 Cg_endo -86.34 111.86 1.07 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.879 2.386 . . . . 1.52 116.651 -174.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.7 t 49.69 19.37 0.4 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.555 -1.202 . . . . 2.17 113.079 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.553 ' N ' ' CE3' ' A' ' 25' ' ' TRP . 11.7 t -173.4 -108.15 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.205 -0.598 . . . . 1.81 111.597 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 1.031 ' HH ' ' HA3' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -176.3 116.59 0.12 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.446 -1.687 . . . . 5.8 106.446 -177.578 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.501 HG21 HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -141.51 31.42 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.772 0.796 . . . . 2.64 111.008 -174.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 41' ' ' ALA . . . -59.59 89.82 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.069 -0.969 . . . . 1.75 110.636 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 40' ' ' ALA . . . 157.02 39.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.138 -0.937 . . . . 2.67 110.763 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 t70 56.67 85.41 0.08 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.816 0.302 . . . . 4.56 111.816 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.473 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -153.94 -159.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 110.083 -0.34 . . . . 4.12 110.083 179.113 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.44 ' CA ' HD12 ' A' ' 39' ' ' ILE . 7.4 p -157.27 118.58 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 113.557 0.947 . . . . 3.1 113.557 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 54.5 p 65.99 4.77 3.17 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 114.696 -1.138 . . . . 1.46 113.757 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 45' ' ' SER . 39.0 tt0 179.38 154.03 0.46 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.099 0.476 . . . . 1.6 111.671 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 t80 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.243 -0.884 . . . . 4.35 110.991 -179.753 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.541 -0.224 . . . . 6.49 112.541 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.9 p -79.71 152.19 30.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.868 0.366 . . . . 4.66 110.757 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 105.82 152.18 20.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.677 -0.773 . . . . 2.65 112.427 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.474 ' HA ' ' CD1' ' A' ' 23' ' ' ILE . 2.7 tm-20 65.46 9.03 5.45 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.868 0.366 . . . . 2.17 111.891 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.1 t -91.39 -36.18 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 122.017 0.913 . . . . 1.44 108.85 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.442 ' N ' HG12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER 68.65 87.45 0.12 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.678 -1.601 . . . . 2.31 111.329 179.014 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -150.31 -144.4 0.15 Allowed 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.995 -1.113 . . . . 2.9 107.995 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.431 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -55.03 118.44 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.006 -0.368 . . . . 2.43 110.006 178.57 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.487 ' HA ' ' CB ' ' A' ' 22' ' ' LEU . 36.6 pt -111.27 136.79 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 114.751 1.389 . . . . 4.33 114.751 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.8 146.43 16.67 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 106.86 -2.496 . . . . 1.14 106.86 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.515 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.6 OUTLIER -153.13 105.94 2.95 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 118.781 1.291 . . . . 1.95 113.408 -175.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -156.3 102.82 2.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.995 -0.548 . . . . 4.16 111.104 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.487 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -121.97 -80.74 0.63 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 119.599 -0.84 . . . . 1.13 112.993 179.402 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -150.05 -57.75 0.19 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.437 -0.505 . . . . 1.14 112.172 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.04 -42.34 1.8 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.538 -0.839 . . . . 0.72 112.158 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -59.38 -33.89 71.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.169 0.509 . . . . 2.82 110.135 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.45 -48.72 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.568 -0.742 . . . . 0.86 111.493 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.49 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -130.55 150.13 51.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.86 -0.422 . . . . 1.15 109.86 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.454 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -163.9 30.08 0.08 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.062 1.134 . . . . 2.5 114.062 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 11.1 mt-10 -148.79 -171.9 3.98 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.287 -1.005 . . . . 1.28 108.287 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.617 ' CD2' ' CZ3' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -154.02 -57.5 0.12 Allowed 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 119.217 3.043 . . . . 5.2 119.217 -176.056 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.488 HD21 ' CE1' ' A' ' 21' ' ' TYR . 8.4 mt -81.24 148.04 29.67 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 118.034 -1.466 . . . . 5.07 114.705 -171.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.51 HD13 ' CD1' ' A' ' 25' ' ' TRP . 3.2 tp -13.23 -105.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 110.818 -2.901 . . . . 3.21 114.07 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.491 ' N ' HG13 ' A' ' 23' ' ' ILE . 8.1 mm-40 42.82 25.85 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 119.39 0.996 . . . . 2.6 111.349 -177.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.536 ' CE3' ' HA ' ' A' ' 37' ' ' SER . 0.5 OUTLIER -136.53 29.01 2.98 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 116.133 -0.485 . . . . 1.71 111.289 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 40.35 30.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 3.74 112.133 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.43 ' HB2' ' CG ' ' A' ' 4' ' ' GLU . 23.8 t70 63.51 34.11 12.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.008 0.432 . . . . 2.14 110.312 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 25' ' ' TRP . . . -45.37 -63.76 2.57 Favored Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 111.045 -0.822 . . . . 0.99 111.045 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.514 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -133.44 109.12 9.09 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 109.047 -0.723 . . . . 3.77 109.047 177.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.446 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 48.1 m 31.0 103.3 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 114.994 1.479 . . . . 1.8 114.994 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.438 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 13.4 Cg_exo -29.87 120.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.257 0 C-N-CA 123.093 2.529 . . . . 0.79 111.372 176.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.601 ' HB2' ' CD2' ' A' ' 38' ' ' TYR . 17.9 t -143.34 -163.72 1.71 Allowed 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 114.345 1.239 . . . . 1.27 114.345 -174.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.617 ' CZ3' ' CD2' ' A' ' 21' ' ' TYR . 4.5 t-105 -123.11 93.11 3.85 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 106.349 -1.722 . . . . 1.48 106.349 175.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.691 HG12 HG22 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -159.85 178.27 1.74 Allowed Pre-proline 0 C--O 1.22 -0.47 0 CA-C-N 115.356 -0.838 . . . . 2.35 111.01 -177.72 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.581 ' N ' HG13 ' A' ' 34' ' ' VAL . 6.4 Cg_endo -95.51 137.27 0.72 Allowed 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.939 3.093 . . . . 1.52 112.444 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 10.7 t 79.83 -62.17 0.27 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.454 0.909 . . . . 2.17 113.454 177.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.536 ' HA ' ' CE3' ' A' ' 25' ' ' TRP . 47.5 t -150.54 -56.89 0.17 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.556 1.317 . . . . 1.81 114.556 -177.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.855 ' HH ' ' CB ' ' A' ' 40' ' ' ALA . 14.4 t80 176.97 152.04 0.19 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.799 -0.445 . . . . 5.8 109.799 -176.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.691 HG22 HG12 ' A' ' 34' ' ' VAL . 0.6 OUTLIER 175.86 67.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.9 0.857 . . . . 2.64 108.851 -179.621 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.855 ' CB ' ' HH ' ' A' ' 38' ' ' TYR . . . -59.66 92.76 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.151 -0.931 . . . . 1.75 111.082 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 174.14 -31.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.337 -0.847 . . . . 2.67 110.983 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 74.08 23.94 2.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.075 -0.511 . . . . 4.56 110.807 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.82 -25.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 4.12 111.211 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.446 ' HB ' HG12 ' A' ' 39' ' ' ILE . 3.5 t -136.07 165.02 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.955 0.407 . . . . 3.1 111.118 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.499 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 29.6 t -96.38 25.46 4.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.873 -0.603 . . . . 1.46 110.689 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -179.72 149.05 0.35 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.437 -0.347 . . . . 1.6 110.996 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.499 ' HB3' ' CD2' ' A' ' 29' ' ' HIS . 10.3 t80 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.212 -0.899 . . . . 4.35 110.944 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.368 -0.293 . . . . 6.49 112.368 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.7 t -140.39 108.35 5.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.901 0.381 . . . . 4.66 111.024 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.48 ' CA ' ' CD1' ' A' ' 23' ' ' ILE . . . 146.86 -148.26 19.77 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.795 -0.716 . . . . 2.65 112.424 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.454 ' HB3' ' HG3' ' A' ' 31' ' ' PRO . 0.0 OUTLIER 78.0 -13.49 0.95 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.144 0.794 . . . . 2.17 113.144 179.484 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 6' ' ' ASN . 11.3 t -77.71 -51.29 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 121.454 0.645 . . . . 1.44 111.12 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.475 ' CA ' HG23 ' A' ' 23' ' ' ILE . 1.1 m-20 99.11 82.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.362 -1.29 . . . . 2.31 109.669 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.9 pttp -150.61 -131.23 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.42 -1.264 . . . . 2.9 108.75 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.481 HG21 HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -47.06 113.83 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 118.306 0.503 . . . . 2.43 109.824 177.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.47 ' HA ' ' CB ' ' A' ' 22' ' ' LEU . 3.1 pt -124.8 116.49 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 114.793 1.405 . . . . 4.33 114.793 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' H ' ' HB2' ' A' ' 22' ' ' LEU . . . -101.72 144.54 16.43 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 107.055 -2.418 . . . . 1.14 107.055 174.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.589 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 15.9 p -155.11 104.38 2.45 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.934 1.087 . . . . 1.95 113.934 -175.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.27 98.22 1.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.944 -0.571 . . . . 4.16 109.881 176.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.484 HG22 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -102.89 -82.16 0.49 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 119.385 -0.926 . . . . 1.13 112.901 179.533 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -142.69 -65.78 0.39 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.692 0.627 . . . . 1.14 112.692 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . 126.19 -35.05 3.07 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.099 -0.8 . . . . 0.72 111.099 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -66.78 -30.52 70.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.27 0.557 . . . . 2.82 109.61 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.418 ' HA2' HG11 ' A' ' 44' ' ' VAL . . . -145.47 -49.1 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.272 -0.876 . . . . 0.86 111.686 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.553 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -118.49 151.55 37.62 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 119.701 -0.19 . . . . 1.15 110.597 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.43 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -160.36 27.03 0.16 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.886 1.439 . . . . 2.5 114.886 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.646 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 12.3 mt-10 -151.1 -174.4 4.79 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.56 -0.533 . . . . 1.28 109.56 177.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.614 ' CD2' ' CZ3' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -153.08 -72.55 0.14 Allowed 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 118.815 2.894 . . . . 5.2 118.815 -177.185 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.529 ' HG ' ' CE2' ' A' ' 21' ' ' TYR . 33.7 mt -82.92 143.09 30.96 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 114.749 1.389 . . . . 5.07 114.749 -172.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.48 ' CD1' ' CA ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER 17.37 -148.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 111.522 -2.581 . . . . 3.21 113.751 -179.297 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER 83.15 -5.88 1.23 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.902 -0.407 . . . . 2.6 109.902 -178.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.574 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 1.3 p90 -121.98 28.57 7.49 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 120.861 -0.336 . . . . 1.71 111.023 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.8 tttt 29.18 62.93 0.14 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.223 0.823 . . . . 3.74 113.223 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.433 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 3.9 p30 45.61 27.4 0.42 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.753 0.311 . . . . 2.14 111.631 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -49.48 -65.9 2.54 Favored Glycine 0 CA--C 1.508 -0.356 0 N-CA-C 110.776 -0.929 . . . . 0.99 110.776 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.566 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -132.56 100.72 5.05 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 108.752 -0.833 . . . . 3.77 108.752 177.374 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.417 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 70.2 m 37.08 109.53 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 N-CA-C 116.24 1.941 . . . . 1.8 116.24 176.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.454 ' HG3' ' HB3' ' A' ' 4' ' ' GLU . 2.8 Cg_exo -34.92 102.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.938 2.425 . . . . 0.79 110.027 174.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.544 ' HB2' ' CD2' ' A' ' 38' ' ' TYR . 28.7 t -124.2 -177.54 3.81 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 114.166 1.173 . . . . 1.27 114.166 -174.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.614 ' CZ3' ' CD2' ' A' ' 21' ' ' TYR . 3.7 t-105 -109.33 100.13 9.28 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 103.235 -2.876 . . . . 1.48 103.235 173.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.646 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -153.07 154.79 31.4 Favored Pre-proline 0 N--CA 1.444 -0.761 0 CA-C-N 115.267 -0.879 . . . . 2.35 112.63 -171.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.553 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 21.2 Cg_endo -59.45 -13.74 22.15 Favored 'Trans proline' 0 N--CA 1.491 1.344 1 C-N-CA 126.35 4.7 . . . . 1.52 117.817 -176.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 18.6 p 178.51 -23.59 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 119.572 1.078 . . . . 2.17 113.764 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.521 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 48.2 t -141.21 -73.23 0.33 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.514 0.673 . . . . 1.81 110.663 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.929 ' HH ' ' HB3' ' A' ' 40' ' ' ALA . 11.7 t80 177.8 131.84 0.06 Allowed 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 115.536 -0.756 . . . . 5.8 109.84 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.492 HG21 HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -146.67 26.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.503 -0.879 . . . . 2.64 110.852 -179.216 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.929 ' HB3' ' HH ' ' A' ' 38' ' ' TYR . . . -64.81 88.7 0.07 Allowed 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.144 -1.022 . . . . 1.75 109.955 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 40' ' ' ALA . . . 151.8 37.84 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.538 -1.21 . . . . 2.67 110.522 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 61.19 88.72 0.08 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.057 0.391 . . . . 4.56 112.057 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.417 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -162.99 -169.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 110.25 -0.278 . . . . 4.12 110.25 178.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.418 HG11 ' HA2' ' A' ' 17' ' ' GLY . 11.4 m -144.59 124.1 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 113.216 0.821 . . . . 3.1 113.216 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.437 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 28.9 t 53.8 16.25 0.99 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.249 -0.887 . . . . 1.46 113.084 178.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 179.84 148.01 0.27 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.724 -0.39 . . . . 1.6 111.925 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.546 ' N ' ' O ' ' A' ' 38' ' ' TYR . 14.4 t80 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.211 -0.899 . . . . 4.35 111.094 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.412 -0.275 . . . . 2.16 112.412 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.462 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 15.0 tt0 61.67 14.05 5.78 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.163 0.506 . . . . 2.17 111.665 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.546 ' N ' HG21 ' A' ' 23' ' ' ILE . 58.0 t -79.67 -42.62 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 O-C-N 121.986 -0.446 . . . . 0.87 111.138 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.633 ' H ' HG21 ' A' ' 23' ' ' ILE . 20.1 t-20 82.06 44.51 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.697 -0.683 . . . . 1.86 111.999 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.501 ' O ' HG23 ' A' ' 9' ' ' ILE . 22.9 ptmt -119.76 -143.2 0.35 Allowed 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.179 -1.045 . . . . 2.42 108.179 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.447 HG22 ' HG3' ' A' ' 7' ' ' LYS . 3.1 tp -45.44 139.26 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 122.219 0.208 . . . . 2.03 111.009 178.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.63 HG22 HG12 ' A' ' 23' ' ' ILE . 27.6 pt -133.94 129.28 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 114.641 1.349 . . . . 3.89 114.641 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.06 144.41 16.0 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 106.865 -2.494 . . . . 1.14 106.865 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.506 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -152.36 105.42 3.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 118.855 1.328 . . . . 1.69 113.471 -175.739 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -156.85 102.87 2.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.847 -0.615 . . . . 3.7 110.874 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.638 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -116.67 -80.82 0.61 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.625 -0.83 . . . . 0.48 113.082 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.41 ' C ' ' HG2' ' A' ' 19' ' ' MET . . . -150.3 -58.79 0.19 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.631 0.604 . . . . 0.45 112.631 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.9 -36.37 3.36 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.577 -0.82 . . . . 0.72 111.757 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.19 -31.21 68.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.39 -0.596 . . . . 2.82 109.39 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.414 ' HA2' HG23 ' A' ' 44' ' ' VAL . . . -147.35 -58.45 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.029 -0.987 . . . . 0.8 110.847 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.487 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . . . -106.21 151.45 24.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.523 -0.338 . . . . 0.51 110.662 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.421 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -165.47 26.01 0.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.07 0.767 . . . . 1.98 113.07 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 5.2 mt-10 -146.54 -171.45 3.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.718 -0.845 . . . . 1.28 108.718 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.603 ' CD2' ' CZ3' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -155.17 -53.96 0.09 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 117.965 2.58 . . . . 4.88 117.965 -177.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.536 ' HB3' HG22 ' A' ' 9' ' ' ILE . 8.7 mt -88.27 151.69 22.47 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 116.324 1.972 . . . . 4.63 116.324 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.633 HG21 ' H ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -7.54 -117.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 111.584 -2.553 . . . . 2.72 114.402 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.452 ' CG ' HD13 ' A' ' 9' ' ' ILE . 0.9 OUTLIER 48.88 24.0 0.78 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.623 0.647 . . . . 2.6 110.221 -177.889 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.576 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -145.81 31.13 1.06 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 113.45 0.907 . . . . 1.71 113.45 -179.302 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.6 mttp 33.54 33.98 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.556 0.576 . . . . 3.35 112.556 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.453 ' HB3' ' CG ' ' A' ' 4' ' ' GLU . 4.1 p-10 46.64 47.81 14.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.886 -0.597 . . . . 2.14 112.194 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.445 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -52.95 -56.11 20.38 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.073 -1.06 . . . . 0.86 111.531 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.487 ' O ' ' O ' ' A' ' 30' ' ' SER . 60.2 m80 -131.1 94.21 3.54 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 109.337 -0.616 . . . . 2.9 109.337 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 29' ' ' HIS . 13.9 m 40.43 106.68 0.01 OUTLIER Pre-proline 0 C--O 1.223 -0.29 0 N-CA-C 113.468 0.914 . . . . 1.46 113.468 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 8.2 Cg_exo -33.53 130.63 0.14 Allowed 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 122.479 2.12 . . . . 0.79 110.037 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.556 ' CB ' ' CG2' ' A' ' 34' ' ' VAL . 64.7 m -150.94 156.36 41.02 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 113.94 1.089 . . . . 0.95 113.94 -173.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.638 ' CD1' HG23 ' A' ' 13' ' ' THR . 3.7 t-105 -86.1 92.26 8.67 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 103.663 -2.717 . . . . 1.24 103.663 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.926 HG12 ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -154.99 -177.8 0.79 Allowed Pre-proline 0 CA--C 1.547 0.855 0 CA-C-N 114.706 -1.133 . . . . 1.74 110.414 -174.607 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.926 ' HD3' HG12 ' A' ' 34' ' ' VAL . 30.4 Cg_endo -86.33 103.22 0.66 Allowed 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 124.185 3.257 . . . . 1.52 116.32 -174.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 t 41.2 28.08 0.06 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.108 0.48 . . . . 1.75 111.251 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.502 ' O ' ' CE3' ' A' ' 25' ' ' TRP . 1.5 m -166.23 -131.85 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.444 -0.798 . . . . 1.49 109.913 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -170.45 98.92 0.26 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 105.004 -2.221 . . . . 5.43 105.004 -177.629 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.861 ' HB ' HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -116.59 37.64 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.823 -1.08 . . . . 2.1 111.624 -173.358 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -69.82 89.98 0.59 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.188 -0.915 . . . . 1.64 110.904 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 152.96 42.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.272 -0.876 . . . . 2.5 110.504 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 t70 54.76 88.67 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.72 0.295 . . . . 4.56 110.778 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.861 HG13 ' HB ' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -169.75 170.6 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.306 -0.628 . . . . 3.73 109.306 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.588 ' HA ' HD12 ' A' ' 39' ' ' ILE . 7.6 p -128.63 132.99 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 114.079 1.14 . . . . 2.57 114.079 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.502 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 16.6 t 61.83 7.59 2.07 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.669 1.359 . . . . 1.34 114.669 176.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.434 ' O ' ' CG2' ' A' ' 43' ' ' VAL . 3.5 tt0 177.8 -173.04 0.12 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.136 -0.626 . . . . 1.6 112.42 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.504 ' HB2' ' HA ' ' A' ' 39' ' ' ILE . 45.5 t80 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.222 -0.894 . . . . 4.12 110.675 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.454 ' HA2' HG12 ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.242 0 N-CA-C 112.616 -0.194 . . . . 2.16 112.616 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.566 ' N ' HG23 ' A' ' 23' ' ' ILE . 0.0 OUTLIER 58.29 12.98 2.16 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.021 0.378 . . . . 2.17 112.021 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 5' ' ' VAL . 23.2 t -89.42 -4.22 10.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 112.274 0.472 . . . . 0.87 112.274 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.599 ' H ' HG22 ' A' ' 23' ' ' ILE . 29.4 t-20 39.09 71.66 0.16 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.007 0.432 . . . . 1.86 111.236 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.587 ' HD3' HG22 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -150.77 -141.98 0.11 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.874 -0.603 . . . . 2.42 109.389 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -56.49 106.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.596 0.712 . . . . 2.03 111.537 179.48 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.755 HD11 ' CZ ' ' A' ' 21' ' ' TYR . 3.0 tp -153.55 171.06 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.845 -0.616 . . . . 3.89 110.763 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.03 169.37 20.45 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 111.824 -0.511 . . . . 1.14 111.824 -175.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.516 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 14.1 p -150.29 103.99 3.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 113.312 0.856 . . . . 1.69 113.312 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.422 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 32.2 ttm180 -159.46 101.36 1.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.481 -0.327 . . . . 3.7 111.845 177.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.582 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -115.69 -85.42 0.62 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.857 1.058 . . . . 0.48 113.857 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.425 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -146.03 -51.57 0.24 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.421 0.555 . . . . 0.45 112.493 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.06 -35.57 4.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.625 -0.798 . . . . 0.72 112.193 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -59.73 -41.99 92.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.224 0.535 . . . . 2.82 110.01 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -136.03 -40.61 0.14 Allowed Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.397 -0.819 . . . . 0.8 111.697 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.513 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . . . -130.59 150.7 51.67 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.439 -0.578 . . . . 0.51 109.439 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.425 ' HG3' ' C ' ' A' ' 14' ' ' ALA . 2.9 ttt -162.74 24.58 0.1 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.1 0.778 . . . . 1.98 113.1 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.56 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 18.5 mt-10 -150.65 178.81 8.74 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.183 -0.673 . . . . 1.28 109.183 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.755 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 2.3 t80 -157.61 9.66 0.18 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.515 0.931 . . . . 4.88 113.515 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.799 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.8 pp -83.6 130.3 34.98 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 116.522 2.045 . . . . 4.63 116.522 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 6' ' ' ASN . 1.4 mp -72.5 10.14 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 CA-C-N 110.016 -3.266 . . . . 2.72 111.1 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.415 ' OE1' ' N ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -78.64 10.86 2.88 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.232 -0.44 . . . . 2.6 110.702 177.411 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.646 ' HZ2' ' H ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -86.98 32.57 0.67 Allowed 'General case' 0 C--N 1.347 0.458 0 CA-C-O 120.627 0.251 . . . . 1.71 111.411 178.847 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 74.6 tttt 48.85 36.3 7.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.626 -0.261 . . . . 3.35 111.212 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.446 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 16.4 t0 57.09 23.08 8.07 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.114 -0.634 . . . . 2.14 109.746 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -43.45 -64.39 1.82 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 120.764 -0.731 . . . . 0.86 111.328 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.528 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -135.16 98.87 4.1 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 109.553 -0.536 . . . . 2.9 109.553 177.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 29' ' ' HIS . 40.6 m 32.43 117.23 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 117.096 2.258 . . . . 1.46 117.096 176.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.479 ' HB3' ' CG1' ' A' ' 23' ' ' ILE . 14.8 Cg_exo -31.5 118.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 123.75 2.967 . . . . 0.79 108.427 172.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.646 ' H ' ' HZ2' ' A' ' 25' ' ' TRP . 7.3 t -152.21 154.35 35.62 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.379 1.252 . . . . 0.95 114.379 -172.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.61 ' CE3' ' CD2' ' A' ' 21' ' ' TYR . 8.4 t-105 -91.52 91.23 7.97 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 104.187 -2.523 . . . . 1.24 104.187 175.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.886 HG12 ' CD ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -156.77 173.97 4.47 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 114.65 -1.159 . . . . 1.74 110.928 -175.066 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.886 ' CD ' HG12 ' A' ' 34' ' ' VAL . 7.3 Cg_endo -92.38 122.24 0.57 Allowed 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.512 2.808 . . . . 1.52 116.447 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.6 m 79.9 -51.72 0.38 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.833 -1.076 . . . . 1.75 113.736 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.561 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 57.9 m -144.16 -65.49 0.36 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.538 0.685 . . . . 1.49 111.272 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.702 ' OH ' ' HB3' ' A' ' 40' ' ' ALA . 10.0 t80 178.7 140.88 0.1 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.251 -0.648 . . . . 5.43 109.251 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.791 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -161.1 30.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 122.801 1.286 . . . . 2.1 109.137 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.702 ' HB3' ' OH ' ' A' ' 38' ' ' TYR . . . -66.23 89.85 0.14 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.748 -1.114 . . . . 1.64 110.507 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 156.62 41.1 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.438 -0.801 . . . . 2.5 110.573 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.414 ' O ' HG22 ' A' ' 43' ' ' VAL . 7.6 m-20 58.18 84.09 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.77 0.319 . . . . 4.56 111.18 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 0.6 OUTLIER -157.21 -151.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.43 -0.582 . . . . 3.73 109.43 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.42 ' N ' HG13 ' A' ' 39' ' ' ILE . 7.6 p -169.05 120.72 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 113.448 0.907 . . . . 2.57 113.448 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.3 t 65.74 7.02 4.23 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 114.089 1.144 . . . . 1.34 114.089 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 179.05 147.01 0.18 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.571 0.582 . . . . 1.6 112.571 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 38' ' ' TYR . 28.6 p90 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.19 -0.91 . . . . 4.12 111.07 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.551 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.36 0 CA-C-O 120.468 -0.073 . . . . 2.16 113.034 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.51 ' CG ' ' HB3' ' A' ' 27' ' ' ASP . 1.8 tm-20 61.39 26.57 16.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 122.274 1.035 . . . . 2.17 109.275 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -104.32 -19.73 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.129 -0.941 . . . . 0.87 111.505 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.455 ' ND2' ' HA ' ' A' ' 24' ' ' GLU . 7.1 m120 47.5 79.1 0.07 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.946 -0.39 . . . . 1.86 109.946 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HE3' HG21 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -135.68 -98.61 0.23 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.887 0.699 . . . . 2.42 112.887 -177.769 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 8' ' ' ILE . 2.1 tp -135.97 111.63 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 109.839 -0.43 . . . . 2.03 109.839 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 1.178 HG23 ' CE2' ' A' ' 21' ' ' TYR . 6.9 tp -150.97 162.73 3.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 112.622 0.601 . . . . 3.89 112.622 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.501 ' N ' HG13 ' A' ' 9' ' ' ILE . . . -109.85 121.15 5.93 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 110.634 -0.986 . . . . 1.14 110.634 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.83 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -102.55 107.85 18.94 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.698 1.237 . . . . 1.69 113.174 -176.055 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -157.68 112.73 2.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 112.433 -2.167 . . . . 3.7 112.311 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.508 ' CB ' ' HA ' ' A' ' 19' ' ' MET . 1.6 m -116.36 -78.21 0.58 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.408 0.521 . . . . 0.48 112.408 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.96 -54.94 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.731 0.301 . . . . 0.45 111.647 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.12 -35.67 4.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.352 -0.928 . . . . 0.72 112.653 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.3 -27.0 65.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.056 0.455 . . . . 2.82 110.342 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -150.38 -43.64 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.694 -0.685 . . . . 0.8 111.582 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.515 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -129.98 151.47 50.5 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.862 -0.421 . . . . 0.51 109.862 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.508 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 4.0 ttp -164.23 51.88 0.13 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.618 1.34 . . . . 1.98 114.618 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.748 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 6.7 mt-10 -151.01 -124.39 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 114.886 1.439 . . . . 1.28 114.886 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 1.178 ' CE2' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -155.72 -126.78 0.03 OUTLIER 'General case' 0 C--O 1.199 -1.556 0 N-CA-C 117.787 2.514 . . . . 4.88 117.787 -173.323 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.94 ' O ' HG21 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -151.53 165.19 34.98 Favored 'General case' 0 N--CA 1.432 -1.358 0 O-C-N 121.409 -0.807 . . . . 4.63 111.128 178.517 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.76 HD13 ' C ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER 56.29 63.04 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 124.505 1.122 . . . . 2.72 113.678 179.193 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.86 ' HB3' ' OH ' ' A' ' 21' ' ' TYR . 5.0 tt0 178.88 38.67 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.861 0.689 . . . . 2.6 112.861 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.546 ' CZ2' ' HA ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -153.15 32.92 0.47 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.682 0.623 . . . . 1.71 112.682 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp 56.17 20.12 4.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.843 0.354 . . . . 3.35 111.425 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.51 ' HB3' ' CG ' ' A' ' 4' ' ' GLU . 2.6 p-10 47.34 40.16 10.19 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.135 0.791 . . . . 2.14 113.135 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.84 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -48.23 -54.89 11.31 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.082 -1.056 . . . . 0.86 112.344 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.526 ' CE1' ' CD2' ' A' ' 47' ' ' TYR . 38.2 t-80 -131.69 95.44 3.72 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 117.244 0.522 . . . . 2.9 110.546 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.511 ' O ' ' O ' ' A' ' 29' ' ' HIS . 14.6 m 37.63 107.48 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.402 0 N-CA-C 113.471 0.915 . . . . 1.46 113.471 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.451 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 7.1 Cg_exo -33.85 125.67 0.16 Allowed 'Trans proline' 0 C--N 1.366 1.45 0 C-N-CA 122.768 2.312 . . . . 0.79 110.275 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.558 ' O ' ' O ' ' A' ' 21' ' ' TYR . 67.3 m -152.24 143.96 23.58 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 119.422 -0.911 . . . . 0.95 112.879 -173.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.583 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 31.5 t-105 -78.59 92.42 4.7 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 104.051 -2.574 . . . . 1.24 104.051 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.892 HG12 ' CD ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -152.67 173.04 4.88 Favored Pre-proline 0 N--CA 1.442 -0.829 0 CA-C-N 112.308 -2.223 . . . . 1.74 108.533 -176.183 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.892 ' CD ' HG12 ' A' ' 34' ' ' VAL . 85.5 Cg_endo -77.46 105.82 2.11 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 123.726 2.95 . . . . 1.52 117.432 -173.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.8 t 43.5 27.25 0.14 Allowed 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.33 -1.305 . . . . 1.75 111.997 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.547 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 12.2 m -166.65 -120.16 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.494 -0.775 . . . . 1.49 109.668 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.84 ' OH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -175.49 101.21 0.08 Allowed 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 106.45 -1.685 . . . . 5.43 106.45 -177.648 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.677 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -127.04 33.16 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 114.745 -1.116 . . . . 2.1 109.154 -176.082 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -58.28 92.79 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.424 -1.262 . . . . 1.64 111.905 -177.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 168.49 -61.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.184 -0.916 . . . . 2.5 110.059 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 9.2 t70 163.29 79.73 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.321 -0.854 . . . . 4.56 109.683 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.557 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -148.91 -157.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.959 -0.296 . . . . 3.73 110.401 -179.361 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.562 ' N ' HD12 ' A' ' 39' ' ' ILE . 4.8 p -155.16 105.9 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.421 0.629 . . . . 2.57 112.531 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.46 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 6.3 p 80.16 2.36 1.98 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.762 -1.108 . . . . 1.34 113.335 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 179.15 140.74 0.11 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.597 0.237 . . . . 1.6 111.311 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.526 ' CD2' ' CE1' ' A' ' 29' ' ' HIS . 11.0 t80 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.195 -0.907 . . . . 4.12 110.069 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.565 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.464 -0.254 . . . . 2.16 112.464 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.496 ' N ' ' HG3' ' A' ' 31' ' ' PRO . 2.1 tm-20 64.36 47.19 3.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.953 0.883 . . . . 2.17 110.137 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.411 HG11 ' HD3' ' A' ' 7' ' ' LYS . 12.0 t -119.94 -16.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.243 -0.89 . . . . 0.87 111.301 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 24.8 t-20 50.37 38.59 18.35 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 108.529 -0.915 . . . . 1.86 108.529 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.9 ' HE3' HG21 ' A' ' 23' ' ' ILE . 21.7 pttp -93.48 -129.6 0.12 Allowed 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.291 -1.322 . . . . 2.42 111.268 -176.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -117.02 117.14 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.048 0.452 . . . . 2.03 111.965 -178.402 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.555 ' HB ' HD11 ' A' ' 23' ' ' ILE . 9.7 tp -149.59 161.88 4.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.958 -0.564 . . . . 3.89 110.849 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -109.34 130.41 9.97 Favored Glycine 0 CA--C 1.505 -0.589 0 N-CA-C 110.363 -1.095 . . . . 1.14 110.363 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.621 ' HB3' ' CG ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -102.16 107.8 19.0 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.562 1.172 . . . . 1.69 113.188 -177.516 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.34 104.4 2.03 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.547 -2.115 . . . . 3.7 111.285 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.488 ' CB ' ' HA ' ' A' ' 19' ' ' MET . 1.3 m -109.59 -81.51 0.57 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 119.953 -0.699 . . . . 0.48 112.562 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.404 ' C ' ' HG2' ' A' ' 19' ' ' MET . . . -149.84 -54.23 0.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.717 0.294 . . . . 0.45 111.417 -178.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.415 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . 117.05 -28.37 7.32 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.313 -0.946 . . . . 0.72 112.893 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.28 -33.43 71.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.336 0.589 . . . . 2.82 109.75 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.643 ' HA2' HG12 ' A' ' 44' ' ' VAL . . . -150.32 -46.9 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.785 -0.926 . . . . 0.8 110.785 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.577 ' HB1' ' HA ' ' A' ' 34' ' ' VAL . . . -115.17 152.17 33.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.263 -0.468 . . . . 0.51 110.027 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.488 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -165.94 46.84 0.08 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.105 0.78 . . . . 1.98 113.105 -179.604 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.755 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 53.3 mt-10 -149.54 -139.77 0.1 Allowed 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 114.621 1.341 . . . . 1.28 114.621 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.621 ' CG ' ' HB3' ' A' ' 11' ' ' SER . 0.1 OUTLIER -123.45 -172.65 2.56 Favored 'General case' 0 C--O 1.191 -2.008 0 N-CA-C 114.728 1.381 . . . . 4.88 114.728 -173.112 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.838 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -137.88 104.74 5.36 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 114.181 1.178 . . . . 4.63 114.181 173.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.9 HG21 ' HE3' ' A' ' 7' ' ' LYS . 2.7 pp 136.57 24.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 126.886 2.075 . . . . 2.72 112.436 176.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.581 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 8.9 tp10 -130.57 53.4 1.96 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.786 0.721 . . . . 2.6 111.925 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.576 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -153.83 -169.4 3.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.108 -0.496 . . . . 1.71 109.782 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.59 36.69 1.6 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.08 0.467 . . . . 3.35 109.791 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.443 ' HB2' ' HG3' ' A' ' 4' ' ' GLU . 24.9 t70 53.31 44.82 29.6 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.809 -0.632 . . . . 2.14 110.862 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.513 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -54.04 -64.27 4.41 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.231 -0.985 . . . . 0.86 112.312 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.464 ' O ' ' CB ' ' A' ' 38' ' ' TYR . 47.5 t-80 -134.41 95.94 3.49 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 117.099 0.449 . . . . 2.9 110.386 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 31' ' ' PRO . 17.4 m 39.12 98.01 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 112.573 0.583 . . . . 1.46 112.573 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.496 ' HG3' ' N ' ' A' ' 4' ' ' GLU . 18.0 Cg_exo -27.24 126.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.365 1.395 0 C-N-CA 123.558 2.839 . . . . 0.79 110.407 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.495 ' O ' ' CH2' ' A' ' 25' ' ' TRP . 8.5 t -152.41 144.64 23.93 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 119.038 -1.065 . . . . 0.95 112.959 -171.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.525 ' N ' ' HB3' ' A' ' 22' ' ' LEU . 9.1 t-105 -83.31 96.07 8.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 104.335 -2.469 . . . . 1.24 104.335 175.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.94 HG12 ' HD3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -151.51 -172.24 0.31 Allowed Pre-proline 0 N--CA 1.434 -1.229 0 CA-C-N 112.548 -2.115 . . . . 1.74 106.659 -175.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.94 ' HD3' HG12 ' A' ' 34' ' ' VAL . 44.9 Cg_endo -88.13 102.69 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.676 2.251 . . . . 1.52 116.142 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.42 ' N ' ' OE1' ' A' ' 20' ' ' GLU . 41.9 t 45.41 23.93 0.15 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.725 -0.671 . . . . 1.75 111.989 177.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.548 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 5.4 m -163.59 -122.93 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 116.476 -0.329 . . . . 1.49 110.22 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -174.47 102.15 0.1 Allowed 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 106.282 -1.747 . . . . 5.43 106.282 -177.748 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.749 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -124.17 34.98 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 114.683 -1.144 . . . . 2.1 110.329 -174.223 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -59.4 91.92 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.346 -1.297 . . . . 1.64 111.695 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 166.72 -60.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.307 -0.86 . . . . 2.5 110.022 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 41' ' ' ALA . 1.6 p30 160.49 78.66 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.567 -0.742 . . . . 4.56 110.398 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.628 HG11 ' O ' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -151.44 -166.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 110.067 -0.346 . . . . 3.73 110.067 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.643 HG12 ' HA2' ' A' ' 17' ' ' GLY . 3.1 m -147.22 121.68 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 112.848 0.684 . . . . 2.57 112.848 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.455 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 22.8 t 69.5 5.01 4.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.207 -0.906 . . . . 1.34 113.199 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 45' ' ' SER . 39.1 tt0 179.02 158.62 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.089 0.471 . . . . 1.6 111.863 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.628 ' O ' HG11 ' A' ' 43' ' ' VAL . 37.4 p90 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.176 -0.916 . . . . 4.12 110.997 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.641 ' O ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.647 -0.181 . . . . 2.16 112.647 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 48.74 26.82 1.36 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.785 0.803 . . . . 2.17 110.348 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 3' ' ' GLY . 5.1 t -105.4 -8.65 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.391 -0.822 . . . . 0.87 112.488 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.545 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 2.0 p30 41.34 74.38 0.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.714 0.293 . . . . 1.86 111.396 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.551 ' HD2' HG22 ' A' ' 8' ' ' ILE . 3.6 pttp -151.44 -107.93 0.06 Allowed 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.963 0.357 . . . . 2.42 111.963 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.678 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -82.77 101.46 7.52 Favored 'Isoleucine or valine' 0 C--N 1.345 0.408 0 N-CA-C 109.485 -0.561 . . . . 2.03 109.485 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.822 HD11 ' CZ ' ' A' ' 21' ' ' TYR . 2.4 tp -153.29 171.38 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 120.031 -0.667 . . . . 3.89 112.371 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.94 169.74 22.77 Favored Glycine 0 CA--C 1.508 -0.374 0 CA-C-N 116.16 -0.473 . . . . 1.14 111.987 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.495 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 2.5 p -150.35 104.48 3.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.128 0.788 . . . . 1.69 113.128 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.444 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 14.9 tpt180 -157.56 102.2 1.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.015 -0.539 . . . . 3.7 110.829 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.485 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -117.08 -84.09 0.64 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 114.008 1.114 . . . . 0.48 114.008 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.43 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -150.34 -56.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.428 -0.509 . . . . 0.45 112.305 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.472 ' N ' ' HG3' ' A' ' 19' ' ' MET . . . 119.4 -29.49 6.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.142 -1.028 . . . . 0.72 112.53 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -58.81 -33.7 70.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.471 0.653 . . . . 2.82 109.245 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 43' ' ' VAL . . . -150.83 -46.0 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 114.777 -1.102 . . . . 0.8 111.068 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.566 ' HA ' ' HG3' ' A' ' 35' ' ' PRO . . . -116.19 151.21 36.15 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.208 -0.293 . . . . 0.51 110.208 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.472 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 2.8 ttp -162.61 24.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.433 0.531 . . . . 1.98 112.433 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 5.7 mt-10 -150.47 -179.91 7.62 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.823 -0.436 . . . . 1.28 109.823 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.822 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -155.52 14.09 0.36 Allowed 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 113.702 1.001 . . . . 4.88 113.702 -179.274 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.681 ' HB3' HG23 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -84.78 135.45 34.11 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 116.003 1.853 . . . . 4.63 116.003 -177.038 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.626 HD13 ' H ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -74.2 16.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 111.505 -2.588 . . . . 2.72 111.126 177.641 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.545 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . 24.6 tt0 -80.09 17.25 1.03 Allowed 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.058 0.543 . . . . 2.6 111.082 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.591 ' HZ2' ' H ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -91.58 32.28 1.1 Allowed 'General case' 0 C--N 1.342 0.272 0 N-CA-C 109.851 -0.426 . . . . 1.71 109.851 177.8 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 25' ' ' TRP . 64.4 pttt 46.78 34.44 2.59 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.142 -0.481 . . . . 3.35 111.154 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 0.3 OUTLIER 65.24 23.89 12.23 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.704 -0.399 . . . . 2.14 110.246 179.424 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -44.32 -68.93 0.79 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.848 -0.691 . . . . 0.86 111.798 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.579 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -133.29 99.46 4.54 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.815 -0.439 . . . . 2.9 109.815 178.587 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.507 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 27.6 t 33.28 113.07 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 116.825 2.157 . . . . 1.46 116.825 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.507 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 13.5 Cg_exo -29.2 116.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.982 3.121 . . . . 0.79 110.053 173.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.591 ' H ' ' HZ2' ' A' ' 25' ' ' TRP . 22.8 t -152.72 -177.6 6.35 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 114.093 1.145 . . . . 0.95 114.093 -174.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.6 ' CE3' ' CG ' ' A' ' 21' ' ' TYR . 11.7 t-105 -106.21 92.19 4.03 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.584 -1.189 . . . . 1.24 108.935 178.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 1.018 HG21 HG23 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -159.76 -179.75 1.16 Allowed Pre-proline 0 C--O 1.214 -0.775 0 CA-C-N 115.822 -0.627 . . . . 1.74 110.815 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.716 ' CD ' HG22 ' A' ' 34' ' ' VAL . 11.7 Cg_endo -98.53 115.74 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 123.605 2.87 . . . . 1.52 115.778 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t 70.63 -8.75 0.87 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 115.37 1.619 . . . . 1.75 115.37 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.553 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 49.4 m -160.86 -90.27 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 118.707 -1.197 . . . . 1.49 114.102 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.784 ' CA ' HG11 ' A' ' 34' ' ' VAL . 12.8 t80 176.75 140.42 0.07 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 110.062 -0.347 . . . . 5.43 110.062 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.018 HG23 HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -165.62 31.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 123.182 1.468 . . . . 2.1 108.365 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -65.85 91.69 0.15 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.359 -1.292 . . . . 1.64 110.93 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 160.2 -26.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.367 -0.833 . . . . 2.5 110.421 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 5.8 m-20 -120.84 -92.04 0.55 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.41 0.522 . . . . 4.56 112.41 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.531 ' CA ' HD11 ' A' ' 39' ' ' ILE . 7.1 p 174.98 -30.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.276 0.472 . . . . 3.73 112.276 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.489 HG23 ' H ' ' A' ' 46' ' ' GLU . 32.6 m -54.51 -170.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 112.495 0.554 . . . . 2.57 112.495 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.477 ' CB ' ' HG2' ' A' ' 35' ' ' PRO . 11.7 t -107.58 21.8 16.92 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.1 0.778 . . . . 1.34 113.1 -177.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.489 ' H ' HG23 ' A' ' 44' ' ' VAL . 41.4 tt0 -172.86 139.18 0.85 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.565 0.58 . . . . 1.6 112.565 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' A' ' 38' ' ' TYR . 4.1 t80 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.273 -0.87 . . . . 4.12 110.989 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 N-CA-C 112.503 -0.239 . . . . 2.16 112.503 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.567 ' H ' HG22 ' A' ' 23' ' ' ILE . 9.8 tt0 61.46 14.78 6.11 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.303 0.573 . . . . 2.17 111.588 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.641 ' H ' HG21 ' A' ' 23' ' ' ILE . 4.9 t -79.87 -35.39 16.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 122.134 -0.354 . . . . 0.87 111.428 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.458 ' H ' HG21 ' A' ' 23' ' ' ILE . 42.8 t-20 58.61 88.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 1.86 110.632 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.476 ' HD2' ' CG1' ' A' ' 5' ' ' VAL . 2.5 ptmm? -150.94 -67.24 0.19 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.176 -0.466 . . . . 2.42 111.73 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.624 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -138.76 128.96 33.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.966 -0.561 . . . . 2.03 109.782 -179.22 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.624 ' N ' HD13 ' A' ' 8' ' ' ILE . 13.5 pt -122.1 131.46 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 113.949 1.092 . . . . 3.89 113.949 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.69 102.77 0.23 Allowed Glycine 0 N--CA 1.453 -0.216 0 N-CA-C 109.419 -1.472 . . . . 1.14 109.419 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.615 ' HB2' ' N ' ' A' ' 21' ' ' TYR . 7.0 m -148.99 169.96 19.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.334 1.235 . . . . 1.69 114.334 -176.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -159.89 102.74 1.49 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.522 -1.672 . . . . 3.7 109.91 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.848 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -87.85 -76.97 0.36 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.022 -0.671 . . . . 0.48 112.043 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -150.95 -63.54 0.19 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.683 0.623 . . . . 0.45 112.683 -178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.481 ' N ' ' HG3' ' A' ' 19' ' ' MET . . . 125.86 -42.05 1.56 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.773 -0.931 . . . . 0.72 110.773 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.408 ' OE2' ' N ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -59.3 -28.16 66.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.576 -0.898 . . . . 2.82 108.576 178.095 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.822 ' HA2' HG12 ' A' ' 44' ' ' VAL . . . -142.1 -65.17 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.958 -1.019 . . . . 0.8 111.179 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.88 ' HB2' HD11 ' A' ' 39' ' ' ILE . . . -109.19 154.0 22.99 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 119.564 -0.255 . . . . 0.51 111.367 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.558 ' HA ' ' H ' ' A' ' 13' ' ' THR . 1.6 ttm -157.05 25.09 0.31 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.49 1.293 . . . . 1.98 114.49 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.702 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 18.1 mt-10 -157.73 175.44 13.89 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 107.668 -1.234 . . . . 1.28 107.668 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.638 ' HB2' ' HA ' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -155.79 -26.69 0.1 Allowed 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 116.047 1.869 . . . . 4.88 116.047 -178.625 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.619 HD21 ' CZ ' ' A' ' 21' ' ' TYR . 2.0 mm? -89.66 138.21 31.67 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 115.308 1.595 . . . . 4.63 115.308 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.641 HG21 ' H ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -8.17 -119.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 111.363 -2.653 . . . . 2.72 114.969 177.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.564 ' HB2' HG21 ' A' ' 9' ' ' ILE . 33.9 tt0 48.23 25.03 0.76 Allowed 'General case' 0 C--N 1.344 0.365 0 O-C-N 121.777 -0.577 . . . . 2.6 109.939 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.927 ' CZ3' HG13 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -138.57 32.17 2.28 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 112.764 0.653 . . . . 1.71 112.764 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.2 tptt 37.3 30.41 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.326 0.491 . . . . 3.35 112.326 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HB3' ' CB ' ' A' ' 4' ' ' GLU . 4.1 p-10 44.15 35.82 1.32 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.09 0.404 . . . . 2.14 112.09 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.744 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -46.69 -53.86 9.63 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.302 -0.952 . . . . 0.86 111.72 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.543 ' CE1' ' CE2' ' A' ' 47' ' ' TYR . 9.6 t60 -132.04 94.57 3.5 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.581 -0.526 . . . . 2.9 109.581 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 29' ' ' HIS . 16.0 t 37.75 112.15 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 115.266 1.58 . . . . 1.46 115.266 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.448 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 17.9 Cg_exo -33.14 122.27 0.11 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.801 2.334 . . . . 0.79 108.768 174.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.492 ' O ' ' CZ2' ' A' ' 25' ' ' TRP . 40.4 m -143.38 174.98 10.26 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 114.201 1.186 . . . . 0.95 114.201 -172.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.848 ' CD1' HG23 ' A' ' 13' ' ' THR . 2.1 t90 -97.96 100.97 12.34 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 104.602 -2.37 . . . . 1.24 104.602 174.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.998 HG21 ' N ' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -151.83 151.62 28.6 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 114.226 -1.352 . . . . 1.74 111.37 -171.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.711 ' HD2' HG23 ' A' ' 34' ' ' VAL . 40.9 Cg_exo -56.37 -14.15 11.78 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 125.127 3.885 . . . . 1.52 116.588 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.771 ' H ' HG22 ' A' ' 34' ' ' VAL . 28.1 t 176.54 -28.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.96 0.726 . . . . 1.75 112.96 -177.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.567 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 49.7 m -114.61 -90.18 0.54 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.0 0.37 . . . . 1.49 112.0 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.998 ' N ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -178.94 123.3 0.09 Allowed 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 106.655 -1.609 . . . . 5.43 106.655 -179.349 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.88 HD11 ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -135.62 27.89 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.746 0.784 . . . . 2.1 110.305 -175.832 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -59.58 92.04 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.022 -0.99 . . . . 1.64 111.59 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 160.83 -60.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.232 -0.895 . . . . 2.5 109.948 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 6.7 t70 163.13 80.72 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.435 -0.802 . . . . 4.56 110.13 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.656 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -148.42 -163.34 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.961 -0.296 . . . . 3.73 110.336 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.822 HG12 ' HA2' ' A' ' 17' ' ' GLY . 15.9 m -141.14 101.74 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 113.073 0.768 . . . . 2.57 113.073 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.503 ' N ' ' HG2' ' A' ' 35' ' ' PRO . 46.9 t 64.39 14.68 8.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.281 -0.872 . . . . 1.34 112.414 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -178.6 133.61 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.487 -0.485 . . . . 1.6 111.822 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.543 ' CE2' ' CE1' ' A' ' 29' ' ' HIS . 90.4 t80 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.228 -0.891 . . . . 4.12 110.927 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.457 ' HA2' HD11 ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.184 -0.366 . . . . 2.16 112.184 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.476 ' CB ' ' HB3' ' A' ' 27' ' ' ASP . 6.9 tt0 67.52 7.27 5.48 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.771 0.286 . . . . 2.17 111.771 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 6' ' ' ASN . 54.9 t -82.53 -43.42 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.035 0.445 . . . . 0.87 110.353 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.658 ' N ' HG21 ' A' ' 23' ' ' ILE . 27.8 t-20 83.56 74.07 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.915 -1.038 . . . . 1.86 110.739 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.752 ' HG3' HG22 ' A' ' 8' ' ' ILE . 36.4 pttt -151.56 -140.36 0.1 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.302 -1.772 . . . . 2.42 108.093 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.958 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -38.95 143.54 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 122.565 0.346 . . . . 2.03 110.884 177.231 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.958 ' N ' HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -147.48 126.88 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 114.32 1.23 . . . . 3.89 114.32 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.03 146.71 16.66 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 107.767 -2.133 . . . . 1.14 107.767 175.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.509 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -154.24 104.43 2.61 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 118.51 1.155 . . . . 1.69 112.917 -176.046 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -157.86 102.65 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.822 -0.627 . . . . 3.7 109.849 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.463 ' H ' ' HA ' ' A' ' 19' ' ' MET . 1.0 OUTLIER -113.86 -82.98 0.6 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.894 1.072 . . . . 0.48 113.894 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.421 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -145.32 -54.52 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.576 -0.45 . . . . 0.45 112.157 -177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.435 ' N ' ' HG3' ' A' ' 19' ' ' MET . . . 116.63 -37.27 3.43 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 119.903 -1.142 . . . . 0.72 112.801 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.18 -27.74 64.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.251 0.548 . . . . 2.82 109.522 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -150.02 -53.98 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.33 -0.85 . . . . 0.8 111.123 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.565 ' HB1' ' HD3' ' A' ' 35' ' ' PRO . . . -115.67 146.58 41.72 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 110.034 -0.358 . . . . 0.51 110.034 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.463 ' HA ' ' H ' ' A' ' 13' ' ' THR . 2.6 ttp -155.68 31.81 0.36 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 111.925 0.343 . . . . 1.98 111.925 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.645 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 9.3 mt-10 -147.29 -176.39 5.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 119.155 -0.45 . . . . 1.28 109.88 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.675 ' HB2' ' CD2' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -154.28 -62.85 0.13 Allowed 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 119.919 3.303 . . . . 4.88 119.919 -174.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.945 ' HG ' HD12 ' A' ' 23' ' ' ILE . 10.6 tp -84.18 155.65 22.44 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 114.864 1.431 . . . . 4.63 114.864 -170.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.945 HD12 ' HG ' ' A' ' 22' ' ' LEU . 3.4 mp -9.86 -112.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 112.462 -2.154 . . . . 2.72 114.85 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.558 ' N ' HG22 ' A' ' 23' ' ' ILE . 5.9 tt0 70.69 -61.35 0.48 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.728 -1.582 . . . . 2.6 106.728 -175.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.566 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 1.1 p90 -57.76 -173.18 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.021 -0.99 . . . . 1.71 111.033 176.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.46 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 3.2 mptp? -116.37 55.2 0.82 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.122 0.487 . . . . 3.35 109.941 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.476 ' HB3' ' CB ' ' A' ' 4' ' ' GLU . 4.0 p30 42.85 33.94 0.55 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.563 -0.744 . . . . 2.14 111.874 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.743 ' N ' ' OH ' ' A' ' 38' ' ' TYR . . . -49.48 -57.54 9.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.534 -0.841 . . . . 0.86 112.722 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.542 ' NE2' ' CE2' ' A' ' 47' ' ' TYR . 54.5 t-80 -131.97 96.29 3.88 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 117.383 0.591 . . . . 2.9 110.694 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 29' ' ' HIS . 23.3 t 39.71 103.24 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 113.761 1.022 . . . . 1.46 113.761 177.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.446 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 15.1 Cg_exo -31.6 114.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.371 1.723 0 C-N-CA 122.816 2.344 . . . . 0.79 109.699 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 21' ' ' TYR . 10.0 t -133.62 -163.31 1.34 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.712 0.634 . . . . 0.95 112.712 -172.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.675 ' CD2' ' HB2' ' A' ' 21' ' ' TYR . 6.4 t-105 -120.41 91.98 3.66 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.15 -1.796 . . . . 1.24 106.15 175.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.699 HG13 ' CD ' ' A' ' 35' ' ' PRO . 1.2 t -158.7 170.65 8.58 Favored Pre-proline 0 N--CA 1.444 -0.751 0 CA-C-N 114.993 -1.003 . . . . 1.74 112.186 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.699 ' CD ' HG13 ' A' ' 34' ' ' VAL . 59.1 Cg_endo -70.39 108.41 2.19 Favored 'Trans proline' 0 N--CA 1.485 1.003 1 C-N-CA 125.484 4.123 . . . . 1.52 116.253 175.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 t 37.55 30.35 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.813 -0.63 . . . . 1.75 112.13 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.544 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -163.11 -136.14 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 116.024 -0.535 . . . . 1.49 110.464 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.743 ' OH ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -174.34 100.68 0.1 Allowed 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.444 -1.688 . . . . 5.43 106.444 -177.709 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.679 HG23 HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -126.14 31.44 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 122.92 1.343 . . . . 2.1 109.477 -175.106 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -60.91 92.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.51 -1.223 . . . . 1.64 111.055 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 164.38 -29.46 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.432 -0.804 . . . . 2.5 110.024 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.574 ' OD2' HG12 ' A' ' 43' ' ' VAL . 23.8 t70 -123.95 -91.46 0.54 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.989 -0.55 . . . . 4.56 112.008 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.574 HG12 ' OD2' ' A' ' 42' ' ' ASP . 14.7 p 175.55 -30.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 112.382 0.512 . . . . 3.73 112.382 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.473 HG23 ' H ' ' A' ' 46' ' ' GLU . 17.1 m -55.45 -169.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.005 0.372 . . . . 2.57 112.005 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.598 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 26.3 t -106.47 35.09 3.08 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.857 0.688 . . . . 1.34 112.857 -177.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.608 ' N ' HG21 ' A' ' 39' ' ' ILE . 34.8 tt0 -179.01 149.21 0.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.81 0.338 . . . . 1.6 110.815 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.542 ' CE2' ' NE2' ' A' ' 29' ' ' HIS . 9.4 t80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.239 -0.886 . . . . 4.12 110.803 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.564 ' HA3' ' HB3' ' A' ' 31' ' ' PRO . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.603 -0.199 . . . . 2.16 112.603 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.418 ' CA ' HG23 ' A' ' 23' ' ' ILE . 0.0 OUTLIER 62.0 7.92 2.32 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.42 0.526 . . . . 2.17 112.42 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.541 HG11 ' HD3' ' A' ' 7' ' ' LYS . 13.9 t -85.31 -50.37 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 120.897 0.379 . . . . 0.87 110.721 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.528 ' C ' HD21 ' A' ' 6' ' ' ASN . 0.2 OUTLIER 93.25 69.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.55 -1.205 . . . . 1.86 108.553 -178.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.541 ' HD3' HG11 ' A' ' 5' ' ' VAL . 17.0 pttp -150.41 -141.58 0.11 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.002 -0.999 . . . . 2.42 109.932 -177.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.708 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -48.1 102.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 121.486 0.66 . . . . 2.03 111.98 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.876 HD11 ' CZ ' ' A' ' 21' ' ' TYR . 5.1 tp -154.06 169.08 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.228 -0.589 . . . . 3.89 111.506 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.91 169.93 20.21 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.542 -0.361 . . . . 1.14 112.524 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.535 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 3.0 p -150.62 104.68 3.22 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 113.264 0.839 . . . . 1.69 113.264 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.428 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 12.6 mmt180 -157.93 103.38 1.87 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.295 -0.411 . . . . 3.7 111.723 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.591 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -125.28 -85.2 0.63 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.207 -0.933 . . . . 0.48 113.488 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.462 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -143.7 -61.36 0.4 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.094 0.405 . . . . 0.45 112.094 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 19' ' ' MET . . . 124.26 -46.98 1.05 Allowed Glycine 0 C--N 1.329 0.166 0 C-N-CA 120.434 -0.889 . . . . 0.72 112.522 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -59.26 -25.59 64.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.015 0.436 . . . . 2.82 110.517 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -141.43 -54.94 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.802 -0.919 . . . . 0.8 110.802 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.525 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . . . -128.76 150.98 50.06 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.454 -0.573 . . . . 0.51 109.454 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.462 ' HG2' ' N ' ' A' ' 14' ' ' ALA . 2.9 tmm? -162.49 22.61 0.1 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.351 0.871 . . . . 1.98 113.351 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.601 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 9.3 mm-40 -148.01 179.75 7.51 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.709 -0.848 . . . . 1.28 108.709 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.876 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -156.2 11.72 0.28 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.513 0.931 . . . . 4.88 113.513 -179.394 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.718 ' HB3' HG23 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -84.99 133.9 34.24 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 117.242 2.312 . . . . 4.63 117.242 -175.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.56 HD13 HG12 ' A' ' 9' ' ' ILE . 1.9 mp -64.4 -6.39 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-N 110.248 -3.16 . . . . 2.72 110.151 176.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.544 ' HB3' HD13 ' A' ' 22' ' ' LEU . 30.8 tt0 -47.83 -12.61 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.92 -0.582 . . . . 2.6 112.172 177.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.606 ' HZ2' ' H ' ' A' ' 32' ' ' SER . 0.2 OUTLIER -72.56 30.41 0.06 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.776 1.028 . . . . 1.71 113.776 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.6 mttm 46.18 35.57 2.68 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 118.048 0.385 . . . . 3.35 111.916 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.4 ' HB2' ' HG2' ' A' ' 4' ' ' GLU . 56.4 t0 62.68 25.34 15.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.955 0.407 . . . . 2.14 110.332 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -46.21 -66.57 1.64 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.408 -0.901 . . . . 0.86 111.393 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.546 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -135.35 99.57 4.27 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.934 -0.307 . . . . 2.9 110.612 178.697 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.485 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 20.1 m 37.18 111.8 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.495 0 N-CA-C 116.469 2.025 . . . . 1.46 116.469 176.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.564 ' HB3' ' HA3' ' A' ' 3' ' ' GLY . 7.3 Cg_exo -33.1 117.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 123.268 2.645 . . . . 0.79 108.935 173.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.606 ' H ' ' HZ2' ' A' ' 25' ' ' TRP . 18.6 t -150.1 176.16 11.07 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.496 0.924 . . . . 0.95 113.496 -173.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.614 ' CG ' ' HB2' ' A' ' 21' ' ' TYR . 12.0 t-105 -104.76 91.3 3.78 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.902 -0.777 . . . . 1.24 108.902 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 1.018 HG21 HG23 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -159.72 175.05 3.43 Favored Pre-proline 0 C--O 1.217 -0.616 0 CA-C-N 115.468 -0.787 . . . . 1.74 111.124 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.597 ' CD ' HG22 ' A' ' 34' ' ' VAL . 26.0 Cg_endo -92.02 142.45 2.59 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.756 2.971 . . . . 1.52 113.118 175.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 27.8 t 72.91 -57.56 0.63 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.965 -1.016 . . . . 1.75 113.65 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.579 ' HA ' ' CE3' ' A' ' 25' ' ' TRP . 42.9 m -148.72 -64.32 0.24 Allowed 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 114.937 1.458 . . . . 1.49 114.937 -177.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.679 ' CA ' HG11 ' A' ' 34' ' ' VAL . 7.9 t80 178.12 149.3 0.19 Allowed 'General case' 0 C--N 1.318 -0.771 0 O-C-N 121.759 -0.588 . . . . 5.43 110.407 -176.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.018 HG23 HG21 ' A' ' 34' ' ' VAL . 0.5 OUTLIER 176.45 74.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.61 0.719 . . . . 2.1 110.019 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.32 92.66 0.06 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.206 -0.906 . . . . 1.64 110.974 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 178.62 -31.9 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.5 -0.773 . . . . 2.5 111.182 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 77.26 25.88 0.74 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.089 -0.505 . . . . 4.56 110.661 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.583 HG23 ' CG2' ' A' ' 44' ' ' VAL . 29.8 m -121.31 0.5 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 3.73 112.106 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.798 ' O ' HG21 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -159.76 169.23 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-O 120.791 0.329 . . . . 2.57 110.947 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.47 ' CB ' ' HG2' ' A' ' 35' ' ' PRO . 47.4 t -105.32 26.03 9.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.971 -0.559 . . . . 1.34 111.281 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -178.8 148.62 0.42 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.028 0.381 . . . . 1.6 112.028 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' TYR . 9.3 t80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.224 -0.893 . . . . 4.12 110.8 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.517 ' O ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.45 -0.381 0 N-CA-C 112.555 -0.218 . . . . 2.16 112.555 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.456 ' HB2' ' CA ' ' A' ' 27' ' ' ASP . 9.4 pt-20 44.6 27.78 0.27 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.888 0.375 . . . . 2.17 111.006 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 3' ' ' GLY . 41.1 t -90.07 -8.97 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.16 -0.473 . . . . 0.87 111.846 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.577 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 32.0 t30 49.14 73.06 0.25 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 110.313 -0.255 . . . . 1.86 110.313 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.618 ' N ' HD13 ' A' ' 23' ' ' ILE . 1.6 ptmm? -140.61 -98.92 0.15 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.298 0.481 . . . . 2.42 112.298 -178.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 8' ' ' ILE . 1.4 tp -137.4 105.34 3.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 CA-C-O 121.034 0.445 . . . . 2.03 110.902 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.946 HG22 ' CG1' ' A' ' 23' ' ' ILE . 3.4 tt -151.85 173.77 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.783 -0.644 . . . . 3.89 110.579 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -100.66 167.59 20.05 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.214 -0.517 . . . . 1.14 113.176 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.771 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 13.6 p -153.63 103.9 2.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 1.69 111.896 -177.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -158.99 102.88 1.65 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.608 -0.724 . . . . 3.7 110.043 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.47 ' H ' ' HA ' ' A' ' 19' ' ' MET . 1.0 OUTLIER -108.7 -85.2 0.53 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.815 1.043 . . . . 0.48 113.815 -178.708 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.448 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -145.38 -54.16 0.29 Allowed 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.163 0.431 . . . . 0.45 112.163 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.83 -34.84 4.68 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.291 -0.957 . . . . 0.72 112.268 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.0 -32.82 70.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.532 0.682 . . . . 2.82 109.183 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.581 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -141.09 -55.72 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.807 -1.088 . . . . 0.8 110.554 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.599 ' CA ' ' HD3' ' A' ' 35' ' ' PRO . . . -120.28 150.0 41.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.816 -0.192 . . . . 0.51 111.001 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.523 ' H ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -155.46 37.36 0.38 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.032 0.752 . . . . 1.98 113.032 178.088 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.636 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 27.8 mt-10 -151.81 -169.45 3.37 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 119.43 -0.319 . . . . 1.28 110.466 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.835 ' O ' ' CH2' ' A' ' 25' ' ' TRP 0.269 2.5 t80 -152.76 -130.77 0.04 OUTLIER 'General case' 0 C--O 1.209 -1.029 0 N-CA-C 116.057 1.873 . . . . 4.88 116.057 -177.46 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.598 ' N ' ' CD1' ' A' ' 21' ' ' TYR . 4.4 mt -78.94 166.67 22.12 Favored 'General case' 0 CA--C 1.491 -1.326 0 O-C-N 120.402 -1.437 . . . . 4.63 114.651 -166.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.946 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.9 OUTLIER 45.5 -166.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 112.848 -1.978 . . . . 2.72 109.679 -179.62 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.773 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.6 OUTLIER 71.08 9.85 6.77 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.721 -0.844 . . . . 2.6 108.721 -177.811 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.835 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -143.48 -173.55 3.98 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 108.694 -0.854 . . . . 1.71 108.694 178.656 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 4.0 mppt? -122.29 65.2 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.604 -0.439 . . . . 3.35 111.99 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.456 ' CA ' ' HB2' ' A' ' 4' ' ' GLU . 3.5 p30 40.63 29.01 0.06 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.283 -0.417 . . . . 2.14 112.105 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.736 ' N ' ' OH ' ' A' ' 38' ' ' TYR . . . -46.7 -62.92 3.4 Favored Glycine 0 C--N 1.329 0.16 0 C-N-CA 120.601 -0.809 . . . . 0.86 113.248 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.571 ' CE1' ' CE2' ' A' ' 47' ' ' TYR . 68.4 t60 -133.09 96.3 3.73 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 117.724 0.762 . . . . 2.9 111.153 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 31' ' ' PRO . 13.8 m 40.47 99.98 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 118.575 -0.726 . . . . 1.46 112.874 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.447 ' C ' ' O ' ' A' ' 30' ' ' SER . 17.9 Cg_exo -27.51 124.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.368 2.712 . . . . 0.79 110.789 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.8 t -148.93 -168.81 3.2 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.525 0.935 . . . . 0.95 113.525 -173.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.646 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 3.7 t-105 -116.08 95.56 5.15 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.254 -1.387 . . . . 1.24 107.254 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.728 HG13 ' CD ' ' A' ' 35' ' ' PRO . 1.0 OUTLIER -157.87 166.3 16.85 Favored Pre-proline 0 C--O 1.221 -0.401 0 CA-C-N 115.872 -0.604 . . . . 1.74 112.469 -178.382 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.728 ' CD ' HG13 ' A' ' 34' ' ' VAL . 12.1 Cg_endo -56.03 69.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.475 0.438 1 C-N-CA 125.44 4.094 . . . . 1.52 116.129 177.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.4 m 60.94 31.21 19.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.436 0.636 . . . . 1.75 110.794 176.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.577 ' O ' ' CZ3' ' A' ' 25' ' ' TRP . 1.5 m -150.79 -131.57 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.859 -1.064 . . . . 1.49 108.445 177.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.736 ' OH ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -174.59 99.91 0.09 Allowed 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 106.374 -1.713 . . . . 5.43 106.374 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.758 HD11 ' H ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -155.2 83.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.184 -1.371 . . . . 2.1 107.691 -175.684 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.67 91.05 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.585 -1.189 . . . . 1.64 111.504 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 46.41 59.3 3.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.08 -0.964 . . . . 2.5 111.772 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.819 ' O ' HG13 ' A' ' 43' ' ' VAL . 25.2 t70 -122.58 -20.95 5.84 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.788 0.662 . . . . 4.56 112.788 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.819 HG13 ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -179.03 -95.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 112.089 0.403 . . . . 3.73 112.089 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 17' ' ' GLY . 4.8 p -179.74 124.93 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 113.159 0.8 . . . . 2.57 113.159 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.501 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 28.8 t 65.87 10.38 6.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.92 -1.037 . . . . 1.34 113.72 176.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.475 ' H ' HG21 ' A' ' 39' ' ' ILE . 2.6 mt-10 176.98 166.38 0.53 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.773 0.657 . . . . 1.6 112.773 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.571 ' CE2' ' CE1' ' A' ' 29' ' ' HIS . 43.6 t80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.22 -0.895 . . . . 4.12 110.344 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 4' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.484 -0.246 . . . . 2.16 112.484 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 27' ' ' ASP . 6.5 pt-20 51.37 21.48 1.19 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.861 0.362 . . . . 2.17 111.6 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.657 ' N ' HG22 ' A' ' 23' ' ' ILE . 18.6 t -78.62 -6.05 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 113.271 0.841 . . . . 0.87 113.271 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.665 ' H ' HG22 ' A' ' 23' ' ' ILE . 26.0 t-20 38.28 85.79 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.843 0.292 . . . . 1.86 110.594 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.447 ' HD3' ' CG1' ' A' ' 5' ' ' VAL . 22.2 pttp -150.99 -135.04 0.06 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 121.098 -0.241 . . . . 2.42 110.563 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.653 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.9 OUTLIER -105.49 97.92 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 112.874 0.694 . . . . 2.03 112.874 -178.78 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.896 ' HB ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -133.46 172.93 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 116.171 -0.468 . . . . 3.89 111.925 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.623 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -99.86 165.38 19.9 Favored Glycine 0 C--O 1.219 -0.815 0 N-CA-C 110.138 -1.185 . . . . 1.14 110.138 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.552 ' HA ' ' HB2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -155.55 109.37 2.82 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 117.916 0.858 . . . . 1.69 113.077 -176.466 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 11' ' ' SER . 2.1 mpt_? -154.63 103.21 2.44 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.38 -0.373 . . . . 3.7 111.196 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.766 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -106.24 -82.72 0.53 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.397 0.888 . . . . 0.48 113.397 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.41 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -146.31 -53.25 0.25 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.072 0.397 . . . . 0.45 112.072 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.49 -35.91 4.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.291 -0.957 . . . . 0.72 112.839 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -58.69 -30.09 67.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.325 0.583 . . . . 2.82 109.762 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.514 ' HA3' ' CG2' ' A' ' 43' ' ' VAL . . . -150.39 -46.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.236 -0.893 . . . . 0.8 110.899 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.62 ' CA ' ' HD3' ' A' ' 35' ' ' PRO . . . -121.53 142.12 50.38 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 121.034 -0.266 . . . . 0.51 111.045 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.55 ' HA ' ' H ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -153.49 39.14 0.49 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.66 0.615 . . . . 1.98 112.66 178.38 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.63 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 27.9 mt-10 -145.79 -151.4 0.37 Allowed 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 118.371 -0.823 . . . . 1.28 111.378 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.851 ' CE2' HD11 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -153.24 -97.19 0.05 OUTLIER 'General case' 0 C--O 1.203 -1.345 0 N-CA-C 119.725 3.231 . . . . 4.88 119.725 -174.228 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.802 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 13.2 tp -120.57 168.6 11.19 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 113.035 0.754 . . . . 4.63 113.035 -174.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.896 HD11 ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER 38.5 -142.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.579 -1.191 . . . . 2.72 110.435 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 53.29 19.32 1.51 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.609 1.095 . . . . 2.6 109.464 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.637 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -152.77 -173.19 4.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.731 -0.668 . . . . 1.71 109.756 -179.398 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -122.52 62.75 0.97 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.792 0.664 . . . . 3.35 112.792 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . 31.2 t70 46.22 26.11 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.187 0.44 . . . . 2.14 112.187 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.579 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -47.52 -61.04 4.9 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 119.707 -1.235 . . . . 0.86 111.884 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.49 ' O ' ' HB2' ' A' ' 38' ' ' TYR . 58.3 t-80 -134.05 95.8 3.5 Favored 'General case' 0 C--O 1.215 -0.721 0 C-N-CA 119.966 -0.694 . . . . 2.9 111.575 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 29' ' ' HIS . 14.8 m 37.88 105.63 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 114.215 1.191 . . . . 1.46 114.215 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.553 ' HB3' HD11 ' A' ' 22' ' ' LEU . 23.7 Cg_exo -30.55 116.86 0.06 OUTLIER 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 123.038 2.492 . . . . 0.79 110.31 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 21' ' ' TYR . 8.5 t -135.94 -150.44 0.37 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.36 0.874 . . . . 0.95 113.36 -173.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.766 ' CD1' HG23 ' A' ' 13' ' ' THR . 6.8 t-105 -135.0 95.08 3.24 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 106.141 -1.8 . . . . 1.24 106.141 174.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.864 HG11 HG22 ' A' ' 39' ' ' ILE . 1.4 t -156.75 162.04 28.36 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 115.132 -0.94 . . . . 1.74 113.092 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.815 ' CD ' HG13 ' A' ' 34' ' ' VAL . 18.6 Cg_endo -55.31 72.5 0.03 OUTLIER 'Trans proline' 0 N--CA 1.477 0.502 1 C-N-CA 126.784 4.989 . . . . 1.52 115.488 177.24 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 35.3 t 65.04 23.7 12.5 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.748 -0.381 . . . . 1.75 111.742 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.547 ' O ' ' CZ3' ' A' ' 25' ' ' TRP . 7.3 m -149.06 -123.06 0.05 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.23 -0.441 . . . . 1.49 110.262 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.579 ' CZ ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -176.83 107.79 0.07 Allowed 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.81 -1.552 . . . . 5.43 106.81 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.864 HG22 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -174.9 39.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 122.937 1.351 . . . . 2.1 108.51 -175.426 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 33' ' ' TRP . . . -77.04 90.14 3.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.862 -1.517 . . . . 1.64 110.596 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.41 -34.87 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.391 -1.277 . . . . 2.5 109.923 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.445 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 32.0 t70 -102.03 -99.48 0.27 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.889 -0.596 . . . . 4.56 111.895 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.2 p 174.09 68.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 119.841 -0.123 . . . . 3.73 110.971 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.484 ' CG2' HG12 ' A' ' 39' ' ' ILE . 25.2 m -156.81 169.99 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 113.995 1.109 . . . . 2.57 113.995 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.638 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 28.2 t -83.44 10.8 7.99 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.607 -1.178 . . . . 1.34 112.487 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.45 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 36.8 tt0 179.16 161.13 0.74 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.113 0.483 . . . . 1.6 111.963 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.481 ' CD2' ' OXT' ' A' ' 47' ' ' TYR . 38.1 p90 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.265 -0.874 . . . . 4.12 110.917 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.625 ' O ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 112.657 -0.177 . . . . 2.16 112.657 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.475 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.0 OUTLIER 56.11 18.09 3.03 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.863 0.363 . . . . 2.17 111.072 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 3' ' ' GLY . 12.7 t -106.79 -4.14 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.33 . . . . 0.87 111.429 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.557 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 9.7 p30 45.28 79.73 0.05 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.33 0.586 . . . . 1.86 110.886 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.426 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 6.2 pttp -143.99 -104.71 0.12 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.138 -0.937 . . . . 2.42 110.442 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.635 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -87.06 103.67 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 108.354 -0.98 . . . . 2.03 108.354 178.458 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.764 HG21 ' HB2' ' A' ' 22' ' ' LEU . 21.9 pt -104.2 165.73 3.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.917 0.865 . . . . 3.89 113.082 -177.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.4 138.83 9.29 Favored Glycine 0 CA--C 1.498 -0.983 0 N-CA-C 107.454 -2.258 . . . . 1.14 107.454 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.49 ' HB2' ' CB ' ' A' ' 20' ' ' GLU . 12.4 p -144.59 104.45 4.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 119.062 1.431 . . . . 1.69 113.415 -176.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.418 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 31.2 ttm180 -159.94 101.09 1.44 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.452 -1.249 . . . . 3.7 111.091 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.536 ' HB ' ' C ' ' A' ' 18' ' ' ALA . 2.9 m -116.68 -87.99 0.6 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 113.981 1.104 . . . . 0.48 113.981 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.41 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -148.63 -60.0 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.218 -0.593 . . . . 0.45 112.581 -177.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.458 ' N ' ' HG3' ' A' ' 19' ' ' MET . . . 125.24 -34.98 3.22 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.327 -0.94 . . . . 0.72 112.13 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -30.28 66.74 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.256 -0.646 . . . . 2.82 109.256 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -146.43 -47.38 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.137 -0.938 . . . . 0.8 110.931 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.566 ' CA ' ' HD3' ' A' ' 35' ' ' PRO . . . -127.02 151.78 48.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 111.488 0.181 . . . . 0.51 111.488 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.458 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 1.6 ttm -151.66 22.0 0.7 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.891 0.33 . . . . 1.98 111.891 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.615 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 18.9 mt-10 -148.36 177.85 9.09 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 122.287 -0.258 . . . . 1.28 111.407 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.67 ' CG ' ' O ' ' A' ' 21' ' ' TYR . 1.0 OUTLIER -159.09 50.91 0.37 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.514 0.673 . . . . 4.88 111.701 -179.413 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.764 ' HB2' HG21 ' A' ' 9' ' ' ILE . 2.0 pp -110.15 114.05 27.24 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 116.266 1.95 . . . . 4.63 116.266 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.656 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 8.2 pt -53.89 -16.92 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 113.195 -1.821 . . . . 2.72 112.376 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.557 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . 35.1 tt0 -67.3 65.51 0.07 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.242 0.544 . . . . 2.6 111.212 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.656 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -142.97 31.69 1.4 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.568 -0.742 . . . . 1.71 110.225 178.439 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 60.06 34.17 21.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.288 -0.869 . . . . 3.35 111.908 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.464 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 4.2 p30 44.77 29.17 0.41 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.88 0.371 . . . . 2.14 111.282 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.467 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -47.63 -61.95 4.37 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.676 -0.774 . . . . 0.86 112.338 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.57 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 49.9 t-80 -135.26 93.71 3.02 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 110.01 -0.367 . . . . 2.9 110.01 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 32' ' ' SER . 28.9 m 39.57 116.39 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 116.3 1.963 . . . . 1.46 116.3 177.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.592 ' HB3' HG22 ' A' ' 23' ' ' ILE . 14.2 Cg_exo -32.08 92.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 124.138 3.226 . . . . 0.79 107.749 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 30' ' ' SER . 33.8 t -111.72 166.32 11.28 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.334 -1.303 . . . . 0.95 113.849 -172.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.626 ' CZ3' ' CD2' ' A' ' 21' ' ' TYR . 15.0 t-105 -97.87 91.23 5.24 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 105.656 -1.979 . . . . 1.24 105.656 176.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.715 HG21 HG23 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -156.36 165.55 18.39 Favored Pre-proline 0 N--CA 1.441 -0.882 0 N-CA-C 113.887 1.069 . . . . 1.74 113.887 -178.376 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.674 ' HD2' HG22 ' A' ' 34' ' ' VAL . 38.2 Cg_endo -67.58 78.05 0.51 Allowed 'Trans proline' 0 C--N 1.352 0.728 1 C-N-CA 125.791 4.327 . . . . 1.52 117.609 177.783 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.8 m 76.09 14.5 2.52 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.641 0.978 . . . . 1.75 113.641 173.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.547 ' O ' ' CE3' ' A' ' 25' ' ' TRP . 1.8 m -162.54 -110.6 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 120.571 -0.451 . . . . 1.49 112.029 176.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.57 ' CG ' ' HB3' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -174.49 132.82 0.37 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.997 -1.853 . . . . 5.43 105.997 -176.774 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.715 HG23 HG21 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -149.68 28.98 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 119.377 -0.929 . . . . 2.1 111.118 -174.805 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.566 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -60.86 89.43 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.574 -0.739 . . . . 1.64 110.25 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.566 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 153.69 38.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.839 -1.073 . . . . 2.5 110.705 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 55.83 87.51 0.05 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.429 0.529 . . . . 4.56 112.429 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.592 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -151.59 -156.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 110.05 -0.352 . . . . 3.73 110.05 178.547 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 44' ' ' VAL . 8.3 p -159.29 120.59 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 113.702 1.001 . . . . 2.57 113.702 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.549 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 28.8 t 63.44 8.71 3.68 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.202 0.816 . . . . 1.34 113.202 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 45' ' ' SER . 38.0 tt0 179.23 154.99 0.47 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.912 0.387 . . . . 1.6 111.931 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 39' ' ' ILE . 35.4 t80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.2 -0.905 . . . . 4.12 110.833 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.437 ' C ' ' HG3' ' A' ' 31' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.495 -0.242 . . . . 2.16 112.495 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.485 ' H ' HG23 ' A' ' 23' ' ' ILE . 0.0 OUTLIER 64.97 3.78 2.23 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 112.179 0.437 . . . . 2.17 112.179 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.497 ' HB ' ' HG2' ' A' ' 7' ' ' LYS . 24.1 t -79.74 -41.21 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 CA-C-O 121.317 0.579 . . . . 0.87 110.807 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.473 ' H ' ' CG2' ' A' ' 23' ' ' ILE . 0.3 OUTLIER 81.68 71.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.821 -1.081 . . . . 1.86 108.421 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.846 ' HD3' HG22 ' A' ' 8' ' ' ILE . 5.3 ptpt -152.41 -107.12 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 112.986 0.736 . . . . 2.42 112.986 -176.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.846 HG22 ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -79.49 97.95 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 C-N-CA 123.217 0.607 . . . . 2.03 110.105 -179.22 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.902 HD11 ' CZ ' ' A' ' 21' ' ' TYR . 3.2 tp -153.42 170.49 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 C-N-CA 120.008 -0.677 . . . . 3.89 111.615 -178.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.24 169.18 20.63 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 121.276 -0.487 . . . . 1.14 111.982 -175.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.534 ' HB2' ' CB ' ' A' ' 20' ' ' GLU . 11.8 p -151.14 102.41 2.94 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 113.403 0.89 . . . . 1.69 113.403 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -163.3 97.32 0.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 119.176 -0.44 . . . . 3.7 111.255 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.761 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -105.02 -81.12 0.54 Allowed 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 119.022 -1.071 . . . . 0.48 113.742 177.563 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.414 ' C ' ' HG2' ' A' ' 19' ' ' MET . . . -150.81 -55.85 0.16 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.824 0.675 . . . . 0.45 112.824 -177.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.486 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . 122.49 -45.35 1.21 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.483 -0.865 . . . . 0.72 111.656 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -59.17 -32.17 69.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.036 -0.727 . . . . 2.82 109.036 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.703 ' HA2' HG12 ' A' ' 44' ' ' VAL . . . -132.46 -68.52 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.03 -0.986 . . . . 0.8 110.948 178.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 1.031 ' HB2' HD11 ' A' ' 39' ' ' ILE . . . -111.48 155.65 22.9 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 119.774 -0.155 . . . . 0.51 110.845 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.504 ' HA ' ' H ' ' A' ' 13' ' ' THR . 0.9 OUTLIER -153.85 16.07 0.5 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.75 1.018 . . . . 1.98 113.75 179.209 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.69 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 18.2 mt-10 -152.69 178.91 9.11 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 119.367 -0.349 . . . . 1.28 110.131 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.902 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 1.1 t80 -160.05 12.94 0.12 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.445 1.276 . . . . 4.88 114.445 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.694 ' HB3' HG23 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -85.43 125.64 33.17 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 117.916 2.561 . . . . 4.63 117.916 -175.807 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.684 HD12 ' HB ' ' A' ' 9' ' ' ILE . 5.7 mt -48.56 -22.48 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-N 111.266 -2.697 . . . . 2.72 110.868 174.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.54 ' HB3' HD13 ' A' ' 22' ' ' LEU . 23.6 tt0 -29.34 -32.19 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.839 0.856 . . . . 2.6 112.517 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.676 ' CZ3' ' CG1' ' A' ' 34' ' ' VAL . 0.4 OUTLIER -55.96 -163.4 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.26 -0.645 . . . . 1.71 109.26 177.014 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.431 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -114.62 54.61 0.77 Allowed 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.513 -0.742 . . . . 3.35 111.104 -178.869 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.423 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 4.2 p30 44.36 28.41 0.29 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.918 -0.583 . . . . 2.14 111.256 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.512 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -49.54 -65.63 2.69 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.471 -0.871 . . . . 0.86 112.087 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.447 ' O ' ' O ' ' A' ' 30' ' ' SER . 14.4 m80 -134.56 94.85 3.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.706 -0.398 . . . . 2.9 110.432 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 29' ' ' HIS . 29.5 t 41.26 114.47 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 116.058 1.873 . . . . 1.46 116.058 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.501 ' HB3' HG12 ' A' ' 23' ' ' ILE . 8.0 Cg_exo -30.96 95.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 124.022 3.148 . . . . 0.79 108.167 172.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.565 ' OG ' ' HB2' ' A' ' 40' ' ' ALA . 33.5 t -119.43 176.67 5.24 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-N 114.462 -1.245 . . . . 0.95 113.782 -172.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.761 ' CD1' HG23 ' A' ' 13' ' ' THR . 4.3 t-105 -104.79 99.83 9.47 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.326 -1.761 . . . . 1.24 107.18 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.948 HG11 ' C ' ' A' ' 37' ' ' SER . 7.4 p -152.42 155.44 32.92 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 115.166 -0.925 . . . . 1.74 111.591 -175.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.757 ' HD2' HG23 ' A' ' 34' ' ' VAL . 53.5 Cg_exo -55.03 -12.75 5.41 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 124.17 3.247 . . . . 1.52 115.789 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 19.4 p 174.07 -19.32 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.328 0.862 . . . . 1.75 113.328 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.948 ' C ' HG11 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -115.32 -95.39 0.47 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.179 0.445 . . . . 1.49 111.7 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.743 ' N ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -178.44 122.98 0.1 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.296 -1.372 . . . . 5.43 107.296 -178.336 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.031 HD11 ' HB2' ' A' ' 18' ' ' ALA . 5.1 pt -145.64 32.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 119.904 -0.718 . . . . 2.1 111.139 -176.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.565 ' HB2' ' OG ' ' A' ' 32' ' ' SER . . . -60.22 90.57 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.944 -1.026 . . . . 1.64 110.489 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 162.5 -61.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.888 -1.051 . . . . 2.5 109.736 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 13.5 t70 165.71 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.918 -0.583 . . . . 4.56 111.406 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.677 HG11 ' O ' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -147.58 -159.51 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 110.083 -0.34 . . . . 3.73 110.083 178.708 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.703 HG12 ' HA2' ' A' ' 17' ' ' GLY . 13.0 m -146.91 109.78 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 113.426 0.898 . . . . 2.57 113.426 -178.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.475 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . 47.2 t 54.26 16.17 1.14 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.816 -0.629 . . . . 1.34 112.481 178.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.417 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 3.0 tt0 178.36 132.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.566 -0.453 . . . . 1.6 111.703 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.677 ' O ' HG11 ' A' ' 43' ' ' VAL . 91.7 t80 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.244 -0.884 . . . . 4.12 110.67 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 31' ' ' PRO . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.487 -0.245 . . . . 2.16 112.487 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.462 ' CB ' ' HB3' ' A' ' 27' ' ' ASP . 1.2 pp20? 44.88 26.15 0.19 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.925 0.393 . . . . 2.17 111.996 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.53 HG11 ' HD3' ' A' ' 7' ' ' LYS . 38.8 t -79.8 -11.91 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.042 -0.527 . . . . 0.87 112.357 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.578 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 10.3 t-20 43.22 81.53 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.496 0.665 . . . . 1.86 109.871 -178.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.53 ' HD3' HG11 ' A' ' 5' ' ' VAL . 62.3 pttt -150.95 -134.02 0.06 Allowed 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.667 -1.151 . . . . 2.42 109.499 -177.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.66 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -96.52 113.69 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 120.989 0.423 . . . . 2.03 110.512 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.793 HD12 ' HB2' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -151.06 167.92 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 119.524 -0.87 . . . . 3.89 112.221 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.716 ' H ' HD13 ' A' ' 9' ' ' ILE . . . -104.12 168.21 16.59 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.75 -0.659 . . . . 1.14 112.703 -178.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.66 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 1.2 p -153.94 103.96 2.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 1.69 111.589 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -157.8 102.15 1.83 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.239 -0.437 . . . . 3.7 110.956 178.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.707 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -110.76 -82.66 0.58 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 119.243 -0.983 . . . . 0.48 113.642 179.686 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.05 -56.72 0.2 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.194 0.442 . . . . 0.45 112.194 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.51 -40.72 2.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.408 -0.901 . . . . 0.72 112.422 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.53 -25.25 64.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.975 0.417 . . . . 2.82 110.301 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 43' ' ' VAL . . . -149.12 -45.92 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.511 -0.636 . . . . 0.8 111.511 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.537 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -131.07 152.59 50.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.767 -0.457 . . . . 0.51 109.767 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.5 ' HA ' ' H ' ' A' ' 13' ' ' THR . 2.8 ttt -163.01 31.68 0.1 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.202 1.186 . . . . 1.98 114.202 -178.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.628 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 35.5 mt-10 -150.64 -160.55 1.18 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 117.508 -1.234 . . . . 1.28 108.618 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 1.146 ' CE1' HD13 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -153.45 -79.35 0.1 Allowed 'General case' 0 C--O 1.204 -1.327 1 N-CA-C 122.151 4.13 . . . . 4.88 122.151 -175.797 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.146 HD13 ' CE1' ' A' ' 21' ' ' TYR . 3.9 tp -114.22 166.59 11.49 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 115.401 1.63 . . . . 4.63 115.401 -173.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.578 ' HB ' ' HA ' ' A' ' 6' ' ' ASN . 1.3 pp 23.75 -150.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 111.956 -2.383 . . . . 2.72 113.03 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.495 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER 63.07 16.56 9.42 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.038 -0.727 . . . . 2.6 109.038 -178.722 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.614 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.3 OUTLIER -152.24 31.14 0.54 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.154 0.502 . . . . 1.71 111.401 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt 17.08 74.55 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.332 1.605 . . . . 3.35 115.332 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.462 ' HB3' ' CB ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 39.16 67.58 0.43 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.6 0.963 . . . . 2.14 113.6 176.969 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.577 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -88.18 -62.24 1.44 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.524 -1.322 . . . . 0.86 109.953 177.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.549 ' CD2' ' CD2' ' A' ' 47' ' ' TYR . 48.3 t-80 -133.2 94.78 3.4 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 109.544 -0.539 . . . . 2.9 109.544 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 31' ' ' PRO . 18.1 t 37.52 98.14 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 113.873 1.064 . . . . 1.46 113.873 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.432 ' C ' ' O ' ' A' ' 30' ' ' SER . 52.9 Cg_exo -27.08 106.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.349 2.7 . . . . 0.79 110.896 176.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 21' ' ' TYR . 8.7 t -122.18 -149.85 0.44 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.421 -0.809 . . . . 0.95 112.309 -173.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.707 ' CD1' HG23 ' A' ' 13' ' ' THR . 6.9 t-105 -137.87 94.48 2.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.069 -1.826 . . . . 1.24 106.069 174.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 1.078 HG13 ' HD2' ' A' ' 35' ' ' PRO . 1.4 t -156.26 165.25 19.02 Favored Pre-proline 0 C--O 1.218 -0.553 0 CA-C-N 116.053 -0.521 . . . . 1.74 111.759 -176.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 1.078 ' HD2' HG13 ' A' ' 34' ' ' VAL . 14.5 Cg_exo -63.81 81.3 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.286 2.657 . . . . 1.52 116.039 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.3 t 63.73 28.27 14.86 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.019 0.438 . . . . 1.75 111.365 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.592 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 5.6 t -151.78 -127.31 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.802 -0.635 . . . . 1.49 110.563 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.592 ' CG ' ' C ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -175.8 102.34 0.07 Allowed 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.317 -1.364 . . . . 5.43 107.317 -177.856 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.804 HG22 HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -158.98 72.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.978 1.371 . . . . 2.1 108.679 -176.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.96 91.31 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.461 -1.7 . . . . 1.64 110.821 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 42' ' ' ASP . . . -166.36 -35.19 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.551 -1.204 . . . . 2.5 110.921 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 15.2 t70 80.86 30.19 0.17 Allowed 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.183 -0.462 . . . . 4.56 110.31 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.8 HG13 HG23 ' A' ' 44' ' ' VAL . 8.9 p -127.85 -3.53 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 112.885 0.698 . . . . 3.73 112.885 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.8 HG23 HG13 ' A' ' 43' ' ' VAL . 3.6 t -158.32 153.38 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.253 0.549 . . . . 2.57 111.787 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.502 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 18.6 p -93.57 21.67 6.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.343 -0.844 . . . . 1.34 111.179 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.484 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 12.4 tt0 -178.99 141.15 0.17 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 120.424 -0.51 . . . . 1.6 112.153 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.549 ' CD2' ' CD2' ' A' ' 29' ' ' HIS . 75.4 t80 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.268 -0.873 . . . . 4.12 110.762 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.961 ' HA2' HD12 ' A' ' 23' ' ' ILE . . . . . . . . 0 CA--C 1.521 0.449 0 N-CA-C 112.557 -0.217 . . . . 2.16 112.557 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 61.48 18.66 9.61 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.431 0.634 . . . . 2.17 111.583 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.748 ' HB ' HD11 ' A' ' 23' ' ' ILE . 23.2 t -107.08 -9.51 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.046 -0.524 . . . . 0.87 111.621 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 44.1 t-20 50.72 88.33 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.021 0.439 . . . . 1.86 110.177 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.446 ' O ' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -138.36 -147.77 0.24 Allowed 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.876 -0.787 . . . . 2.42 108.876 -178.295 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.3 OUTLIER -65.08 117.44 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 109.824 -0.435 . . . . 2.03 109.824 178.347 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.78 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -129.25 136.25 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 114.096 1.147 . . . . 3.89 114.096 -178.125 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -116.51 106.97 1.55 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 107.693 -2.163 . . . . 1.14 107.693 176.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.667 ' CB ' ' CD2' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -102.76 108.34 19.53 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 114.736 1.384 . . . . 1.69 114.736 -174.722 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -158.18 102.69 1.79 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 112.91 -1.95 . . . . 3.7 112.39 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.515 ' CB ' ' HA ' ' A' ' 19' ' ' MET . 0.2 OUTLIER -111.74 -82.29 0.58 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.25 -0.906 . . . . 0.48 112.478 178.638 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.429 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -140.61 -50.82 0.46 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.689 0.281 . . . . 0.45 111.416 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.455 ' CA ' ' HG3' ' A' ' 19' ' ' MET . . . 110.74 -44.41 1.51 Allowed Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.312 -0.947 . . . . 0.72 112.732 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -58.62 -24.98 62.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.229 0.538 . . . . 2.82 109.811 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.517 ' HA3' ' CB ' ' A' ' 43' ' ' VAL . . . -145.14 -69.32 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.519 -1.032 . . . . 0.8 110.519 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.656 ' HB1' ' HA ' ' A' ' 34' ' ' VAL . . . -105.18 150.46 25.06 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.407 -0.59 . . . . 0.51 109.407 178.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.515 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 2.4 tmm? -165.01 42.48 0.08 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 114.218 1.192 . . . . 1.98 114.218 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.614 ' HA ' ' OG ' ' A' ' 11' ' ' SER . 32.0 mt-10 -143.47 -147.8 0.22 Allowed 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 114.398 1.259 . . . . 1.28 114.398 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.724 ' CE2' ' CG1' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -113.27 -174.41 2.45 Favored 'General case' 0 CA--C 1.456 -2.659 0 C-N-CA 124.837 1.255 . . . . 4.88 112.097 -173.672 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.583 ' HB3' ' N ' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -127.39 78.64 1.83 Allowed 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 115.823 1.786 . . . . 4.63 115.823 175.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.961 HD12 ' HA2' ' A' ' 3' ' ' GLY . 4.6 tt 152.41 71.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.136 0 N-CA-C 113.75 1.019 . . . . 2.72 113.75 171.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.74 ' HB2' HG21 ' A' ' 9' ' ' ILE . 14.2 tt0 178.58 59.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.154 -0.475 . . . . 2.6 111.96 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.539 ' CD1' ' N ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -154.22 29.86 0.44 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.854 0.359 . . . . 1.71 110.898 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.465 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 9.6 mptt 55.17 22.54 4.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.217 -0.447 . . . . 3.35 110.816 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.43 ' HB2' ' HG3' ' A' ' 4' ' ' GLU . 16.1 t70 59.29 109.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.588 0.709 . . . . 2.14 111.617 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.568 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -121.08 -62.52 0.24 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 109.857 -1.297 . . . . 0.86 109.857 178.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.473 ' O ' ' CB ' ' A' ' 38' ' ' TYR . 39.7 m80 -135.17 94.45 3.13 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.605 -0.517 . . . . 2.9 109.605 177.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.46 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 15.5 m 39.99 102.69 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 113.338 0.866 . . . . 1.46 113.338 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 14.8 Cg_exo -25.69 125.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.877 3.052 . . . . 0.79 109.705 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.549 ' C ' ' HB3' ' A' ' 22' ' ' LEU . 3.8 t -154.19 138.95 17.05 Favored 'General case' 0 C--O 1.21 -0.989 0 N-CA-C 114.62 1.341 . . . . 0.95 114.62 -171.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.583 ' N ' ' HB3' ' A' ' 22' ' ' LEU . 5.5 t-105 -83.6 96.58 8.69 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.593 -2.373 . . . . 1.24 104.593 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 1.016 HG12 ' HD3' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -150.88 -159.73 0.04 OUTLIER Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-N 113.271 -1.786 . . . . 1.74 107.631 -175.613 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 1.016 ' HD3' HG12 ' A' ' 34' ' ' VAL . 60.5 Cg_endo -95.25 99.01 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 122.708 2.003 . . . . 1.52 116.683 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.45 ' H ' ' CG ' ' A' ' 20' ' ' GLU . 47.0 t 55.18 16.79 1.74 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.709 -0.678 . . . . 1.75 112.223 176.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.557 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 50.4 m -162.76 -109.65 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 120.402 -0.519 . . . . 1.49 111.48 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.568 ' OH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -177.71 102.07 0.05 OUTLIER 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 106.645 -1.613 . . . . 5.43 106.645 -176.713 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.71 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -159.05 71.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.418 -0.81 . . . . 2.1 110.199 -176.078 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.65 91.6 5.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.974 -1.012 . . . . 1.64 110.676 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.8 -43.74 0.15 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.999 -1.001 . . . . 2.5 109.964 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.799 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.8 m-20 -142.53 -74.14 0.29 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.841 -0.618 . . . . 4.56 111.242 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 175.46 74.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.234 -0.439 . . . . 3.73 111.354 -178.375 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 35' ' ' PRO . 24.0 t -133.84 150.33 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 120.957 -0.297 . . . . 2.57 111.757 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.552 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 45.4 t -68.07 1.79 2.53 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.372 1.249 . . . . 1.34 114.372 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.477 ' N ' HG21 ' A' ' 39' ' ' ILE . 38.0 tt0 -179.59 155.67 0.67 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.607 0.242 . . . . 1.6 110.695 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.425 ' N ' ' HB ' ' A' ' 39' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.186 -0.911 . . . . 4.12 110.47 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.55 ' HA2' HG23 ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.671 -0.172 . . . . 2.16 112.671 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.522 ' CG ' ' HB3' ' A' ' 27' ' ' ASP . 1.1 tm-20 51.16 54.27 11.48 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 122.549 1.166 . . . . 2.17 109.268 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 3' ' ' GLY . 12.0 t -131.42 -24.25 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.033 -0.985 . . . . 0.87 112.49 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 50.96 78.26 0.11 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.188 -0.671 . . . . 1.86 109.188 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.463 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -138.39 -98.16 0.18 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.844 0.683 . . . . 2.42 112.844 -176.941 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 8' ' ' ILE . 2.3 tp -137.69 114.03 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 109.765 -0.457 . . . . 2.03 109.765 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 1.036 HG23 ' CE2' ' A' ' 21' ' ' TYR . 6.4 tp -150.03 165.06 3.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.315 -0.402 . . . . 3.89 111.987 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.496 ' N ' HG13 ' A' ' 9' ' ' ILE . . . -111.57 115.99 4.05 Favored Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.0 -1.24 . . . . 1.14 110.0 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.823 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -101.11 106.36 17.61 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 123.063 1.411 . . . . 1.69 112.819 -174.497 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -157.93 109.02 2.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 111.723 -2.49 . . . . 3.7 111.987 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.524 ' HB ' ' HA ' ' A' ' 19' ' ' MET . 3.2 m -115.24 -80.92 0.6 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.703 0.631 . . . . 0.48 112.703 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.69 -59.92 0.33 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.341 0.497 . . . . 0.45 112.341 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.11 -41.53 1.77 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.64 -0.791 . . . . 0.72 112.472 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.19 -26.67 65.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.025 0.44 . . . . 2.82 110.138 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -150.77 -50.75 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.75 -0.659 . . . . 0.8 111.577 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.66 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -117.52 152.33 35.3 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.153 -0.684 . . . . 0.51 109.153 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.557 ' N ' ' HG3' ' A' ' 35' ' ' PRO . 3.4 ttt -169.74 34.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 115.387 1.625 . . . . 1.98 115.387 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.816 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 7.2 mt-10 -141.09 -122.25 0.1 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 119.198 -1.001 . . . . 1.28 111.982 176.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 1.036 ' CE2' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -154.74 -117.47 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 117.996 2.591 . . . . 4.88 117.996 -175.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.935 ' O ' HG21 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -152.67 168.89 24.15 Favored 'General case' 0 N--CA 1.424 -1.774 0 O-C-N 121.398 -0.814 . . . . 4.63 110.497 -178.591 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.801 HD11 ' HB ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER 47.43 58.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.874 -0.603 . . . . 2.72 111.38 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.515 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 0.3 OUTLIER -168.03 28.72 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.088 -0.506 . . . . 2.6 112.23 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.874 ' CH2' HG13 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -142.86 31.24 1.43 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.862 0.363 . . . . 1.71 110.245 177.32 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.406 ' O ' ' OD2' ' A' ' 27' ' ' ASP . 7.4 mtpm? 47.85 38.8 9.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 3.35 110.183 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.522 ' HB3' ' CG ' ' A' ' 4' ' ' GLU . 1.3 p30 53.88 38.83 29.56 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.554 -0.748 . . . . 2.14 110.985 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -43.41 -70.13 0.57 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.838 -0.696 . . . . 0.86 111.659 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.497 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -132.9 100.23 4.84 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 120.877 -0.329 . . . . 2.9 110.349 178.175 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.475 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 19.5 m 38.83 103.32 0.02 OUTLIER Pre-proline 0 C--O 1.218 -0.562 0 N-CA-C 114.095 1.146 . . . . 1.46 114.095 176.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.482 ' HB3' ' CA ' ' A' ' 3' ' ' GLY . 25.6 Cg_exo -25.21 138.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.966 3.111 . . . . 0.79 112.518 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.655 ' HB2' ' CD2' ' A' ' 38' ' ' TYR . 43.7 t -152.36 -155.85 0.65 Allowed 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 113.362 0.875 . . . . 0.95 113.362 -175.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.516 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 48.6 t-105 -139.3 95.0 2.86 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 101.524 -3.51 . . . . 1.24 101.524 172.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 1.05 HG11 ' HA ' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -154.42 163.73 23.22 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 114.086 -1.415 . . . . 1.74 109.745 -171.336 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.912 ' HD2' HG23 ' A' ' 34' ' ' VAL . 24.0 Cg_exo -62.81 -11.12 22.57 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.542 2.828 . . . . 1.52 118.379 -175.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 35' ' ' PRO . 1.9 m 157.98 31.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 114.051 1.13 . . . . 1.75 114.051 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.524 ' N ' ' CE3' ' A' ' 25' ' ' TRP . 37.8 m -176.55 -85.86 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.02 0.438 . . . . 1.49 110.126 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 1.05 ' HA ' HG11 ' A' ' 34' ' ' VAL . 29.4 t80 -177.96 152.75 0.77 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.757 -0.656 . . . . 5.43 110.602 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.854 HG21 ' O ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER 175.55 73.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.869 0.366 . . . . 2.1 110.197 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.553 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . . . -66.46 91.94 0.19 Allowed 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.98 -0.688 . . . . 1.64 110.618 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 172.06 -31.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.51 -0.768 . . . . 2.5 110.95 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 17.7 t70 75.9 28.92 0.84 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.043 -0.526 . . . . 4.56 110.963 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.486 ' O ' HG12 ' A' ' 43' ' ' VAL . 47.0 t -119.71 -9.15 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.222 -0.444 . . . . 3.73 112.142 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.854 ' O ' HG21 ' A' ' 39' ' ' ILE . 11.2 t -145.41 162.97 12.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.389 0.138 . . . . 2.57 110.899 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.567 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 78.1 p -97.64 17.39 17.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.397 -0.365 . . . . 1.34 111.761 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' TYR . 0.7 OUTLIER 178.39 140.46 0.09 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 120.696 -0.402 . . . . 1.6 111.632 -179.276 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 38' ' ' TYR . 7.5 t80 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.234 -0.888 . . . . 4.12 111.052 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.489 -0.244 . . . . 2.16 112.489 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.545 ' HA ' ' CD1' ' A' ' 23' ' ' ILE . 1.6 tt0 60.27 14.71 4.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.281 0.562 . . . . 2.17 111.404 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -91.18 -21.77 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.648 -0.501 . . . . 0.87 109.648 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.478 ' ND2' ' HA ' ' A' ' 24' ' ' GLU . 34.5 t-20 58.45 80.23 0.19 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.881 -0.6 . . . . 1.86 109.476 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.453 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 17.8 pttp -147.75 -140.39 0.1 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.037 -0.983 . . . . 2.42 108.423 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.643 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -67.79 132.34 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.467 -0.938 . . . . 2.03 108.467 177.195 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.643 ' N ' HD13 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -148.7 173.19 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 113.965 1.098 . . . . 3.89 113.965 -176.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.68 159.51 21.55 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 113.545 -1.661 . . . . 1.14 110.388 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.547 ' HB2' ' CB ' ' A' ' 20' ' ' GLU . 2.8 p -154.79 103.71 2.45 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.319 0.859 . . . . 1.69 113.319 -177.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.1 ttp-105 -161.68 98.41 1.1 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.504 0.928 . . . . 3.7 113.504 176.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.71 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -110.54 -81.3 0.58 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 119.031 -1.068 . . . . 0.48 113.521 176.005 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -151.16 -57.44 0.16 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.645 0.609 . . . . 0.45 112.645 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . 125.14 -41.6 1.66 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.0 -0.619 . . . . 0.72 111.771 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -72.76 -9.39 58.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.767 0.318 . . . . 2.82 111.26 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 43' ' ' VAL . . . -151.55 -55.47 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.216 -1.154 . . . . 0.8 110.216 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.792 ' HB2' HD11 ' A' ' 39' ' ' ILE . . . -131.52 153.04 50.22 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 108.774 -0.825 . . . . 0.51 108.774 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.527 ' N ' ' HG3' ' A' ' 35' ' ' PRO . 2.6 ttt -154.33 11.06 0.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.969 1.1 . . . . 1.98 113.969 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.745 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 14.8 mt-10 -151.55 -177.82 6.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.484 -0.932 . . . . 1.28 108.484 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.718 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -157.87 9.35 0.17 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.258 0.836 . . . . 4.88 113.258 178.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.643 ' HA ' HG21 ' A' ' 9' ' ' ILE . 3.6 pp -87.23 128.5 35.15 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 115.343 1.609 . . . . 4.63 115.343 -175.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.763 HD12 ' CD1' ' A' ' 25' ' ' TRP . 0.4 OUTLIER -42.02 -104.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 112.508 -2.133 . . . . 2.72 108.522 173.704 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.522 ' H ' HG23 ' A' ' 23' ' ' ILE . 7.4 tp10 34.72 30.15 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.609 1.095 . . . . 2.6 112.561 177.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.763 ' CD1' HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -134.53 32.29 3.35 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.068 -0.515 . . . . 1.71 111.052 -178.284 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 50.95 29.4 4.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.873 -0.603 . . . . 3.35 111.167 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.415 ' HB3' ' CB ' ' A' ' 4' ' ' GLU . 4.2 p30 43.64 38.07 1.79 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.524 . . . . 2.14 111.696 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.685 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -47.94 -57.4 7.83 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.547 -0.835 . . . . 0.86 112.287 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.576 ' HB2' ' CD1' ' A' ' 38' ' ' TYR . 76.2 m80 -133.65 92.17 2.94 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.245 -0.65 . . . . 2.9 109.245 178.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 29' ' ' HIS . 22.7 t 39.62 117.71 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 116.082 1.882 . . . . 1.46 116.082 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 4' ' ' GLU . 11.1 Cg_exo -32.88 95.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.95 3.1 . . . . 0.79 107.953 172.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 30' ' ' SER . 18.3 m -117.21 173.34 6.74 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 114.463 1.283 . . . . 0.95 114.463 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.71 ' CD1' HG23 ' A' ' 13' ' ' THR . 7.4 t-105 -104.08 100.49 10.24 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 105.314 -2.106 . . . . 1.24 105.314 176.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.945 ' CG2' HG23 ' A' ' 39' ' ' ILE . 4.4 p -151.39 158.98 34.15 Favored Pre-proline 0 C--O 1.204 -1.309 0 CA-C-N 114.19 -1.368 . . . . 1.74 111.417 -173.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.738 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 50.3 Cg_exo -61.48 -6.43 7.0 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 124.07 3.18 . . . . 1.52 115.712 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m 172.2 -12.91 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.182 1.179 . . . . 1.75 114.182 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.945 ' C ' HG11 ' A' ' 34' ' ' VAL . 73.9 m -138.75 -87.49 0.23 Allowed 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 118.816 0.734 . . . . 1.49 112.138 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.685 ' OH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -177.05 102.47 0.05 Allowed 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.223 -1.029 . . . . 5.43 108.223 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.945 HG23 ' CG2' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -127.68 59.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 122.746 1.26 . . . . 2.1 110.583 -174.578 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -55.0 92.63 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 113.852 -1.522 . . . . 1.64 110.934 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 164.95 -29.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 113.966 -1.47 . . . . 2.5 109.177 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 77.15 54.82 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.434 -0.803 . . . . 4.56 111.856 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 43' ' ' VAL . 3.4 t -154.76 23.77 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 112.643 0.608 . . . . 3.73 112.643 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 39' ' ' ILE . 2.4 t -157.88 152.32 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 113.083 0.771 . . . . 2.57 113.083 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.633 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 39.0 t -82.44 -2.71 54.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.747 -0.66 . . . . 1.34 111.409 177.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.474 ' HG2' ' CB ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 176.51 153.71 0.2 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.233 0.457 . . . . 1.6 112.233 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.487 ' CB ' ' O ' ' A' ' 38' ' ' TYR . 36.6 t80 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.26 -0.876 . . . . 4.12 110.754 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.565 ' O ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.449 -0.456 0 N-CA-C 112.554 -0.218 . . . . 2.16 112.554 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.478 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.0 OUTLIER 53.66 20.57 2.24 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.66 0.743 . . . . 2.17 109.536 -178.926 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 3' ' ' GLY . 17.4 t -98.61 -19.55 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.656 -0.702 . . . . 0.87 111.0 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.557 HD21 ' C ' ' A' ' 6' ' ' ASN . 0.1 OUTLIER 62.88 62.35 1.06 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.929 0.871 . . . . 1.86 108.851 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.449 ' HG3' HG22 ' A' ' 8' ' ' ILE . 18.1 ptmt -134.99 -133.34 0.16 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.13 -1.395 . . . . 2.42 108.272 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 8' ' ' ILE . 6.8 tp -45.45 105.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.341 0 N-CA-C 109.213 -0.662 . . . . 2.03 109.213 177.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.894 ' CG2' HD23 ' A' ' 22' ' ' LEU . 1.4 pt -104.03 109.63 27.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 113.757 1.021 . . . . 3.89 113.757 -176.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 22' ' ' LEU . . . -107.61 139.01 14.85 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 108.685 -1.766 . . . . 1.14 108.685 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.648 ' HA ' ' H ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -153.53 109.34 3.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 114.66 1.356 . . . . 1.69 114.66 -175.07 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.47 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 15.0 tpt180 -158.61 100.0 1.6 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.029 -0.668 . . . . 3.7 112.361 177.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.556 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -117.24 -79.48 0.59 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 119.406 -0.918 . . . . 0.48 113.326 178.688 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.45 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -149.15 -59.35 0.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.721 -0.392 . . . . 0.45 112.022 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 19' ' ' MET . . . 118.33 -50.55 0.8 Allowed Glycine 0 C--N 1.329 0.162 0 C-N-CA 119.906 -1.14 . . . . 0.72 112.617 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -58.38 -21.1 49.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.047 0.451 . . . . 2.82 109.971 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.454 ' HA3' ' CG2' ' A' ' 43' ' ' VAL . . . -143.71 -57.2 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.862 -0.608 . . . . 0.8 111.875 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.671 ' HA ' ' HB3' ' A' ' 35' ' ' PRO . . . -129.21 149.82 50.85 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.616 -0.883 . . . . 0.51 108.616 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.546 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -167.51 20.7 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 116.629 2.085 . . . . 1.98 116.629 -178.277 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 34' ' ' VAL . 2.8 mt-10 -154.68 98.67 2.09 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 118.928 0.786 . . . . 1.28 112.044 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.674 ' HB2' ' CG ' ' A' ' 33' ' ' TRP . 3.0 t80 -79.13 8.1 6.38 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 113.486 0.921 . . . . 4.88 113.486 -177.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.894 HD23 ' CG2' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -89.16 130.37 35.6 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 116.095 1.887 . . . . 4.63 116.095 -176.848 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.73 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -47.77 -137.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 111.758 -2.473 . . . . 2.72 112.118 174.825 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.414 ' HA ' ' OD1' ' A' ' 6' ' ' ASN . 33.1 tt0 60.27 16.5 6.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 120.934 -1.104 . . . . 2.6 109.698 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.73 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -112.15 31.26 6.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.287 0.565 . . . . 1.71 110.423 179.486 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.5 OUTLIER 57.95 28.38 16.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.384 -0.826 . . . . 3.35 111.941 177.698 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.471 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 4.6 p-10 44.87 32.15 0.78 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.751 0.31 . . . . 2.14 111.346 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.775 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -47.82 -59.94 5.78 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.498 -0.858 . . . . 0.86 112.285 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.592 ' HB2' ' CD1' ' A' ' 38' ' ' TYR . 56.7 m80 -134.89 91.3 2.74 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 119.897 -0.721 . . . . 2.9 109.618 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 29' ' ' HIS . 24.2 t 42.22 120.16 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 115.68 1.733 . . . . 1.46 115.68 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.478 ' HD3' ' CB ' ' A' ' 4' ' ' GLU . 2.9 Cg_exo -38.05 101.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 122.86 2.374 . . . . 0.79 107.425 172.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.57 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 68.7 m -124.0 155.82 37.56 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-N 115.176 -0.92 . . . . 0.95 112.81 -172.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.674 ' CG ' ' HB2' ' A' ' 21' ' ' TYR . 6.8 t-105 -90.29 92.81 9.08 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.43 -2.433 . . . . 1.24 104.43 176.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 1.041 HG12 ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -155.05 -166.46 0.15 Allowed Pre-proline 0 C--O 1.186 -2.272 0 CA-C-N 115.354 -0.839 . . . . 1.74 112.258 -173.115 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 1.041 ' HD3' HG12 ' A' ' 34' ' ' VAL . 65.6 Cg_endo -95.67 105.78 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.108 0 CA-C-N 122.566 1.952 . . . . 1.52 116.278 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.439 ' H ' ' HB2' ' A' ' 20' ' ' GLU . 29.4 t 37.48 30.08 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.293 0.568 . . . . 1.75 111.359 177.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.539 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 1.3 m -168.4 -130.31 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.059 -0.973 . . . . 1.49 108.922 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.775 ' OH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -173.17 100.9 0.12 Allowed 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 106.562 -1.644 . . . . 5.43 106.562 -178.006 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.806 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -121.95 31.8 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.526 -0.761 . . . . 2.1 112.245 -174.137 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -55.69 93.05 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.743 -0.783 . . . . 1.64 111.415 -176.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 163.08 -30.1 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 114.192 -1.367 . . . . 2.5 109.404 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.513 ' O ' HG12 ' A' ' 39' ' ' ILE . 4.8 p-10 -177.3 104.19 0.05 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.863 -0.608 . . . . 4.56 111.009 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.723 ' HA ' HD11 ' A' ' 39' ' ' ILE . 23.0 m -51.05 126.82 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.098 -0.501 . . . . 3.73 112.276 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 44' ' ' VAL . 5.1 p -173.66 34.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.519 0 N-CA-C 114.615 1.339 . . . . 2.57 114.615 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.579 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 30.1 t 68.41 2.9 3.52 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 114.373 1.249 . . . . 1.34 114.373 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 36.4 tt0 179.37 153.01 0.42 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.827 0.677 . . . . 1.6 112.827 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.574 ' CD2' ' CE1' ' A' ' 29' ' ' HIS . 17.3 t80 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.23 -0.89 . . . . 4.12 110.939 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.587 ' O ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.222 -0.351 . . . . 2.16 112.222 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.494 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER 51.65 22.2 1.54 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.638 0.732 . . . . 2.17 110.044 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 3' ' ' GLY . 2.9 t -104.54 -17.14 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.72 -0.673 . . . . 0.87 111.137 -179.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.592 HD21 ' C ' ' A' ' 6' ' ' ASN . 0.1 OUTLIER 61.17 66.17 0.91 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.998 -0.742 . . . . 1.86 108.998 -178.781 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.478 ' HG2' HD11 ' A' ' 23' ' ' ILE . 19.8 pttp -150.72 -146.96 0.21 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.05 -0.523 . . . . 2.42 109.65 -178.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -47.59 98.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 121.956 0.884 . . . . 2.03 111.525 178.669 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.865 HD11 ' CZ ' ' A' ' 21' ' ' TYR . 3.4 tp -152.85 170.07 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.659 -0.701 . . . . 3.89 110.177 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -130.76 168.6 21.76 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.88 -0.676 . . . . 1.14 112.113 -175.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.506 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 35.4 p -148.24 103.57 3.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 113.398 0.888 . . . . 1.69 113.398 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.431 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 51.0 ttp180 -159.96 101.6 1.45 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.003 -0.544 . . . . 3.7 111.254 176.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.612 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -115.45 -84.81 0.62 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.532 0.938 . . . . 0.48 113.532 179.237 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.6 -55.72 0.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.425 -0.51 . . . . 0.45 112.357 -178.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.81 -34.14 4.48 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.342 -0.933 . . . . 0.72 112.489 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.19 -29.38 67.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.206 0.527 . . . . 2.82 109.763 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 35' ' ' PRO . . . -150.44 -41.23 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.422 -0.808 . . . . 0.8 111.879 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.532 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . . . -130.54 151.2 51.27 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.449 -0.575 . . . . 0.51 109.449 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.475 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 4.7 ttp -163.17 27.71 0.09 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.705 1.002 . . . . 1.98 113.705 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 20.4 mt-10 -151.4 -179.71 7.61 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.516 -0.55 . . . . 1.28 109.516 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.865 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 2.8 t80 -159.66 11.09 0.12 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.57 0.952 . . . . 4.88 113.57 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.623 ' HB2' ' CG2' ' A' ' 9' ' ' ILE . 2.4 pt? -86.66 120.76 28.31 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 117.327 2.343 . . . . 4.63 117.327 -176.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.738 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 5.7 pt -55.49 -15.02 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 111.967 -2.379 . . . . 2.72 110.497 174.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.559 ' CB ' HD12 ' A' ' 22' ' ' LEU . 29.4 tp10 -39.14 -27.57 0.02 OUTLIER 'General case' 0 C--N 1.344 0.332 0 CA-C-N 116.065 -0.516 . . . . 2.6 110.682 177.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.738 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -57.58 -163.19 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.803 -0.814 . . . . 1.71 108.803 176.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -107.41 44.76 1.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.449 -0.782 . . . . 3.35 111.379 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.455 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 3.5 p30 42.01 28.51 0.1 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.268 -0.424 . . . . 2.14 111.585 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.779 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -53.57 -55.53 24.59 Favored Glycine 0 CA--C 1.507 -0.422 0 C-N-CA 120.202 -0.999 . . . . 0.86 111.797 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.598 ' HB2' ' CD1' ' A' ' 38' ' ' TYR . 72.8 m80 -134.1 92.8 2.99 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 119.882 -0.727 . . . . 2.9 110.322 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 29' ' ' HIS . 17.0 m 41.62 119.45 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 116.54 2.052 . . . . 1.46 116.54 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.537 ' HB3' HG22 ' A' ' 23' ' ' ILE . 12.5 Cg_exo -34.25 97.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 123.493 2.795 . . . . 0.79 107.856 170.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.611 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 67.2 m -121.06 155.16 35.01 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 114.263 1.209 . . . . 0.95 114.263 -172.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.64 ' CE3' ' CD2' ' A' ' 21' ' ' TYR . 6.7 t-105 -90.75 91.37 8.35 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 104.107 -2.553 . . . . 1.24 104.107 175.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.903 HG12 ' CD ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -155.76 177.79 1.91 Allowed Pre-proline 0 C--O 1.215 -0.74 0 CA-C-N 114.896 -1.047 . . . . 1.74 110.974 -174.736 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.903 ' CD ' HG12 ' A' ' 34' ' ' VAL . 28.8 Cg_endo -86.34 111.86 1.07 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.879 2.386 . . . . 1.52 116.651 -174.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.7 t 49.69 19.37 0.4 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.555 -1.202 . . . . 1.75 113.079 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.553 ' N ' ' CE3' ' A' ' 25' ' ' TRP . 11.7 t -173.4 -108.15 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.205 -0.598 . . . . 1.49 111.597 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.779 ' OH ' ' HA3' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -176.3 116.59 0.12 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.446 -1.687 . . . . 5.43 106.446 -177.578 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.798 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -141.51 31.42 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.772 0.796 . . . . 2.1 111.008 -174.753 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -59.59 89.82 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.069 -0.969 . . . . 1.64 110.636 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 157.02 39.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.138 -0.937 . . . . 2.5 110.763 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 t70 56.67 85.41 0.08 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.816 0.302 . . . . 4.56 111.816 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.605 HG11 ' OXT' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -153.94 -159.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 110.083 -0.34 . . . . 3.73 110.083 179.113 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.639 ' N ' HD12 ' A' ' 39' ' ' ILE . 7.4 p -157.27 118.58 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 113.557 0.947 . . . . 2.57 113.557 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.451 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 54.5 p 65.99 4.77 3.17 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 114.696 -1.138 . . . . 1.34 113.757 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 45' ' ' SER . 39.0 tt0 179.38 154.03 0.46 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.099 0.476 . . . . 1.6 111.671 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.605 ' OXT' HG11 ' A' ' 43' ' ' VAL . 50.9 t80 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.243 -0.884 . . . . 4.12 110.991 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 31' ' ' PRO . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.427 -0.269 . . . . 2.16 112.427 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.603 ' HA ' HD13 ' A' ' 23' ' ' ILE . 2.7 tm-20 65.46 9.03 5.45 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.868 0.366 . . . . 2.17 111.891 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.525 ' O ' ' ND2' ' A' ' 6' ' ' ASN . 10.1 t -91.39 -36.18 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 122.017 0.913 . . . . 0.87 108.85 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER 68.65 87.45 0.12 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.678 -1.601 . . . . 1.86 111.329 179.014 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.474 ' O ' HG23 ' A' ' 9' ' ' ILE . 21.4 ptmt -150.31 -144.4 0.15 Allowed 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.995 -1.113 . . . . 2.42 107.995 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.495 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -55.03 118.44 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.006 -0.368 . . . . 2.03 110.006 178.57 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.8 HG22 ' HB3' ' A' ' 22' ' ' LEU . 36.6 pt -111.27 136.79 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 114.751 1.389 . . . . 3.89 114.751 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.8 146.43 16.67 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 106.86 -2.496 . . . . 1.14 106.86 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.626 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.6 OUTLIER -153.13 105.94 2.95 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 118.781 1.291 . . . . 1.69 113.408 -175.728 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -156.3 102.82 2.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.995 -0.548 . . . . 3.7 111.104 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.688 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -121.97 -80.74 0.63 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 119.599 -0.84 . . . . 0.48 112.993 179.402 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.442 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -150.05 -57.75 0.19 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.437 -0.505 . . . . 0.45 112.172 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.405 ' HA2' ' HB2' ' A' ' 19' ' ' MET . . . 119.04 -42.34 1.8 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.538 -0.839 . . . . 0.72 112.158 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -59.38 -33.89 71.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.169 0.509 . . . . 2.82 110.135 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.45 -48.72 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.568 -0.742 . . . . 0.8 111.493 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.537 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -130.55 150.13 51.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.86 -0.422 . . . . 0.51 109.86 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.487 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -163.9 30.08 0.08 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.062 1.134 . . . . 1.98 114.062 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.626 ' HA ' ' HB2' ' A' ' 11' ' ' SER . 11.1 mt-10 -148.79 -171.9 3.98 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.287 -1.005 . . . . 1.28 108.287 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.63 ' HB2' ' CD2' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -154.02 -57.5 0.12 Allowed 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 119.217 3.043 . . . . 4.88 119.217 -176.056 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.8 ' HB3' HG22 ' A' ' 9' ' ' ILE . 8.4 mt -81.24 148.04 29.67 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 118.034 -1.466 . . . . 4.63 114.705 -171.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.621 HD12 ' CD1' ' A' ' 25' ' ' TRP . 3.2 tp -13.23 -105.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 110.818 -2.901 . . . . 2.72 114.07 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.643 ' HG3' HD13 ' A' ' 9' ' ' ILE . 8.1 mm-40 42.82 25.85 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 119.39 0.996 . . . . 2.6 111.349 -177.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.621 ' CD1' HD12 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -136.53 29.01 2.98 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 116.133 -0.485 . . . . 1.71 111.289 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 40.35 30.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 3.35 112.133 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.434 ' HB2' ' CG ' ' A' ' 4' ' ' GLU . 23.8 t70 63.51 34.11 12.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.008 0.432 . . . . 2.14 110.312 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 25' ' ' TRP . . . -45.37 -63.76 2.57 Favored Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 111.045 -0.822 . . . . 0.86 111.045 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.522 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -133.44 109.12 9.09 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 109.047 -0.723 . . . . 2.9 109.047 177.663 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.446 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 48.1 m 31.0 103.3 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 114.994 1.479 . . . . 1.46 114.994 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.441 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 13.4 Cg_exo -29.87 120.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.257 0 C-N-CA 123.093 2.529 . . . . 0.79 111.372 176.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.652 ' HB2' ' CD2' ' A' ' 38' ' ' TYR . 17.9 t -143.34 -163.72 1.71 Allowed 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 114.345 1.239 . . . . 0.95 114.345 -174.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.688 ' CD1' HG23 ' A' ' 13' ' ' THR . 4.5 t-105 -123.11 93.11 3.85 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 106.349 -1.722 . . . . 1.24 106.349 175.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.956 HG21 HG23 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -159.85 178.27 1.74 Allowed Pre-proline 0 C--O 1.22 -0.47 0 CA-C-N 115.356 -0.838 . . . . 1.74 111.01 -177.72 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.676 ' HD2' HG13 ' A' ' 34' ' ' VAL . 6.4 Cg_endo -95.51 137.27 0.72 Allowed 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.939 3.093 . . . . 1.52 112.444 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 10.7 t 79.83 -62.17 0.27 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.454 0.909 . . . . 1.75 113.454 177.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.611 ' HA ' ' CE3' ' A' ' 25' ' ' TRP . 47.5 t -150.54 -56.89 0.17 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.556 1.317 . . . . 1.49 114.556 -177.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.718 ' CA ' HG11 ' A' ' 34' ' ' VAL . 14.4 t80 176.97 152.04 0.19 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.799 -0.445 . . . . 5.43 109.799 -176.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.956 HG23 HG21 ' A' ' 34' ' ' VAL . 0.6 OUTLIER 175.86 67.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.9 0.857 . . . . 2.1 108.851 -179.621 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.557 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . . . -59.66 92.76 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.151 -0.931 . . . . 1.64 111.082 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 174.14 -31.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.337 -0.847 . . . . 2.5 110.983 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 74.08 23.94 2.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.075 -0.511 . . . . 4.56 110.807 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.82 -25.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 3.73 111.211 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.781 ' O ' HG21 ' A' ' 39' ' ' ILE . 3.5 t -136.07 165.02 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.955 0.407 . . . . 2.57 111.118 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.549 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 29.6 t -96.38 25.46 4.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.873 -0.603 . . . . 1.34 110.689 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -179.72 149.05 0.35 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.437 -0.347 . . . . 1.6 110.996 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.522 ' HB3' ' CD2' ' A' ' 29' ' ' HIS . 10.3 t80 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.212 -0.899 . . . . 4.12 110.944 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.48 ' CA ' ' CD1' ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.404 0 N-CA-C 112.424 -0.27 . . . . 2.16 112.424 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.475 ' HB3' ' HG3' ' A' ' 31' ' ' PRO . 0.0 OUTLIER 78.0 -13.49 0.95 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.144 0.794 . . . . 2.17 113.144 179.484 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 6' ' ' ASN . 11.3 t -77.71 -51.29 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 121.454 0.645 . . . . 0.87 111.12 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 1.015 ' N ' HG21 ' A' ' 23' ' ' ILE . 1.1 m-20 99.11 82.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.362 -1.29 . . . . 1.86 109.669 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.427 ' HG3' HG22 ' A' ' 8' ' ' ILE . 12.9 pttp -150.61 -131.23 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.42 -1.264 . . . . 2.42 108.75 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.648 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -47.06 113.83 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 118.306 0.503 . . . . 2.03 109.824 177.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.642 HG22 ' C ' ' A' ' 22' ' ' LEU . 3.1 pt -124.8 116.49 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 114.793 1.405 . . . . 3.89 114.793 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.634 ' H ' HD12 ' A' ' 22' ' ' LEU . . . -101.72 144.54 16.43 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 107.055 -2.418 . . . . 1.14 107.055 174.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.616 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 15.9 p -155.11 104.38 2.45 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.934 1.087 . . . . 1.69 113.934 -175.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.27 98.22 1.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.944 -0.571 . . . . 3.7 109.881 176.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.754 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -102.89 -82.16 0.49 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 119.385 -0.926 . . . . 0.48 112.901 179.533 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -142.69 -65.78 0.39 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.692 0.627 . . . . 0.45 112.692 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . 126.19 -35.05 3.07 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.099 -0.8 . . . . 0.72 111.099 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -66.78 -30.52 70.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.27 0.557 . . . . 2.82 109.61 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.783 ' HA2' HG12 ' A' ' 44' ' ' VAL . . . -145.47 -49.1 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.272 -0.876 . . . . 0.8 111.686 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.589 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . . . -118.49 151.55 37.62 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 119.701 -0.19 . . . . 0.51 110.597 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.463 ' HA ' ' H ' ' A' ' 13' ' ' THR . 0.2 OUTLIER -160.36 27.03 0.16 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.886 1.439 . . . . 1.98 114.886 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.682 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 12.3 mt-10 -151.1 -174.4 4.79 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.56 -0.533 . . . . 1.28 109.56 177.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.616 ' HB3' ' HA ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -153.08 -72.55 0.14 Allowed 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 118.815 2.894 . . . . 4.88 118.815 -177.185 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.642 ' C ' HG22 ' A' ' 9' ' ' ILE . 33.7 mt -82.92 143.09 30.96 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 114.749 1.389 . . . . 4.63 114.749 -172.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.015 HG21 ' N ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER 17.37 -148.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 111.522 -2.581 . . . . 2.72 113.751 -179.297 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER 83.15 -5.88 1.23 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.902 -0.407 . . . . 2.6 109.902 -178.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 1.119 ' CH2' HG13 ' A' ' 34' ' ' VAL . 1.3 p90 -121.98 28.57 7.49 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 120.861 -0.336 . . . . 1.71 111.023 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.8 tttt 29.18 62.93 0.14 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.223 0.823 . . . . 3.35 113.223 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.453 ' HB3' ' CG ' ' A' ' 4' ' ' GLU . 3.9 p30 45.61 27.4 0.42 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.753 0.311 . . . . 2.14 111.631 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -49.48 -65.9 2.54 Favored Glycine 0 CA--C 1.508 -0.356 0 N-CA-C 110.776 -0.929 . . . . 0.86 110.776 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.566 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -132.56 100.72 5.05 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 108.752 -0.833 . . . . 2.9 108.752 177.374 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.487 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 70.2 m 37.08 109.53 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 N-CA-C 116.24 1.941 . . . . 1.46 116.24 176.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.487 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 2.8 Cg_exo -34.92 102.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.938 2.425 . . . . 0.79 110.027 174.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.582 ' HB2' ' CD2' ' A' ' 38' ' ' TYR . 28.7 t -124.2 -177.54 3.81 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 114.166 1.173 . . . . 0.95 114.166 -174.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.754 ' CD1' HG23 ' A' ' 13' ' ' THR . 3.7 t-105 -109.33 100.13 9.28 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 103.235 -2.876 . . . . 1.24 103.235 173.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 1.119 HG13 ' CH2' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -153.07 154.79 31.4 Favored Pre-proline 0 N--CA 1.444 -0.761 0 CA-C-N 115.267 -0.879 . . . . 1.74 112.63 -171.755 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.688 ' HD2' HG23 ' A' ' 34' ' ' VAL . 21.2 Cg_endo -59.45 -13.74 22.15 Favored 'Trans proline' 0 N--CA 1.491 1.344 1 C-N-CA 126.35 4.7 . . . . 1.52 117.817 -176.869 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.423 ' H ' HG22 ' A' ' 34' ' ' VAL . 18.6 p 178.51 -23.59 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 119.572 1.078 . . . . 1.75 113.764 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.521 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 48.2 t -141.21 -73.23 0.33 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.514 0.673 . . . . 1.49 110.663 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.983 ' OH ' ' HB3' ' A' ' 40' ' ' ALA . 11.7 t80 177.8 131.84 0.06 Allowed 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 115.536 -0.756 . . . . 5.43 109.84 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.489 ' O ' HG12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -146.67 26.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.503 -0.879 . . . . 2.1 110.852 -179.216 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.983 ' HB3' ' OH ' ' A' ' 38' ' ' TYR . . . -64.81 88.7 0.07 Allowed 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.144 -1.022 . . . . 1.64 109.955 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 151.8 37.84 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.538 -1.21 . . . . 2.5 110.522 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 61.19 88.72 0.08 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.057 0.391 . . . . 4.56 112.057 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.481 HG23 ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -162.99 -169.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 110.25 -0.278 . . . . 3.73 110.25 178.625 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.783 HG12 ' HA2' ' A' ' 17' ' ' GLY . 11.4 m -144.59 124.1 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 113.216 0.821 . . . . 2.57 113.216 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.469 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 28.9 t 53.8 16.25 0.99 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.249 -0.887 . . . . 1.34 113.084 178.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 179.84 148.01 0.27 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.724 -0.39 . . . . 1.6 111.925 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.546 ' N ' ' O ' ' A' ' 38' ' ' TYR . 14.4 t80 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.211 -0.899 . . . . 4.12 111.094 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.544 -0.222 . . . . 6.11 112.544 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.2 m 56.0 54.24 8.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.908 0.385 . . . . 4.17 110.852 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.75 144.59 8.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.782 -0.723 . . . . 2.16 112.412 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.462 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 15.0 tt0 61.67 14.05 5.78 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.163 0.506 . . . . 2.17 111.665 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.546 ' N ' HG21 ' A' ' 23' ' ' ILE . 58.0 t -79.67 -42.62 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 O-C-N 121.986 -0.446 . . . . 0.87 111.138 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.633 ' H ' HG21 ' A' ' 23' ' ' ILE . 20.1 t-20 82.06 44.51 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.697 -0.683 . . . . 1.86 111.999 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.501 ' O ' HG23 ' A' ' 9' ' ' ILE . 22.9 ptmt -119.76 -143.2 0.35 Allowed 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.179 -1.045 . . . . 2.42 108.179 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.447 HG22 ' HG3' ' A' ' 7' ' ' LYS . 3.1 tp -45.44 139.26 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 122.219 0.208 . . . . 2.03 111.009 178.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.63 HG22 HG12 ' A' ' 23' ' ' ILE . 27.6 pt -133.94 129.28 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 114.641 1.349 . . . . 3.89 114.641 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.06 144.41 16.0 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 106.865 -2.494 . . . . 1.14 106.865 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.506 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -152.36 105.42 3.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 118.855 1.328 . . . . 1.69 113.471 -175.739 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -156.85 102.87 2.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.847 -0.615 . . . . 3.7 110.874 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.638 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -116.67 -80.82 0.61 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.625 -0.83 . . . . 0.48 113.082 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.41 ' C ' ' HG2' ' A' ' 19' ' ' MET . . . -150.3 -58.79 0.19 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.631 0.604 . . . . 0.45 112.631 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.9 -36.37 3.36 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.577 -0.82 . . . . 0.72 111.757 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.19 -31.21 68.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.39 -0.596 . . . . 2.82 109.39 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.414 ' HA2' HG23 ' A' ' 44' ' ' VAL . . . -147.35 -58.45 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.029 -0.987 . . . . 0.8 110.847 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.487 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . . . -106.21 151.45 24.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.523 -0.338 . . . . 0.51 110.662 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.421 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -165.47 26.01 0.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.07 0.767 . . . . 1.98 113.07 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 5.2 mt-10 -146.54 -171.45 3.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.718 -0.845 . . . . 1.28 108.718 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.603 ' CD2' ' CZ3' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -155.17 -53.96 0.09 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 117.965 2.58 . . . . 4.88 117.965 -177.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.536 ' HB3' HG22 ' A' ' 9' ' ' ILE . 8.7 mt -88.27 151.69 22.47 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 116.324 1.972 . . . . 4.63 116.324 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.633 HG21 ' H ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -7.54 -117.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 111.584 -2.553 . . . . 2.72 114.402 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.452 ' CG ' HD13 ' A' ' 9' ' ' ILE . 0.9 OUTLIER 48.88 24.0 0.78 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.623 0.647 . . . . 2.6 110.221 -177.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.576 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -145.81 31.13 1.06 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 113.45 0.907 . . . . 1.71 113.45 -179.302 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.6 mttp 33.54 33.98 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.556 0.576 . . . . 3.35 112.556 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.453 ' HB3' ' CG ' ' A' ' 4' ' ' GLU . 4.1 p-10 46.64 47.81 14.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.886 -0.597 . . . . 2.14 112.194 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.445 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -52.95 -56.11 20.38 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.073 -1.06 . . . . 0.86 111.531 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.487 ' O ' ' O ' ' A' ' 30' ' ' SER . 60.2 m80 -131.1 94.21 3.54 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 109.337 -0.616 . . . . 2.9 109.337 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 29' ' ' HIS . 13.9 m 40.43 106.68 0.01 OUTLIER Pre-proline 0 C--O 1.223 -0.29 0 N-CA-C 113.468 0.914 . . . . 1.46 113.468 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 8.2 Cg_exo -33.53 130.63 0.14 Allowed 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 122.479 2.12 . . . . 0.79 110.037 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.556 ' CB ' ' CG2' ' A' ' 34' ' ' VAL . 64.7 m -150.94 156.36 41.02 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 113.94 1.089 . . . . 0.95 113.94 -173.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.638 ' CD1' HG23 ' A' ' 13' ' ' THR . 3.7 t-105 -86.1 92.26 8.67 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 103.663 -2.717 . . . . 1.24 103.663 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.926 HG12 ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -154.99 -177.8 0.79 Allowed Pre-proline 0 CA--C 1.547 0.855 0 CA-C-N 114.706 -1.133 . . . . 1.74 110.414 -174.607 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.926 ' HD3' HG12 ' A' ' 34' ' ' VAL . 30.4 Cg_endo -86.33 103.22 0.66 Allowed 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 124.185 3.257 . . . . 1.52 116.32 -174.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 t 41.2 28.08 0.06 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.108 0.48 . . . . 1.75 111.251 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.502 ' O ' ' CE3' ' A' ' 25' ' ' TRP . 1.5 m -166.23 -131.85 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.444 -0.798 . . . . 1.49 109.913 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -170.45 98.92 0.26 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 105.004 -2.221 . . . . 5.43 105.004 -177.629 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.861 ' HB ' HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -116.59 37.64 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.823 -1.08 . . . . 2.1 111.624 -173.358 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -69.82 89.98 0.59 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.188 -0.915 . . . . 1.64 110.904 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 152.96 42.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.272 -0.876 . . . . 2.5 110.504 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 t70 54.76 88.67 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.72 0.295 . . . . 4.56 110.778 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.861 HG13 ' HB ' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -169.75 170.6 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.306 -0.628 . . . . 3.73 109.306 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.588 ' HA ' HD12 ' A' ' 39' ' ' ILE . 7.6 p -128.63 132.99 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 114.079 1.14 . . . . 2.57 114.079 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.502 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 16.6 t 61.83 7.59 2.07 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.669 1.359 . . . . 1.34 114.669 176.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' O ' ' CG2' ' A' ' 43' ' ' VAL . 3.5 tt0 177.8 -173.04 0.12 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.136 -0.626 . . . . 1.6 112.42 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.504 ' HB2' ' HA ' ' A' ' 39' ' ' ILE . 45.5 t80 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.222 -0.894 . . . . 4.12 110.675 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.503 -0.239 . . . . 6.11 112.503 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.5 t 63.16 45.18 5.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.851 0.358 . . . . 4.17 111.055 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.454 ' HA2' HG12 ' A' ' 23' ' ' ILE . . . -168.91 146.75 10.54 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.678 -0.772 . . . . 2.16 112.616 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.566 ' N ' HG23 ' A' ' 23' ' ' ILE . 0.0 OUTLIER 58.29 12.98 2.16 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.021 0.378 . . . . 2.17 112.021 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 5' ' ' VAL . 23.2 t -89.42 -4.22 10.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 112.274 0.472 . . . . 0.87 112.274 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.599 ' H ' HG22 ' A' ' 23' ' ' ILE . 29.4 t-20 39.09 71.66 0.16 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.007 0.432 . . . . 1.86 111.236 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.587 ' HD3' HG22 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -150.77 -141.98 0.11 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.874 -0.603 . . . . 2.42 109.389 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -56.49 106.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.596 0.712 . . . . 2.03 111.537 179.48 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.755 HD11 ' CZ ' ' A' ' 21' ' ' TYR . 3.0 tp -153.55 171.06 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.845 -0.616 . . . . 3.89 110.763 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.03 169.37 20.45 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 111.824 -0.511 . . . . 1.14 111.824 -175.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.516 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 14.1 p -150.29 103.99 3.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 113.312 0.856 . . . . 1.69 113.312 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.422 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 32.2 ttm180 -159.46 101.36 1.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.481 -0.327 . . . . 3.7 111.845 177.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.582 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -115.69 -85.42 0.62 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.857 1.058 . . . . 0.48 113.857 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.425 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -146.03 -51.57 0.24 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.421 0.555 . . . . 0.45 112.493 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.06 -35.57 4.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.625 -0.798 . . . . 0.72 112.193 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -59.73 -41.99 92.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.224 0.535 . . . . 2.82 110.01 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -136.03 -40.61 0.14 Allowed Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.397 -0.819 . . . . 0.8 111.697 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.513 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . . . -130.59 150.7 51.67 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.439 -0.578 . . . . 0.51 109.439 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.425 ' HG3' ' C ' ' A' ' 14' ' ' ALA . 2.9 ttt -162.74 24.58 0.1 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.1 0.778 . . . . 1.98 113.1 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.56 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 18.5 mt-10 -150.65 178.81 8.74 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.183 -0.673 . . . . 1.28 109.183 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.755 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 2.3 t80 -157.61 9.66 0.18 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.515 0.931 . . . . 4.88 113.515 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.799 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.8 pp -83.6 130.3 34.98 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 116.522 2.045 . . . . 4.63 116.522 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 6' ' ' ASN . 1.4 mp -72.5 10.14 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 CA-C-N 110.016 -3.266 . . . . 2.72 111.1 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.415 ' OE1' ' N ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -78.64 10.86 2.88 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.232 -0.44 . . . . 2.6 110.702 177.411 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.646 ' HZ2' ' H ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -86.98 32.57 0.67 Allowed 'General case' 0 C--N 1.347 0.458 0 CA-C-O 120.627 0.251 . . . . 1.71 111.411 178.847 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 74.6 tttt 48.85 36.3 7.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.626 -0.261 . . . . 3.35 111.212 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.446 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 16.4 t0 57.09 23.08 8.07 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.114 -0.634 . . . . 2.14 109.746 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -43.45 -64.39 1.82 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 120.764 -0.731 . . . . 0.86 111.328 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.528 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -135.16 98.87 4.1 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 109.553 -0.536 . . . . 2.9 109.553 177.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 29' ' ' HIS . 40.6 m 32.43 117.23 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 117.096 2.258 . . . . 1.46 117.096 176.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.479 ' HB3' ' CG1' ' A' ' 23' ' ' ILE . 14.8 Cg_exo -31.5 118.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 123.75 2.967 . . . . 0.79 108.427 172.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.646 ' H ' ' HZ2' ' A' ' 25' ' ' TRP . 7.3 t -152.21 154.35 35.62 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.379 1.252 . . . . 0.95 114.379 -172.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.61 ' CE3' ' CD2' ' A' ' 21' ' ' TYR . 8.4 t-105 -91.52 91.23 7.97 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 104.187 -2.523 . . . . 1.24 104.187 175.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.886 HG12 ' CD ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -156.77 173.97 4.47 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 114.65 -1.159 . . . . 1.74 110.928 -175.066 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.886 ' CD ' HG12 ' A' ' 34' ' ' VAL . 7.3 Cg_endo -92.38 122.24 0.57 Allowed 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.512 2.808 . . . . 1.52 116.447 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.6 m 79.9 -51.72 0.38 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.833 -1.076 . . . . 1.75 113.736 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.561 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 57.9 m -144.16 -65.49 0.36 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.538 0.685 . . . . 1.49 111.272 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.702 ' OH ' ' HB3' ' A' ' 40' ' ' ALA . 10.0 t80 178.7 140.88 0.1 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.251 -0.648 . . . . 5.43 109.251 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.791 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -161.1 30.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 122.801 1.286 . . . . 2.1 109.137 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.702 ' HB3' ' OH ' ' A' ' 38' ' ' TYR . . . -66.23 89.85 0.14 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.748 -1.114 . . . . 1.64 110.507 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 156.62 41.1 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.438 -0.801 . . . . 2.5 110.573 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.414 ' O ' HG22 ' A' ' 43' ' ' VAL . 7.6 m-20 58.18 84.09 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.77 0.319 . . . . 4.56 111.18 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 0.6 OUTLIER -157.21 -151.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.43 -0.582 . . . . 3.73 109.43 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.42 ' N ' HG13 ' A' ' 39' ' ' ILE . 7.6 p -169.05 120.72 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 113.448 0.907 . . . . 2.57 113.448 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.3 t 65.74 7.02 4.23 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 114.089 1.144 . . . . 1.34 114.089 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 179.05 147.01 0.18 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.571 0.582 . . . . 1.6 112.571 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 38' ' ' TYR . 28.6 p90 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.19 -0.91 . . . . 4.12 111.07 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.567 -0.213 . . . . 6.11 112.567 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.6 t -110.18 -30.89 7.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 4.17 110.857 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.551 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . -127.55 -116.59 2.0 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.657 -0.782 . . . . 2.16 113.034 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.51 ' CG ' ' HB3' ' A' ' 27' ' ' ASP . 1.8 tm-20 61.39 26.57 16.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 122.274 1.035 . . . . 2.17 109.275 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -104.32 -19.73 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.129 -0.941 . . . . 0.87 111.505 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.455 ' ND2' ' HA ' ' A' ' 24' ' ' GLU . 7.1 m120 47.5 79.1 0.07 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.946 -0.39 . . . . 1.86 109.946 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HE3' HG21 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -135.68 -98.61 0.23 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.887 0.699 . . . . 2.42 112.887 -177.769 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 8' ' ' ILE . 2.1 tp -135.97 111.63 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 109.839 -0.43 . . . . 2.03 109.839 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 1.178 HG23 ' CE2' ' A' ' 21' ' ' TYR . 6.9 tp -150.97 162.73 3.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 112.622 0.601 . . . . 3.89 112.622 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.501 ' N ' HG13 ' A' ' 9' ' ' ILE . . . -109.85 121.15 5.93 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 110.634 -0.986 . . . . 1.14 110.634 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.83 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -102.55 107.85 18.94 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.698 1.237 . . . . 1.69 113.174 -176.055 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -157.68 112.73 2.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 112.433 -2.167 . . . . 3.7 112.311 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.508 ' CB ' ' HA ' ' A' ' 19' ' ' MET . 1.6 m -116.36 -78.21 0.58 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.408 0.521 . . . . 0.48 112.408 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.96 -54.94 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.731 0.301 . . . . 0.45 111.647 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.12 -35.67 4.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.352 -0.928 . . . . 0.72 112.653 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.3 -27.0 65.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.056 0.455 . . . . 2.82 110.342 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -150.38 -43.64 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.694 -0.685 . . . . 0.8 111.582 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.515 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -129.98 151.47 50.5 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.862 -0.421 . . . . 0.51 109.862 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.508 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 4.0 ttp -164.23 51.88 0.13 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.618 1.34 . . . . 1.98 114.618 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.748 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 6.7 mt-10 -151.01 -124.39 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 114.886 1.439 . . . . 1.28 114.886 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 1.178 ' CE2' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -155.72 -126.78 0.03 OUTLIER 'General case' 0 C--O 1.199 -1.556 0 N-CA-C 117.787 2.514 . . . . 4.88 117.787 -173.323 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.94 ' O ' HG21 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -151.53 165.19 34.98 Favored 'General case' 0 N--CA 1.432 -1.358 0 O-C-N 121.409 -0.807 . . . . 4.63 111.128 178.517 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.76 HD13 ' C ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER 56.29 63.04 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 124.505 1.122 . . . . 2.72 113.678 179.193 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.86 ' HB3' ' OH ' ' A' ' 21' ' ' TYR . 5.0 tt0 178.88 38.67 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.861 0.689 . . . . 2.6 112.861 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.546 ' CZ2' ' HA ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -153.15 32.92 0.47 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.682 0.623 . . . . 1.71 112.682 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp 56.17 20.12 4.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.843 0.354 . . . . 3.35 111.425 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.51 ' HB3' ' CG ' ' A' ' 4' ' ' GLU . 2.6 p-10 47.34 40.16 10.19 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.135 0.791 . . . . 2.14 113.135 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.84 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -48.23 -54.89 11.31 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.082 -1.056 . . . . 0.86 112.344 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.526 ' CE1' ' CD2' ' A' ' 47' ' ' TYR . 38.2 t-80 -131.69 95.44 3.72 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 117.244 0.522 . . . . 2.9 110.546 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.511 ' O ' ' O ' ' A' ' 29' ' ' HIS . 14.6 m 37.63 107.48 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.402 0 N-CA-C 113.471 0.915 . . . . 1.46 113.471 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.451 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 7.1 Cg_exo -33.85 125.67 0.16 Allowed 'Trans proline' 0 C--N 1.366 1.45 0 C-N-CA 122.768 2.312 . . . . 0.79 110.275 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.558 ' O ' ' O ' ' A' ' 21' ' ' TYR . 67.3 m -152.24 143.96 23.58 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 119.422 -0.911 . . . . 0.95 112.879 -173.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.583 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 31.5 t-105 -78.59 92.42 4.7 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 104.051 -2.574 . . . . 1.24 104.051 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.892 HG12 ' CD ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -152.67 173.04 4.88 Favored Pre-proline 0 N--CA 1.442 -0.829 0 CA-C-N 112.308 -2.223 . . . . 1.74 108.533 -176.183 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.892 ' CD ' HG12 ' A' ' 34' ' ' VAL . 85.5 Cg_endo -77.46 105.82 2.11 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 123.726 2.95 . . . . 1.52 117.432 -173.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.8 t 43.5 27.25 0.14 Allowed 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.33 -1.305 . . . . 1.75 111.997 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.547 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 12.2 m -166.65 -120.16 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.494 -0.775 . . . . 1.49 109.668 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.84 ' OH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -175.49 101.21 0.08 Allowed 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 106.45 -1.685 . . . . 5.43 106.45 -177.648 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.677 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -127.04 33.16 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 114.745 -1.116 . . . . 2.1 109.154 -176.082 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -58.28 92.79 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.424 -1.262 . . . . 1.64 111.905 -177.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 168.49 -61.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.184 -0.916 . . . . 2.5 110.059 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 9.2 t70 163.29 79.73 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.321 -0.854 . . . . 4.56 109.683 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.557 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -148.91 -157.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.959 -0.296 . . . . 3.73 110.401 -179.361 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.562 ' N ' HD12 ' A' ' 39' ' ' ILE . 4.8 p -155.16 105.9 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.421 0.629 . . . . 2.57 112.531 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.46 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 6.3 p 80.16 2.36 1.98 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.762 -1.108 . . . . 1.34 113.335 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 179.15 140.74 0.11 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.597 0.237 . . . . 1.6 111.311 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.526 ' CD2' ' CE1' ' A' ' 29' ' ' HIS . 11.0 t80 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.195 -0.907 . . . . 4.12 110.069 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.519 -0.232 . . . . 6.11 112.519 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.6 p -87.97 94.7 9.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 4.17 110.917 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.565 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . -151.25 -143.66 3.76 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.791 -0.718 . . . . 2.16 112.464 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.496 ' N ' ' HG3' ' A' ' 31' ' ' PRO . 2.1 tm-20 64.36 47.19 3.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.953 0.883 . . . . 2.17 110.137 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.411 HG11 ' HD3' ' A' ' 7' ' ' LYS . 12.0 t -119.94 -16.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.243 -0.89 . . . . 0.87 111.301 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 24.8 t-20 50.37 38.59 18.35 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 108.529 -0.915 . . . . 1.86 108.529 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.9 ' HE3' HG21 ' A' ' 23' ' ' ILE . 21.7 pttp -93.48 -129.6 0.12 Allowed 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.291 -1.322 . . . . 2.42 111.268 -176.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -117.02 117.14 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.048 0.452 . . . . 2.03 111.965 -178.402 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.555 ' HB ' HD11 ' A' ' 23' ' ' ILE . 9.7 tp -149.59 161.88 4.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.958 -0.564 . . . . 3.89 110.849 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -109.34 130.41 9.97 Favored Glycine 0 CA--C 1.505 -0.589 0 N-CA-C 110.363 -1.095 . . . . 1.14 110.363 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.621 ' HB3' ' CG ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -102.16 107.8 19.0 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.562 1.172 . . . . 1.69 113.188 -177.516 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.34 104.4 2.03 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.547 -2.115 . . . . 3.7 111.285 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.488 ' CB ' ' HA ' ' A' ' 19' ' ' MET . 1.3 m -109.59 -81.51 0.57 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 119.953 -0.699 . . . . 0.48 112.562 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.404 ' C ' ' HG2' ' A' ' 19' ' ' MET . . . -149.84 -54.23 0.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.717 0.294 . . . . 0.45 111.417 -178.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.415 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . 117.05 -28.37 7.32 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.313 -0.946 . . . . 0.72 112.893 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.28 -33.43 71.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.336 0.589 . . . . 2.82 109.75 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.643 ' HA2' HG12 ' A' ' 44' ' ' VAL . . . -150.32 -46.9 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.785 -0.926 . . . . 0.8 110.785 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.577 ' HB1' ' HA ' ' A' ' 34' ' ' VAL . . . -115.17 152.17 33.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.263 -0.468 . . . . 0.51 110.027 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.488 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -165.94 46.84 0.08 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.105 0.78 . . . . 1.98 113.105 -179.604 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.755 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 53.3 mt-10 -149.54 -139.77 0.1 Allowed 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 114.621 1.341 . . . . 1.28 114.621 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.621 ' CG ' ' HB3' ' A' ' 11' ' ' SER . 0.1 OUTLIER -123.45 -172.65 2.56 Favored 'General case' 0 C--O 1.191 -2.008 0 N-CA-C 114.728 1.381 . . . . 4.88 114.728 -173.112 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.838 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -137.88 104.74 5.36 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 114.181 1.178 . . . . 4.63 114.181 173.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.9 HG21 ' HE3' ' A' ' 7' ' ' LYS . 2.7 pp 136.57 24.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 126.886 2.075 . . . . 2.72 112.436 176.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.581 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 8.9 tp10 -130.57 53.4 1.96 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.786 0.721 . . . . 2.6 111.925 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.576 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -153.83 -169.4 3.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.108 -0.496 . . . . 1.71 109.782 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.59 36.69 1.6 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.08 0.467 . . . . 3.35 109.791 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.443 ' HB2' ' HG3' ' A' ' 4' ' ' GLU . 24.9 t70 53.31 44.82 29.6 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.809 -0.632 . . . . 2.14 110.862 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.513 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -54.04 -64.27 4.41 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.231 -0.985 . . . . 0.86 112.312 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.464 ' O ' ' CB ' ' A' ' 38' ' ' TYR . 47.5 t-80 -134.41 95.94 3.49 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 117.099 0.449 . . . . 2.9 110.386 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 31' ' ' PRO . 17.4 m 39.12 98.01 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 112.573 0.583 . . . . 1.46 112.573 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.496 ' HG3' ' N ' ' A' ' 4' ' ' GLU . 18.0 Cg_exo -27.24 126.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.365 1.395 0 C-N-CA 123.558 2.839 . . . . 0.79 110.407 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.495 ' O ' ' CH2' ' A' ' 25' ' ' TRP . 8.5 t -152.41 144.64 23.93 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 119.038 -1.065 . . . . 0.95 112.959 -171.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.525 ' N ' ' HB3' ' A' ' 22' ' ' LEU . 9.1 t-105 -83.31 96.07 8.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 104.335 -2.469 . . . . 1.24 104.335 175.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.94 HG12 ' HD3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -151.51 -172.24 0.31 Allowed Pre-proline 0 N--CA 1.434 -1.229 0 CA-C-N 112.548 -2.115 . . . . 1.74 106.659 -175.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.94 ' HD3' HG12 ' A' ' 34' ' ' VAL . 44.9 Cg_endo -88.13 102.69 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.676 2.251 . . . . 1.52 116.142 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.42 ' N ' ' OE1' ' A' ' 20' ' ' GLU . 41.9 t 45.41 23.93 0.15 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.725 -0.671 . . . . 1.75 111.989 177.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.548 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 5.4 m -163.59 -122.93 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 116.476 -0.329 . . . . 1.49 110.22 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -174.47 102.15 0.1 Allowed 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 106.282 -1.747 . . . . 5.43 106.282 -177.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.749 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -124.17 34.98 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 114.683 -1.144 . . . . 2.1 110.329 -174.223 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -59.4 91.92 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.346 -1.297 . . . . 1.64 111.695 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 166.72 -60.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.307 -0.86 . . . . 2.5 110.022 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 41' ' ' ALA . 1.6 p30 160.49 78.66 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.567 -0.742 . . . . 4.56 110.398 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.628 HG11 ' O ' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -151.44 -166.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 110.067 -0.346 . . . . 3.73 110.067 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.643 HG12 ' HA2' ' A' ' 17' ' ' GLY . 3.1 m -147.22 121.68 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 112.848 0.684 . . . . 2.57 112.848 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.455 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 22.8 t 69.5 5.01 4.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.207 -0.906 . . . . 1.34 113.199 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 45' ' ' SER . 39.1 tt0 179.02 158.62 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.089 0.471 . . . . 1.6 111.863 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.628 ' O ' HG11 ' A' ' 43' ' ' VAL . 37.4 p90 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.176 -0.916 . . . . 4.12 110.997 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.529 -0.229 . . . . 6.11 112.529 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.1 p -94.05 173.6 7.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.765 0.317 . . . . 4.17 110.908 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.641 ' O ' HG23 ' A' ' 5' ' ' VAL . . . 81.56 144.84 4.57 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.724 -0.751 . . . . 2.16 112.647 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 48.74 26.82 1.36 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.785 0.803 . . . . 2.17 110.348 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 3' ' ' GLY . 5.1 t -105.4 -8.65 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.391 -0.822 . . . . 0.87 112.488 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.545 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 2.0 p30 41.34 74.38 0.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.714 0.293 . . . . 1.86 111.396 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.551 ' HD2' HG22 ' A' ' 8' ' ' ILE . 3.6 pttp -151.44 -107.93 0.06 Allowed 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.963 0.357 . . . . 2.42 111.963 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.678 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -82.77 101.46 7.52 Favored 'Isoleucine or valine' 0 C--N 1.345 0.408 0 N-CA-C 109.485 -0.561 . . . . 2.03 109.485 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.822 HD11 ' CZ ' ' A' ' 21' ' ' TYR . 2.4 tp -153.29 171.38 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 120.031 -0.667 . . . . 3.89 112.371 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.94 169.74 22.77 Favored Glycine 0 CA--C 1.508 -0.374 0 CA-C-N 116.16 -0.473 . . . . 1.14 111.987 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.495 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 2.5 p -150.35 104.48 3.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.128 0.788 . . . . 1.69 113.128 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.444 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 14.9 tpt180 -157.56 102.2 1.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.015 -0.539 . . . . 3.7 110.829 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.485 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -117.08 -84.09 0.64 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 114.008 1.114 . . . . 0.48 114.008 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.43 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -150.34 -56.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.428 -0.509 . . . . 0.45 112.305 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.472 ' N ' ' HG3' ' A' ' 19' ' ' MET . . . 119.4 -29.49 6.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.142 -1.028 . . . . 0.72 112.53 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -58.81 -33.7 70.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.471 0.653 . . . . 2.82 109.245 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 43' ' ' VAL . . . -150.83 -46.0 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 114.777 -1.102 . . . . 0.8 111.068 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.566 ' HA ' ' HG3' ' A' ' 35' ' ' PRO . . . -116.19 151.21 36.15 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.208 -0.293 . . . . 0.51 110.208 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.472 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 2.8 ttp -162.61 24.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.433 0.531 . . . . 1.98 112.433 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 5.7 mt-10 -150.47 -179.91 7.62 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.823 -0.436 . . . . 1.28 109.823 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.822 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -155.52 14.09 0.36 Allowed 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 113.702 1.001 . . . . 4.88 113.702 -179.274 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.681 ' HB3' HG23 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -84.78 135.45 34.11 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 116.003 1.853 . . . . 4.63 116.003 -177.038 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.626 HD13 ' H ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -74.2 16.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 111.505 -2.588 . . . . 2.72 111.126 177.641 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.545 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . 24.6 tt0 -80.09 17.25 1.03 Allowed 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.058 0.543 . . . . 2.6 111.082 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.591 ' HZ2' ' H ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -91.58 32.28 1.1 Allowed 'General case' 0 C--N 1.342 0.272 0 N-CA-C 109.851 -0.426 . . . . 1.71 109.851 177.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 25' ' ' TRP . 64.4 pttt 46.78 34.44 2.59 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.142 -0.481 . . . . 3.35 111.154 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 0.3 OUTLIER 65.24 23.89 12.23 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.704 -0.399 . . . . 2.14 110.246 179.424 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -44.32 -68.93 0.79 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.848 -0.691 . . . . 0.86 111.798 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.579 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -133.29 99.46 4.54 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.815 -0.439 . . . . 2.9 109.815 178.587 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.507 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 27.6 t 33.28 113.07 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 116.825 2.157 . . . . 1.46 116.825 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.507 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 13.5 Cg_exo -29.2 116.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.982 3.121 . . . . 0.79 110.053 173.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.591 ' H ' ' HZ2' ' A' ' 25' ' ' TRP . 22.8 t -152.72 -177.6 6.35 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 114.093 1.145 . . . . 0.95 114.093 -174.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.6 ' CE3' ' CG ' ' A' ' 21' ' ' TYR . 11.7 t-105 -106.21 92.19 4.03 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.584 -1.189 . . . . 1.24 108.935 178.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.018 HG21 HG23 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -159.76 -179.75 1.16 Allowed Pre-proline 0 C--O 1.214 -0.775 0 CA-C-N 115.822 -0.627 . . . . 1.74 110.815 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.716 ' CD ' HG22 ' A' ' 34' ' ' VAL . 11.7 Cg_endo -98.53 115.74 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 123.605 2.87 . . . . 1.52 115.778 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t 70.63 -8.75 0.87 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 115.37 1.619 . . . . 1.75 115.37 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.553 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 49.4 m -160.86 -90.27 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 118.707 -1.197 . . . . 1.49 114.102 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.784 ' CA ' HG11 ' A' ' 34' ' ' VAL . 12.8 t80 176.75 140.42 0.07 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 110.062 -0.347 . . . . 5.43 110.062 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.018 HG23 HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -165.62 31.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 123.182 1.468 . . . . 2.1 108.365 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -65.85 91.69 0.15 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.359 -1.292 . . . . 1.64 110.93 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 160.2 -26.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.367 -0.833 . . . . 2.5 110.421 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 5.8 m-20 -120.84 -92.04 0.55 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.41 0.522 . . . . 4.56 112.41 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.531 ' CA ' HD11 ' A' ' 39' ' ' ILE . 7.1 p 174.98 -30.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.276 0.472 . . . . 3.73 112.276 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.489 HG23 ' H ' ' A' ' 46' ' ' GLU . 32.6 m -54.51 -170.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 112.495 0.554 . . . . 2.57 112.495 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.477 ' CB ' ' HG2' ' A' ' 35' ' ' PRO . 11.7 t -107.58 21.8 16.92 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.1 0.778 . . . . 1.34 113.1 -177.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.489 ' H ' HG23 ' A' ' 44' ' ' VAL . 41.4 tt0 -172.86 139.18 0.85 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.565 0.58 . . . . 1.6 112.565 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' A' ' 38' ' ' TYR . 4.1 t80 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.273 -0.87 . . . . 4.12 110.989 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.511 -0.236 . . . . 6.11 112.511 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.3 m -153.96 144.08 22.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 4.17 110.919 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 70.18 162.67 4.0 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.704 -0.76 . . . . 2.16 112.503 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.567 ' H ' HG22 ' A' ' 23' ' ' ILE . 9.8 tt0 61.46 14.78 6.11 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.303 0.573 . . . . 2.17 111.588 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.641 ' H ' HG21 ' A' ' 23' ' ' ILE . 4.9 t -79.87 -35.39 16.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 122.134 -0.354 . . . . 0.87 111.428 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.458 ' H ' HG21 ' A' ' 23' ' ' ILE . 42.8 t-20 58.61 88.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 1.86 110.632 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.476 ' HD2' ' CG1' ' A' ' 5' ' ' VAL . 2.5 ptmm? -150.94 -67.24 0.19 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.176 -0.466 . . . . 2.42 111.73 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.624 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -138.76 128.96 33.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.966 -0.561 . . . . 2.03 109.782 -179.22 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.624 ' N ' HD13 ' A' ' 8' ' ' ILE . 13.5 pt -122.1 131.46 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 113.949 1.092 . . . . 3.89 113.949 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.69 102.77 0.23 Allowed Glycine 0 N--CA 1.453 -0.216 0 N-CA-C 109.419 -1.472 . . . . 1.14 109.419 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.615 ' HB2' ' N ' ' A' ' 21' ' ' TYR . 7.0 m -148.99 169.96 19.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.334 1.235 . . . . 1.69 114.334 -176.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -159.89 102.74 1.49 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.522 -1.672 . . . . 3.7 109.91 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.848 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -87.85 -76.97 0.36 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.022 -0.671 . . . . 0.48 112.043 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -150.95 -63.54 0.19 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.683 0.623 . . . . 0.45 112.683 -178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.481 ' N ' ' HG3' ' A' ' 19' ' ' MET . . . 125.86 -42.05 1.56 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.773 -0.931 . . . . 0.72 110.773 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.408 ' OE2' ' N ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -59.3 -28.16 66.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.576 -0.898 . . . . 2.82 108.576 178.095 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.822 ' HA2' HG12 ' A' ' 44' ' ' VAL . . . -142.1 -65.17 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.958 -1.019 . . . . 0.8 111.179 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.88 ' HB2' HD11 ' A' ' 39' ' ' ILE . . . -109.19 154.0 22.99 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 119.564 -0.255 . . . . 0.51 111.367 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.558 ' HA ' ' H ' ' A' ' 13' ' ' THR . 1.6 ttm -157.05 25.09 0.31 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.49 1.293 . . . . 1.98 114.49 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.702 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 18.1 mt-10 -157.73 175.44 13.89 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 107.668 -1.234 . . . . 1.28 107.668 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.638 ' HB2' ' HA ' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -155.79 -26.69 0.1 Allowed 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 116.047 1.869 . . . . 4.88 116.047 -178.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.619 HD21 ' CZ ' ' A' ' 21' ' ' TYR . 2.0 mm? -89.66 138.21 31.67 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 115.308 1.595 . . . . 4.63 115.308 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.641 HG21 ' H ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -8.17 -119.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 111.363 -2.653 . . . . 2.72 114.969 177.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.564 ' HB2' HG21 ' A' ' 9' ' ' ILE . 33.9 tt0 48.23 25.03 0.76 Allowed 'General case' 0 C--N 1.344 0.365 0 O-C-N 121.777 -0.577 . . . . 2.6 109.939 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.927 ' CZ3' HG13 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -138.57 32.17 2.28 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 112.764 0.653 . . . . 1.71 112.764 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.2 tptt 37.3 30.41 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.326 0.491 . . . . 3.35 112.326 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HB3' ' CB ' ' A' ' 4' ' ' GLU . 4.1 p-10 44.15 35.82 1.32 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.09 0.404 . . . . 2.14 112.09 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.744 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -46.69 -53.86 9.63 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.302 -0.952 . . . . 0.86 111.72 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.543 ' CE1' ' CE2' ' A' ' 47' ' ' TYR . 9.6 t60 -132.04 94.57 3.5 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.581 -0.526 . . . . 2.9 109.581 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 29' ' ' HIS . 16.0 t 37.75 112.15 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 115.266 1.58 . . . . 1.46 115.266 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.448 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 17.9 Cg_exo -33.14 122.27 0.11 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.801 2.334 . . . . 0.79 108.768 174.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.492 ' O ' ' CZ2' ' A' ' 25' ' ' TRP . 40.4 m -143.38 174.98 10.26 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 114.201 1.186 . . . . 0.95 114.201 -172.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.848 ' CD1' HG23 ' A' ' 13' ' ' THR . 2.1 t90 -97.96 100.97 12.34 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 104.602 -2.37 . . . . 1.24 104.602 174.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.998 HG21 ' N ' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -151.83 151.62 28.6 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 114.226 -1.352 . . . . 1.74 111.37 -171.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.711 ' HD2' HG23 ' A' ' 34' ' ' VAL . 40.9 Cg_exo -56.37 -14.15 11.78 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 125.127 3.885 . . . . 1.52 116.588 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.771 ' H ' HG22 ' A' ' 34' ' ' VAL . 28.1 t 176.54 -28.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.96 0.726 . . . . 1.75 112.96 -177.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.567 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 49.7 m -114.61 -90.18 0.54 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.0 0.37 . . . . 1.49 112.0 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.998 ' N ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -178.94 123.3 0.09 Allowed 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 106.655 -1.609 . . . . 5.43 106.655 -179.349 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.88 HD11 ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -135.62 27.89 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.746 0.784 . . . . 2.1 110.305 -175.832 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -59.58 92.04 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.022 -0.99 . . . . 1.64 111.59 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 160.83 -60.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.232 -0.895 . . . . 2.5 109.948 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 6.7 t70 163.13 80.72 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.435 -0.802 . . . . 4.56 110.13 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.656 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -148.42 -163.34 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.961 -0.296 . . . . 3.73 110.336 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.822 HG12 ' HA2' ' A' ' 17' ' ' GLY . 15.9 m -141.14 101.74 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 113.073 0.768 . . . . 2.57 113.073 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.503 ' N ' ' HG2' ' A' ' 35' ' ' PRO . 46.9 t 64.39 14.68 8.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.281 -0.872 . . . . 1.34 112.414 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -178.6 133.61 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.487 -0.485 . . . . 1.6 111.822 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.543 ' CE2' ' CE1' ' A' ' 29' ' ' HIS . 90.4 t80 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.228 -0.891 . . . . 4.12 110.927 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 112.545 -0.222 . . . . 6.11 112.545 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 81.3 p 51.27 -173.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.938 0.399 . . . . 4.17 110.945 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.457 ' HA2' HD11 ' A' ' 23' ' ' ILE . . . 146.32 158.5 7.79 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.882 -0.675 . . . . 2.16 112.184 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.476 ' CB ' ' HB3' ' A' ' 27' ' ' ASP . 6.9 tt0 67.52 7.27 5.48 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.771 0.286 . . . . 2.17 111.771 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 6' ' ' ASN . 54.9 t -82.53 -43.42 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.035 0.445 . . . . 0.87 110.353 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.658 ' N ' HG21 ' A' ' 23' ' ' ILE . 27.8 t-20 83.56 74.07 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.915 -1.038 . . . . 1.86 110.739 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.752 ' HG3' HG22 ' A' ' 8' ' ' ILE . 36.4 pttt -151.56 -140.36 0.1 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.302 -1.772 . . . . 2.42 108.093 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.958 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -38.95 143.54 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 122.565 0.346 . . . . 2.03 110.884 177.231 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.958 ' N ' HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -147.48 126.88 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 114.32 1.23 . . . . 3.89 114.32 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.03 146.71 16.66 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 107.767 -2.133 . . . . 1.14 107.767 175.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.509 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -154.24 104.43 2.61 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 118.51 1.155 . . . . 1.69 112.917 -176.046 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -157.86 102.65 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.822 -0.627 . . . . 3.7 109.849 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.463 ' H ' ' HA ' ' A' ' 19' ' ' MET . 1.0 OUTLIER -113.86 -82.98 0.6 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.894 1.072 . . . . 0.48 113.894 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.421 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -145.32 -54.52 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.576 -0.45 . . . . 0.45 112.157 -177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.435 ' N ' ' HG3' ' A' ' 19' ' ' MET . . . 116.63 -37.27 3.43 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 119.903 -1.142 . . . . 0.72 112.801 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.18 -27.74 64.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.251 0.548 . . . . 2.82 109.522 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -150.02 -53.98 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.33 -0.85 . . . . 0.8 111.123 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.565 ' HB1' ' HD3' ' A' ' 35' ' ' PRO . . . -115.67 146.58 41.72 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 110.034 -0.358 . . . . 0.51 110.034 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.463 ' HA ' ' H ' ' A' ' 13' ' ' THR . 2.6 ttp -155.68 31.81 0.36 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 111.925 0.343 . . . . 1.98 111.925 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.645 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 9.3 mt-10 -147.29 -176.39 5.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 119.155 -0.45 . . . . 1.28 109.88 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.675 ' HB2' ' CD2' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -154.28 -62.85 0.13 Allowed 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 119.919 3.303 . . . . 4.88 119.919 -174.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.945 ' HG ' HD12 ' A' ' 23' ' ' ILE . 10.6 tp -84.18 155.65 22.44 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 114.864 1.431 . . . . 4.63 114.864 -170.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.945 HD12 ' HG ' ' A' ' 22' ' ' LEU . 3.4 mp -9.86 -112.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 112.462 -2.154 . . . . 2.72 114.85 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.558 ' N ' HG22 ' A' ' 23' ' ' ILE . 5.9 tt0 70.69 -61.35 0.48 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.728 -1.582 . . . . 2.6 106.728 -175.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.566 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 1.1 p90 -57.76 -173.18 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.021 -0.99 . . . . 1.71 111.033 176.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.46 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 3.2 mptp? -116.37 55.2 0.82 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.122 0.487 . . . . 3.35 109.941 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.476 ' HB3' ' CB ' ' A' ' 4' ' ' GLU . 4.0 p30 42.85 33.94 0.55 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.563 -0.744 . . . . 2.14 111.874 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.743 ' N ' ' OH ' ' A' ' 38' ' ' TYR . . . -49.48 -57.54 9.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.534 -0.841 . . . . 0.86 112.722 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.542 ' NE2' ' CE2' ' A' ' 47' ' ' TYR . 54.5 t-80 -131.97 96.29 3.88 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 117.383 0.591 . . . . 2.9 110.694 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 29' ' ' HIS . 23.3 t 39.71 103.24 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 113.761 1.022 . . . . 1.46 113.761 177.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.446 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 15.1 Cg_exo -31.6 114.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.371 1.723 0 C-N-CA 122.816 2.344 . . . . 0.79 109.699 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 21' ' ' TYR . 10.0 t -133.62 -163.31 1.34 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.712 0.634 . . . . 0.95 112.712 -172.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.675 ' CD2' ' HB2' ' A' ' 21' ' ' TYR . 6.4 t-105 -120.41 91.98 3.66 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.15 -1.796 . . . . 1.24 106.15 175.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.699 HG13 ' CD ' ' A' ' 35' ' ' PRO . 1.2 t -158.7 170.65 8.58 Favored Pre-proline 0 N--CA 1.444 -0.751 0 CA-C-N 114.993 -1.003 . . . . 1.74 112.186 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.699 ' CD ' HG13 ' A' ' 34' ' ' VAL . 59.1 Cg_endo -70.39 108.41 2.19 Favored 'Trans proline' 0 N--CA 1.485 1.003 1 C-N-CA 125.484 4.123 . . . . 1.52 116.253 175.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 t 37.55 30.35 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.813 -0.63 . . . . 1.75 112.13 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.544 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -163.11 -136.14 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 116.024 -0.535 . . . . 1.49 110.464 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.743 ' OH ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -174.34 100.68 0.1 Allowed 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.444 -1.688 . . . . 5.43 106.444 -177.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.679 HG23 HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -126.14 31.44 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 122.92 1.343 . . . . 2.1 109.477 -175.106 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -60.91 92.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.51 -1.223 . . . . 1.64 111.055 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 164.38 -29.46 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.432 -0.804 . . . . 2.5 110.024 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.574 ' OD2' HG12 ' A' ' 43' ' ' VAL . 23.8 t70 -123.95 -91.46 0.54 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.989 -0.55 . . . . 4.56 112.008 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.574 HG12 ' OD2' ' A' ' 42' ' ' ASP . 14.7 p 175.55 -30.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 112.382 0.512 . . . . 3.73 112.382 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.473 HG23 ' H ' ' A' ' 46' ' ' GLU . 17.1 m -55.45 -169.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.005 0.372 . . . . 2.57 112.005 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.598 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 26.3 t -106.47 35.09 3.08 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.857 0.688 . . . . 1.34 112.857 -177.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.608 ' N ' HG21 ' A' ' 39' ' ' ILE . 34.8 tt0 -179.01 149.21 0.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.81 0.338 . . . . 1.6 110.815 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.542 ' CE2' ' NE2' ' A' ' 29' ' ' HIS . 9.4 t80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.239 -0.886 . . . . 4.12 110.803 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.501 -0.24 . . . . 6.11 112.501 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.5 p -72.41 -177.72 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.747 0.308 . . . . 4.17 110.73 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.564 ' HA3' ' HB3' ' A' ' 31' ' ' PRO . . . 148.25 -158.47 27.7 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.482 -0.866 . . . . 2.16 112.603 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.418 ' CA ' HG23 ' A' ' 23' ' ' ILE . 0.0 OUTLIER 62.0 7.92 2.32 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.42 0.526 . . . . 2.17 112.42 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.541 HG11 ' HD3' ' A' ' 7' ' ' LYS . 13.9 t -85.31 -50.37 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 120.897 0.379 . . . . 0.87 110.721 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.528 ' C ' HD21 ' A' ' 6' ' ' ASN . 0.2 OUTLIER 93.25 69.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.55 -1.205 . . . . 1.86 108.553 -178.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.541 ' HD3' HG11 ' A' ' 5' ' ' VAL . 17.0 pttp -150.41 -141.58 0.11 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.002 -0.999 . . . . 2.42 109.932 -177.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.708 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -48.1 102.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 121.486 0.66 . . . . 2.03 111.98 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.876 HD11 ' CZ ' ' A' ' 21' ' ' TYR . 5.1 tp -154.06 169.08 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.228 -0.589 . . . . 3.89 111.506 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.91 169.93 20.21 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.542 -0.361 . . . . 1.14 112.524 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.535 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 3.0 p -150.62 104.68 3.22 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 113.264 0.839 . . . . 1.69 113.264 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.428 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 12.6 mmt180 -157.93 103.38 1.87 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.295 -0.411 . . . . 3.7 111.723 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.591 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -125.28 -85.2 0.63 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.207 -0.933 . . . . 0.48 113.488 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.462 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -143.7 -61.36 0.4 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.094 0.405 . . . . 0.45 112.094 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 19' ' ' MET . . . 124.26 -46.98 1.05 Allowed Glycine 0 C--N 1.329 0.166 0 C-N-CA 120.434 -0.889 . . . . 0.72 112.522 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -59.26 -25.59 64.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.015 0.436 . . . . 2.82 110.517 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -141.43 -54.94 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.802 -0.919 . . . . 0.8 110.802 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.525 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . . . -128.76 150.98 50.06 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.454 -0.573 . . . . 0.51 109.454 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.462 ' HG2' ' N ' ' A' ' 14' ' ' ALA . 2.9 tmm? -162.49 22.61 0.1 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.351 0.871 . . . . 1.98 113.351 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.601 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 9.3 mm-40 -148.01 179.75 7.51 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.709 -0.848 . . . . 1.28 108.709 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.876 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -156.2 11.72 0.28 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.513 0.931 . . . . 4.88 113.513 -179.394 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.718 ' HB3' HG23 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -84.99 133.9 34.24 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 117.242 2.312 . . . . 4.63 117.242 -175.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.56 HD13 HG12 ' A' ' 9' ' ' ILE . 1.9 mp -64.4 -6.39 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-N 110.248 -3.16 . . . . 2.72 110.151 176.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.544 ' HB3' HD13 ' A' ' 22' ' ' LEU . 30.8 tt0 -47.83 -12.61 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.92 -0.582 . . . . 2.6 112.172 177.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.606 ' HZ2' ' H ' ' A' ' 32' ' ' SER . 0.2 OUTLIER -72.56 30.41 0.06 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.776 1.028 . . . . 1.71 113.776 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.6 mttm 46.18 35.57 2.68 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 118.048 0.385 . . . . 3.35 111.916 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.4 ' HB2' ' HG2' ' A' ' 4' ' ' GLU . 56.4 t0 62.68 25.34 15.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.955 0.407 . . . . 2.14 110.332 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -46.21 -66.57 1.64 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.408 -0.901 . . . . 0.86 111.393 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.546 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -135.35 99.57 4.27 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.934 -0.307 . . . . 2.9 110.612 178.697 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.485 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 20.1 m 37.18 111.8 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.495 0 N-CA-C 116.469 2.025 . . . . 1.46 116.469 176.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.564 ' HB3' ' HA3' ' A' ' 3' ' ' GLY . 7.3 Cg_exo -33.1 117.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 123.268 2.645 . . . . 0.79 108.935 173.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.606 ' H ' ' HZ2' ' A' ' 25' ' ' TRP . 18.6 t -150.1 176.16 11.07 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.496 0.924 . . . . 0.95 113.496 -173.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.614 ' CG ' ' HB2' ' A' ' 21' ' ' TYR . 12.0 t-105 -104.76 91.3 3.78 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.902 -0.777 . . . . 1.24 108.902 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.018 HG21 HG23 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -159.72 175.05 3.43 Favored Pre-proline 0 C--O 1.217 -0.616 0 CA-C-N 115.468 -0.787 . . . . 1.74 111.124 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.597 ' CD ' HG22 ' A' ' 34' ' ' VAL . 26.0 Cg_endo -92.02 142.45 2.59 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.756 2.971 . . . . 1.52 113.118 175.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 27.8 t 72.91 -57.56 0.63 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.965 -1.016 . . . . 1.75 113.65 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.579 ' HA ' ' CE3' ' A' ' 25' ' ' TRP . 42.9 m -148.72 -64.32 0.24 Allowed 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 114.937 1.458 . . . . 1.49 114.937 -177.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.679 ' CA ' HG11 ' A' ' 34' ' ' VAL . 7.9 t80 178.12 149.3 0.19 Allowed 'General case' 0 C--N 1.318 -0.771 0 O-C-N 121.759 -0.588 . . . . 5.43 110.407 -176.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.018 HG23 HG21 ' A' ' 34' ' ' VAL . 0.5 OUTLIER 176.45 74.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.61 0.719 . . . . 2.1 110.019 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.32 92.66 0.06 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.206 -0.906 . . . . 1.64 110.974 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 178.62 -31.9 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.5 -0.773 . . . . 2.5 111.182 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 77.26 25.88 0.74 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.089 -0.505 . . . . 4.56 110.661 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.583 HG23 ' CG2' ' A' ' 44' ' ' VAL . 29.8 m -121.31 0.5 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 3.73 112.106 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.798 ' O ' HG21 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -159.76 169.23 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-O 120.791 0.329 . . . . 2.57 110.947 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.47 ' CB ' ' HG2' ' A' ' 35' ' ' PRO . 47.4 t -105.32 26.03 9.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.971 -0.559 . . . . 1.34 111.281 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -178.8 148.62 0.42 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.028 0.381 . . . . 1.6 112.028 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' TYR . 9.3 t80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.224 -0.893 . . . . 4.12 110.8 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 112.612 -0.195 . . . . 6.11 112.612 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m -121.12 -57.07 1.89 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.321 . . . . 4.17 110.85 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.517 ' O ' HG23 ' A' ' 5' ' ' VAL . . . -121.07 -102.47 1.82 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.678 -0.773 . . . . 2.16 112.555 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.456 ' HB2' ' CA ' ' A' ' 27' ' ' ASP . 9.4 pt-20 44.6 27.78 0.27 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.888 0.375 . . . . 2.17 111.006 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 3' ' ' GLY . 41.1 t -90.07 -8.97 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.16 -0.473 . . . . 0.87 111.846 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.577 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 32.0 t30 49.14 73.06 0.25 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 110.313 -0.255 . . . . 1.86 110.313 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.618 ' N ' HD13 ' A' ' 23' ' ' ILE . 1.6 ptmm? -140.61 -98.92 0.15 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.298 0.481 . . . . 2.42 112.298 -178.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 8' ' ' ILE . 1.4 tp -137.4 105.34 3.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 CA-C-O 121.034 0.445 . . . . 2.03 110.902 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.946 HG22 ' CG1' ' A' ' 23' ' ' ILE . 3.4 tt -151.85 173.77 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.783 -0.644 . . . . 3.89 110.579 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -100.66 167.59 20.05 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.214 -0.517 . . . . 1.14 113.176 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.771 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 13.6 p -153.63 103.9 2.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 1.69 111.896 -177.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -158.99 102.88 1.65 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.608 -0.724 . . . . 3.7 110.043 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.47 ' H ' ' HA ' ' A' ' 19' ' ' MET . 1.0 OUTLIER -108.7 -85.2 0.53 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.815 1.043 . . . . 0.48 113.815 -178.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.448 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -145.38 -54.16 0.29 Allowed 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.163 0.431 . . . . 0.45 112.163 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.83 -34.84 4.68 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.291 -0.957 . . . . 0.72 112.268 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.0 -32.82 70.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.532 0.682 . . . . 2.82 109.183 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.581 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -141.09 -55.72 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.807 -1.088 . . . . 0.8 110.554 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.599 ' CA ' ' HD3' ' A' ' 35' ' ' PRO . . . -120.28 150.0 41.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.816 -0.192 . . . . 0.51 111.001 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.523 ' H ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -155.46 37.36 0.38 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.032 0.752 . . . . 1.98 113.032 178.088 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.636 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 27.8 mt-10 -151.81 -169.45 3.37 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 119.43 -0.319 . . . . 1.28 110.466 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.835 ' O ' ' CH2' ' A' ' 25' ' ' TRP 0.269 2.5 t80 -152.76 -130.77 0.04 OUTLIER 'General case' 0 C--O 1.209 -1.029 0 N-CA-C 116.057 1.873 . . . . 4.88 116.057 -177.46 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.598 ' N ' ' CD1' ' A' ' 21' ' ' TYR . 4.4 mt -78.94 166.67 22.12 Favored 'General case' 0 CA--C 1.491 -1.326 0 O-C-N 120.402 -1.437 . . . . 4.63 114.651 -166.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.946 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.9 OUTLIER 45.5 -166.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 112.848 -1.978 . . . . 2.72 109.679 -179.62 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.773 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.6 OUTLIER 71.08 9.85 6.77 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.721 -0.844 . . . . 2.6 108.721 -177.811 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.835 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -143.48 -173.55 3.98 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 108.694 -0.854 . . . . 1.71 108.694 178.656 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 4.0 mppt? -122.29 65.2 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.604 -0.439 . . . . 3.35 111.99 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.456 ' CA ' ' HB2' ' A' ' 4' ' ' GLU . 3.5 p30 40.63 29.01 0.06 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.283 -0.417 . . . . 2.14 112.105 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.736 ' N ' ' OH ' ' A' ' 38' ' ' TYR . . . -46.7 -62.92 3.4 Favored Glycine 0 C--N 1.329 0.16 0 C-N-CA 120.601 -0.809 . . . . 0.86 113.248 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.571 ' CE1' ' CE2' ' A' ' 47' ' ' TYR . 68.4 t60 -133.09 96.3 3.73 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 117.724 0.762 . . . . 2.9 111.153 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 31' ' ' PRO . 13.8 m 40.47 99.98 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 118.575 -0.726 . . . . 1.46 112.874 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.447 ' C ' ' O ' ' A' ' 30' ' ' SER . 17.9 Cg_exo -27.51 124.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.368 2.712 . . . . 0.79 110.789 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.8 t -148.93 -168.81 3.2 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.525 0.935 . . . . 0.95 113.525 -173.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.646 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 3.7 t-105 -116.08 95.56 5.15 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.254 -1.387 . . . . 1.24 107.254 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.728 HG13 ' CD ' ' A' ' 35' ' ' PRO . 1.0 OUTLIER -157.87 166.3 16.85 Favored Pre-proline 0 C--O 1.221 -0.401 0 CA-C-N 115.872 -0.604 . . . . 1.74 112.469 -178.382 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.728 ' CD ' HG13 ' A' ' 34' ' ' VAL . 12.1 Cg_endo -56.03 69.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.475 0.438 1 C-N-CA 125.44 4.094 . . . . 1.52 116.129 177.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.4 m 60.94 31.21 19.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.436 0.636 . . . . 1.75 110.794 176.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.577 ' O ' ' CZ3' ' A' ' 25' ' ' TRP . 1.5 m -150.79 -131.57 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.859 -1.064 . . . . 1.49 108.445 177.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.736 ' OH ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -174.59 99.91 0.09 Allowed 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 106.374 -1.713 . . . . 5.43 106.374 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.758 HD11 ' H ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -155.2 83.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.184 -1.371 . . . . 2.1 107.691 -175.684 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.67 91.05 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.585 -1.189 . . . . 1.64 111.504 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 46.41 59.3 3.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.08 -0.964 . . . . 2.5 111.772 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.819 ' O ' HG13 ' A' ' 43' ' ' VAL . 25.2 t70 -122.58 -20.95 5.84 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.788 0.662 . . . . 4.56 112.788 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.819 HG13 ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -179.03 -95.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 112.089 0.403 . . . . 3.73 112.089 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 17' ' ' GLY . 4.8 p -179.74 124.93 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 113.159 0.8 . . . . 2.57 113.159 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.501 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 28.8 t 65.87 10.38 6.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.92 -1.037 . . . . 1.34 113.72 176.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.475 ' H ' HG21 ' A' ' 39' ' ' ILE . 2.6 mt-10 176.98 166.38 0.53 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.773 0.657 . . . . 1.6 112.773 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.571 ' CE2' ' CE1' ' A' ' 29' ' ' HIS . 43.6 t80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.22 -0.895 . . . . 4.12 110.344 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 112.589 -0.204 . . . . 6.11 112.589 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.0 m 61.57 170.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.796 0.331 . . . . 4.17 110.873 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 4' ' ' GLU . . . 106.39 134.73 7.81 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 2.16 112.484 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 27' ' ' ASP . 6.5 pt-20 51.37 21.48 1.19 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.861 0.362 . . . . 2.17 111.6 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.657 ' N ' HG22 ' A' ' 23' ' ' ILE . 18.6 t -78.62 -6.05 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 113.271 0.841 . . . . 0.87 113.271 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.665 ' H ' HG22 ' A' ' 23' ' ' ILE . 26.0 t-20 38.28 85.79 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.843 0.292 . . . . 1.86 110.594 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.447 ' HD3' ' CG1' ' A' ' 5' ' ' VAL . 22.2 pttp -150.99 -135.04 0.06 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 121.098 -0.241 . . . . 2.42 110.563 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.653 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.9 OUTLIER -105.49 97.92 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 112.874 0.694 . . . . 2.03 112.874 -178.78 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.896 ' HB ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -133.46 172.93 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 116.171 -0.468 . . . . 3.89 111.925 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.623 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -99.86 165.38 19.9 Favored Glycine 0 C--O 1.219 -0.815 0 N-CA-C 110.138 -1.185 . . . . 1.14 110.138 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.552 ' HA ' ' HB2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -155.55 109.37 2.82 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 117.916 0.858 . . . . 1.69 113.077 -176.466 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 11' ' ' SER . 2.1 mpt_? -154.63 103.21 2.44 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.38 -0.373 . . . . 3.7 111.196 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.766 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -106.24 -82.72 0.53 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.397 0.888 . . . . 0.48 113.397 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.41 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -146.31 -53.25 0.25 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.072 0.397 . . . . 0.45 112.072 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.49 -35.91 4.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.291 -0.957 . . . . 0.72 112.839 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -58.69 -30.09 67.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.325 0.583 . . . . 2.82 109.762 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.514 ' HA3' ' CG2' ' A' ' 43' ' ' VAL . . . -150.39 -46.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.236 -0.893 . . . . 0.8 110.899 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.62 ' CA ' ' HD3' ' A' ' 35' ' ' PRO . . . -121.53 142.12 50.38 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 121.034 -0.266 . . . . 0.51 111.045 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.55 ' HA ' ' H ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -153.49 39.14 0.49 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.66 0.615 . . . . 1.98 112.66 178.38 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.63 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 27.9 mt-10 -145.79 -151.4 0.37 Allowed 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 118.371 -0.823 . . . . 1.28 111.378 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.851 ' CE2' HD11 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -153.24 -97.19 0.05 OUTLIER 'General case' 0 C--O 1.203 -1.345 0 N-CA-C 119.725 3.231 . . . . 4.88 119.725 -174.228 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.802 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 13.2 tp -120.57 168.6 11.19 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 113.035 0.754 . . . . 4.63 113.035 -174.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.896 HD11 ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER 38.5 -142.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.579 -1.191 . . . . 2.72 110.435 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 53.29 19.32 1.51 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.609 1.095 . . . . 2.6 109.464 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.637 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -152.77 -173.19 4.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.731 -0.668 . . . . 1.71 109.756 -179.398 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -122.52 62.75 0.97 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.792 0.664 . . . . 3.35 112.792 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . 31.2 t70 46.22 26.11 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.187 0.44 . . . . 2.14 112.187 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.579 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -47.52 -61.04 4.9 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 119.707 -1.235 . . . . 0.86 111.884 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.49 ' O ' ' HB2' ' A' ' 38' ' ' TYR . 58.3 t-80 -134.05 95.8 3.5 Favored 'General case' 0 C--O 1.215 -0.721 0 C-N-CA 119.966 -0.694 . . . . 2.9 111.575 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 29' ' ' HIS . 14.8 m 37.88 105.63 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 114.215 1.191 . . . . 1.46 114.215 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.553 ' HB3' HD11 ' A' ' 22' ' ' LEU . 23.7 Cg_exo -30.55 116.86 0.06 OUTLIER 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 123.038 2.492 . . . . 0.79 110.31 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 21' ' ' TYR . 8.5 t -135.94 -150.44 0.37 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.36 0.874 . . . . 0.95 113.36 -173.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.766 ' CD1' HG23 ' A' ' 13' ' ' THR . 6.8 t-105 -135.0 95.08 3.24 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 106.141 -1.8 . . . . 1.24 106.141 174.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.864 HG11 HG22 ' A' ' 39' ' ' ILE . 1.4 t -156.75 162.04 28.36 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 115.132 -0.94 . . . . 1.74 113.092 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.815 ' CD ' HG13 ' A' ' 34' ' ' VAL . 18.6 Cg_endo -55.31 72.5 0.03 OUTLIER 'Trans proline' 0 N--CA 1.477 0.502 1 C-N-CA 126.784 4.989 . . . . 1.52 115.488 177.24 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 35.3 t 65.04 23.7 12.5 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.748 -0.381 . . . . 1.75 111.742 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.547 ' O ' ' CZ3' ' A' ' 25' ' ' TRP . 7.3 m -149.06 -123.06 0.05 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.23 -0.441 . . . . 1.49 110.262 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.579 ' CZ ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -176.83 107.79 0.07 Allowed 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.81 -1.552 . . . . 5.43 106.81 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.864 HG22 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -174.9 39.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 122.937 1.351 . . . . 2.1 108.51 -175.426 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 33' ' ' TRP . . . -77.04 90.14 3.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.862 -1.517 . . . . 1.64 110.596 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.41 -34.87 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.391 -1.277 . . . . 2.5 109.923 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.445 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 32.0 t70 -102.03 -99.48 0.27 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.889 -0.596 . . . . 4.56 111.895 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.2 p 174.09 68.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 119.841 -0.123 . . . . 3.73 110.971 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.484 ' CG2' HG12 ' A' ' 39' ' ' ILE . 25.2 m -156.81 169.99 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 113.995 1.109 . . . . 2.57 113.995 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.638 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 28.2 t -83.44 10.8 7.99 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.607 -1.178 . . . . 1.34 112.487 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.45 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 36.8 tt0 179.16 161.13 0.74 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.113 0.483 . . . . 1.6 111.963 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.481 ' CD2' ' OXT' ' A' ' 47' ' ' TYR . 38.1 p90 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.265 -0.874 . . . . 4.12 110.917 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.463 -0.255 . . . . 6.11 112.463 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.2 p -155.63 60.57 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.738 0.304 . . . . 4.17 110.824 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.625 ' O ' HG23 ' A' ' 5' ' ' VAL . . . 129.47 176.91 14.61 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.6 -0.81 . . . . 2.16 112.657 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.475 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.0 OUTLIER 56.11 18.09 3.03 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.863 0.363 . . . . 2.17 111.072 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 3' ' ' GLY . 12.7 t -106.79 -4.14 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.33 . . . . 0.87 111.429 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.557 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 9.7 p30 45.28 79.73 0.05 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.33 0.586 . . . . 1.86 110.886 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.426 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 6.2 pttp -143.99 -104.71 0.12 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.138 -0.937 . . . . 2.42 110.442 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.635 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -87.06 103.67 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 108.354 -0.98 . . . . 2.03 108.354 178.458 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.764 HG21 ' HB2' ' A' ' 22' ' ' LEU . 21.9 pt -104.2 165.73 3.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.917 0.865 . . . . 3.89 113.082 -177.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.4 138.83 9.29 Favored Glycine 0 CA--C 1.498 -0.983 0 N-CA-C 107.454 -2.258 . . . . 1.14 107.454 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.49 ' HB2' ' CB ' ' A' ' 20' ' ' GLU . 12.4 p -144.59 104.45 4.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 119.062 1.431 . . . . 1.69 113.415 -176.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.418 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 31.2 ttm180 -159.94 101.09 1.44 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.452 -1.249 . . . . 3.7 111.091 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.536 ' HB ' ' C ' ' A' ' 18' ' ' ALA . 2.9 m -116.68 -87.99 0.6 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 113.981 1.104 . . . . 0.48 113.981 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.41 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -148.63 -60.0 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.218 -0.593 . . . . 0.45 112.581 -177.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.458 ' N ' ' HG3' ' A' ' 19' ' ' MET . . . 125.24 -34.98 3.22 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.327 -0.94 . . . . 0.72 112.13 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -30.28 66.74 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.256 -0.646 . . . . 2.82 109.256 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -146.43 -47.38 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.137 -0.938 . . . . 0.8 110.931 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.566 ' CA ' ' HD3' ' A' ' 35' ' ' PRO . . . -127.02 151.78 48.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 111.488 0.181 . . . . 0.51 111.488 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.458 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 1.6 ttm -151.66 22.0 0.7 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.891 0.33 . . . . 1.98 111.891 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.615 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 18.9 mt-10 -148.36 177.85 9.09 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 122.287 -0.258 . . . . 1.28 111.407 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.67 ' CG ' ' O ' ' A' ' 21' ' ' TYR . 1.0 OUTLIER -159.09 50.91 0.37 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.514 0.673 . . . . 4.88 111.701 -179.413 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.764 ' HB2' HG21 ' A' ' 9' ' ' ILE . 2.0 pp -110.15 114.05 27.24 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 116.266 1.95 . . . . 4.63 116.266 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.656 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 8.2 pt -53.89 -16.92 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 113.195 -1.821 . . . . 2.72 112.376 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.557 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . 35.1 tt0 -67.3 65.51 0.07 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.242 0.544 . . . . 2.6 111.212 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.656 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -142.97 31.69 1.4 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.568 -0.742 . . . . 1.71 110.225 178.439 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 60.06 34.17 21.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.288 -0.869 . . . . 3.35 111.908 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.464 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 4.2 p30 44.77 29.17 0.41 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.88 0.371 . . . . 2.14 111.282 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.467 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -47.63 -61.95 4.37 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.676 -0.774 . . . . 0.86 112.338 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.57 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 49.9 t-80 -135.26 93.71 3.02 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 110.01 -0.367 . . . . 2.9 110.01 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 32' ' ' SER . 28.9 m 39.57 116.39 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 116.3 1.963 . . . . 1.46 116.3 177.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.592 ' HB3' HG22 ' A' ' 23' ' ' ILE . 14.2 Cg_exo -32.08 92.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 124.138 3.226 . . . . 0.79 107.749 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 30' ' ' SER . 33.8 t -111.72 166.32 11.28 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.334 -1.303 . . . . 0.95 113.849 -172.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.626 ' CZ3' ' CD2' ' A' ' 21' ' ' TYR . 15.0 t-105 -97.87 91.23 5.24 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 105.656 -1.979 . . . . 1.24 105.656 176.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.715 HG21 HG23 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -156.36 165.55 18.39 Favored Pre-proline 0 N--CA 1.441 -0.882 0 N-CA-C 113.887 1.069 . . . . 1.74 113.887 -178.376 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.674 ' HD2' HG22 ' A' ' 34' ' ' VAL . 38.2 Cg_endo -67.58 78.05 0.51 Allowed 'Trans proline' 0 C--N 1.352 0.728 1 C-N-CA 125.791 4.327 . . . . 1.52 117.609 177.783 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.8 m 76.09 14.5 2.52 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.641 0.978 . . . . 1.75 113.641 173.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.547 ' O ' ' CE3' ' A' ' 25' ' ' TRP . 1.8 m -162.54 -110.6 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 120.571 -0.451 . . . . 1.49 112.029 176.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.57 ' CG ' ' HB3' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -174.49 132.82 0.37 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.997 -1.853 . . . . 5.43 105.997 -176.774 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.715 HG23 HG21 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -149.68 28.98 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 119.377 -0.929 . . . . 2.1 111.118 -174.805 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.566 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -60.86 89.43 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.574 -0.739 . . . . 1.64 110.25 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.566 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 153.69 38.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.839 -1.073 . . . . 2.5 110.705 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 55.83 87.51 0.05 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.429 0.529 . . . . 4.56 112.429 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.592 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -151.59 -156.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 110.05 -0.352 . . . . 3.73 110.05 178.547 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 44' ' ' VAL . 8.3 p -159.29 120.59 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 113.702 1.001 . . . . 2.57 113.702 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.549 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 28.8 t 63.44 8.71 3.68 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.202 0.816 . . . . 1.34 113.202 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 45' ' ' SER . 38.0 tt0 179.23 154.99 0.47 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.912 0.387 . . . . 1.6 111.931 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 39' ' ' ILE . 35.4 t80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.2 -0.905 . . . . 4.12 110.833 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 112.501 -0.24 . . . . 6.11 112.501 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.2 t -139.44 135.76 33.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.783 0.325 . . . . 4.17 110.878 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.437 ' C ' ' HG3' ' A' ' 31' ' ' PRO . . . 143.53 154.03 6.03 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.686 -0.769 . . . . 2.16 112.495 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.485 ' H ' HG23 ' A' ' 23' ' ' ILE . 0.0 OUTLIER 64.97 3.78 2.23 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 112.179 0.437 . . . . 2.17 112.179 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.497 ' HB ' ' HG2' ' A' ' 7' ' ' LYS . 24.1 t -79.74 -41.21 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 CA-C-O 121.317 0.579 . . . . 0.87 110.807 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.473 ' H ' ' CG2' ' A' ' 23' ' ' ILE . 0.3 OUTLIER 81.68 71.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.821 -1.081 . . . . 1.86 108.421 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.846 ' HD3' HG22 ' A' ' 8' ' ' ILE . 5.3 ptpt -152.41 -107.12 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 112.986 0.736 . . . . 2.42 112.986 -176.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.846 HG22 ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -79.49 97.95 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 C-N-CA 123.217 0.607 . . . . 2.03 110.105 -179.22 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.902 HD11 ' CZ ' ' A' ' 21' ' ' TYR . 3.2 tp -153.42 170.49 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 C-N-CA 120.008 -0.677 . . . . 3.89 111.615 -178.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.24 169.18 20.63 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 121.276 -0.487 . . . . 1.14 111.982 -175.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.534 ' HB2' ' CB ' ' A' ' 20' ' ' GLU . 11.8 p -151.14 102.41 2.94 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 113.403 0.89 . . . . 1.69 113.403 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -163.3 97.32 0.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 119.176 -0.44 . . . . 3.7 111.255 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.761 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -105.02 -81.12 0.54 Allowed 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 119.022 -1.071 . . . . 0.48 113.742 177.563 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.414 ' C ' ' HG2' ' A' ' 19' ' ' MET . . . -150.81 -55.85 0.16 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.824 0.675 . . . . 0.45 112.824 -177.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.486 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . 122.49 -45.35 1.21 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.483 -0.865 . . . . 0.72 111.656 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -59.17 -32.17 69.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.036 -0.727 . . . . 2.82 109.036 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.703 ' HA2' HG12 ' A' ' 44' ' ' VAL . . . -132.46 -68.52 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.03 -0.986 . . . . 0.8 110.948 178.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 1.031 ' HB2' HD11 ' A' ' 39' ' ' ILE . . . -111.48 155.65 22.9 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 119.774 -0.155 . . . . 0.51 110.845 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.504 ' HA ' ' H ' ' A' ' 13' ' ' THR . 0.9 OUTLIER -153.85 16.07 0.5 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.75 1.018 . . . . 1.98 113.75 179.209 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.69 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 18.2 mt-10 -152.69 178.91 9.11 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 119.367 -0.349 . . . . 1.28 110.131 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.902 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 1.1 t80 -160.05 12.94 0.12 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.445 1.276 . . . . 4.88 114.445 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.694 ' HB3' HG23 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -85.43 125.64 33.17 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 117.916 2.561 . . . . 4.63 117.916 -175.807 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.684 HD12 ' HB ' ' A' ' 9' ' ' ILE . 5.7 mt -48.56 -22.48 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-N 111.266 -2.697 . . . . 2.72 110.868 174.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.54 ' HB3' HD13 ' A' ' 22' ' ' LEU . 23.6 tt0 -29.34 -32.19 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.839 0.856 . . . . 2.6 112.517 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.676 ' CZ3' ' CG1' ' A' ' 34' ' ' VAL . 0.4 OUTLIER -55.96 -163.4 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.26 -0.645 . . . . 1.71 109.26 177.014 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.431 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -114.62 54.61 0.77 Allowed 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.513 -0.742 . . . . 3.35 111.104 -178.869 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.423 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 4.2 p30 44.36 28.41 0.29 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.918 -0.583 . . . . 2.14 111.256 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.512 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -49.54 -65.63 2.69 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.471 -0.871 . . . . 0.86 112.087 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.447 ' O ' ' O ' ' A' ' 30' ' ' SER . 14.4 m80 -134.56 94.85 3.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.706 -0.398 . . . . 2.9 110.432 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 29' ' ' HIS . 29.5 t 41.26 114.47 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 116.058 1.873 . . . . 1.46 116.058 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.501 ' HB3' HG12 ' A' ' 23' ' ' ILE . 8.0 Cg_exo -30.96 95.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 124.022 3.148 . . . . 0.79 108.167 172.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.565 ' OG ' ' HB2' ' A' ' 40' ' ' ALA . 33.5 t -119.43 176.67 5.24 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-N 114.462 -1.245 . . . . 0.95 113.782 -172.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.761 ' CD1' HG23 ' A' ' 13' ' ' THR . 4.3 t-105 -104.79 99.83 9.47 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.326 -1.761 . . . . 1.24 107.18 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.948 HG11 ' C ' ' A' ' 37' ' ' SER . 7.4 p -152.42 155.44 32.92 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 115.166 -0.925 . . . . 1.74 111.591 -175.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.757 ' HD2' HG23 ' A' ' 34' ' ' VAL . 53.5 Cg_exo -55.03 -12.75 5.41 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 124.17 3.247 . . . . 1.52 115.789 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 19.4 p 174.07 -19.32 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.328 0.862 . . . . 1.75 113.328 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.948 ' C ' HG11 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -115.32 -95.39 0.47 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.179 0.445 . . . . 1.49 111.7 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.743 ' N ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -178.44 122.98 0.1 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.296 -1.372 . . . . 5.43 107.296 -178.336 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.031 HD11 ' HB2' ' A' ' 18' ' ' ALA . 5.1 pt -145.64 32.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 119.904 -0.718 . . . . 2.1 111.139 -176.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.565 ' HB2' ' OG ' ' A' ' 32' ' ' SER . . . -60.22 90.57 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.944 -1.026 . . . . 1.64 110.489 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 162.5 -61.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.888 -1.051 . . . . 2.5 109.736 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 13.5 t70 165.71 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.918 -0.583 . . . . 4.56 111.406 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.677 HG11 ' O ' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -147.58 -159.51 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 110.083 -0.34 . . . . 3.73 110.083 178.708 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.703 HG12 ' HA2' ' A' ' 17' ' ' GLY . 13.0 m -146.91 109.78 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 113.426 0.898 . . . . 2.57 113.426 -178.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.475 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . 47.2 t 54.26 16.17 1.14 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.816 -0.629 . . . . 1.34 112.481 178.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.417 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 3.0 tt0 178.36 132.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.566 -0.453 . . . . 1.6 111.703 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.677 ' O ' HG11 ' A' ' 43' ' ' VAL . 91.7 t80 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.244 -0.884 . . . . 4.12 110.67 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.557 -0.217 . . . . 6.11 112.557 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.8 t -122.36 -52.14 1.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.766 0.317 . . . . 4.17 110.921 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 31' ' ' PRO . . . 175.55 -151.38 11.86 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.692 -0.766 . . . . 2.16 112.487 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.462 ' CB ' ' HB3' ' A' ' 27' ' ' ASP . 1.2 pp20? 44.88 26.15 0.19 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.925 0.393 . . . . 2.17 111.996 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.53 HG11 ' HD3' ' A' ' 7' ' ' LYS . 38.8 t -79.8 -11.91 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.042 -0.527 . . . . 0.87 112.357 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.578 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 10.3 t-20 43.22 81.53 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.496 0.665 . . . . 1.86 109.871 -178.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.53 ' HD3' HG11 ' A' ' 5' ' ' VAL . 62.3 pttt -150.95 -134.02 0.06 Allowed 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.667 -1.151 . . . . 2.42 109.499 -177.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.66 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -96.52 113.69 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 120.989 0.423 . . . . 2.03 110.512 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.793 HD12 ' HB2' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -151.06 167.92 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 119.524 -0.87 . . . . 3.89 112.221 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.716 ' H ' HD13 ' A' ' 9' ' ' ILE . . . -104.12 168.21 16.59 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.75 -0.659 . . . . 1.14 112.703 -178.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.66 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 1.2 p -153.94 103.96 2.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 1.69 111.589 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -157.8 102.15 1.83 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.239 -0.437 . . . . 3.7 110.956 178.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.707 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -110.76 -82.66 0.58 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 119.243 -0.983 . . . . 0.48 113.642 179.686 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.05 -56.72 0.2 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.194 0.442 . . . . 0.45 112.194 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.51 -40.72 2.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.408 -0.901 . . . . 0.72 112.422 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.53 -25.25 64.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.975 0.417 . . . . 2.82 110.301 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 43' ' ' VAL . . . -149.12 -45.92 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.511 -0.636 . . . . 0.8 111.511 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.537 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -131.07 152.59 50.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.767 -0.457 . . . . 0.51 109.767 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.5 ' HA ' ' H ' ' A' ' 13' ' ' THR . 2.8 ttt -163.01 31.68 0.1 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.202 1.186 . . . . 1.98 114.202 -178.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.628 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 35.5 mt-10 -150.64 -160.55 1.18 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 117.508 -1.234 . . . . 1.28 108.618 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 1.146 ' CE1' HD13 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -153.45 -79.35 0.1 Allowed 'General case' 0 C--O 1.204 -1.327 1 N-CA-C 122.151 4.13 . . . . 4.88 122.151 -175.797 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.146 HD13 ' CE1' ' A' ' 21' ' ' TYR . 3.9 tp -114.22 166.59 11.49 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 115.401 1.63 . . . . 4.63 115.401 -173.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.578 ' HB ' ' HA ' ' A' ' 6' ' ' ASN . 1.3 pp 23.75 -150.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 111.956 -2.383 . . . . 2.72 113.03 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.495 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER 63.07 16.56 9.42 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.038 -0.727 . . . . 2.6 109.038 -178.722 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.614 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.3 OUTLIER -152.24 31.14 0.54 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.154 0.502 . . . . 1.71 111.401 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt 17.08 74.55 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.332 1.605 . . . . 3.35 115.332 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.462 ' HB3' ' CB ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 39.16 67.58 0.43 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.6 0.963 . . . . 2.14 113.6 176.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.577 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -88.18 -62.24 1.44 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.524 -1.322 . . . . 0.86 109.953 177.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.549 ' CD2' ' CD2' ' A' ' 47' ' ' TYR . 48.3 t-80 -133.2 94.78 3.4 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 109.544 -0.539 . . . . 2.9 109.544 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 31' ' ' PRO . 18.1 t 37.52 98.14 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 113.873 1.064 . . . . 1.46 113.873 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.432 ' C ' ' O ' ' A' ' 30' ' ' SER . 52.9 Cg_exo -27.08 106.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.349 2.7 . . . . 0.79 110.896 176.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 21' ' ' TYR . 8.7 t -122.18 -149.85 0.44 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.421 -0.809 . . . . 0.95 112.309 -173.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.707 ' CD1' HG23 ' A' ' 13' ' ' THR . 6.9 t-105 -137.87 94.48 2.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.069 -1.826 . . . . 1.24 106.069 174.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.078 HG13 ' HD2' ' A' ' 35' ' ' PRO . 1.4 t -156.26 165.25 19.02 Favored Pre-proline 0 C--O 1.218 -0.553 0 CA-C-N 116.053 -0.521 . . . . 1.74 111.759 -176.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 1.078 ' HD2' HG13 ' A' ' 34' ' ' VAL . 14.5 Cg_exo -63.81 81.3 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.286 2.657 . . . . 1.52 116.039 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.3 t 63.73 28.27 14.86 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.019 0.438 . . . . 1.75 111.365 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.592 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 5.6 t -151.78 -127.31 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.802 -0.635 . . . . 1.49 110.563 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.592 ' CG ' ' C ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -175.8 102.34 0.07 Allowed 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.317 -1.364 . . . . 5.43 107.317 -177.856 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.804 HG22 HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -158.98 72.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.978 1.371 . . . . 2.1 108.679 -176.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.96 91.31 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.461 -1.7 . . . . 1.64 110.821 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 42' ' ' ASP . . . -166.36 -35.19 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.551 -1.204 . . . . 2.5 110.921 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 15.2 t70 80.86 30.19 0.17 Allowed 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.183 -0.462 . . . . 4.56 110.31 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.8 HG13 HG23 ' A' ' 44' ' ' VAL . 8.9 p -127.85 -3.53 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 112.885 0.698 . . . . 3.73 112.885 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.8 HG23 HG13 ' A' ' 43' ' ' VAL . 3.6 t -158.32 153.38 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.253 0.549 . . . . 2.57 111.787 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.502 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 18.6 p -93.57 21.67 6.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.343 -0.844 . . . . 1.34 111.179 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.484 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 12.4 tt0 -178.99 141.15 0.17 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 120.424 -0.51 . . . . 1.6 112.153 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.549 ' CD2' ' CD2' ' A' ' 29' ' ' HIS . 75.4 t80 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.268 -0.873 . . . . 4.12 110.762 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.448 -0.261 . . . . 6.11 112.448 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.1 t -120.21 -57.27 1.94 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.715 0.293 . . . . 4.17 110.934 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.961 ' HA2' HD12 ' A' ' 23' ' ' ILE . . . -103.26 -125.56 5.66 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.531 -0.842 . . . . 2.16 112.557 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 61.48 18.66 9.61 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.431 0.634 . . . . 2.17 111.583 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.748 ' HB ' HD11 ' A' ' 23' ' ' ILE . 23.2 t -107.08 -9.51 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.046 -0.524 . . . . 0.87 111.621 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 44.1 t-20 50.72 88.33 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.021 0.439 . . . . 1.86 110.177 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.446 ' O ' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -138.36 -147.77 0.24 Allowed 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.876 -0.787 . . . . 2.42 108.876 -178.295 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.3 OUTLIER -65.08 117.44 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 109.824 -0.435 . . . . 2.03 109.824 178.347 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.78 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -129.25 136.25 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 114.096 1.147 . . . . 3.89 114.096 -178.125 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -116.51 106.97 1.55 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 107.693 -2.163 . . . . 1.14 107.693 176.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.667 ' CB ' ' CD2' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -102.76 108.34 19.53 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 114.736 1.384 . . . . 1.69 114.736 -174.722 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -158.18 102.69 1.79 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 112.91 -1.95 . . . . 3.7 112.39 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.515 ' CB ' ' HA ' ' A' ' 19' ' ' MET . 0.2 OUTLIER -111.74 -82.29 0.58 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.25 -0.906 . . . . 0.48 112.478 178.638 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.429 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -140.61 -50.82 0.46 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.689 0.281 . . . . 0.45 111.416 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.455 ' CA ' ' HG3' ' A' ' 19' ' ' MET . . . 110.74 -44.41 1.51 Allowed Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.312 -0.947 . . . . 0.72 112.732 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -58.62 -24.98 62.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.229 0.538 . . . . 2.82 109.811 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.517 ' HA3' ' CB ' ' A' ' 43' ' ' VAL . . . -145.14 -69.32 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.519 -1.032 . . . . 0.8 110.519 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.656 ' HB1' ' HA ' ' A' ' 34' ' ' VAL . . . -105.18 150.46 25.06 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.407 -0.59 . . . . 0.51 109.407 178.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.515 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 2.4 tmm? -165.01 42.48 0.08 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 114.218 1.192 . . . . 1.98 114.218 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.614 ' HA ' ' OG ' ' A' ' 11' ' ' SER . 32.0 mt-10 -143.47 -147.8 0.22 Allowed 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 114.398 1.259 . . . . 1.28 114.398 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.724 ' CE2' ' CG1' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -113.27 -174.41 2.45 Favored 'General case' 0 CA--C 1.456 -2.659 0 C-N-CA 124.837 1.255 . . . . 4.88 112.097 -173.672 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.583 ' HB3' ' N ' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -127.39 78.64 1.83 Allowed 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 115.823 1.786 . . . . 4.63 115.823 175.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.961 HD12 ' HA2' ' A' ' 3' ' ' GLY . 4.6 tt 152.41 71.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.136 0 N-CA-C 113.75 1.019 . . . . 2.72 113.75 171.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.74 ' HB2' HG21 ' A' ' 9' ' ' ILE . 14.2 tt0 178.58 59.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.154 -0.475 . . . . 2.6 111.96 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.539 ' CD1' ' N ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -154.22 29.86 0.44 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.854 0.359 . . . . 1.71 110.898 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.465 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 9.6 mptt 55.17 22.54 4.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.217 -0.447 . . . . 3.35 110.816 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.43 ' HB2' ' HG3' ' A' ' 4' ' ' GLU . 16.1 t70 59.29 109.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.588 0.709 . . . . 2.14 111.617 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.568 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -121.08 -62.52 0.24 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 109.857 -1.297 . . . . 0.86 109.857 178.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.473 ' O ' ' CB ' ' A' ' 38' ' ' TYR . 39.7 m80 -135.17 94.45 3.13 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.605 -0.517 . . . . 2.9 109.605 177.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.46 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 15.5 m 39.99 102.69 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 113.338 0.866 . . . . 1.46 113.338 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 14.8 Cg_exo -25.69 125.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.877 3.052 . . . . 0.79 109.705 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.549 ' C ' ' HB3' ' A' ' 22' ' ' LEU . 3.8 t -154.19 138.95 17.05 Favored 'General case' 0 C--O 1.21 -0.989 0 N-CA-C 114.62 1.341 . . . . 0.95 114.62 -171.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.583 ' N ' ' HB3' ' A' ' 22' ' ' LEU . 5.5 t-105 -83.6 96.58 8.69 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.593 -2.373 . . . . 1.24 104.593 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.016 HG12 ' HD3' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -150.88 -159.73 0.04 OUTLIER Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-N 113.271 -1.786 . . . . 1.74 107.631 -175.613 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 1.016 ' HD3' HG12 ' A' ' 34' ' ' VAL . 60.5 Cg_endo -95.25 99.01 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 122.708 2.003 . . . . 1.52 116.683 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.45 ' H ' ' CG ' ' A' ' 20' ' ' GLU . 47.0 t 55.18 16.79 1.74 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.709 -0.678 . . . . 1.75 112.223 176.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.557 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 50.4 m -162.76 -109.65 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 120.402 -0.519 . . . . 1.49 111.48 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.568 ' OH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -177.71 102.07 0.05 OUTLIER 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 106.645 -1.613 . . . . 5.43 106.645 -176.713 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.71 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -159.05 71.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.418 -0.81 . . . . 2.1 110.199 -176.078 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.65 91.6 5.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.974 -1.012 . . . . 1.64 110.676 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.8 -43.74 0.15 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.999 -1.001 . . . . 2.5 109.964 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.799 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.8 m-20 -142.53 -74.14 0.29 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.841 -0.618 . . . . 4.56 111.242 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 175.46 74.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.234 -0.439 . . . . 3.73 111.354 -178.375 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 35' ' ' PRO . 24.0 t -133.84 150.33 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 120.957 -0.297 . . . . 2.57 111.757 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.552 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 45.4 t -68.07 1.79 2.53 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.372 1.249 . . . . 1.34 114.372 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.477 ' N ' HG21 ' A' ' 39' ' ' ILE . 38.0 tt0 -179.59 155.67 0.67 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.607 0.242 . . . . 1.6 110.695 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.425 ' N ' ' HB ' ' A' ' 39' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.186 -0.911 . . . . 4.12 110.47 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 112.487 -0.245 . . . . 6.11 112.487 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m -101.36 -62.15 1.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.756 0.312 . . . . 4.17 110.731 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.55 ' HA2' HG23 ' A' ' 23' ' ' ILE . . . 93.97 155.14 31.56 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.634 -0.793 . . . . 2.16 112.671 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.522 ' CG ' ' HB3' ' A' ' 27' ' ' ASP . 1.1 tm-20 51.16 54.27 11.48 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 122.549 1.166 . . . . 2.17 109.268 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 3' ' ' GLY . 12.0 t -131.42 -24.25 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.033 -0.985 . . . . 0.87 112.49 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 50.96 78.26 0.11 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.188 -0.671 . . . . 1.86 109.188 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.463 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -138.39 -98.16 0.18 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.844 0.683 . . . . 2.42 112.844 -176.941 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 8' ' ' ILE . 2.3 tp -137.69 114.03 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 109.765 -0.457 . . . . 2.03 109.765 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 1.036 HG23 ' CE2' ' A' ' 21' ' ' TYR . 6.4 tp -150.03 165.06 3.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.315 -0.402 . . . . 3.89 111.987 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.496 ' N ' HG13 ' A' ' 9' ' ' ILE . . . -111.57 115.99 4.05 Favored Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.0 -1.24 . . . . 1.14 110.0 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.823 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -101.11 106.36 17.61 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 123.063 1.411 . . . . 1.69 112.819 -174.497 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -157.93 109.02 2.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 111.723 -2.49 . . . . 3.7 111.987 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.524 ' HB ' ' HA ' ' A' ' 19' ' ' MET . 3.2 m -115.24 -80.92 0.6 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.703 0.631 . . . . 0.48 112.703 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.69 -59.92 0.33 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.341 0.497 . . . . 0.45 112.341 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.11 -41.53 1.77 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.64 -0.791 . . . . 0.72 112.472 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.19 -26.67 65.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.025 0.44 . . . . 2.82 110.138 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -150.77 -50.75 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.75 -0.659 . . . . 0.8 111.577 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.66 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -117.52 152.33 35.3 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.153 -0.684 . . . . 0.51 109.153 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.557 ' N ' ' HG3' ' A' ' 35' ' ' PRO . 3.4 ttt -169.74 34.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 115.387 1.625 . . . . 1.98 115.387 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.816 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 7.2 mt-10 -141.09 -122.25 0.1 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 119.198 -1.001 . . . . 1.28 111.982 176.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 1.036 ' CE2' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -154.74 -117.47 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 117.996 2.591 . . . . 4.88 117.996 -175.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.935 ' O ' HG21 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -152.67 168.89 24.15 Favored 'General case' 0 N--CA 1.424 -1.774 0 O-C-N 121.398 -0.814 . . . . 4.63 110.497 -178.591 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.801 HD11 ' HB ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER 47.43 58.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.874 -0.603 . . . . 2.72 111.38 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.515 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 0.3 OUTLIER -168.03 28.72 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.088 -0.506 . . . . 2.6 112.23 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.874 ' CH2' HG13 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -142.86 31.24 1.43 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.862 0.363 . . . . 1.71 110.245 177.32 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.406 ' O ' ' OD2' ' A' ' 27' ' ' ASP . 7.4 mtpm? 47.85 38.8 9.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 3.35 110.183 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.522 ' HB3' ' CG ' ' A' ' 4' ' ' GLU . 1.3 p30 53.88 38.83 29.56 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.554 -0.748 . . . . 2.14 110.985 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -43.41 -70.13 0.57 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.838 -0.696 . . . . 0.86 111.659 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.497 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -132.9 100.23 4.84 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 120.877 -0.329 . . . . 2.9 110.349 178.175 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.475 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 19.5 m 38.83 103.32 0.02 OUTLIER Pre-proline 0 C--O 1.218 -0.562 0 N-CA-C 114.095 1.146 . . . . 1.46 114.095 176.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.482 ' HB3' ' CA ' ' A' ' 3' ' ' GLY . 25.6 Cg_exo -25.21 138.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.966 3.111 . . . . 0.79 112.518 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.655 ' HB2' ' CD2' ' A' ' 38' ' ' TYR . 43.7 t -152.36 -155.85 0.65 Allowed 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 113.362 0.875 . . . . 0.95 113.362 -175.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.516 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 48.6 t-105 -139.3 95.0 2.86 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 101.524 -3.51 . . . . 1.24 101.524 172.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.05 HG11 ' HA ' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -154.42 163.73 23.22 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 114.086 -1.415 . . . . 1.74 109.745 -171.336 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.912 ' HD2' HG23 ' A' ' 34' ' ' VAL . 24.0 Cg_exo -62.81 -11.12 22.57 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.542 2.828 . . . . 1.52 118.379 -175.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 35' ' ' PRO . 1.9 m 157.98 31.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 114.051 1.13 . . . . 1.75 114.051 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.524 ' N ' ' CE3' ' A' ' 25' ' ' TRP . 37.8 m -176.55 -85.86 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.02 0.438 . . . . 1.49 110.126 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 1.05 ' HA ' HG11 ' A' ' 34' ' ' VAL . 29.4 t80 -177.96 152.75 0.77 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.757 -0.656 . . . . 5.43 110.602 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.854 HG21 ' O ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER 175.55 73.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.869 0.366 . . . . 2.1 110.197 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.553 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . . . -66.46 91.94 0.19 Allowed 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.98 -0.688 . . . . 1.64 110.618 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 172.06 -31.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.51 -0.768 . . . . 2.5 110.95 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 17.7 t70 75.9 28.92 0.84 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.043 -0.526 . . . . 4.56 110.963 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.486 ' O ' HG12 ' A' ' 43' ' ' VAL . 47.0 t -119.71 -9.15 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.222 -0.444 . . . . 3.73 112.142 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.854 ' O ' HG21 ' A' ' 39' ' ' ILE . 11.2 t -145.41 162.97 12.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.389 0.138 . . . . 2.57 110.899 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.567 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 78.1 p -97.64 17.39 17.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.397 -0.365 . . . . 1.34 111.761 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' TYR . 0.7 OUTLIER 178.39 140.46 0.09 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 120.696 -0.402 . . . . 1.6 111.632 -179.276 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 38' ' ' TYR . 7.5 t80 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.234 -0.888 . . . . 4.12 111.052 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.491 -0.244 . . . . 6.11 112.491 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.7 p 50.48 45.83 26.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.864 0.364 . . . . 4.17 110.922 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.22 163.24 29.4 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.756 -0.735 . . . . 2.16 112.489 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.545 ' HA ' ' CD1' ' A' ' 23' ' ' ILE . 1.6 tt0 60.27 14.71 4.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.281 0.562 . . . . 2.17 111.404 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -91.18 -21.77 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.648 -0.501 . . . . 0.87 109.648 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.478 ' ND2' ' HA ' ' A' ' 24' ' ' GLU . 34.5 t-20 58.45 80.23 0.19 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.881 -0.6 . . . . 1.86 109.476 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.453 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 17.8 pttp -147.75 -140.39 0.1 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.037 -0.983 . . . . 2.42 108.423 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.643 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -67.79 132.34 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.467 -0.938 . . . . 2.03 108.467 177.195 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.643 ' N ' HD13 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -148.7 173.19 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 113.965 1.098 . . . . 3.89 113.965 -176.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.68 159.51 21.55 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 113.545 -1.661 . . . . 1.14 110.388 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.547 ' HB2' ' CB ' ' A' ' 20' ' ' GLU . 2.8 p -154.79 103.71 2.45 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.319 0.859 . . . . 1.69 113.319 -177.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.1 ttp-105 -161.68 98.41 1.1 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.504 0.928 . . . . 3.7 113.504 176.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.71 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -110.54 -81.3 0.58 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 119.031 -1.068 . . . . 0.48 113.521 176.005 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -151.16 -57.44 0.16 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.645 0.609 . . . . 0.45 112.645 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . 125.14 -41.6 1.66 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.0 -0.619 . . . . 0.72 111.771 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -72.76 -9.39 58.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.767 0.318 . . . . 2.82 111.26 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 43' ' ' VAL . . . -151.55 -55.47 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.216 -1.154 . . . . 0.8 110.216 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.792 ' HB2' HD11 ' A' ' 39' ' ' ILE . . . -131.52 153.04 50.22 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 108.774 -0.825 . . . . 0.51 108.774 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.527 ' N ' ' HG3' ' A' ' 35' ' ' PRO . 2.6 ttt -154.33 11.06 0.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.969 1.1 . . . . 1.98 113.969 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.745 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 14.8 mt-10 -151.55 -177.82 6.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.484 -0.932 . . . . 1.28 108.484 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.718 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -157.87 9.35 0.17 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.258 0.836 . . . . 4.88 113.258 178.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.643 ' HA ' HG21 ' A' ' 9' ' ' ILE . 3.6 pp -87.23 128.5 35.15 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 115.343 1.609 . . . . 4.63 115.343 -175.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.763 HD12 ' CD1' ' A' ' 25' ' ' TRP . 0.4 OUTLIER -42.02 -104.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 112.508 -2.133 . . . . 2.72 108.522 173.704 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.522 ' H ' HG23 ' A' ' 23' ' ' ILE . 7.4 tp10 34.72 30.15 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.609 1.095 . . . . 2.6 112.561 177.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.763 ' CD1' HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -134.53 32.29 3.35 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.068 -0.515 . . . . 1.71 111.052 -178.284 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 50.95 29.4 4.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.873 -0.603 . . . . 3.35 111.167 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.415 ' HB3' ' CB ' ' A' ' 4' ' ' GLU . 4.2 p30 43.64 38.07 1.79 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.524 . . . . 2.14 111.696 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.685 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -47.94 -57.4 7.83 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.547 -0.835 . . . . 0.86 112.287 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.576 ' HB2' ' CD1' ' A' ' 38' ' ' TYR . 76.2 m80 -133.65 92.17 2.94 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.245 -0.65 . . . . 2.9 109.245 178.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 29' ' ' HIS . 22.7 t 39.62 117.71 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 116.082 1.882 . . . . 1.46 116.082 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 4' ' ' GLU . 11.1 Cg_exo -32.88 95.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.95 3.1 . . . . 0.79 107.953 172.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 30' ' ' SER . 18.3 m -117.21 173.34 6.74 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 114.463 1.283 . . . . 0.95 114.463 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.71 ' CD1' HG23 ' A' ' 13' ' ' THR . 7.4 t-105 -104.08 100.49 10.24 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 105.314 -2.106 . . . . 1.24 105.314 176.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.945 ' CG2' HG23 ' A' ' 39' ' ' ILE . 4.4 p -151.39 158.98 34.15 Favored Pre-proline 0 C--O 1.204 -1.309 0 CA-C-N 114.19 -1.368 . . . . 1.74 111.417 -173.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.738 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 50.3 Cg_exo -61.48 -6.43 7.0 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 124.07 3.18 . . . . 1.52 115.712 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m 172.2 -12.91 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.182 1.179 . . . . 1.75 114.182 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.945 ' C ' HG11 ' A' ' 34' ' ' VAL . 73.9 m -138.75 -87.49 0.23 Allowed 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 118.816 0.734 . . . . 1.49 112.138 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.685 ' OH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -177.05 102.47 0.05 Allowed 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.223 -1.029 . . . . 5.43 108.223 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.945 HG23 ' CG2' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -127.68 59.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 122.746 1.26 . . . . 2.1 110.583 -174.578 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -55.0 92.63 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 113.852 -1.522 . . . . 1.64 110.934 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 164.95 -29.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 113.966 -1.47 . . . . 2.5 109.177 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 77.15 54.82 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.434 -0.803 . . . . 4.56 111.856 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 43' ' ' VAL . 3.4 t -154.76 23.77 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 112.643 0.608 . . . . 3.73 112.643 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 39' ' ' ILE . 2.4 t -157.88 152.32 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 113.083 0.771 . . . . 2.57 113.083 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.633 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 39.0 t -82.44 -2.71 54.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.747 -0.66 . . . . 1.34 111.409 177.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.474 ' HG2' ' CB ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 176.51 153.71 0.2 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.233 0.457 . . . . 1.6 112.233 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.487 ' CB ' ' O ' ' A' ' 38' ' ' TYR . 36.6 t80 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.26 -0.876 . . . . 4.12 110.754 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.771 -0.132 . . . . 6.11 112.771 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.5 p -101.26 -77.49 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.976 0.417 . . . . 4.17 110.691 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.565 ' O ' HG23 ' A' ' 5' ' ' VAL . . . 131.95 -116.68 1.91 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.834 -0.698 . . . . 2.16 112.554 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.478 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.0 OUTLIER 53.66 20.57 2.24 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.66 0.743 . . . . 2.17 109.536 -178.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 3' ' ' GLY . 17.4 t -98.61 -19.55 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.656 -0.702 . . . . 0.87 111.0 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.557 HD21 ' C ' ' A' ' 6' ' ' ASN . 0.1 OUTLIER 62.88 62.35 1.06 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.929 0.871 . . . . 1.86 108.851 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.449 ' HG3' HG22 ' A' ' 8' ' ' ILE . 18.1 ptmt -134.99 -133.34 0.16 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.13 -1.395 . . . . 2.42 108.272 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 8' ' ' ILE . 6.8 tp -45.45 105.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.341 0 N-CA-C 109.213 -0.662 . . . . 2.03 109.213 177.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.894 ' CG2' HD23 ' A' ' 22' ' ' LEU . 1.4 pt -104.03 109.63 27.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 113.757 1.021 . . . . 3.89 113.757 -176.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 22' ' ' LEU . . . -107.61 139.01 14.85 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 108.685 -1.766 . . . . 1.14 108.685 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.648 ' HA ' ' H ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -153.53 109.34 3.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 114.66 1.356 . . . . 1.69 114.66 -175.07 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.47 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 15.0 tpt180 -158.61 100.0 1.6 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.029 -0.668 . . . . 3.7 112.361 177.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.556 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -117.24 -79.48 0.59 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 119.406 -0.918 . . . . 0.48 113.326 178.688 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.45 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -149.15 -59.35 0.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.721 -0.392 . . . . 0.45 112.022 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 19' ' ' MET . . . 118.33 -50.55 0.8 Allowed Glycine 0 C--N 1.329 0.162 0 C-N-CA 119.906 -1.14 . . . . 0.72 112.617 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -58.38 -21.1 49.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.047 0.451 . . . . 2.82 109.971 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.454 ' HA3' ' CG2' ' A' ' 43' ' ' VAL . . . -143.71 -57.2 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.862 -0.608 . . . . 0.8 111.875 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.671 ' HA ' ' HB3' ' A' ' 35' ' ' PRO . . . -129.21 149.82 50.85 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.616 -0.883 . . . . 0.51 108.616 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.546 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -167.51 20.7 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 116.629 2.085 . . . . 1.98 116.629 -178.277 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 34' ' ' VAL . 2.8 mt-10 -154.68 98.67 2.09 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 118.928 0.786 . . . . 1.28 112.044 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.674 ' HB2' ' CG ' ' A' ' 33' ' ' TRP . 3.0 t80 -79.13 8.1 6.38 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 113.486 0.921 . . . . 4.88 113.486 -177.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.894 HD23 ' CG2' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -89.16 130.37 35.6 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 116.095 1.887 . . . . 4.63 116.095 -176.848 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.73 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -47.77 -137.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 111.758 -2.473 . . . . 2.72 112.118 174.825 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.414 ' HA ' ' OD1' ' A' ' 6' ' ' ASN . 33.1 tt0 60.27 16.5 6.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 120.934 -1.104 . . . . 2.6 109.698 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.73 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -112.15 31.26 6.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.287 0.565 . . . . 1.71 110.423 179.486 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.5 OUTLIER 57.95 28.38 16.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.384 -0.826 . . . . 3.35 111.941 177.698 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.471 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 4.6 p-10 44.87 32.15 0.78 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.751 0.31 . . . . 2.14 111.346 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.775 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -47.82 -59.94 5.78 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.498 -0.858 . . . . 0.86 112.285 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.592 ' HB2' ' CD1' ' A' ' 38' ' ' TYR . 56.7 m80 -134.89 91.3 2.74 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 119.897 -0.721 . . . . 2.9 109.618 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 29' ' ' HIS . 24.2 t 42.22 120.16 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 115.68 1.733 . . . . 1.46 115.68 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.478 ' HD3' ' CB ' ' A' ' 4' ' ' GLU . 2.9 Cg_exo -38.05 101.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 122.86 2.374 . . . . 0.79 107.425 172.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.57 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 68.7 m -124.0 155.82 37.56 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-N 115.176 -0.92 . . . . 0.95 112.81 -172.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.674 ' CG ' ' HB2' ' A' ' 21' ' ' TYR . 6.8 t-105 -90.29 92.81 9.08 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.43 -2.433 . . . . 1.24 104.43 176.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.041 HG12 ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -155.05 -166.46 0.15 Allowed Pre-proline 0 C--O 1.186 -2.272 0 CA-C-N 115.354 -0.839 . . . . 1.74 112.258 -173.115 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 1.041 ' HD3' HG12 ' A' ' 34' ' ' VAL . 65.6 Cg_endo -95.67 105.78 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.108 0 CA-C-N 122.566 1.952 . . . . 1.52 116.278 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.439 ' H ' ' HB2' ' A' ' 20' ' ' GLU . 29.4 t 37.48 30.08 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.293 0.568 . . . . 1.75 111.359 177.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.539 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 1.3 m -168.4 -130.31 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.059 -0.973 . . . . 1.49 108.922 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.775 ' OH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -173.17 100.9 0.12 Allowed 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 106.562 -1.644 . . . . 5.43 106.562 -178.006 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.806 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -121.95 31.8 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.526 -0.761 . . . . 2.1 112.245 -174.137 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -55.69 93.05 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.743 -0.783 . . . . 1.64 111.415 -176.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 163.08 -30.1 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 114.192 -1.367 . . . . 2.5 109.404 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.513 ' O ' HG12 ' A' ' 39' ' ' ILE . 4.8 p-10 -177.3 104.19 0.05 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.863 -0.608 . . . . 4.56 111.009 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.723 ' HA ' HD11 ' A' ' 39' ' ' ILE . 23.0 m -51.05 126.82 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.098 -0.501 . . . . 3.73 112.276 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 44' ' ' VAL . 5.1 p -173.66 34.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.519 0 N-CA-C 114.615 1.339 . . . . 2.57 114.615 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.579 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 30.1 t 68.41 2.9 3.52 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 114.373 1.249 . . . . 1.34 114.373 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 36.4 tt0 179.37 153.01 0.42 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.827 0.677 . . . . 1.6 112.827 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.574 ' CD2' ' CE1' ' A' ' 29' ' ' HIS . 17.3 t80 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.23 -0.89 . . . . 4.12 110.939 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.436 -0.266 . . . . 6.11 112.436 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.0 t -177.33 39.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.918 0.389 . . . . 4.17 110.718 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.587 ' O ' HG23 ' A' ' 5' ' ' VAL . . . 113.32 -176.08 17.07 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.912 -0.661 . . . . 2.16 112.222 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.494 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER 51.65 22.2 1.54 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.638 0.732 . . . . 2.17 110.044 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 3' ' ' GLY . 2.9 t -104.54 -17.14 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.72 -0.673 . . . . 0.87 111.137 -179.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.592 HD21 ' C ' ' A' ' 6' ' ' ASN . 0.1 OUTLIER 61.17 66.17 0.91 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.998 -0.742 . . . . 1.86 108.998 -178.781 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' HG2' HD11 ' A' ' 23' ' ' ILE . 19.8 pttp -150.72 -146.96 0.21 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.05 -0.523 . . . . 2.42 109.65 -178.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -47.59 98.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 121.956 0.884 . . . . 2.03 111.525 178.669 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.865 HD11 ' CZ ' ' A' ' 21' ' ' TYR . 3.4 tp -152.85 170.07 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.659 -0.701 . . . . 3.89 110.177 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -130.76 168.6 21.76 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.88 -0.676 . . . . 1.14 112.113 -175.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.506 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 35.4 p -148.24 103.57 3.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 113.398 0.888 . . . . 1.69 113.398 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.431 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 51.0 ttp180 -159.96 101.6 1.45 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.003 -0.544 . . . . 3.7 111.254 176.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.612 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -115.45 -84.81 0.62 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.532 0.938 . . . . 0.48 113.532 179.237 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.6 -55.72 0.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.425 -0.51 . . . . 0.45 112.357 -178.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.81 -34.14 4.48 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.342 -0.933 . . . . 0.72 112.489 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.19 -29.38 67.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.206 0.527 . . . . 2.82 109.763 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 35' ' ' PRO . . . -150.44 -41.23 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.422 -0.808 . . . . 0.8 111.879 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.532 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . . . -130.54 151.2 51.27 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.449 -0.575 . . . . 0.51 109.449 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.475 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 4.7 ttp -163.17 27.71 0.09 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.705 1.002 . . . . 1.98 113.705 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 20.4 mt-10 -151.4 -179.71 7.61 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.516 -0.55 . . . . 1.28 109.516 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.865 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 2.8 t80 -159.66 11.09 0.12 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.57 0.952 . . . . 4.88 113.57 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.623 ' HB2' ' CG2' ' A' ' 9' ' ' ILE . 2.4 pt? -86.66 120.76 28.31 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 117.327 2.343 . . . . 4.63 117.327 -176.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.738 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 5.7 pt -55.49 -15.02 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 111.967 -2.379 . . . . 2.72 110.497 174.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.559 ' CB ' HD12 ' A' ' 22' ' ' LEU . 29.4 tp10 -39.14 -27.57 0.02 OUTLIER 'General case' 0 C--N 1.344 0.332 0 CA-C-N 116.065 -0.516 . . . . 2.6 110.682 177.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.738 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -57.58 -163.19 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.803 -0.814 . . . . 1.71 108.803 176.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -107.41 44.76 1.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.449 -0.782 . . . . 3.35 111.379 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.455 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 3.5 p30 42.01 28.51 0.1 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.268 -0.424 . . . . 2.14 111.585 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.779 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -53.57 -55.53 24.59 Favored Glycine 0 CA--C 1.507 -0.422 0 C-N-CA 120.202 -0.999 . . . . 0.86 111.797 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.598 ' HB2' ' CD1' ' A' ' 38' ' ' TYR . 72.8 m80 -134.1 92.8 2.99 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 119.882 -0.727 . . . . 2.9 110.322 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 29' ' ' HIS . 17.0 m 41.62 119.45 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 116.54 2.052 . . . . 1.46 116.54 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.537 ' HB3' HG22 ' A' ' 23' ' ' ILE . 12.5 Cg_exo -34.25 97.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 123.493 2.795 . . . . 0.79 107.856 170.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.611 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 67.2 m -121.06 155.16 35.01 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 114.263 1.209 . . . . 0.95 114.263 -172.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.64 ' CE3' ' CD2' ' A' ' 21' ' ' TYR . 6.7 t-105 -90.75 91.37 8.35 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 104.107 -2.553 . . . . 1.24 104.107 175.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.903 HG12 ' CD ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -155.76 177.79 1.91 Allowed Pre-proline 0 C--O 1.215 -0.74 0 CA-C-N 114.896 -1.047 . . . . 1.74 110.974 -174.736 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.903 ' CD ' HG12 ' A' ' 34' ' ' VAL . 28.8 Cg_endo -86.34 111.86 1.07 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.879 2.386 . . . . 1.52 116.651 -174.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.7 t 49.69 19.37 0.4 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.555 -1.202 . . . . 1.75 113.079 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.553 ' N ' ' CE3' ' A' ' 25' ' ' TRP . 11.7 t -173.4 -108.15 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.205 -0.598 . . . . 1.49 111.597 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.779 ' OH ' ' HA3' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -176.3 116.59 0.12 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.446 -1.687 . . . . 5.43 106.446 -177.578 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.798 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -141.51 31.42 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.772 0.796 . . . . 2.1 111.008 -174.753 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -59.59 89.82 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.069 -0.969 . . . . 1.64 110.636 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 157.02 39.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.138 -0.937 . . . . 2.5 110.763 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 t70 56.67 85.41 0.08 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.816 0.302 . . . . 4.56 111.816 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.605 HG11 ' OXT' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -153.94 -159.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 110.083 -0.34 . . . . 3.73 110.083 179.113 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.639 ' N ' HD12 ' A' ' 39' ' ' ILE . 7.4 p -157.27 118.58 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 113.557 0.947 . . . . 2.57 113.557 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.451 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 54.5 p 65.99 4.77 3.17 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 114.696 -1.138 . . . . 1.34 113.757 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 45' ' ' SER . 39.0 tt0 179.38 154.03 0.46 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.099 0.476 . . . . 1.6 111.671 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.605 ' OXT' HG11 ' A' ' 43' ' ' VAL . 50.9 t80 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.243 -0.884 . . . . 4.12 110.991 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.541 -0.224 . . . . 6.11 112.541 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.9 p -79.71 152.19 30.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.868 0.366 . . . . 4.17 110.757 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 31' ' ' PRO . . . 105.82 152.18 20.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.677 -0.773 . . . . 2.16 112.427 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.603 ' HA ' HD13 ' A' ' 23' ' ' ILE . 2.7 tm-20 65.46 9.03 5.45 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.868 0.366 . . . . 2.17 111.891 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.525 ' O ' ' ND2' ' A' ' 6' ' ' ASN . 10.1 t -91.39 -36.18 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 122.017 0.913 . . . . 0.87 108.85 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER 68.65 87.45 0.12 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.678 -1.601 . . . . 1.86 111.329 179.014 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.474 ' O ' HG23 ' A' ' 9' ' ' ILE . 21.4 ptmt -150.31 -144.4 0.15 Allowed 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.995 -1.113 . . . . 2.42 107.995 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.495 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -55.03 118.44 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.006 -0.368 . . . . 2.03 110.006 178.57 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.8 HG22 ' HB3' ' A' ' 22' ' ' LEU . 36.6 pt -111.27 136.79 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 114.751 1.389 . . . . 3.89 114.751 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.8 146.43 16.67 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 106.86 -2.496 . . . . 1.14 106.86 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.626 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.6 OUTLIER -153.13 105.94 2.95 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 118.781 1.291 . . . . 1.69 113.408 -175.728 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -156.3 102.82 2.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.995 -0.548 . . . . 3.7 111.104 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.688 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -121.97 -80.74 0.63 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 119.599 -0.84 . . . . 0.48 112.993 179.402 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.442 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -150.05 -57.75 0.19 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.437 -0.505 . . . . 0.45 112.172 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.405 ' HA2' ' HB2' ' A' ' 19' ' ' MET . . . 119.04 -42.34 1.8 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.538 -0.839 . . . . 0.72 112.158 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -59.38 -33.89 71.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.169 0.509 . . . . 2.82 110.135 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.45 -48.72 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.568 -0.742 . . . . 0.8 111.493 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.537 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -130.55 150.13 51.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.86 -0.422 . . . . 0.51 109.86 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.487 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -163.9 30.08 0.08 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.062 1.134 . . . . 1.98 114.062 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.626 ' HA ' ' HB2' ' A' ' 11' ' ' SER . 11.1 mt-10 -148.79 -171.9 3.98 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.287 -1.005 . . . . 1.28 108.287 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.63 ' HB2' ' CD2' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -154.02 -57.5 0.12 Allowed 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 119.217 3.043 . . . . 4.88 119.217 -176.056 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.8 ' HB3' HG22 ' A' ' 9' ' ' ILE . 8.4 mt -81.24 148.04 29.67 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 118.034 -1.466 . . . . 4.63 114.705 -171.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.621 HD12 ' CD1' ' A' ' 25' ' ' TRP . 3.2 tp -13.23 -105.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 110.818 -2.901 . . . . 2.72 114.07 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.643 ' HG3' HD13 ' A' ' 9' ' ' ILE . 8.1 mm-40 42.82 25.85 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 119.39 0.996 . . . . 2.6 111.349 -177.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.621 ' CD1' HD12 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -136.53 29.01 2.98 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 116.133 -0.485 . . . . 1.71 111.289 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 40.35 30.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 3.35 112.133 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.434 ' HB2' ' CG ' ' A' ' 4' ' ' GLU . 23.8 t70 63.51 34.11 12.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.008 0.432 . . . . 2.14 110.312 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 25' ' ' TRP . . . -45.37 -63.76 2.57 Favored Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 111.045 -0.822 . . . . 0.86 111.045 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.522 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -133.44 109.12 9.09 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 109.047 -0.723 . . . . 2.9 109.047 177.663 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.446 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 48.1 m 31.0 103.3 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 114.994 1.479 . . . . 1.46 114.994 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.441 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 13.4 Cg_exo -29.87 120.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.257 0 C-N-CA 123.093 2.529 . . . . 0.79 111.372 176.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.652 ' HB2' ' CD2' ' A' ' 38' ' ' TYR . 17.9 t -143.34 -163.72 1.71 Allowed 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 114.345 1.239 . . . . 0.95 114.345 -174.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.688 ' CD1' HG23 ' A' ' 13' ' ' THR . 4.5 t-105 -123.11 93.11 3.85 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 106.349 -1.722 . . . . 1.24 106.349 175.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.956 HG21 HG23 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -159.85 178.27 1.74 Allowed Pre-proline 0 C--O 1.22 -0.47 0 CA-C-N 115.356 -0.838 . . . . 1.74 111.01 -177.72 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.676 ' HD2' HG13 ' A' ' 34' ' ' VAL . 6.4 Cg_endo -95.51 137.27 0.72 Allowed 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.939 3.093 . . . . 1.52 112.444 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 10.7 t 79.83 -62.17 0.27 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.454 0.909 . . . . 1.75 113.454 177.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.611 ' HA ' ' CE3' ' A' ' 25' ' ' TRP . 47.5 t -150.54 -56.89 0.17 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.556 1.317 . . . . 1.49 114.556 -177.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.718 ' CA ' HG11 ' A' ' 34' ' ' VAL . 14.4 t80 176.97 152.04 0.19 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.799 -0.445 . . . . 5.43 109.799 -176.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.956 HG23 HG21 ' A' ' 34' ' ' VAL . 0.6 OUTLIER 175.86 67.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.9 0.857 . . . . 2.1 108.851 -179.621 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.557 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . . . -59.66 92.76 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.151 -0.931 . . . . 1.64 111.082 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 174.14 -31.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.337 -0.847 . . . . 2.5 110.983 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 74.08 23.94 2.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.075 -0.511 . . . . 4.56 110.807 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.82 -25.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 3.73 111.211 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.781 ' O ' HG21 ' A' ' 39' ' ' ILE . 3.5 t -136.07 165.02 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.955 0.407 . . . . 2.57 111.118 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.549 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 29.6 t -96.38 25.46 4.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.873 -0.603 . . . . 1.34 110.689 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -179.72 149.05 0.35 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.437 -0.347 . . . . 1.6 110.996 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.522 ' HB3' ' CD2' ' A' ' 29' ' ' HIS . 10.3 t80 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.212 -0.899 . . . . 4.12 110.944 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.368 -0.293 . . . . 6.11 112.368 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.7 t -140.39 108.35 5.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.901 0.381 . . . . 4.17 111.024 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.48 ' CA ' ' CD1' ' A' ' 23' ' ' ILE . . . 146.86 -148.26 19.77 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.795 -0.716 . . . . 2.16 112.424 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.475 ' HB3' ' HG3' ' A' ' 31' ' ' PRO . 0.0 OUTLIER 78.0 -13.49 0.95 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.144 0.794 . . . . 2.17 113.144 179.484 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 6' ' ' ASN . 11.3 t -77.71 -51.29 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 121.454 0.645 . . . . 0.87 111.12 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 1.015 ' N ' HG21 ' A' ' 23' ' ' ILE . 1.1 m-20 99.11 82.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.362 -1.29 . . . . 1.86 109.669 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.427 ' HG3' HG22 ' A' ' 8' ' ' ILE . 12.9 pttp -150.61 -131.23 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.42 -1.264 . . . . 2.42 108.75 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.648 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -47.06 113.83 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 118.306 0.503 . . . . 2.03 109.824 177.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.642 HG22 ' C ' ' A' ' 22' ' ' LEU . 3.1 pt -124.8 116.49 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 114.793 1.405 . . . . 3.89 114.793 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.634 ' H ' HD12 ' A' ' 22' ' ' LEU . . . -101.72 144.54 16.43 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 107.055 -2.418 . . . . 1.14 107.055 174.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.616 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 15.9 p -155.11 104.38 2.45 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.934 1.087 . . . . 1.69 113.934 -175.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.27 98.22 1.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.944 -0.571 . . . . 3.7 109.881 176.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.754 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -102.89 -82.16 0.49 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 119.385 -0.926 . . . . 0.48 112.901 179.533 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -142.69 -65.78 0.39 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.692 0.627 . . . . 0.45 112.692 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . 126.19 -35.05 3.07 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.099 -0.8 . . . . 0.72 111.099 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -66.78 -30.52 70.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.27 0.557 . . . . 2.82 109.61 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.783 ' HA2' HG12 ' A' ' 44' ' ' VAL . . . -145.47 -49.1 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.272 -0.876 . . . . 0.8 111.686 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.589 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . . . -118.49 151.55 37.62 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 119.701 -0.19 . . . . 0.51 110.597 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.463 ' HA ' ' H ' ' A' ' 13' ' ' THR . 0.2 OUTLIER -160.36 27.03 0.16 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.886 1.439 . . . . 1.98 114.886 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.682 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 12.3 mt-10 -151.1 -174.4 4.79 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.56 -0.533 . . . . 1.28 109.56 177.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.616 ' HB3' ' HA ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -153.08 -72.55 0.14 Allowed 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 118.815 2.894 . . . . 4.88 118.815 -177.185 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.642 ' C ' HG22 ' A' ' 9' ' ' ILE . 33.7 mt -82.92 143.09 30.96 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 114.749 1.389 . . . . 4.63 114.749 -172.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.015 HG21 ' N ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER 17.37 -148.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 111.522 -2.581 . . . . 2.72 113.751 -179.297 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER 83.15 -5.88 1.23 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.902 -0.407 . . . . 2.6 109.902 -178.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 1.119 ' CH2' HG13 ' A' ' 34' ' ' VAL . 1.3 p90 -121.98 28.57 7.49 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 120.861 -0.336 . . . . 1.71 111.023 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.8 tttt 29.18 62.93 0.14 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.223 0.823 . . . . 3.35 113.223 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.453 ' HB3' ' CG ' ' A' ' 4' ' ' GLU . 3.9 p30 45.61 27.4 0.42 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.753 0.311 . . . . 2.14 111.631 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -49.48 -65.9 2.54 Favored Glycine 0 CA--C 1.508 -0.356 0 N-CA-C 110.776 -0.929 . . . . 0.86 110.776 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.566 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -132.56 100.72 5.05 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 108.752 -0.833 . . . . 2.9 108.752 177.374 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.487 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 70.2 m 37.08 109.53 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 N-CA-C 116.24 1.941 . . . . 1.46 116.24 176.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.487 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 2.8 Cg_exo -34.92 102.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.938 2.425 . . . . 0.79 110.027 174.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.582 ' HB2' ' CD2' ' A' ' 38' ' ' TYR . 28.7 t -124.2 -177.54 3.81 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 114.166 1.173 . . . . 0.95 114.166 -174.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.754 ' CD1' HG23 ' A' ' 13' ' ' THR . 3.7 t-105 -109.33 100.13 9.28 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 103.235 -2.876 . . . . 1.24 103.235 173.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.119 HG13 ' CH2' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -153.07 154.79 31.4 Favored Pre-proline 0 N--CA 1.444 -0.761 0 CA-C-N 115.267 -0.879 . . . . 1.74 112.63 -171.755 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.688 ' HD2' HG23 ' A' ' 34' ' ' VAL . 21.2 Cg_endo -59.45 -13.74 22.15 Favored 'Trans proline' 0 N--CA 1.491 1.344 1 C-N-CA 126.35 4.7 . . . . 1.52 117.817 -176.869 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.423 ' H ' HG22 ' A' ' 34' ' ' VAL . 18.6 p 178.51 -23.59 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 119.572 1.078 . . . . 1.75 113.764 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.521 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 48.2 t -141.21 -73.23 0.33 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.514 0.673 . . . . 1.49 110.663 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.983 ' OH ' ' HB3' ' A' ' 40' ' ' ALA . 11.7 t80 177.8 131.84 0.06 Allowed 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 115.536 -0.756 . . . . 5.43 109.84 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.489 ' O ' HG12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -146.67 26.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.503 -0.879 . . . . 2.1 110.852 -179.216 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.983 ' HB3' ' OH ' ' A' ' 38' ' ' TYR . . . -64.81 88.7 0.07 Allowed 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.144 -1.022 . . . . 1.64 109.955 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 151.8 37.84 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.538 -1.21 . . . . 2.5 110.522 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 61.19 88.72 0.08 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.057 0.391 . . . . 4.56 112.057 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.481 HG23 ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -162.99 -169.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 110.25 -0.278 . . . . 3.73 110.25 178.625 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.783 HG12 ' HA2' ' A' ' 17' ' ' GLY . 11.4 m -144.59 124.1 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 113.216 0.821 . . . . 2.57 113.216 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.469 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 28.9 t 53.8 16.25 0.99 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.249 -0.887 . . . . 1.34 113.084 178.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 179.84 148.01 0.27 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.724 -0.39 . . . . 1.6 111.925 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.546 ' N ' ' O ' ' A' ' 38' ' ' TYR . 14.4 t80 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.211 -0.899 . . . . 4.12 111.094 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.412 -0.275 . . . . 2.16 112.412 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.462 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 15.0 tt0 61.67 14.05 5.78 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.163 0.506 . . . . 2.17 111.665 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.546 ' N ' HG21 ' A' ' 23' ' ' ILE . 58.0 t -79.67 -42.62 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 O-C-N 121.986 -0.446 . . . . 0.87 111.138 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.633 ' H ' HG21 ' A' ' 23' ' ' ILE . 20.1 t-20 82.06 44.51 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.697 -0.683 . . . . 1.86 111.999 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.501 ' O ' HG23 ' A' ' 9' ' ' ILE . 22.9 ptmt -119.76 -143.2 0.35 Allowed 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.179 -1.045 . . . . 2.42 108.179 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.447 HG22 ' HG3' ' A' ' 7' ' ' LYS . 3.1 tp -45.44 139.26 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 122.219 0.208 . . . . 2.03 111.009 178.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.63 HG22 HG12 ' A' ' 23' ' ' ILE . 27.6 pt -133.94 129.28 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 114.641 1.349 . . . . 3.89 114.641 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.06 144.41 16.0 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 106.865 -2.494 . . . . 1.14 106.865 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.506 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -152.36 105.42 3.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 118.855 1.328 . . . . 1.69 113.471 -175.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -156.85 102.87 2.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.847 -0.615 . . . . 3.7 110.874 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.638 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -116.67 -80.82 0.61 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.625 -0.83 . . . . 0.48 113.082 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.41 ' C ' ' HG2' ' A' ' 19' ' ' MET . . . -150.3 -58.79 0.19 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.631 0.604 . . . . 0.45 112.631 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.9 -36.37 3.36 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.577 -0.82 . . . . 0.72 111.757 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.19 -31.21 68.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.39 -0.596 . . . . 2.82 109.39 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.414 ' HA2' HG23 ' A' ' 44' ' ' VAL . . . -147.35 -58.45 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.029 -0.987 . . . . 0.8 110.847 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.487 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . . . -106.21 151.45 24.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.523 -0.338 . . . . 0.51 110.662 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.421 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -165.47 26.01 0.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.07 0.767 . . . . 1.98 113.07 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 5.2 mt-10 -146.54 -171.45 3.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.718 -0.845 . . . . 1.28 108.718 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.603 ' CD2' ' CZ3' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -155.17 -53.96 0.09 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 117.965 2.58 . . . . 4.88 117.965 -177.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.536 ' HB3' HG22 ' A' ' 9' ' ' ILE . 8.7 mt -88.27 151.69 22.47 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 116.324 1.972 . . . . 4.63 116.324 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.633 HG21 ' H ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -7.54 -117.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 111.584 -2.553 . . . . 2.72 114.402 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.452 ' CG ' HD13 ' A' ' 9' ' ' ILE . 0.9 OUTLIER 48.88 24.0 0.78 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.623 0.647 . . . . 2.6 110.221 -177.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.576 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -145.81 31.13 1.06 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 113.45 0.907 . . . . 1.71 113.45 -179.302 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.6 mttp 33.54 33.98 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.556 0.576 . . . . 3.35 112.556 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.453 ' HB3' ' CG ' ' A' ' 4' ' ' GLU . 4.1 p-10 46.64 47.81 14.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.886 -0.597 . . . . 2.14 112.194 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.445 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -52.95 -56.11 20.38 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.073 -1.06 . . . . 0.86 111.531 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.487 ' O ' ' O ' ' A' ' 30' ' ' SER . 85.8 m-70 -131.1 94.21 3.54 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 109.337 -0.616 . . . . 2.9 109.337 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 29' ' ' HIS . 13.9 m 40.43 106.68 0.01 OUTLIER Pre-proline 0 C--O 1.223 -0.29 0 N-CA-C 113.468 0.914 . . . . 1.46 113.468 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 8.2 Cg_exo -33.53 130.63 0.14 Allowed 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 122.479 2.12 . . . . 0.79 110.037 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.556 ' CB ' ' CG2' ' A' ' 34' ' ' VAL . 64.7 m -150.94 156.36 41.02 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 113.94 1.089 . . . . 0.95 113.94 -173.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.638 ' CD1' HG23 ' A' ' 13' ' ' THR . 3.7 t-105 -86.1 92.26 8.67 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 103.663 -2.717 . . . . 1.24 103.663 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.926 HG12 ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -154.99 -177.8 0.79 Allowed Pre-proline 0 CA--C 1.547 0.855 0 CA-C-N 114.706 -1.133 . . . . 1.74 110.414 -174.607 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.926 ' HD3' HG12 ' A' ' 34' ' ' VAL . 30.4 Cg_endo -86.33 103.22 0.66 Allowed 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 124.185 3.257 . . . . 1.52 116.32 -174.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 t 41.2 28.08 0.06 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.108 0.48 . . . . 1.75 111.251 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.502 ' O ' ' CE3' ' A' ' 25' ' ' TRP . 1.5 m -166.23 -131.85 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.444 -0.798 . . . . 1.49 109.913 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -170.45 98.92 0.26 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 105.004 -2.221 . . . . 5.43 105.004 -177.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.861 ' HB ' HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -116.59 37.64 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.823 -1.08 . . . . 2.1 111.624 -173.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -69.82 89.98 0.59 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.188 -0.915 . . . . 1.64 110.904 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 152.96 42.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.272 -0.876 . . . . 2.5 110.504 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 t70 54.76 88.67 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.72 0.295 . . . . 4.56 110.778 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.861 HG13 ' HB ' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -169.75 170.6 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.306 -0.628 . . . . 3.73 109.306 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.588 ' HA ' HD12 ' A' ' 39' ' ' ILE . 7.6 p -128.63 132.99 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 114.079 1.14 . . . . 2.57 114.079 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.502 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 16.6 t 61.83 7.59 2.07 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.669 1.359 . . . . 1.34 114.669 176.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.434 ' O ' ' CG2' ' A' ' 43' ' ' VAL . 3.5 tt0 177.8 -173.04 0.12 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.136 -0.626 . . . . 1.6 112.42 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.504 ' HB2' ' HA ' ' A' ' 39' ' ' ILE . 45.5 t80 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.222 -0.894 . . . . 4.12 110.675 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.454 ' HA2' HG12 ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.242 0 N-CA-C 112.616 -0.194 . . . . 2.16 112.616 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.566 ' N ' HG23 ' A' ' 23' ' ' ILE . 0.0 OUTLIER 58.29 12.98 2.16 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.021 0.378 . . . . 2.17 112.021 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 5' ' ' VAL . 23.2 t -89.42 -4.22 10.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 112.274 0.472 . . . . 0.87 112.274 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.599 ' H ' HG22 ' A' ' 23' ' ' ILE . 29.4 t-20 39.09 71.66 0.16 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.007 0.432 . . . . 1.86 111.236 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.587 ' HD3' HG22 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -150.77 -141.98 0.11 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.874 -0.603 . . . . 2.42 109.389 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -56.49 106.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.596 0.712 . . . . 2.03 111.537 179.48 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.755 HD11 ' CZ ' ' A' ' 21' ' ' TYR . 3.0 tp -153.55 171.06 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.845 -0.616 . . . . 3.89 110.763 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.03 169.37 20.45 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 111.824 -0.511 . . . . 1.14 111.824 -175.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.516 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 14.1 p -150.29 103.99 3.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 113.312 0.856 . . . . 1.69 113.312 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.422 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 32.2 ttm180 -159.46 101.36 1.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.481 -0.327 . . . . 3.7 111.845 177.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.582 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -115.69 -85.42 0.62 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.857 1.058 . . . . 0.48 113.857 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.425 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -146.03 -51.57 0.24 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.421 0.555 . . . . 0.45 112.493 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.06 -35.57 4.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.625 -0.798 . . . . 0.72 112.193 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -59.73 -41.99 92.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.224 0.535 . . . . 2.82 110.01 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -136.03 -40.61 0.14 Allowed Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.397 -0.819 . . . . 0.8 111.697 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.513 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . . . -130.59 150.7 51.67 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.439 -0.578 . . . . 0.51 109.439 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.425 ' HG3' ' C ' ' A' ' 14' ' ' ALA . 2.9 ttt -162.74 24.58 0.1 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.1 0.778 . . . . 1.98 113.1 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.56 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 18.5 mt-10 -150.65 178.81 8.74 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.183 -0.673 . . . . 1.28 109.183 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.755 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 2.3 t80 -157.61 9.66 0.18 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.515 0.931 . . . . 4.88 113.515 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.799 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.8 pp -83.6 130.3 34.98 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 116.522 2.045 . . . . 4.63 116.522 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 6' ' ' ASN . 1.4 mp -72.5 10.14 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 CA-C-N 110.016 -3.266 . . . . 2.72 111.1 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.415 ' OE1' ' N ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -78.64 10.86 2.88 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.232 -0.44 . . . . 2.6 110.702 177.411 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.646 ' HZ2' ' H ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -86.98 32.57 0.67 Allowed 'General case' 0 C--N 1.347 0.458 0 CA-C-O 120.627 0.251 . . . . 1.71 111.411 178.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 74.6 tttt 48.85 36.3 7.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.626 -0.261 . . . . 3.35 111.212 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.446 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 16.4 t0 57.09 23.08 8.07 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.114 -0.634 . . . . 2.14 109.746 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -43.45 -64.39 1.82 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 120.764 -0.731 . . . . 0.86 111.328 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.528 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -135.16 98.87 4.1 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 109.553 -0.536 . . . . 2.9 109.553 177.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 29' ' ' HIS . 40.6 m 32.43 117.23 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 117.096 2.258 . . . . 1.46 117.096 176.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.479 ' HB3' ' CG1' ' A' ' 23' ' ' ILE . 14.8 Cg_exo -31.5 118.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 123.75 2.967 . . . . 0.79 108.427 172.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.646 ' H ' ' HZ2' ' A' ' 25' ' ' TRP . 7.3 t -152.21 154.35 35.62 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.379 1.252 . . . . 0.95 114.379 -172.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.61 ' CE3' ' CD2' ' A' ' 21' ' ' TYR . 8.4 t-105 -91.52 91.23 7.97 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 104.187 -2.523 . . . . 1.24 104.187 175.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.886 HG12 ' CD ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -156.77 173.97 4.47 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 114.65 -1.159 . . . . 1.74 110.928 -175.066 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.886 ' CD ' HG12 ' A' ' 34' ' ' VAL . 7.3 Cg_endo -92.38 122.24 0.57 Allowed 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.512 2.808 . . . . 1.52 116.447 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.6 m 79.9 -51.72 0.38 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.833 -1.076 . . . . 1.75 113.736 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.561 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 57.9 m -144.16 -65.49 0.36 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.538 0.685 . . . . 1.49 111.272 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.702 ' OH ' ' HB3' ' A' ' 40' ' ' ALA . 10.0 t80 178.7 140.88 0.1 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.251 -0.648 . . . . 5.43 109.251 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.791 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -161.1 30.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 122.801 1.286 . . . . 2.1 109.137 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.702 ' HB3' ' OH ' ' A' ' 38' ' ' TYR . . . -66.23 89.85 0.14 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.748 -1.114 . . . . 1.64 110.507 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 156.62 41.1 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.438 -0.801 . . . . 2.5 110.573 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.414 ' O ' HG22 ' A' ' 43' ' ' VAL . 7.6 m-20 58.18 84.09 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.77 0.319 . . . . 4.56 111.18 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 0.6 OUTLIER -157.21 -151.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.43 -0.582 . . . . 3.73 109.43 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.42 ' N ' HG13 ' A' ' 39' ' ' ILE . 7.6 p -169.05 120.72 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 113.448 0.907 . . . . 2.57 113.448 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.3 t 65.74 7.02 4.23 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 114.089 1.144 . . . . 1.34 114.089 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 179.05 147.01 0.18 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.571 0.582 . . . . 1.6 112.571 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 38' ' ' TYR . 28.6 p90 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.19 -0.91 . . . . 4.12 111.07 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.551 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.36 0 CA-C-O 120.468 -0.073 . . . . 2.16 113.034 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.51 ' CG ' ' HB3' ' A' ' 27' ' ' ASP . 1.8 tm-20 61.39 26.57 16.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 122.274 1.035 . . . . 2.17 109.275 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -104.32 -19.73 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.129 -0.941 . . . . 0.87 111.505 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.455 ' ND2' ' HA ' ' A' ' 24' ' ' GLU . 7.1 m120 47.5 79.1 0.07 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.946 -0.39 . . . . 1.86 109.946 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HE3' HG21 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -135.68 -98.61 0.23 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.887 0.699 . . . . 2.42 112.887 -177.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 8' ' ' ILE . 2.1 tp -135.97 111.63 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 109.839 -0.43 . . . . 2.03 109.839 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 1.178 HG23 ' CE2' ' A' ' 21' ' ' TYR . 6.9 tp -150.97 162.73 3.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 112.622 0.601 . . . . 3.89 112.622 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.501 ' N ' HG13 ' A' ' 9' ' ' ILE . . . -109.85 121.15 5.93 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 110.634 -0.986 . . . . 1.14 110.634 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.83 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -102.55 107.85 18.94 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.698 1.237 . . . . 1.69 113.174 -176.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -157.68 112.73 2.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 112.433 -2.167 . . . . 3.7 112.311 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.508 ' CB ' ' HA ' ' A' ' 19' ' ' MET . 1.6 m -116.36 -78.21 0.58 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.408 0.521 . . . . 0.48 112.408 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.96 -54.94 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.731 0.301 . . . . 0.45 111.647 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.12 -35.67 4.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.352 -0.928 . . . . 0.72 112.653 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.3 -27.0 65.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.056 0.455 . . . . 2.82 110.342 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -150.38 -43.64 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.694 -0.685 . . . . 0.8 111.582 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.515 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -129.98 151.47 50.5 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.862 -0.421 . . . . 0.51 109.862 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.508 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 4.0 ttp -164.23 51.88 0.13 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.618 1.34 . . . . 1.98 114.618 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.748 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 6.7 mt-10 -151.01 -124.39 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 114.886 1.439 . . . . 1.28 114.886 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 1.178 ' CE2' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -155.72 -126.78 0.03 OUTLIER 'General case' 0 C--O 1.199 -1.556 0 N-CA-C 117.787 2.514 . . . . 4.88 117.787 -173.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.94 ' O ' HG21 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -151.53 165.19 34.98 Favored 'General case' 0 N--CA 1.432 -1.358 0 O-C-N 121.409 -0.807 . . . . 4.63 111.128 178.517 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.76 HD13 ' C ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER 56.29 63.04 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 124.505 1.122 . . . . 2.72 113.678 179.193 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.86 ' HB3' ' OH ' ' A' ' 21' ' ' TYR . 5.0 tt0 178.88 38.67 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.861 0.689 . . . . 2.6 112.861 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.546 ' CZ2' ' HA ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -153.15 32.92 0.47 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.682 0.623 . . . . 1.71 112.682 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp 56.17 20.12 4.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.843 0.354 . . . . 3.35 111.425 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.51 ' HB3' ' CG ' ' A' ' 4' ' ' GLU . 2.6 p-10 47.34 40.16 10.19 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.135 0.791 . . . . 2.14 113.135 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.84 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -48.23 -54.89 11.31 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.082 -1.056 . . . . 0.86 112.344 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.591 ' CE1' ' CE2' ' A' ' 47' ' ' TYR . 69.8 t60 -131.69 95.44 3.72 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 117.244 0.522 . . . . 2.9 110.546 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.511 ' O ' ' O ' ' A' ' 29' ' ' HIS . 14.6 m 37.63 107.48 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.402 0 N-CA-C 113.471 0.915 . . . . 1.46 113.471 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.451 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 7.1 Cg_exo -33.85 125.67 0.16 Allowed 'Trans proline' 0 C--N 1.366 1.45 0 C-N-CA 122.768 2.312 . . . . 0.79 110.275 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.558 ' O ' ' O ' ' A' ' 21' ' ' TYR . 67.3 m -152.24 143.96 23.58 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 119.422 -0.911 . . . . 0.95 112.879 -173.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.583 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 31.5 t-105 -78.59 92.42 4.7 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 104.051 -2.574 . . . . 1.24 104.051 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.892 HG12 ' CD ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -152.67 173.04 4.88 Favored Pre-proline 0 N--CA 1.442 -0.829 0 CA-C-N 112.308 -2.223 . . . . 1.74 108.533 -176.183 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.892 ' CD ' HG12 ' A' ' 34' ' ' VAL . 85.5 Cg_endo -77.46 105.82 2.11 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 123.726 2.95 . . . . 1.52 117.432 -173.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.8 t 43.5 27.25 0.14 Allowed 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.33 -1.305 . . . . 1.75 111.997 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.547 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 12.2 m -166.65 -120.16 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.494 -0.775 . . . . 1.49 109.668 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.84 ' OH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -175.49 101.21 0.08 Allowed 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 106.45 -1.685 . . . . 5.43 106.45 -177.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.677 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -127.04 33.16 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 114.745 -1.116 . . . . 2.1 109.154 -176.082 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -58.28 92.79 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.424 -1.262 . . . . 1.64 111.905 -177.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 168.49 -61.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.184 -0.916 . . . . 2.5 110.059 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 9.2 t70 163.29 79.73 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.321 -0.854 . . . . 4.56 109.683 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.557 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -148.91 -157.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.959 -0.296 . . . . 3.73 110.401 -179.361 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.562 ' N ' HD12 ' A' ' 39' ' ' ILE . 4.8 p -155.16 105.9 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.421 0.629 . . . . 2.57 112.531 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.46 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 6.3 p 80.16 2.36 1.98 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.762 -1.108 . . . . 1.34 113.335 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 179.15 140.74 0.11 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.597 0.237 . . . . 1.6 111.311 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.591 ' CE2' ' CE1' ' A' ' 29' ' ' HIS . 11.0 t80 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.195 -0.907 . . . . 4.12 110.069 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.565 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.464 -0.254 . . . . 2.16 112.464 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.496 ' N ' ' HG3' ' A' ' 31' ' ' PRO . 2.1 tm-20 64.36 47.19 3.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.953 0.883 . . . . 2.17 110.137 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.411 HG11 ' HD3' ' A' ' 7' ' ' LYS . 12.0 t -119.94 -16.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.243 -0.89 . . . . 0.87 111.301 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 24.8 t-20 50.37 38.59 18.35 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 108.529 -0.915 . . . . 1.86 108.529 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.9 ' HE3' HG21 ' A' ' 23' ' ' ILE . 21.7 pttp -93.48 -129.6 0.12 Allowed 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.291 -1.322 . . . . 2.42 111.268 -176.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -117.02 117.14 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.048 0.452 . . . . 2.03 111.965 -178.402 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.555 ' HB ' HD11 ' A' ' 23' ' ' ILE . 9.7 tp -149.59 161.88 4.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.958 -0.564 . . . . 3.89 110.849 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -109.34 130.41 9.97 Favored Glycine 0 CA--C 1.505 -0.589 0 N-CA-C 110.363 -1.095 . . . . 1.14 110.363 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.621 ' HB3' ' CG ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -102.16 107.8 19.0 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.562 1.172 . . . . 1.69 113.188 -177.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.34 104.4 2.03 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.547 -2.115 . . . . 3.7 111.285 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.488 ' CB ' ' HA ' ' A' ' 19' ' ' MET . 1.3 m -109.59 -81.51 0.57 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 119.953 -0.699 . . . . 0.48 112.562 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.404 ' C ' ' HG2' ' A' ' 19' ' ' MET . . . -149.84 -54.23 0.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.717 0.294 . . . . 0.45 111.417 -178.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.415 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . 117.05 -28.37 7.32 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.313 -0.946 . . . . 0.72 112.893 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.28 -33.43 71.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.336 0.589 . . . . 2.82 109.75 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.643 ' HA2' HG12 ' A' ' 44' ' ' VAL . . . -150.32 -46.9 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.785 -0.926 . . . . 0.8 110.785 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.577 ' HB1' ' HA ' ' A' ' 34' ' ' VAL . . . -115.17 152.17 33.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.263 -0.468 . . . . 0.51 110.027 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.488 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -165.94 46.84 0.08 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.105 0.78 . . . . 1.98 113.105 -179.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.755 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 53.3 mt-10 -149.54 -139.77 0.1 Allowed 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 114.621 1.341 . . . . 1.28 114.621 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.621 ' CG ' ' HB3' ' A' ' 11' ' ' SER . 0.1 OUTLIER -123.45 -172.65 2.56 Favored 'General case' 0 C--O 1.191 -2.008 0 N-CA-C 114.728 1.381 . . . . 4.88 114.728 -173.112 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.838 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -137.88 104.74 5.36 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 114.181 1.178 . . . . 4.63 114.181 173.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.9 HG21 ' HE3' ' A' ' 7' ' ' LYS . 2.7 pp 136.57 24.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 126.886 2.075 . . . . 2.72 112.436 176.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.581 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 8.9 tp10 -130.57 53.4 1.96 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.786 0.721 . . . . 2.6 111.925 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.576 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -153.83 -169.4 3.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.108 -0.496 . . . . 1.71 109.782 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.59 36.69 1.6 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.08 0.467 . . . . 3.35 109.791 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.443 ' HB2' ' HG3' ' A' ' 4' ' ' GLU . 24.9 t70 53.31 44.82 29.6 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.809 -0.632 . . . . 2.14 110.862 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.513 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -54.04 -64.27 4.41 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.231 -0.985 . . . . 0.86 112.312 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.464 ' O ' ' CB ' ' A' ' 38' ' ' TYR . 47.5 t-80 -134.41 95.94 3.49 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 117.099 0.449 . . . . 2.9 110.386 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 31' ' ' PRO . 17.4 m 39.12 98.01 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 112.573 0.583 . . . . 1.46 112.573 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.496 ' HG3' ' N ' ' A' ' 4' ' ' GLU . 18.0 Cg_exo -27.24 126.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.365 1.395 0 C-N-CA 123.558 2.839 . . . . 0.79 110.407 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.495 ' O ' ' CH2' ' A' ' 25' ' ' TRP . 8.5 t -152.41 144.64 23.93 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 119.038 -1.065 . . . . 0.95 112.959 -171.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.525 ' N ' ' HB3' ' A' ' 22' ' ' LEU . 9.1 t-105 -83.31 96.07 8.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 104.335 -2.469 . . . . 1.24 104.335 175.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.94 HG12 ' HD3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -151.51 -172.24 0.31 Allowed Pre-proline 0 N--CA 1.434 -1.229 0 CA-C-N 112.548 -2.115 . . . . 1.74 106.659 -175.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.94 ' HD3' HG12 ' A' ' 34' ' ' VAL . 44.9 Cg_endo -88.13 102.69 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.676 2.251 . . . . 1.52 116.142 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.42 ' N ' ' OE1' ' A' ' 20' ' ' GLU . 41.9 t 45.41 23.93 0.15 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.725 -0.671 . . . . 1.75 111.989 177.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.548 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 5.4 m -163.59 -122.93 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 116.476 -0.329 . . . . 1.49 110.22 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -174.47 102.15 0.1 Allowed 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 106.282 -1.747 . . . . 5.43 106.282 -177.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.749 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -124.17 34.98 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 114.683 -1.144 . . . . 2.1 110.329 -174.223 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -59.4 91.92 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.346 -1.297 . . . . 1.64 111.695 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 166.72 -60.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.307 -0.86 . . . . 2.5 110.022 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 41' ' ' ALA . 1.6 p30 160.49 78.66 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.567 -0.742 . . . . 4.56 110.398 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.628 HG11 ' O ' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -151.44 -166.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 110.067 -0.346 . . . . 3.73 110.067 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.643 HG12 ' HA2' ' A' ' 17' ' ' GLY . 3.1 m -147.22 121.68 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 112.848 0.684 . . . . 2.57 112.848 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.455 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 22.8 t 69.5 5.01 4.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.207 -0.906 . . . . 1.34 113.199 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 45' ' ' SER . 39.1 tt0 179.02 158.62 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.089 0.471 . . . . 1.6 111.863 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.628 ' O ' HG11 ' A' ' 43' ' ' VAL . 37.4 p90 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.176 -0.916 . . . . 4.12 110.997 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.641 ' O ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.647 -0.181 . . . . 2.16 112.647 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 48.74 26.82 1.36 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.785 0.803 . . . . 2.17 110.348 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 3' ' ' GLY . 5.1 t -105.4 -8.65 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.391 -0.822 . . . . 0.87 112.488 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.545 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 2.0 p30 41.34 74.38 0.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.714 0.293 . . . . 1.86 111.396 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.551 ' HD2' HG22 ' A' ' 8' ' ' ILE . 3.6 pttp -151.44 -107.93 0.06 Allowed 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.963 0.357 . . . . 2.42 111.963 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.678 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -82.77 101.46 7.52 Favored 'Isoleucine or valine' 0 C--N 1.345 0.408 0 N-CA-C 109.485 -0.561 . . . . 2.03 109.485 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.822 HD11 ' CZ ' ' A' ' 21' ' ' TYR . 2.4 tp -153.29 171.38 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 120.031 -0.667 . . . . 3.89 112.371 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.94 169.74 22.77 Favored Glycine 0 CA--C 1.508 -0.374 0 CA-C-N 116.16 -0.473 . . . . 1.14 111.987 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.495 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 2.5 p -150.35 104.48 3.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.128 0.788 . . . . 1.69 113.128 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.444 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 14.9 tpt180 -157.56 102.2 1.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.015 -0.539 . . . . 3.7 110.829 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.485 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -117.08 -84.09 0.64 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 114.008 1.114 . . . . 0.48 114.008 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.43 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -150.34 -56.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.428 -0.509 . . . . 0.45 112.305 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.472 ' N ' ' HG3' ' A' ' 19' ' ' MET . . . 119.4 -29.49 6.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.142 -1.028 . . . . 0.72 112.53 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -58.81 -33.7 70.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.471 0.653 . . . . 2.82 109.245 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 43' ' ' VAL . . . -150.83 -46.0 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 114.777 -1.102 . . . . 0.8 111.068 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.566 ' HA ' ' HG3' ' A' ' 35' ' ' PRO . . . -116.19 151.21 36.15 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.208 -0.293 . . . . 0.51 110.208 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.472 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 2.8 ttp -162.61 24.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.433 0.531 . . . . 1.98 112.433 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 5.7 mt-10 -150.47 -179.91 7.62 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.823 -0.436 . . . . 1.28 109.823 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.822 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -155.52 14.09 0.36 Allowed 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 113.702 1.001 . . . . 4.88 113.702 -179.274 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.681 ' HB3' HG23 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -84.78 135.45 34.11 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 116.003 1.853 . . . . 4.63 116.003 -177.038 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.626 HD13 ' H ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -74.2 16.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 111.505 -2.588 . . . . 2.72 111.126 177.641 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.545 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . 24.6 tt0 -80.09 17.25 1.03 Allowed 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.058 0.543 . . . . 2.6 111.082 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.591 ' HZ2' ' H ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -91.58 32.28 1.1 Allowed 'General case' 0 C--N 1.342 0.272 0 N-CA-C 109.851 -0.426 . . . . 1.71 109.851 177.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 25' ' ' TRP . 64.4 pttt 46.78 34.44 2.59 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.142 -0.481 . . . . 3.35 111.154 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 0.3 OUTLIER 65.24 23.89 12.23 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.704 -0.399 . . . . 2.14 110.246 179.424 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -44.32 -68.93 0.79 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.848 -0.691 . . . . 0.86 111.798 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.579 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -133.29 99.46 4.54 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.815 -0.439 . . . . 2.9 109.815 178.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.507 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 27.6 t 33.28 113.07 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 116.825 2.157 . . . . 1.46 116.825 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.507 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 13.5 Cg_exo -29.2 116.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.982 3.121 . . . . 0.79 110.053 173.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.591 ' H ' ' HZ2' ' A' ' 25' ' ' TRP . 22.8 t -152.72 -177.6 6.35 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 114.093 1.145 . . . . 0.95 114.093 -174.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.6 ' CE3' ' CG ' ' A' ' 21' ' ' TYR . 11.7 t-105 -106.21 92.19 4.03 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.584 -1.189 . . . . 1.24 108.935 178.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 1.018 HG21 HG23 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -159.76 -179.75 1.16 Allowed Pre-proline 0 C--O 1.214 -0.775 0 CA-C-N 115.822 -0.627 . . . . 1.74 110.815 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.716 ' CD ' HG22 ' A' ' 34' ' ' VAL . 11.7 Cg_endo -98.53 115.74 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 123.605 2.87 . . . . 1.52 115.778 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t 70.63 -8.75 0.87 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 115.37 1.619 . . . . 1.75 115.37 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.553 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 49.4 m -160.86 -90.27 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 118.707 -1.197 . . . . 1.49 114.102 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.784 ' CA ' HG11 ' A' ' 34' ' ' VAL . 12.8 t80 176.75 140.42 0.07 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 110.062 -0.347 . . . . 5.43 110.062 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.018 HG23 HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -165.62 31.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 123.182 1.468 . . . . 2.1 108.365 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -65.85 91.69 0.15 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.359 -1.292 . . . . 1.64 110.93 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 160.2 -26.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.367 -0.833 . . . . 2.5 110.421 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 5.8 m-20 -120.84 -92.04 0.55 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.41 0.522 . . . . 4.56 112.41 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.531 ' CA ' HD11 ' A' ' 39' ' ' ILE . 7.1 p 174.98 -30.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.276 0.472 . . . . 3.73 112.276 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.489 HG23 ' H ' ' A' ' 46' ' ' GLU . 32.6 m -54.51 -170.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 112.495 0.554 . . . . 2.57 112.495 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.477 ' CB ' ' HG2' ' A' ' 35' ' ' PRO . 11.7 t -107.58 21.8 16.92 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.1 0.778 . . . . 1.34 113.1 -177.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.489 ' H ' HG23 ' A' ' 44' ' ' VAL . 41.4 tt0 -172.86 139.18 0.85 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.565 0.58 . . . . 1.6 112.565 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' A' ' 38' ' ' TYR . 4.1 t80 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.273 -0.87 . . . . 4.12 110.989 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 N-CA-C 112.503 -0.239 . . . . 2.16 112.503 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.567 ' H ' HG22 ' A' ' 23' ' ' ILE . 9.8 tt0 61.46 14.78 6.11 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.303 0.573 . . . . 2.17 111.588 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.641 ' H ' HG21 ' A' ' 23' ' ' ILE . 4.9 t -79.87 -35.39 16.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 122.134 -0.354 . . . . 0.87 111.428 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.458 ' H ' HG21 ' A' ' 23' ' ' ILE . 42.8 t-20 58.61 88.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 1.86 110.632 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.476 ' HD2' ' CG1' ' A' ' 5' ' ' VAL . 2.5 ptmm? -150.94 -67.24 0.19 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.176 -0.466 . . . . 2.42 111.73 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.624 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -138.76 128.96 33.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.966 -0.561 . . . . 2.03 109.782 -179.22 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.624 ' N ' HD13 ' A' ' 8' ' ' ILE . 13.5 pt -122.1 131.46 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 113.949 1.092 . . . . 3.89 113.949 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.69 102.77 0.23 Allowed Glycine 0 N--CA 1.453 -0.216 0 N-CA-C 109.419 -1.472 . . . . 1.14 109.419 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.615 ' HB2' ' N ' ' A' ' 21' ' ' TYR . 7.0 m -148.99 169.96 19.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.334 1.235 . . . . 1.69 114.334 -176.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -159.89 102.74 1.49 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.522 -1.672 . . . . 3.7 109.91 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.848 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -87.85 -76.97 0.36 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.022 -0.671 . . . . 0.48 112.043 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -150.95 -63.54 0.19 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.683 0.623 . . . . 0.45 112.683 -178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.481 ' N ' ' HG3' ' A' ' 19' ' ' MET . . . 125.86 -42.05 1.56 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.773 -0.931 . . . . 0.72 110.773 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.408 ' OE2' ' N ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -59.3 -28.16 66.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.576 -0.898 . . . . 2.82 108.576 178.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.822 ' HA2' HG12 ' A' ' 44' ' ' VAL . . . -142.1 -65.17 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.958 -1.019 . . . . 0.8 111.179 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.88 ' HB2' HD11 ' A' ' 39' ' ' ILE . . . -109.19 154.0 22.99 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 119.564 -0.255 . . . . 0.51 111.367 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.558 ' HA ' ' H ' ' A' ' 13' ' ' THR . 1.6 ttm -157.05 25.09 0.31 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.49 1.293 . . . . 1.98 114.49 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.702 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 18.1 mt-10 -157.73 175.44 13.89 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 107.668 -1.234 . . . . 1.28 107.668 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.638 ' HB2' ' HA ' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -155.79 -26.69 0.1 Allowed 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 116.047 1.869 . . . . 4.88 116.047 -178.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.619 HD21 ' CZ ' ' A' ' 21' ' ' TYR . 2.0 mm? -89.66 138.21 31.67 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 115.308 1.595 . . . . 4.63 115.308 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.641 HG21 ' H ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -8.17 -119.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 111.363 -2.653 . . . . 2.72 114.969 177.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.564 ' HB2' HG21 ' A' ' 9' ' ' ILE . 33.9 tt0 48.23 25.03 0.76 Allowed 'General case' 0 C--N 1.344 0.365 0 O-C-N 121.777 -0.577 . . . . 2.6 109.939 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.927 ' CZ3' HG13 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -138.57 32.17 2.28 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 112.764 0.653 . . . . 1.71 112.764 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.2 tptt 37.3 30.41 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.326 0.491 . . . . 3.35 112.326 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HB3' ' CB ' ' A' ' 4' ' ' GLU . 4.1 p-10 44.15 35.82 1.32 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.09 0.404 . . . . 2.14 112.09 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.744 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -46.69 -53.86 9.63 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.302 -0.952 . . . . 0.86 111.72 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.543 ' CE1' ' CE2' ' A' ' 47' ' ' TYR . 9.6 t60 -132.04 94.57 3.5 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.581 -0.526 . . . . 2.9 109.581 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 29' ' ' HIS . 16.0 t 37.75 112.15 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 115.266 1.58 . . . . 1.46 115.266 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.448 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 17.9 Cg_exo -33.14 122.27 0.11 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.801 2.334 . . . . 0.79 108.768 174.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.492 ' O ' ' CZ2' ' A' ' 25' ' ' TRP . 40.4 m -143.38 174.98 10.26 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 114.201 1.186 . . . . 0.95 114.201 -172.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.848 ' CD1' HG23 ' A' ' 13' ' ' THR . 2.1 t90 -97.96 100.97 12.34 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 104.602 -2.37 . . . . 1.24 104.602 174.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.998 HG21 ' N ' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -151.83 151.62 28.6 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 114.226 -1.352 . . . . 1.74 111.37 -171.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.711 ' HD2' HG23 ' A' ' 34' ' ' VAL . 40.9 Cg_exo -56.37 -14.15 11.78 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 125.127 3.885 . . . . 1.52 116.588 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.771 ' H ' HG22 ' A' ' 34' ' ' VAL . 28.1 t 176.54 -28.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.96 0.726 . . . . 1.75 112.96 -177.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.567 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 49.7 m -114.61 -90.18 0.54 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.0 0.37 . . . . 1.49 112.0 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.998 ' N ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -178.94 123.3 0.09 Allowed 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 106.655 -1.609 . . . . 5.43 106.655 -179.349 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.88 HD11 ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -135.62 27.89 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.746 0.784 . . . . 2.1 110.305 -175.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -59.58 92.04 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.022 -0.99 . . . . 1.64 111.59 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 160.83 -60.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.232 -0.895 . . . . 2.5 109.948 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 6.7 t70 163.13 80.72 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.435 -0.802 . . . . 4.56 110.13 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.656 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -148.42 -163.34 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.961 -0.296 . . . . 3.73 110.336 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.822 HG12 ' HA2' ' A' ' 17' ' ' GLY . 15.9 m -141.14 101.74 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 113.073 0.768 . . . . 2.57 113.073 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.503 ' N ' ' HG2' ' A' ' 35' ' ' PRO . 46.9 t 64.39 14.68 8.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.281 -0.872 . . . . 1.34 112.414 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -178.6 133.61 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.487 -0.485 . . . . 1.6 111.822 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.543 ' CE2' ' CE1' ' A' ' 29' ' ' HIS . 90.4 t80 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.228 -0.891 . . . . 4.12 110.927 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.457 ' HA2' HD11 ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.184 -0.366 . . . . 2.16 112.184 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.476 ' CB ' ' HB3' ' A' ' 27' ' ' ASP . 6.9 tt0 67.52 7.27 5.48 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.771 0.286 . . . . 2.17 111.771 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 6' ' ' ASN . 54.9 t -82.53 -43.42 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.035 0.445 . . . . 0.87 110.353 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.658 ' N ' HG21 ' A' ' 23' ' ' ILE . 27.8 t-20 83.56 74.07 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.915 -1.038 . . . . 1.86 110.739 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.752 ' HG3' HG22 ' A' ' 8' ' ' ILE . 36.4 pttt -151.56 -140.36 0.1 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.302 -1.772 . . . . 2.42 108.093 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.958 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -38.95 143.54 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 122.565 0.346 . . . . 2.03 110.884 177.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.958 ' N ' HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -147.48 126.88 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 114.32 1.23 . . . . 3.89 114.32 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.03 146.71 16.66 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 107.767 -2.133 . . . . 1.14 107.767 175.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.509 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -154.24 104.43 2.61 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 118.51 1.155 . . . . 1.69 112.917 -176.046 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -157.86 102.65 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.822 -0.627 . . . . 3.7 109.849 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.463 ' H ' ' HA ' ' A' ' 19' ' ' MET . 1.0 OUTLIER -113.86 -82.98 0.6 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.894 1.072 . . . . 0.48 113.894 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.421 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -145.32 -54.52 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.576 -0.45 . . . . 0.45 112.157 -177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.435 ' N ' ' HG3' ' A' ' 19' ' ' MET . . . 116.63 -37.27 3.43 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 119.903 -1.142 . . . . 0.72 112.801 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.18 -27.74 64.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.251 0.548 . . . . 2.82 109.522 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -150.02 -53.98 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.33 -0.85 . . . . 0.8 111.123 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.565 ' HB1' ' HD3' ' A' ' 35' ' ' PRO . . . -115.67 146.58 41.72 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 110.034 -0.358 . . . . 0.51 110.034 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.463 ' HA ' ' H ' ' A' ' 13' ' ' THR . 2.6 ttp -155.68 31.81 0.36 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 111.925 0.343 . . . . 1.98 111.925 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.645 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 9.3 mt-10 -147.29 -176.39 5.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 119.155 -0.45 . . . . 1.28 109.88 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.675 ' HB2' ' CD2' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -154.28 -62.85 0.13 Allowed 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 119.919 3.303 . . . . 4.88 119.919 -174.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.945 ' HG ' HD12 ' A' ' 23' ' ' ILE . 10.6 tp -84.18 155.65 22.44 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 114.864 1.431 . . . . 4.63 114.864 -170.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.945 HD12 ' HG ' ' A' ' 22' ' ' LEU . 3.4 mp -9.86 -112.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 112.462 -2.154 . . . . 2.72 114.85 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.558 ' N ' HG22 ' A' ' 23' ' ' ILE . 5.9 tt0 70.69 -61.35 0.48 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.728 -1.582 . . . . 2.6 106.728 -175.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.566 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 1.1 p90 -57.76 -173.18 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.021 -0.99 . . . . 1.71 111.033 176.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.46 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 3.2 mptp? -116.37 55.2 0.82 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.122 0.487 . . . . 3.35 109.941 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.476 ' HB3' ' CB ' ' A' ' 4' ' ' GLU . 4.0 p30 42.85 33.94 0.55 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.563 -0.744 . . . . 2.14 111.874 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.743 ' N ' ' OH ' ' A' ' 38' ' ' TYR . . . -49.48 -57.54 9.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.534 -0.841 . . . . 0.86 112.722 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.542 ' NE2' ' CE2' ' A' ' 47' ' ' TYR . 54.5 t-80 -131.97 96.29 3.88 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 117.383 0.591 . . . . 2.9 110.694 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 29' ' ' HIS . 23.3 t 39.71 103.24 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 113.761 1.022 . . . . 1.46 113.761 177.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.446 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 15.1 Cg_exo -31.6 114.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.371 1.723 0 C-N-CA 122.816 2.344 . . . . 0.79 109.699 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 21' ' ' TYR . 10.0 t -133.62 -163.31 1.34 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.712 0.634 . . . . 0.95 112.712 -172.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.675 ' CD2' ' HB2' ' A' ' 21' ' ' TYR . 6.4 t-105 -120.41 91.98 3.66 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.15 -1.796 . . . . 1.24 106.15 175.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.699 HG13 ' CD ' ' A' ' 35' ' ' PRO . 1.2 t -158.7 170.65 8.58 Favored Pre-proline 0 N--CA 1.444 -0.751 0 CA-C-N 114.993 -1.003 . . . . 1.74 112.186 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.699 ' CD ' HG13 ' A' ' 34' ' ' VAL . 59.1 Cg_endo -70.39 108.41 2.19 Favored 'Trans proline' 0 N--CA 1.485 1.003 1 C-N-CA 125.484 4.123 . . . . 1.52 116.253 175.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 t 37.55 30.35 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.813 -0.63 . . . . 1.75 112.13 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.544 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -163.11 -136.14 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 116.024 -0.535 . . . . 1.49 110.464 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.743 ' OH ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -174.34 100.68 0.1 Allowed 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.444 -1.688 . . . . 5.43 106.444 -177.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.679 HG23 HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -126.14 31.44 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 122.92 1.343 . . . . 2.1 109.477 -175.106 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -60.91 92.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.51 -1.223 . . . . 1.64 111.055 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 164.38 -29.46 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.432 -0.804 . . . . 2.5 110.024 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.574 ' OD2' HG12 ' A' ' 43' ' ' VAL . 23.8 t70 -123.95 -91.46 0.54 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.989 -0.55 . . . . 4.56 112.008 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.574 HG12 ' OD2' ' A' ' 42' ' ' ASP . 14.7 p 175.55 -30.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 112.382 0.512 . . . . 3.73 112.382 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.473 HG23 ' H ' ' A' ' 46' ' ' GLU . 17.1 m -55.45 -169.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.005 0.372 . . . . 2.57 112.005 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.598 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 26.3 t -106.47 35.09 3.08 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.857 0.688 . . . . 1.34 112.857 -177.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.608 ' N ' HG21 ' A' ' 39' ' ' ILE . 34.8 tt0 -179.01 149.21 0.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.81 0.338 . . . . 1.6 110.815 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.542 ' CE2' ' NE2' ' A' ' 29' ' ' HIS . 9.4 t80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.239 -0.886 . . . . 4.12 110.803 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.564 ' HA3' ' HB3' ' A' ' 31' ' ' PRO . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.603 -0.199 . . . . 2.16 112.603 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.418 ' CA ' HG23 ' A' ' 23' ' ' ILE . 0.0 OUTLIER 62.0 7.92 2.32 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.42 0.526 . . . . 2.17 112.42 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.541 HG11 ' HD3' ' A' ' 7' ' ' LYS . 13.9 t -85.31 -50.37 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 120.897 0.379 . . . . 0.87 110.721 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 5' ' ' VAL . 34.5 t-20 93.25 69.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.55 -1.205 . . . . 1.86 108.553 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.541 ' HD3' HG11 ' A' ' 5' ' ' VAL . 17.0 pttp -150.41 -141.58 0.11 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.002 -0.999 . . . . 2.42 109.932 -177.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.708 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -48.1 102.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 121.486 0.66 . . . . 2.03 111.98 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.876 HD11 ' CZ ' ' A' ' 21' ' ' TYR . 5.1 tp -154.06 169.08 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.228 -0.589 . . . . 3.89 111.506 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.91 169.93 20.21 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.542 -0.361 . . . . 1.14 112.524 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.535 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 3.0 p -150.62 104.68 3.22 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 113.264 0.839 . . . . 1.69 113.264 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.428 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 12.6 mmt180 -157.93 103.38 1.87 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.295 -0.411 . . . . 3.7 111.723 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.591 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -125.28 -85.2 0.63 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.207 -0.933 . . . . 0.48 113.488 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.462 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -143.7 -61.36 0.4 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.094 0.405 . . . . 0.45 112.094 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 19' ' ' MET . . . 124.26 -46.98 1.05 Allowed Glycine 0 C--N 1.329 0.166 0 C-N-CA 120.434 -0.889 . . . . 0.72 112.522 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -59.26 -25.59 64.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.015 0.436 . . . . 2.82 110.517 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -141.43 -54.94 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.802 -0.919 . . . . 0.8 110.802 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.525 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . . . -128.76 150.98 50.06 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.454 -0.573 . . . . 0.51 109.454 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.462 ' HG2' ' N ' ' A' ' 14' ' ' ALA . 2.9 tmm? -162.49 22.61 0.1 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.351 0.871 . . . . 1.98 113.351 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.601 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 9.3 mm-40 -148.01 179.75 7.51 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.709 -0.848 . . . . 1.28 108.709 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.876 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -156.2 11.72 0.28 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.513 0.931 . . . . 4.88 113.513 -179.394 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.718 ' HB3' HG23 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -84.99 133.9 34.24 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 117.242 2.312 . . . . 4.63 117.242 -175.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.56 HD13 HG12 ' A' ' 9' ' ' ILE . 1.9 mp -64.4 -6.39 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-N 110.248 -3.16 . . . . 2.72 110.151 176.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.544 ' HB3' HD13 ' A' ' 22' ' ' LEU . 30.8 tt0 -47.83 -12.61 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.92 -0.582 . . . . 2.6 112.172 177.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.606 ' HZ2' ' H ' ' A' ' 32' ' ' SER . 0.2 OUTLIER -72.56 30.41 0.06 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.776 1.028 . . . . 1.71 113.776 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.6 mttm 46.18 35.57 2.68 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 118.048 0.385 . . . . 3.35 111.916 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.4 ' HB2' ' HG2' ' A' ' 4' ' ' GLU . 56.4 t0 62.68 25.34 15.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.955 0.407 . . . . 2.14 110.332 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -46.21 -66.57 1.64 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.408 -0.901 . . . . 0.86 111.393 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.546 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -135.35 99.57 4.27 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.934 -0.307 . . . . 2.9 110.612 178.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.485 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 20.1 m 37.18 111.8 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.495 0 N-CA-C 116.469 2.025 . . . . 1.46 116.469 176.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.564 ' HB3' ' HA3' ' A' ' 3' ' ' GLY . 7.3 Cg_exo -33.1 117.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 123.268 2.645 . . . . 0.79 108.935 173.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.606 ' H ' ' HZ2' ' A' ' 25' ' ' TRP . 18.6 t -150.1 176.16 11.07 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.496 0.924 . . . . 0.95 113.496 -173.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.614 ' CG ' ' HB2' ' A' ' 21' ' ' TYR . 12.0 t-105 -104.76 91.3 3.78 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.902 -0.777 . . . . 1.24 108.902 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 1.018 HG21 HG23 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -159.72 175.05 3.43 Favored Pre-proline 0 C--O 1.217 -0.616 0 CA-C-N 115.468 -0.787 . . . . 1.74 111.124 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.597 ' CD ' HG22 ' A' ' 34' ' ' VAL . 26.0 Cg_endo -92.02 142.45 2.59 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.756 2.971 . . . . 1.52 113.118 175.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 27.8 t 72.91 -57.56 0.63 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.965 -1.016 . . . . 1.75 113.65 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.579 ' HA ' ' CE3' ' A' ' 25' ' ' TRP . 42.9 m -148.72 -64.32 0.24 Allowed 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 114.937 1.458 . . . . 1.49 114.937 -177.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.679 ' CA ' HG11 ' A' ' 34' ' ' VAL . 7.9 t80 178.12 149.3 0.19 Allowed 'General case' 0 C--N 1.318 -0.771 0 O-C-N 121.759 -0.588 . . . . 5.43 110.407 -176.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.018 HG23 HG21 ' A' ' 34' ' ' VAL . 0.5 OUTLIER 176.45 74.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.61 0.719 . . . . 2.1 110.019 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.32 92.66 0.06 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.206 -0.906 . . . . 1.64 110.974 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 178.62 -31.9 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.5 -0.773 . . . . 2.5 111.182 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 77.26 25.88 0.74 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.089 -0.505 . . . . 4.56 110.661 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.583 HG23 ' CG2' ' A' ' 44' ' ' VAL . 29.8 m -121.31 0.5 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 3.73 112.106 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.798 ' O ' HG21 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -159.76 169.23 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-O 120.791 0.329 . . . . 2.57 110.947 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.47 ' CB ' ' HG2' ' A' ' 35' ' ' PRO . 47.4 t -105.32 26.03 9.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.971 -0.559 . . . . 1.34 111.281 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -178.8 148.62 0.42 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.028 0.381 . . . . 1.6 112.028 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' TYR . 9.3 t80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.224 -0.893 . . . . 4.12 110.8 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.517 ' O ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.45 -0.381 0 N-CA-C 112.555 -0.218 . . . . 2.16 112.555 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.456 ' HB2' ' CA ' ' A' ' 27' ' ' ASP . 9.4 pt-20 44.6 27.78 0.27 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.888 0.375 . . . . 2.17 111.006 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 3' ' ' GLY . 41.1 t -90.07 -8.97 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.16 -0.473 . . . . 0.87 111.846 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.577 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 3.2 t-20 49.14 73.06 0.25 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 110.313 -0.255 . . . . 1.86 110.313 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.618 ' N ' HD13 ' A' ' 23' ' ' ILE . 1.6 ptmm? -140.61 -98.92 0.15 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.298 0.481 . . . . 2.42 112.298 -178.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 8' ' ' ILE . 1.4 tp -137.4 105.34 3.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 CA-C-O 121.034 0.445 . . . . 2.03 110.902 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.946 HG22 ' CG1' ' A' ' 23' ' ' ILE . 3.4 tt -151.85 173.77 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.783 -0.644 . . . . 3.89 110.579 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -100.66 167.59 20.05 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.214 -0.517 . . . . 1.14 113.176 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.771 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 13.6 p -153.63 103.9 2.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 1.69 111.896 -177.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -158.99 102.88 1.65 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.608 -0.724 . . . . 3.7 110.043 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.47 ' H ' ' HA ' ' A' ' 19' ' ' MET . 1.0 OUTLIER -108.7 -85.2 0.53 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.815 1.043 . . . . 0.48 113.815 -178.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.448 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -145.38 -54.16 0.29 Allowed 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.163 0.431 . . . . 0.45 112.163 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.83 -34.84 4.68 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.291 -0.957 . . . . 0.72 112.268 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.0 -32.82 70.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.532 0.682 . . . . 2.82 109.183 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.581 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -141.09 -55.72 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.807 -1.088 . . . . 0.8 110.554 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.599 ' CA ' ' HD3' ' A' ' 35' ' ' PRO . . . -120.28 150.0 41.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.816 -0.192 . . . . 0.51 111.001 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.523 ' H ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -155.46 37.36 0.38 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.032 0.752 . . . . 1.98 113.032 178.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.636 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 27.8 mt-10 -151.81 -169.45 3.37 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 119.43 -0.319 . . . . 1.28 110.466 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.835 ' O ' ' CH2' ' A' ' 25' ' ' TRP 0.269 2.5 t80 -152.76 -130.77 0.04 OUTLIER 'General case' 0 C--O 1.209 -1.029 0 N-CA-C 116.057 1.873 . . . . 4.88 116.057 -177.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.598 ' N ' ' CD1' ' A' ' 21' ' ' TYR . 4.4 mt -78.94 166.67 22.12 Favored 'General case' 0 CA--C 1.491 -1.326 0 O-C-N 120.402 -1.437 . . . . 4.63 114.651 -166.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.946 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.9 OUTLIER 45.5 -166.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 112.848 -1.978 . . . . 2.72 109.679 -179.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.773 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.6 OUTLIER 71.08 9.85 6.77 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.721 -0.844 . . . . 2.6 108.721 -177.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.835 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -143.48 -173.55 3.98 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 108.694 -0.854 . . . . 1.71 108.694 178.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 4.0 mppt? -122.29 65.2 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.604 -0.439 . . . . 3.35 111.99 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.456 ' CA ' ' HB2' ' A' ' 4' ' ' GLU . 3.5 p30 40.63 29.01 0.06 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.283 -0.417 . . . . 2.14 112.105 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.736 ' N ' ' OH ' ' A' ' 38' ' ' TYR . . . -46.7 -62.92 3.4 Favored Glycine 0 C--N 1.329 0.16 0 C-N-CA 120.601 -0.809 . . . . 0.86 113.248 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.571 ' CE1' ' CE2' ' A' ' 47' ' ' TYR . 68.4 t60 -133.09 96.3 3.73 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 117.724 0.762 . . . . 2.9 111.153 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 31' ' ' PRO . 13.8 m 40.47 99.98 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 118.575 -0.726 . . . . 1.46 112.874 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.447 ' C ' ' O ' ' A' ' 30' ' ' SER . 17.9 Cg_exo -27.51 124.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.368 2.712 . . . . 0.79 110.789 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.8 t -148.93 -168.81 3.2 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.525 0.935 . . . . 0.95 113.525 -173.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.646 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 3.7 t-105 -116.08 95.56 5.15 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.254 -1.387 . . . . 1.24 107.254 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.728 HG13 ' CD ' ' A' ' 35' ' ' PRO . 1.0 OUTLIER -157.87 166.3 16.85 Favored Pre-proline 0 C--O 1.221 -0.401 0 CA-C-N 115.872 -0.604 . . . . 1.74 112.469 -178.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.728 ' CD ' HG13 ' A' ' 34' ' ' VAL . 12.1 Cg_endo -56.03 69.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.475 0.438 1 C-N-CA 125.44 4.094 . . . . 1.52 116.129 177.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.4 m 60.94 31.21 19.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.436 0.636 . . . . 1.75 110.794 176.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.577 ' O ' ' CZ3' ' A' ' 25' ' ' TRP . 1.5 m -150.79 -131.57 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.859 -1.064 . . . . 1.49 108.445 177.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.736 ' OH ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -174.59 99.91 0.09 Allowed 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 106.374 -1.713 . . . . 5.43 106.374 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.758 HD11 ' H ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -155.2 83.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.184 -1.371 . . . . 2.1 107.691 -175.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.67 91.05 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.585 -1.189 . . . . 1.64 111.504 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 46.41 59.3 3.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.08 -0.964 . . . . 2.5 111.772 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.819 ' O ' HG13 ' A' ' 43' ' ' VAL . 25.2 t70 -122.58 -20.95 5.84 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.788 0.662 . . . . 4.56 112.788 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.819 HG13 ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -179.03 -95.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 112.089 0.403 . . . . 3.73 112.089 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 17' ' ' GLY . 4.8 p -179.74 124.93 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 113.159 0.8 . . . . 2.57 113.159 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.501 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 28.8 t 65.87 10.38 6.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.92 -1.037 . . . . 1.34 113.72 176.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.475 ' H ' HG21 ' A' ' 39' ' ' ILE . 2.6 mt-10 176.98 166.38 0.53 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.773 0.657 . . . . 1.6 112.773 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.571 ' CE2' ' CE1' ' A' ' 29' ' ' HIS . 43.6 t80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.22 -0.895 . . . . 4.12 110.344 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 4' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.484 -0.246 . . . . 2.16 112.484 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 27' ' ' ASP . 6.5 pt-20 51.37 21.48 1.19 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.861 0.362 . . . . 2.17 111.6 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.657 ' N ' HG22 ' A' ' 23' ' ' ILE . 18.6 t -78.62 -6.05 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 113.271 0.841 . . . . 0.87 113.271 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.665 ' H ' HG22 ' A' ' 23' ' ' ILE . 26.0 t-20 38.28 85.79 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.843 0.292 . . . . 1.86 110.594 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.447 ' HD3' ' CG1' ' A' ' 5' ' ' VAL . 22.2 pttp -150.99 -135.04 0.06 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 121.098 -0.241 . . . . 2.42 110.563 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.653 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.9 OUTLIER -105.49 97.92 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 112.874 0.694 . . . . 2.03 112.874 -178.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.896 ' HB ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -133.46 172.93 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 116.171 -0.468 . . . . 3.89 111.925 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.623 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -99.86 165.38 19.9 Favored Glycine 0 C--O 1.219 -0.815 0 N-CA-C 110.138 -1.185 . . . . 1.14 110.138 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.552 ' HA ' ' HB2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -155.55 109.37 2.82 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 117.916 0.858 . . . . 1.69 113.077 -176.466 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 11' ' ' SER . 2.1 mpt_? -154.63 103.21 2.44 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.38 -0.373 . . . . 3.7 111.196 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.766 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -106.24 -82.72 0.53 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.397 0.888 . . . . 0.48 113.397 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.41 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -146.31 -53.25 0.25 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.072 0.397 . . . . 0.45 112.072 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.49 -35.91 4.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.291 -0.957 . . . . 0.72 112.839 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -58.69 -30.09 67.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.325 0.583 . . . . 2.82 109.762 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.514 ' HA3' ' CG2' ' A' ' 43' ' ' VAL . . . -150.39 -46.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.236 -0.893 . . . . 0.8 110.899 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.62 ' CA ' ' HD3' ' A' ' 35' ' ' PRO . . . -121.53 142.12 50.38 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 121.034 -0.266 . . . . 0.51 111.045 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.55 ' HA ' ' H ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -153.49 39.14 0.49 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.66 0.615 . . . . 1.98 112.66 178.38 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.63 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 27.9 mt-10 -145.79 -151.4 0.37 Allowed 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 118.371 -0.823 . . . . 1.28 111.378 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.851 ' CE2' HD11 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -153.24 -97.19 0.05 OUTLIER 'General case' 0 C--O 1.203 -1.345 0 N-CA-C 119.725 3.231 . . . . 4.88 119.725 -174.228 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.802 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 13.2 tp -120.57 168.6 11.19 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 113.035 0.754 . . . . 4.63 113.035 -174.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.896 HD11 ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER 38.5 -142.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.579 -1.191 . . . . 2.72 110.435 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 53.29 19.32 1.51 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.609 1.095 . . . . 2.6 109.464 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.637 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -152.77 -173.19 4.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.731 -0.668 . . . . 1.71 109.756 -179.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -122.52 62.75 0.97 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.792 0.664 . . . . 3.35 112.792 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . 31.2 t70 46.22 26.11 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.187 0.44 . . . . 2.14 112.187 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.579 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -47.52 -61.04 4.9 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 119.707 -1.235 . . . . 0.86 111.884 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.49 ' O ' ' HB2' ' A' ' 38' ' ' TYR . 58.3 t-80 -134.05 95.8 3.5 Favored 'General case' 0 C--O 1.215 -0.721 0 C-N-CA 119.966 -0.694 . . . . 2.9 111.575 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 29' ' ' HIS . 14.8 m 37.88 105.63 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 114.215 1.191 . . . . 1.46 114.215 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.553 ' HB3' HD11 ' A' ' 22' ' ' LEU . 23.7 Cg_exo -30.55 116.86 0.06 OUTLIER 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 123.038 2.492 . . . . 0.79 110.31 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 21' ' ' TYR . 8.5 t -135.94 -150.44 0.37 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.36 0.874 . . . . 0.95 113.36 -173.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.766 ' CD1' HG23 ' A' ' 13' ' ' THR . 6.8 t-105 -135.0 95.08 3.24 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 106.141 -1.8 . . . . 1.24 106.141 174.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.864 HG11 HG22 ' A' ' 39' ' ' ILE . 1.4 t -156.75 162.04 28.36 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 115.132 -0.94 . . . . 1.74 113.092 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.815 ' CD ' HG13 ' A' ' 34' ' ' VAL . 18.6 Cg_endo -55.31 72.5 0.03 OUTLIER 'Trans proline' 0 N--CA 1.477 0.502 1 C-N-CA 126.784 4.989 . . . . 1.52 115.488 177.24 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 35.3 t 65.04 23.7 12.5 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.748 -0.381 . . . . 1.75 111.742 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.547 ' O ' ' CZ3' ' A' ' 25' ' ' TRP . 7.3 m -149.06 -123.06 0.05 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.23 -0.441 . . . . 1.49 110.262 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.579 ' CZ ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -176.83 107.79 0.07 Allowed 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.81 -1.552 . . . . 5.43 106.81 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.864 HG22 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -174.9 39.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 122.937 1.351 . . . . 2.1 108.51 -175.426 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 33' ' ' TRP . . . -77.04 90.14 3.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.862 -1.517 . . . . 1.64 110.596 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.41 -34.87 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.391 -1.277 . . . . 2.5 109.923 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.445 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 32.0 t70 -102.03 -99.48 0.27 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.889 -0.596 . . . . 4.56 111.895 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.2 p 174.09 68.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 119.841 -0.123 . . . . 3.73 110.971 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.484 ' CG2' HG12 ' A' ' 39' ' ' ILE . 25.2 m -156.81 169.99 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 113.995 1.109 . . . . 2.57 113.995 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.638 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 28.2 t -83.44 10.8 7.99 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.607 -1.178 . . . . 1.34 112.487 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.45 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 36.8 tt0 179.16 161.13 0.74 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.113 0.483 . . . . 1.6 111.963 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.481 ' CD2' ' OXT' ' A' ' 47' ' ' TYR . 38.1 p90 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.265 -0.874 . . . . 4.12 110.917 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.625 ' O ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 112.657 -0.177 . . . . 2.16 112.657 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.475 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.0 OUTLIER 56.11 18.09 3.03 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.863 0.363 . . . . 2.17 111.072 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 3' ' ' GLY . 12.7 t -106.79 -4.14 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.33 . . . . 0.87 111.429 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.557 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 9.7 p30 45.28 79.73 0.05 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.33 0.586 . . . . 1.86 110.886 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.426 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 6.2 pttp -143.99 -104.71 0.12 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.138 -0.937 . . . . 2.42 110.442 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.635 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -87.06 103.67 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 108.354 -0.98 . . . . 2.03 108.354 178.458 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.764 HG21 ' HB2' ' A' ' 22' ' ' LEU . 21.9 pt -104.2 165.73 3.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.917 0.865 . . . . 3.89 113.082 -177.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.4 138.83 9.29 Favored Glycine 0 CA--C 1.498 -0.983 0 N-CA-C 107.454 -2.258 . . . . 1.14 107.454 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.49 ' HB2' ' CB ' ' A' ' 20' ' ' GLU . 12.4 p -144.59 104.45 4.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 119.062 1.431 . . . . 1.69 113.415 -176.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.418 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 31.2 ttm180 -159.94 101.09 1.44 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.452 -1.249 . . . . 3.7 111.091 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.536 ' HB ' ' C ' ' A' ' 18' ' ' ALA . 2.9 m -116.68 -87.99 0.6 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 113.981 1.104 . . . . 0.48 113.981 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.41 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -148.63 -60.0 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.218 -0.593 . . . . 0.45 112.581 -177.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.458 ' N ' ' HG3' ' A' ' 19' ' ' MET . . . 125.24 -34.98 3.22 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.327 -0.94 . . . . 0.72 112.13 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -30.28 66.74 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.256 -0.646 . . . . 2.82 109.256 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -146.43 -47.38 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.137 -0.938 . . . . 0.8 110.931 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.566 ' CA ' ' HD3' ' A' ' 35' ' ' PRO . . . -127.02 151.78 48.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 111.488 0.181 . . . . 0.51 111.488 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.458 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 1.6 ttm -151.66 22.0 0.7 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.891 0.33 . . . . 1.98 111.891 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.615 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 18.9 mt-10 -148.36 177.85 9.09 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 122.287 -0.258 . . . . 1.28 111.407 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.67 ' CG ' ' O ' ' A' ' 21' ' ' TYR . 1.0 OUTLIER -159.09 50.91 0.37 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.514 0.673 . . . . 4.88 111.701 -179.413 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.764 ' HB2' HG21 ' A' ' 9' ' ' ILE . 2.0 pp -110.15 114.05 27.24 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 116.266 1.95 . . . . 4.63 116.266 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.656 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 8.2 pt -53.89 -16.92 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 113.195 -1.821 . . . . 2.72 112.376 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.557 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . 35.1 tt0 -67.3 65.51 0.07 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.242 0.544 . . . . 2.6 111.212 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.656 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -142.97 31.69 1.4 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.568 -0.742 . . . . 1.71 110.225 178.439 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 60.06 34.17 21.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.288 -0.869 . . . . 3.35 111.908 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.464 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 4.2 p30 44.77 29.17 0.41 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.88 0.371 . . . . 2.14 111.282 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.467 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -47.63 -61.95 4.37 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.676 -0.774 . . . . 0.86 112.338 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.57 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 35.8 t60 -135.26 93.71 3.02 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 110.01 -0.367 . . . . 2.9 110.01 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 32' ' ' SER . 28.9 m 39.57 116.39 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 116.3 1.963 . . . . 1.46 116.3 177.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.592 ' HB3' HG22 ' A' ' 23' ' ' ILE . 14.2 Cg_exo -32.08 92.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 124.138 3.226 . . . . 0.79 107.749 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 30' ' ' SER . 33.8 t -111.72 166.32 11.28 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.334 -1.303 . . . . 0.95 113.849 -172.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.626 ' CZ3' ' CD2' ' A' ' 21' ' ' TYR . 15.0 t-105 -97.87 91.23 5.24 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 105.656 -1.979 . . . . 1.24 105.656 176.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.715 HG21 HG23 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -156.36 165.55 18.39 Favored Pre-proline 0 N--CA 1.441 -0.882 0 N-CA-C 113.887 1.069 . . . . 1.74 113.887 -178.376 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.674 ' HD2' HG22 ' A' ' 34' ' ' VAL . 38.2 Cg_endo -67.58 78.05 0.51 Allowed 'Trans proline' 0 C--N 1.352 0.728 1 C-N-CA 125.791 4.327 . . . . 1.52 117.609 177.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.8 m 76.09 14.5 2.52 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.641 0.978 . . . . 1.75 113.641 173.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.547 ' O ' ' CE3' ' A' ' 25' ' ' TRP . 1.8 m -162.54 -110.6 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 120.571 -0.451 . . . . 1.49 112.029 176.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.57 ' CG ' ' HB3' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -174.49 132.82 0.37 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.997 -1.853 . . . . 5.43 105.997 -176.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.715 HG23 HG21 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -149.68 28.98 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 119.377 -0.929 . . . . 2.1 111.118 -174.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.566 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -60.86 89.43 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.574 -0.739 . . . . 1.64 110.25 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.566 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 153.69 38.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.839 -1.073 . . . . 2.5 110.705 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 55.83 87.51 0.05 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.429 0.529 . . . . 4.56 112.429 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.592 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -151.59 -156.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 110.05 -0.352 . . . . 3.73 110.05 178.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 44' ' ' VAL . 8.3 p -159.29 120.59 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 113.702 1.001 . . . . 2.57 113.702 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.549 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 28.8 t 63.44 8.71 3.68 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.202 0.816 . . . . 1.34 113.202 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 45' ' ' SER . 38.0 tt0 179.23 154.99 0.47 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.912 0.387 . . . . 1.6 111.931 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 39' ' ' ILE . 35.4 t80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.2 -0.905 . . . . 4.12 110.833 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.437 ' C ' ' HG3' ' A' ' 31' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.495 -0.242 . . . . 2.16 112.495 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.485 ' H ' HG23 ' A' ' 23' ' ' ILE . 0.0 OUTLIER 64.97 3.78 2.23 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 112.179 0.437 . . . . 2.17 112.179 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.497 ' HB ' ' HG2' ' A' ' 7' ' ' LYS . 24.1 t -79.74 -41.21 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 CA-C-O 121.317 0.579 . . . . 0.87 110.807 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.473 ' H ' ' CG2' ' A' ' 23' ' ' ILE . 0.3 OUTLIER 81.68 71.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.821 -1.081 . . . . 1.86 108.421 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.846 ' HD3' HG22 ' A' ' 8' ' ' ILE . 5.3 ptpt -152.41 -107.12 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 112.986 0.736 . . . . 2.42 112.986 -176.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.846 HG22 ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -79.49 97.95 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 C-N-CA 123.217 0.607 . . . . 2.03 110.105 -179.22 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.902 HD11 ' CZ ' ' A' ' 21' ' ' TYR . 3.2 tp -153.42 170.49 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 C-N-CA 120.008 -0.677 . . . . 3.89 111.615 -178.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.24 169.18 20.63 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 121.276 -0.487 . . . . 1.14 111.982 -175.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.534 ' HB2' ' CB ' ' A' ' 20' ' ' GLU . 11.8 p -151.14 102.41 2.94 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 113.403 0.89 . . . . 1.69 113.403 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -163.3 97.32 0.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 119.176 -0.44 . . . . 3.7 111.255 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.761 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -105.02 -81.12 0.54 Allowed 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 119.022 -1.071 . . . . 0.48 113.742 177.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.414 ' C ' ' HG2' ' A' ' 19' ' ' MET . . . -150.81 -55.85 0.16 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.824 0.675 . . . . 0.45 112.824 -177.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.486 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . 122.49 -45.35 1.21 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.483 -0.865 . . . . 0.72 111.656 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -59.17 -32.17 69.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.036 -0.727 . . . . 2.82 109.036 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.703 ' HA2' HG12 ' A' ' 44' ' ' VAL . . . -132.46 -68.52 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.03 -0.986 . . . . 0.8 110.948 178.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 1.031 ' HB2' HD11 ' A' ' 39' ' ' ILE . . . -111.48 155.65 22.9 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 119.774 -0.155 . . . . 0.51 110.845 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.504 ' HA ' ' H ' ' A' ' 13' ' ' THR . 0.9 OUTLIER -153.85 16.07 0.5 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.75 1.018 . . . . 1.98 113.75 179.209 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.69 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 18.2 mt-10 -152.69 178.91 9.11 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 119.367 -0.349 . . . . 1.28 110.131 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.902 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 1.1 t80 -160.05 12.94 0.12 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.445 1.276 . . . . 4.88 114.445 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.694 ' HB3' HG23 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -85.43 125.64 33.17 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 117.916 2.561 . . . . 4.63 117.916 -175.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.684 HD12 ' HB ' ' A' ' 9' ' ' ILE . 5.7 mt -48.56 -22.48 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-N 111.266 -2.697 . . . . 2.72 110.868 174.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.54 ' HB3' HD13 ' A' ' 22' ' ' LEU . 23.6 tt0 -29.34 -32.19 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.839 0.856 . . . . 2.6 112.517 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.676 ' CZ3' ' CG1' ' A' ' 34' ' ' VAL . 0.4 OUTLIER -55.96 -163.4 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.26 -0.645 . . . . 1.71 109.26 177.014 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.431 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -114.62 54.61 0.77 Allowed 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.513 -0.742 . . . . 3.35 111.104 -178.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.423 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 4.2 p30 44.36 28.41 0.29 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.918 -0.583 . . . . 2.14 111.256 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.512 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -49.54 -65.63 2.69 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.471 -0.871 . . . . 0.86 112.087 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.447 ' O ' ' O ' ' A' ' 30' ' ' SER . 41.5 m-70 -134.56 94.85 3.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.706 -0.398 . . . . 2.9 110.432 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 29' ' ' HIS . 29.5 t 41.26 114.47 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 116.058 1.873 . . . . 1.46 116.058 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.501 ' HB3' HG12 ' A' ' 23' ' ' ILE . 8.0 Cg_exo -30.96 95.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 124.022 3.148 . . . . 0.79 108.167 172.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.565 ' OG ' ' HB2' ' A' ' 40' ' ' ALA . 33.5 t -119.43 176.67 5.24 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-N 114.462 -1.245 . . . . 0.95 113.782 -172.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.761 ' CD1' HG23 ' A' ' 13' ' ' THR . 4.3 t-105 -104.79 99.83 9.47 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.326 -1.761 . . . . 1.24 107.18 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.948 HG11 ' C ' ' A' ' 37' ' ' SER . 7.4 p -152.42 155.44 32.92 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 115.166 -0.925 . . . . 1.74 111.591 -175.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.757 ' HD2' HG23 ' A' ' 34' ' ' VAL . 53.5 Cg_exo -55.03 -12.75 5.41 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 124.17 3.247 . . . . 1.52 115.789 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 19.4 p 174.07 -19.32 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.328 0.862 . . . . 1.75 113.328 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.948 ' C ' HG11 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -115.32 -95.39 0.47 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.179 0.445 . . . . 1.49 111.7 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.743 ' N ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -178.44 122.98 0.1 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.296 -1.372 . . . . 5.43 107.296 -178.336 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.031 HD11 ' HB2' ' A' ' 18' ' ' ALA . 5.1 pt -145.64 32.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 119.904 -0.718 . . . . 2.1 111.139 -176.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.565 ' HB2' ' OG ' ' A' ' 32' ' ' SER . . . -60.22 90.57 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.944 -1.026 . . . . 1.64 110.489 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 162.5 -61.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.888 -1.051 . . . . 2.5 109.736 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 13.5 t70 165.71 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.918 -0.583 . . . . 4.56 111.406 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.677 HG11 ' O ' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -147.58 -159.51 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 110.083 -0.34 . . . . 3.73 110.083 178.708 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.703 HG12 ' HA2' ' A' ' 17' ' ' GLY . 13.0 m -146.91 109.78 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 113.426 0.898 . . . . 2.57 113.426 -178.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.475 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . 47.2 t 54.26 16.17 1.14 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.816 -0.629 . . . . 1.34 112.481 178.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.417 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 3.0 tt0 178.36 132.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.566 -0.453 . . . . 1.6 111.703 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.677 ' O ' HG11 ' A' ' 43' ' ' VAL . 91.7 t80 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.244 -0.884 . . . . 4.12 110.67 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 31' ' ' PRO . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.487 -0.245 . . . . 2.16 112.487 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.462 ' CB ' ' HB3' ' A' ' 27' ' ' ASP . 1.2 pp20? 44.88 26.15 0.19 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.925 0.393 . . . . 2.17 111.996 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.53 HG11 ' HD3' ' A' ' 7' ' ' LYS . 38.8 t -79.8 -11.91 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.042 -0.527 . . . . 0.87 112.357 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.578 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 10.3 t-20 43.22 81.53 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.496 0.665 . . . . 1.86 109.871 -178.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.53 ' HD3' HG11 ' A' ' 5' ' ' VAL . 62.3 pttt -150.95 -134.02 0.06 Allowed 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.667 -1.151 . . . . 2.42 109.499 -177.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.66 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -96.52 113.69 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 120.989 0.423 . . . . 2.03 110.512 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.793 HD12 ' HB2' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -151.06 167.92 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 119.524 -0.87 . . . . 3.89 112.221 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.716 ' H ' HD13 ' A' ' 9' ' ' ILE . . . -104.12 168.21 16.59 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.75 -0.659 . . . . 1.14 112.703 -178.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.66 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 1.2 p -153.94 103.96 2.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 1.69 111.589 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -157.8 102.15 1.83 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.239 -0.437 . . . . 3.7 110.956 178.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.707 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -110.76 -82.66 0.58 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 119.243 -0.983 . . . . 0.48 113.642 179.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.05 -56.72 0.2 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.194 0.442 . . . . 0.45 112.194 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.51 -40.72 2.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.408 -0.901 . . . . 0.72 112.422 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.53 -25.25 64.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.975 0.417 . . . . 2.82 110.301 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 43' ' ' VAL . . . -149.12 -45.92 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.511 -0.636 . . . . 0.8 111.511 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.537 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -131.07 152.59 50.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.767 -0.457 . . . . 0.51 109.767 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.5 ' HA ' ' H ' ' A' ' 13' ' ' THR . 2.8 ttt -163.01 31.68 0.1 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.202 1.186 . . . . 1.98 114.202 -178.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.628 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 35.5 mt-10 -150.64 -160.55 1.18 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 117.508 -1.234 . . . . 1.28 108.618 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 1.146 ' CE1' HD13 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -153.45 -79.35 0.1 Allowed 'General case' 0 C--O 1.204 -1.327 1 N-CA-C 122.151 4.13 . . . . 4.88 122.151 -175.797 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.146 HD13 ' CE1' ' A' ' 21' ' ' TYR . 3.9 tp -114.22 166.59 11.49 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 115.401 1.63 . . . . 4.63 115.401 -173.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.578 ' HB ' ' HA ' ' A' ' 6' ' ' ASN . 1.3 pp 23.75 -150.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 111.956 -2.383 . . . . 2.72 113.03 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.495 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER 63.07 16.56 9.42 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.038 -0.727 . . . . 2.6 109.038 -178.722 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.614 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.3 OUTLIER -152.24 31.14 0.54 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.154 0.502 . . . . 1.71 111.401 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt 17.08 74.55 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.332 1.605 . . . . 3.35 115.332 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.462 ' HB3' ' CB ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 39.16 67.58 0.43 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.6 0.963 . . . . 2.14 113.6 176.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.577 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -88.18 -62.24 1.44 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.524 -1.322 . . . . 0.86 109.953 177.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.549 ' CD2' ' CD2' ' A' ' 47' ' ' TYR . 48.3 t-80 -133.2 94.78 3.4 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 109.544 -0.539 . . . . 2.9 109.544 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 31' ' ' PRO . 18.1 t 37.52 98.14 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 113.873 1.064 . . . . 1.46 113.873 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.432 ' C ' ' O ' ' A' ' 30' ' ' SER . 52.9 Cg_exo -27.08 106.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.349 2.7 . . . . 0.79 110.896 176.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 21' ' ' TYR . 8.7 t -122.18 -149.85 0.44 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.421 -0.809 . . . . 0.95 112.309 -173.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.707 ' CD1' HG23 ' A' ' 13' ' ' THR . 6.9 t-105 -137.87 94.48 2.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.069 -1.826 . . . . 1.24 106.069 174.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 1.078 HG13 ' HD2' ' A' ' 35' ' ' PRO . 1.4 t -156.26 165.25 19.02 Favored Pre-proline 0 C--O 1.218 -0.553 0 CA-C-N 116.053 -0.521 . . . . 1.74 111.759 -176.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 1.078 ' HD2' HG13 ' A' ' 34' ' ' VAL . 14.5 Cg_exo -63.81 81.3 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.286 2.657 . . . . 1.52 116.039 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.3 t 63.73 28.27 14.86 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.019 0.438 . . . . 1.75 111.365 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.592 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 5.6 t -151.78 -127.31 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.802 -0.635 . . . . 1.49 110.563 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.592 ' CG ' ' C ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -175.8 102.34 0.07 Allowed 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.317 -1.364 . . . . 5.43 107.317 -177.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.804 HG22 HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -158.98 72.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.978 1.371 . . . . 2.1 108.679 -176.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.96 91.31 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.461 -1.7 . . . . 1.64 110.821 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 42' ' ' ASP . . . -166.36 -35.19 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.551 -1.204 . . . . 2.5 110.921 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 15.2 t70 80.86 30.19 0.17 Allowed 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.183 -0.462 . . . . 4.56 110.31 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.8 HG13 HG23 ' A' ' 44' ' ' VAL . 8.9 p -127.85 -3.53 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 112.885 0.698 . . . . 3.73 112.885 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.8 HG23 HG13 ' A' ' 43' ' ' VAL . 3.6 t -158.32 153.38 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.253 0.549 . . . . 2.57 111.787 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.502 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 18.6 p -93.57 21.67 6.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.343 -0.844 . . . . 1.34 111.179 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.484 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 12.4 tt0 -178.99 141.15 0.17 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 120.424 -0.51 . . . . 1.6 112.153 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.549 ' CD2' ' CD2' ' A' ' 29' ' ' HIS . 75.4 t80 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.268 -0.873 . . . . 4.12 110.762 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.961 ' HA2' HD12 ' A' ' 23' ' ' ILE . . . . . . . . 0 CA--C 1.521 0.449 0 N-CA-C 112.557 -0.217 . . . . 2.16 112.557 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 61.48 18.66 9.61 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.431 0.634 . . . . 2.17 111.583 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.748 ' HB ' HD11 ' A' ' 23' ' ' ILE . 23.2 t -107.08 -9.51 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.046 -0.524 . . . . 0.87 111.621 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 44.1 t-20 50.72 88.33 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.021 0.439 . . . . 1.86 110.177 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.446 ' O ' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -138.36 -147.77 0.24 Allowed 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.876 -0.787 . . . . 2.42 108.876 -178.295 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.3 OUTLIER -65.08 117.44 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 109.824 -0.435 . . . . 2.03 109.824 178.347 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.78 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -129.25 136.25 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 114.096 1.147 . . . . 3.89 114.096 -178.125 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -116.51 106.97 1.55 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 107.693 -2.163 . . . . 1.14 107.693 176.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.667 ' CB ' ' CD2' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -102.76 108.34 19.53 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 114.736 1.384 . . . . 1.69 114.736 -174.722 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -158.18 102.69 1.79 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 112.91 -1.95 . . . . 3.7 112.39 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.515 ' CB ' ' HA ' ' A' ' 19' ' ' MET . 0.2 OUTLIER -111.74 -82.29 0.58 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.25 -0.906 . . . . 0.48 112.478 178.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.429 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -140.61 -50.82 0.46 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.689 0.281 . . . . 0.45 111.416 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.455 ' CA ' ' HG3' ' A' ' 19' ' ' MET . . . 110.74 -44.41 1.51 Allowed Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.312 -0.947 . . . . 0.72 112.732 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -58.62 -24.98 62.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.229 0.538 . . . . 2.82 109.811 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.517 ' HA3' ' CB ' ' A' ' 43' ' ' VAL . . . -145.14 -69.32 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.519 -1.032 . . . . 0.8 110.519 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.656 ' HB1' ' HA ' ' A' ' 34' ' ' VAL . . . -105.18 150.46 25.06 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.407 -0.59 . . . . 0.51 109.407 178.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.515 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 2.4 tmm? -165.01 42.48 0.08 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 114.218 1.192 . . . . 1.98 114.218 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.614 ' HA ' ' OG ' ' A' ' 11' ' ' SER . 32.0 mt-10 -143.47 -147.8 0.22 Allowed 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 114.398 1.259 . . . . 1.28 114.398 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.724 ' CE2' ' CG1' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -113.27 -174.41 2.45 Favored 'General case' 0 CA--C 1.456 -2.659 0 C-N-CA 124.837 1.255 . . . . 4.88 112.097 -173.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.583 ' HB3' ' N ' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -127.39 78.64 1.83 Allowed 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 115.823 1.786 . . . . 4.63 115.823 175.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.961 HD12 ' HA2' ' A' ' 3' ' ' GLY . 4.6 tt 152.41 71.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.136 0 N-CA-C 113.75 1.019 . . . . 2.72 113.75 171.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.74 ' HB2' HG21 ' A' ' 9' ' ' ILE . 14.2 tt0 178.58 59.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.154 -0.475 . . . . 2.6 111.96 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.539 ' CD1' ' N ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -154.22 29.86 0.44 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.854 0.359 . . . . 1.71 110.898 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.465 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 9.6 mptt 55.17 22.54 4.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.217 -0.447 . . . . 3.35 110.816 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.43 ' HB2' ' HG3' ' A' ' 4' ' ' GLU . 16.1 t70 59.29 109.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.588 0.709 . . . . 2.14 111.617 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.568 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -121.08 -62.52 0.24 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 109.857 -1.297 . . . . 0.86 109.857 178.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.473 ' O ' ' CB ' ' A' ' 38' ' ' TYR . 39.7 m80 -135.17 94.45 3.13 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.605 -0.517 . . . . 2.9 109.605 177.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.46 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 15.5 m 39.99 102.69 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 113.338 0.866 . . . . 1.46 113.338 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 14.8 Cg_exo -25.69 125.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.877 3.052 . . . . 0.79 109.705 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.549 ' C ' ' HB3' ' A' ' 22' ' ' LEU . 3.8 t -154.19 138.95 17.05 Favored 'General case' 0 C--O 1.21 -0.989 0 N-CA-C 114.62 1.341 . . . . 0.95 114.62 -171.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.583 ' N ' ' HB3' ' A' ' 22' ' ' LEU . 5.5 t-105 -83.6 96.58 8.69 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.593 -2.373 . . . . 1.24 104.593 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 1.016 HG12 ' HD3' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -150.88 -159.73 0.04 OUTLIER Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-N 113.271 -1.786 . . . . 1.74 107.631 -175.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 1.016 ' HD3' HG12 ' A' ' 34' ' ' VAL . 60.5 Cg_endo -95.25 99.01 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 122.708 2.003 . . . . 1.52 116.683 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.45 ' H ' ' CG ' ' A' ' 20' ' ' GLU . 47.0 t 55.18 16.79 1.74 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.709 -0.678 . . . . 1.75 112.223 176.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.557 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 50.4 m -162.76 -109.65 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 120.402 -0.519 . . . . 1.49 111.48 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.568 ' OH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -177.71 102.07 0.05 OUTLIER 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 106.645 -1.613 . . . . 5.43 106.645 -176.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.71 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -159.05 71.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.418 -0.81 . . . . 2.1 110.199 -176.078 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.65 91.6 5.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.974 -1.012 . . . . 1.64 110.676 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.8 -43.74 0.15 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.999 -1.001 . . . . 2.5 109.964 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.799 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.8 m-20 -142.53 -74.14 0.29 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.841 -0.618 . . . . 4.56 111.242 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 175.46 74.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.234 -0.439 . . . . 3.73 111.354 -178.375 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 35' ' ' PRO . 24.0 t -133.84 150.33 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 120.957 -0.297 . . . . 2.57 111.757 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.552 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 45.4 t -68.07 1.79 2.53 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.372 1.249 . . . . 1.34 114.372 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.477 ' N ' HG21 ' A' ' 39' ' ' ILE . 38.0 tt0 -179.59 155.67 0.67 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.607 0.242 . . . . 1.6 110.695 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.425 ' N ' ' HB ' ' A' ' 39' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.186 -0.911 . . . . 4.12 110.47 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.55 ' HA2' HG23 ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.671 -0.172 . . . . 2.16 112.671 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.522 ' CG ' ' HB3' ' A' ' 27' ' ' ASP . 1.1 tm-20 51.16 54.27 11.48 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 122.549 1.166 . . . . 2.17 109.268 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 3' ' ' GLY . 12.0 t -131.42 -24.25 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.033 -0.985 . . . . 0.87 112.49 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 50.96 78.26 0.11 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.188 -0.671 . . . . 1.86 109.188 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.463 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -138.39 -98.16 0.18 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.844 0.683 . . . . 2.42 112.844 -176.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 8' ' ' ILE . 2.3 tp -137.69 114.03 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 109.765 -0.457 . . . . 2.03 109.765 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 1.036 HG23 ' CE2' ' A' ' 21' ' ' TYR . 6.4 tp -150.03 165.06 3.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.315 -0.402 . . . . 3.89 111.987 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.496 ' N ' HG13 ' A' ' 9' ' ' ILE . . . -111.57 115.99 4.05 Favored Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.0 -1.24 . . . . 1.14 110.0 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.823 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -101.11 106.36 17.61 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 123.063 1.411 . . . . 1.69 112.819 -174.497 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -157.93 109.02 2.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 111.723 -2.49 . . . . 3.7 111.987 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.524 ' HB ' ' HA ' ' A' ' 19' ' ' MET . 3.2 m -115.24 -80.92 0.6 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.703 0.631 . . . . 0.48 112.703 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.69 -59.92 0.33 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.341 0.497 . . . . 0.45 112.341 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.11 -41.53 1.77 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.64 -0.791 . . . . 0.72 112.472 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.19 -26.67 65.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.025 0.44 . . . . 2.82 110.138 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -150.77 -50.75 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.75 -0.659 . . . . 0.8 111.577 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.66 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -117.52 152.33 35.3 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.153 -0.684 . . . . 0.51 109.153 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.557 ' N ' ' HG3' ' A' ' 35' ' ' PRO . 3.4 ttt -169.74 34.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 115.387 1.625 . . . . 1.98 115.387 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.816 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 7.2 mt-10 -141.09 -122.25 0.1 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 119.198 -1.001 . . . . 1.28 111.982 176.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 1.036 ' CE2' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -154.74 -117.47 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 117.996 2.591 . . . . 4.88 117.996 -175.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.935 ' O ' HG21 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -152.67 168.89 24.15 Favored 'General case' 0 N--CA 1.424 -1.774 0 O-C-N 121.398 -0.814 . . . . 4.63 110.497 -178.591 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.801 HD11 ' HB ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER 47.43 58.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.874 -0.603 . . . . 2.72 111.38 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.515 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 0.3 OUTLIER -168.03 28.72 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.088 -0.506 . . . . 2.6 112.23 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.874 ' CH2' HG13 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -142.86 31.24 1.43 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.862 0.363 . . . . 1.71 110.245 177.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.406 ' O ' ' OD2' ' A' ' 27' ' ' ASP . 7.4 mtpm? 47.85 38.8 9.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 3.35 110.183 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.522 ' HB3' ' CG ' ' A' ' 4' ' ' GLU . 1.3 p30 53.88 38.83 29.56 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.554 -0.748 . . . . 2.14 110.985 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -43.41 -70.13 0.57 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.838 -0.696 . . . . 0.86 111.659 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.497 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -132.9 100.23 4.84 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 120.877 -0.329 . . . . 2.9 110.349 178.175 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.475 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 19.5 m 38.83 103.32 0.02 OUTLIER Pre-proline 0 C--O 1.218 -0.562 0 N-CA-C 114.095 1.146 . . . . 1.46 114.095 176.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.482 ' HB3' ' CA ' ' A' ' 3' ' ' GLY . 25.6 Cg_exo -25.21 138.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.966 3.111 . . . . 0.79 112.518 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.655 ' HB2' ' CD2' ' A' ' 38' ' ' TYR . 43.7 t -152.36 -155.85 0.65 Allowed 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 113.362 0.875 . . . . 0.95 113.362 -175.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.516 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 48.6 t-105 -139.3 95.0 2.86 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 101.524 -3.51 . . . . 1.24 101.524 172.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 1.05 HG11 ' HA ' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -154.42 163.73 23.22 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 114.086 -1.415 . . . . 1.74 109.745 -171.336 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.912 ' HD2' HG23 ' A' ' 34' ' ' VAL . 24.0 Cg_exo -62.81 -11.12 22.57 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.542 2.828 . . . . 1.52 118.379 -175.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 35' ' ' PRO . 1.9 m 157.98 31.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 114.051 1.13 . . . . 1.75 114.051 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.524 ' N ' ' CE3' ' A' ' 25' ' ' TRP . 37.8 m -176.55 -85.86 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.02 0.438 . . . . 1.49 110.126 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 1.05 ' HA ' HG11 ' A' ' 34' ' ' VAL . 29.4 t80 -177.96 152.75 0.77 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.757 -0.656 . . . . 5.43 110.602 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.854 HG21 ' O ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER 175.55 73.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.869 0.366 . . . . 2.1 110.197 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.553 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . . . -66.46 91.94 0.19 Allowed 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.98 -0.688 . . . . 1.64 110.618 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 172.06 -31.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.51 -0.768 . . . . 2.5 110.95 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 17.7 t70 75.9 28.92 0.84 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.043 -0.526 . . . . 4.56 110.963 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.486 ' O ' HG12 ' A' ' 43' ' ' VAL . 47.0 t -119.71 -9.15 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.222 -0.444 . . . . 3.73 112.142 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.854 ' O ' HG21 ' A' ' 39' ' ' ILE . 11.2 t -145.41 162.97 12.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.389 0.138 . . . . 2.57 110.899 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.567 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 78.1 p -97.64 17.39 17.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.397 -0.365 . . . . 1.34 111.761 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' TYR . 0.7 OUTLIER 178.39 140.46 0.09 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 120.696 -0.402 . . . . 1.6 111.632 -179.276 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 38' ' ' TYR . 7.5 t80 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.234 -0.888 . . . . 4.12 111.052 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.489 -0.244 . . . . 2.16 112.489 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.545 ' HA ' ' CD1' ' A' ' 23' ' ' ILE . 1.6 tt0 60.27 14.71 4.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.281 0.562 . . . . 2.17 111.404 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -91.18 -21.77 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.648 -0.501 . . . . 0.87 109.648 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.478 ' ND2' ' HA ' ' A' ' 24' ' ' GLU . 34.5 t-20 58.45 80.23 0.19 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.881 -0.6 . . . . 1.86 109.476 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.453 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 17.8 pttp -147.75 -140.39 0.1 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.037 -0.983 . . . . 2.42 108.423 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.643 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -67.79 132.34 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.467 -0.938 . . . . 2.03 108.467 177.195 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.643 ' N ' HD13 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -148.7 173.19 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 113.965 1.098 . . . . 3.89 113.965 -176.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.68 159.51 21.55 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 113.545 -1.661 . . . . 1.14 110.388 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.547 ' HB2' ' CB ' ' A' ' 20' ' ' GLU . 2.8 p -154.79 103.71 2.45 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.319 0.859 . . . . 1.69 113.319 -177.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.1 ttp-105 -161.68 98.41 1.1 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.504 0.928 . . . . 3.7 113.504 176.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.71 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -110.54 -81.3 0.58 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 119.031 -1.068 . . . . 0.48 113.521 176.005 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -151.16 -57.44 0.16 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.645 0.609 . . . . 0.45 112.645 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . 125.14 -41.6 1.66 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.0 -0.619 . . . . 0.72 111.771 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -72.76 -9.39 58.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.767 0.318 . . . . 2.82 111.26 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 43' ' ' VAL . . . -151.55 -55.47 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.216 -1.154 . . . . 0.8 110.216 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.792 ' HB2' HD11 ' A' ' 39' ' ' ILE . . . -131.52 153.04 50.22 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 108.774 -0.825 . . . . 0.51 108.774 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.527 ' N ' ' HG3' ' A' ' 35' ' ' PRO . 2.6 ttt -154.33 11.06 0.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.969 1.1 . . . . 1.98 113.969 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.745 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 14.8 mt-10 -151.55 -177.82 6.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.484 -0.932 . . . . 1.28 108.484 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.718 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -157.87 9.35 0.17 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.258 0.836 . . . . 4.88 113.258 178.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.643 ' HA ' HG21 ' A' ' 9' ' ' ILE . 3.6 pp -87.23 128.5 35.15 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 115.343 1.609 . . . . 4.63 115.343 -175.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.763 HD12 ' CD1' ' A' ' 25' ' ' TRP . 0.4 OUTLIER -42.02 -104.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 112.508 -2.133 . . . . 2.72 108.522 173.704 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.522 ' H ' HG23 ' A' ' 23' ' ' ILE . 7.4 tp10 34.72 30.15 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.609 1.095 . . . . 2.6 112.561 177.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.763 ' CD1' HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -134.53 32.29 3.35 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.068 -0.515 . . . . 1.71 111.052 -178.284 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 50.95 29.4 4.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.873 -0.603 . . . . 3.35 111.167 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.415 ' HB3' ' CB ' ' A' ' 4' ' ' GLU . 4.2 p30 43.64 38.07 1.79 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.524 . . . . 2.14 111.696 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.685 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -47.94 -57.4 7.83 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.547 -0.835 . . . . 0.86 112.287 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.576 ' HB2' ' CD1' ' A' ' 38' ' ' TYR . 76.2 m80 -133.65 92.17 2.94 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.245 -0.65 . . . . 2.9 109.245 178.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 29' ' ' HIS . 22.7 t 39.62 117.71 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 116.082 1.882 . . . . 1.46 116.082 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 4' ' ' GLU . 11.1 Cg_exo -32.88 95.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.95 3.1 . . . . 0.79 107.953 172.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 30' ' ' SER . 18.3 m -117.21 173.34 6.74 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 114.463 1.283 . . . . 0.95 114.463 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.71 ' CD1' HG23 ' A' ' 13' ' ' THR . 7.4 t-105 -104.08 100.49 10.24 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 105.314 -2.106 . . . . 1.24 105.314 176.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.945 ' CG2' HG23 ' A' ' 39' ' ' ILE . 4.4 p -151.39 158.98 34.15 Favored Pre-proline 0 C--O 1.204 -1.309 0 CA-C-N 114.19 -1.368 . . . . 1.74 111.417 -173.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.738 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 50.3 Cg_exo -61.48 -6.43 7.0 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 124.07 3.18 . . . . 1.52 115.712 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m 172.2 -12.91 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.182 1.179 . . . . 1.75 114.182 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.945 ' C ' HG11 ' A' ' 34' ' ' VAL . 73.9 m -138.75 -87.49 0.23 Allowed 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 118.816 0.734 . . . . 1.49 112.138 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.685 ' OH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -177.05 102.47 0.05 Allowed 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.223 -1.029 . . . . 5.43 108.223 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.945 HG23 ' CG2' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -127.68 59.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 122.746 1.26 . . . . 2.1 110.583 -174.578 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -55.0 92.63 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 113.852 -1.522 . . . . 1.64 110.934 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 164.95 -29.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 113.966 -1.47 . . . . 2.5 109.177 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 77.15 54.82 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.434 -0.803 . . . . 4.56 111.856 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 43' ' ' VAL . 3.4 t -154.76 23.77 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 112.643 0.608 . . . . 3.73 112.643 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 39' ' ' ILE . 2.4 t -157.88 152.32 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 113.083 0.771 . . . . 2.57 113.083 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.633 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 39.0 t -82.44 -2.71 54.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.747 -0.66 . . . . 1.34 111.409 177.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.474 ' HG2' ' CB ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 176.51 153.71 0.2 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.233 0.457 . . . . 1.6 112.233 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.487 ' CB ' ' O ' ' A' ' 38' ' ' TYR . 36.6 t80 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.26 -0.876 . . . . 4.12 110.754 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.565 ' O ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.449 -0.456 0 N-CA-C 112.554 -0.218 . . . . 2.16 112.554 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.478 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.0 OUTLIER 53.66 20.57 2.24 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.66 0.743 . . . . 2.17 109.536 -178.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 3' ' ' GLY . 17.4 t -98.61 -19.55 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.656 -0.702 . . . . 0.87 111.0 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.575 ' ND2' ' HA ' ' A' ' 24' ' ' GLU . 30.7 t-20 62.88 62.35 1.06 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.929 0.871 . . . . 1.86 108.851 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.449 ' HG3' HG22 ' A' ' 8' ' ' ILE . 18.1 ptmt -134.99 -133.34 0.16 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.13 -1.395 . . . . 2.42 108.272 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 8' ' ' ILE . 6.8 tp -45.45 105.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.341 0 N-CA-C 109.213 -0.662 . . . . 2.03 109.213 177.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.894 ' CG2' HD23 ' A' ' 22' ' ' LEU . 1.4 pt -104.03 109.63 27.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 113.757 1.021 . . . . 3.89 113.757 -176.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 22' ' ' LEU . . . -107.61 139.01 14.85 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 108.685 -1.766 . . . . 1.14 108.685 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.648 ' HA ' ' H ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -153.53 109.34 3.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 114.66 1.356 . . . . 1.69 114.66 -175.07 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.47 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 15.0 tpt180 -158.61 100.0 1.6 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.029 -0.668 . . . . 3.7 112.361 177.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.556 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -117.24 -79.48 0.59 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 119.406 -0.918 . . . . 0.48 113.326 178.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.45 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -149.15 -59.35 0.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.721 -0.392 . . . . 0.45 112.022 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 19' ' ' MET . . . 118.33 -50.55 0.8 Allowed Glycine 0 C--N 1.329 0.162 0 C-N-CA 119.906 -1.14 . . . . 0.72 112.617 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -58.38 -21.1 49.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.047 0.451 . . . . 2.82 109.971 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.454 ' HA3' ' CG2' ' A' ' 43' ' ' VAL . . . -143.71 -57.2 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.862 -0.608 . . . . 0.8 111.875 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.671 ' HA ' ' HB3' ' A' ' 35' ' ' PRO . . . -129.21 149.82 50.85 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.616 -0.883 . . . . 0.51 108.616 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.546 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -167.51 20.7 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 116.629 2.085 . . . . 1.98 116.629 -178.277 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 34' ' ' VAL . 2.8 mt-10 -154.68 98.67 2.09 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 118.928 0.786 . . . . 1.28 112.044 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.674 ' HB2' ' CG ' ' A' ' 33' ' ' TRP . 3.0 t80 -79.13 8.1 6.38 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 113.486 0.921 . . . . 4.88 113.486 -177.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.894 HD23 ' CG2' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -89.16 130.37 35.6 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 116.095 1.887 . . . . 4.63 116.095 -176.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.73 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -47.77 -137.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 111.758 -2.473 . . . . 2.72 112.118 174.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.575 ' HA ' ' ND2' ' A' ' 6' ' ' ASN . 33.1 tt0 60.27 16.5 6.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 120.934 -1.104 . . . . 2.6 109.698 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.73 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -112.15 31.26 6.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.287 0.565 . . . . 1.71 110.423 179.486 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.5 OUTLIER 57.95 28.38 16.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.384 -0.826 . . . . 3.35 111.941 177.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.471 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 4.6 p-10 44.87 32.15 0.78 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.751 0.31 . . . . 2.14 111.346 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.775 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -47.82 -59.94 5.78 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.498 -0.858 . . . . 0.86 112.285 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.592 ' HB2' ' CD1' ' A' ' 38' ' ' TYR . 99.2 m-70 -134.89 91.3 2.74 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 119.897 -0.721 . . . . 2.9 109.618 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 29' ' ' HIS . 24.2 t 42.22 120.16 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 115.68 1.733 . . . . 1.46 115.68 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.478 ' HD3' ' CB ' ' A' ' 4' ' ' GLU . 2.9 Cg_exo -38.05 101.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 122.86 2.374 . . . . 0.79 107.425 172.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.57 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 68.7 m -124.0 155.82 37.56 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-N 115.176 -0.92 . . . . 0.95 112.81 -172.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.674 ' CG ' ' HB2' ' A' ' 21' ' ' TYR . 6.8 t-105 -90.29 92.81 9.08 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.43 -2.433 . . . . 1.24 104.43 176.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 1.041 HG12 ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -155.05 -166.46 0.15 Allowed Pre-proline 0 C--O 1.186 -2.272 0 CA-C-N 115.354 -0.839 . . . . 1.74 112.258 -173.115 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 1.041 ' HD3' HG12 ' A' ' 34' ' ' VAL . 65.6 Cg_endo -95.67 105.78 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.108 0 CA-C-N 122.566 1.952 . . . . 1.52 116.278 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.439 ' H ' ' HB2' ' A' ' 20' ' ' GLU . 29.4 t 37.48 30.08 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.293 0.568 . . . . 1.75 111.359 177.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.539 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 1.3 m -168.4 -130.31 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.059 -0.973 . . . . 1.49 108.922 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.775 ' OH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -173.17 100.9 0.12 Allowed 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 106.562 -1.644 . . . . 5.43 106.562 -178.006 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.806 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -121.95 31.8 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.526 -0.761 . . . . 2.1 112.245 -174.137 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -55.69 93.05 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.743 -0.783 . . . . 1.64 111.415 -176.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 163.08 -30.1 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 114.192 -1.367 . . . . 2.5 109.404 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.513 ' O ' HG12 ' A' ' 39' ' ' ILE . 4.8 p-10 -177.3 104.19 0.05 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.863 -0.608 . . . . 4.56 111.009 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.723 ' HA ' HD11 ' A' ' 39' ' ' ILE . 23.0 m -51.05 126.82 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.098 -0.501 . . . . 3.73 112.276 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 44' ' ' VAL . 5.1 p -173.66 34.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.519 0 N-CA-C 114.615 1.339 . . . . 2.57 114.615 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.579 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 30.1 t 68.41 2.9 3.52 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 114.373 1.249 . . . . 1.34 114.373 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 36.4 tt0 179.37 153.01 0.42 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.827 0.677 . . . . 1.6 112.827 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.433 ' CD2' ' CE1' ' A' ' 29' ' ' HIS . 17.3 t80 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.23 -0.89 . . . . 4.12 110.939 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.587 ' O ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.222 -0.351 . . . . 2.16 112.222 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.494 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER 51.65 22.2 1.54 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.638 0.732 . . . . 2.17 110.044 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 3' ' ' GLY . 2.9 t -104.54 -17.14 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.72 -0.673 . . . . 0.87 111.137 -179.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 24' ' ' GLU . 31.4 t-20 61.17 66.17 0.91 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.998 -0.742 . . . . 1.86 108.998 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.478 ' HG2' HD11 ' A' ' 23' ' ' ILE . 19.8 pttp -150.72 -146.96 0.21 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.05 -0.523 . . . . 2.42 109.65 -178.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -47.59 98.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 121.956 0.884 . . . . 2.03 111.525 178.669 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.865 HD11 ' CZ ' ' A' ' 21' ' ' TYR . 3.4 tp -152.85 170.07 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.659 -0.701 . . . . 3.89 110.177 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -130.76 168.6 21.76 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.88 -0.676 . . . . 1.14 112.113 -175.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.506 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 35.4 p -148.24 103.57 3.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 113.398 0.888 . . . . 1.69 113.398 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.431 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 51.0 ttp180 -159.96 101.6 1.45 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.003 -0.544 . . . . 3.7 111.254 176.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.612 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -115.45 -84.81 0.62 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.532 0.938 . . . . 0.48 113.532 179.237 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.6 -55.72 0.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.425 -0.51 . . . . 0.45 112.357 -178.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.81 -34.14 4.48 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.342 -0.933 . . . . 0.72 112.489 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.19 -29.38 67.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.206 0.527 . . . . 2.82 109.763 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 35' ' ' PRO . . . -150.44 -41.23 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.422 -0.808 . . . . 0.8 111.879 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.532 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . . . -130.54 151.2 51.27 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.449 -0.575 . . . . 0.51 109.449 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.475 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 4.7 ttp -163.17 27.71 0.09 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.705 1.002 . . . . 1.98 113.705 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 20.4 mt-10 -151.4 -179.71 7.61 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.516 -0.55 . . . . 1.28 109.516 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.865 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 2.8 t80 -159.66 11.09 0.12 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.57 0.952 . . . . 4.88 113.57 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.623 ' HB2' ' CG2' ' A' ' 9' ' ' ILE . 2.4 pt? -86.66 120.76 28.31 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 117.327 2.343 . . . . 4.63 117.327 -176.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.738 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 5.7 pt -55.49 -15.02 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 111.967 -2.379 . . . . 2.72 110.497 174.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.559 ' CB ' HD12 ' A' ' 22' ' ' LEU . 29.4 tp10 -39.14 -27.57 0.02 OUTLIER 'General case' 0 C--N 1.344 0.332 0 CA-C-N 116.065 -0.516 . . . . 2.6 110.682 177.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.738 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -57.58 -163.19 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.803 -0.814 . . . . 1.71 108.803 176.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -107.41 44.76 1.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.449 -0.782 . . . . 3.35 111.379 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.455 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 3.5 p30 42.01 28.51 0.1 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.268 -0.424 . . . . 2.14 111.585 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.779 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -53.57 -55.53 24.59 Favored Glycine 0 CA--C 1.507 -0.422 0 C-N-CA 120.202 -0.999 . . . . 0.86 111.797 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.598 ' HB2' ' CD1' ' A' ' 38' ' ' TYR . 72.8 m80 -134.1 92.8 2.99 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 119.882 -0.727 . . . . 2.9 110.322 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 29' ' ' HIS . 17.0 m 41.62 119.45 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 116.54 2.052 . . . . 1.46 116.54 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.537 ' HB3' HG22 ' A' ' 23' ' ' ILE . 12.5 Cg_exo -34.25 97.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 123.493 2.795 . . . . 0.79 107.856 170.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.611 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 67.2 m -121.06 155.16 35.01 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 114.263 1.209 . . . . 0.95 114.263 -172.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.64 ' CE3' ' CD2' ' A' ' 21' ' ' TYR . 6.7 t-105 -90.75 91.37 8.35 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 104.107 -2.553 . . . . 1.24 104.107 175.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.903 HG12 ' CD ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -155.76 177.79 1.91 Allowed Pre-proline 0 C--O 1.215 -0.74 0 CA-C-N 114.896 -1.047 . . . . 1.74 110.974 -174.736 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.903 ' CD ' HG12 ' A' ' 34' ' ' VAL . 28.8 Cg_endo -86.34 111.86 1.07 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.879 2.386 . . . . 1.52 116.651 -174.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.7 t 49.69 19.37 0.4 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.555 -1.202 . . . . 1.75 113.079 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.553 ' N ' ' CE3' ' A' ' 25' ' ' TRP . 11.7 t -173.4 -108.15 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.205 -0.598 . . . . 1.49 111.597 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.779 ' OH ' ' HA3' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -176.3 116.59 0.12 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.446 -1.687 . . . . 5.43 106.446 -177.578 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.798 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -141.51 31.42 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.772 0.796 . . . . 2.1 111.008 -174.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -59.59 89.82 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.069 -0.969 . . . . 1.64 110.636 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 157.02 39.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.138 -0.937 . . . . 2.5 110.763 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 t70 56.67 85.41 0.08 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.816 0.302 . . . . 4.56 111.816 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.605 HG11 ' OXT' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -153.94 -159.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 110.083 -0.34 . . . . 3.73 110.083 179.113 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.639 ' N ' HD12 ' A' ' 39' ' ' ILE . 7.4 p -157.27 118.58 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 113.557 0.947 . . . . 2.57 113.557 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.451 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 54.5 p 65.99 4.77 3.17 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 114.696 -1.138 . . . . 1.34 113.757 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 45' ' ' SER . 39.0 tt0 179.38 154.03 0.46 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.099 0.476 . . . . 1.6 111.671 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.605 ' OXT' HG11 ' A' ' 43' ' ' VAL . 50.9 t80 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.243 -0.884 . . . . 4.12 110.991 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 31' ' ' PRO . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.427 -0.269 . . . . 2.16 112.427 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.603 ' HA ' HD13 ' A' ' 23' ' ' ILE . 2.7 tm-20 65.46 9.03 5.45 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.868 0.366 . . . . 2.17 111.891 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.1 t -91.39 -36.18 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 122.017 0.913 . . . . 0.87 108.85 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.507 ' H ' HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER 68.65 87.45 0.12 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.678 -1.601 . . . . 1.86 111.329 179.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.474 ' O ' HG23 ' A' ' 9' ' ' ILE . 21.4 ptmt -150.31 -144.4 0.15 Allowed 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.995 -1.113 . . . . 2.42 107.995 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.495 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -55.03 118.44 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.006 -0.368 . . . . 2.03 110.006 178.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.8 HG22 ' HB3' ' A' ' 22' ' ' LEU . 36.6 pt -111.27 136.79 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 114.751 1.389 . . . . 3.89 114.751 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.8 146.43 16.67 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 106.86 -2.496 . . . . 1.14 106.86 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.626 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.6 OUTLIER -153.13 105.94 2.95 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 118.781 1.291 . . . . 1.69 113.408 -175.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -156.3 102.82 2.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.995 -0.548 . . . . 3.7 111.104 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.688 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -121.97 -80.74 0.63 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 119.599 -0.84 . . . . 0.48 112.993 179.402 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.442 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -150.05 -57.75 0.19 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.437 -0.505 . . . . 0.45 112.172 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.405 ' HA2' ' HB2' ' A' ' 19' ' ' MET . . . 119.04 -42.34 1.8 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.538 -0.839 . . . . 0.72 112.158 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -59.38 -33.89 71.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.169 0.509 . . . . 2.82 110.135 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.45 -48.72 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.568 -0.742 . . . . 0.8 111.493 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.537 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -130.55 150.13 51.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.86 -0.422 . . . . 0.51 109.86 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.487 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -163.9 30.08 0.08 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.062 1.134 . . . . 1.98 114.062 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.626 ' HA ' ' HB2' ' A' ' 11' ' ' SER . 11.1 mt-10 -148.79 -171.9 3.98 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.287 -1.005 . . . . 1.28 108.287 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.63 ' HB2' ' CD2' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -154.02 -57.5 0.12 Allowed 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 119.217 3.043 . . . . 4.88 119.217 -176.056 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.8 ' HB3' HG22 ' A' ' 9' ' ' ILE . 8.4 mt -81.24 148.04 29.67 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 118.034 -1.466 . . . . 4.63 114.705 -171.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.621 HD12 ' CD1' ' A' ' 25' ' ' TRP . 3.2 tp -13.23 -105.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 110.818 -2.901 . . . . 2.72 114.07 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.643 ' HG3' HD13 ' A' ' 9' ' ' ILE . 8.1 mm-40 42.82 25.85 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 119.39 0.996 . . . . 2.6 111.349 -177.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.621 ' CD1' HD12 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -136.53 29.01 2.98 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 116.133 -0.485 . . . . 1.71 111.289 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 40.35 30.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 3.35 112.133 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.434 ' HB2' ' CG ' ' A' ' 4' ' ' GLU . 23.8 t70 63.51 34.11 12.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.008 0.432 . . . . 2.14 110.312 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 25' ' ' TRP . . . -45.37 -63.76 2.57 Favored Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 111.045 -0.822 . . . . 0.86 111.045 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.522 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -133.44 109.12 9.09 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 109.047 -0.723 . . . . 2.9 109.047 177.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.446 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 48.1 m 31.0 103.3 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 114.994 1.479 . . . . 1.46 114.994 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.441 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 13.4 Cg_exo -29.87 120.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.257 0 C-N-CA 123.093 2.529 . . . . 0.79 111.372 176.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.652 ' HB2' ' CD2' ' A' ' 38' ' ' TYR . 17.9 t -143.34 -163.72 1.71 Allowed 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 114.345 1.239 . . . . 0.95 114.345 -174.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.688 ' CD1' HG23 ' A' ' 13' ' ' THR . 4.5 t-105 -123.11 93.11 3.85 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 106.349 -1.722 . . . . 1.24 106.349 175.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.956 HG21 HG23 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -159.85 178.27 1.74 Allowed Pre-proline 0 C--O 1.22 -0.47 0 CA-C-N 115.356 -0.838 . . . . 1.74 111.01 -177.72 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.676 ' HD2' HG13 ' A' ' 34' ' ' VAL . 6.4 Cg_endo -95.51 137.27 0.72 Allowed 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.939 3.093 . . . . 1.52 112.444 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 10.7 t 79.83 -62.17 0.27 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.454 0.909 . . . . 1.75 113.454 177.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.611 ' HA ' ' CE3' ' A' ' 25' ' ' TRP . 47.5 t -150.54 -56.89 0.17 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.556 1.317 . . . . 1.49 114.556 -177.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.718 ' CA ' HG11 ' A' ' 34' ' ' VAL . 14.4 t80 176.97 152.04 0.19 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.799 -0.445 . . . . 5.43 109.799 -176.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.956 HG23 HG21 ' A' ' 34' ' ' VAL . 0.6 OUTLIER 175.86 67.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.9 0.857 . . . . 2.1 108.851 -179.621 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.557 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . . . -59.66 92.76 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.151 -0.931 . . . . 1.64 111.082 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 174.14 -31.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.337 -0.847 . . . . 2.5 110.983 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 74.08 23.94 2.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.075 -0.511 . . . . 4.56 110.807 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.82 -25.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 3.73 111.211 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.781 ' O ' HG21 ' A' ' 39' ' ' ILE . 3.5 t -136.07 165.02 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.955 0.407 . . . . 2.57 111.118 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.549 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 29.6 t -96.38 25.46 4.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.873 -0.603 . . . . 1.34 110.689 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -179.72 149.05 0.35 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.437 -0.347 . . . . 1.6 110.996 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.522 ' HB3' ' CD2' ' A' ' 29' ' ' HIS . 10.3 t80 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.212 -0.899 . . . . 4.12 110.944 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.48 ' CA ' ' CD1' ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.404 0 N-CA-C 112.424 -0.27 . . . . 2.16 112.424 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.475 ' HB3' ' HG3' ' A' ' 31' ' ' PRO . 0.0 OUTLIER 78.0 -13.49 0.95 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.144 0.794 . . . . 2.17 113.144 179.484 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 6' ' ' ASN . 11.3 t -77.71 -51.29 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 121.454 0.645 . . . . 0.87 111.12 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 1.015 ' N ' HG21 ' A' ' 23' ' ' ILE . 1.1 m-20 99.11 82.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.362 -1.29 . . . . 1.86 109.669 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.427 ' HG3' HG22 ' A' ' 8' ' ' ILE . 12.9 pttp -150.61 -131.23 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.42 -1.264 . . . . 2.42 108.75 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.648 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -47.06 113.83 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 118.306 0.503 . . . . 2.03 109.824 177.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.642 HG22 ' C ' ' A' ' 22' ' ' LEU . 3.1 pt -124.8 116.49 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 114.793 1.405 . . . . 3.89 114.793 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.634 ' H ' HD12 ' A' ' 22' ' ' LEU . . . -101.72 144.54 16.43 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 107.055 -2.418 . . . . 1.14 107.055 174.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.616 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 15.9 p -155.11 104.38 2.45 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.934 1.087 . . . . 1.69 113.934 -175.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.27 98.22 1.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.944 -0.571 . . . . 3.7 109.881 176.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.754 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -102.89 -82.16 0.49 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 119.385 -0.926 . . . . 0.48 112.901 179.533 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -142.69 -65.78 0.39 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.692 0.627 . . . . 0.45 112.692 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . 126.19 -35.05 3.07 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.099 -0.8 . . . . 0.72 111.099 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -66.78 -30.52 70.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.27 0.557 . . . . 2.82 109.61 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.783 ' HA2' HG12 ' A' ' 44' ' ' VAL . . . -145.47 -49.1 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.272 -0.876 . . . . 0.8 111.686 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.589 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . . . -118.49 151.55 37.62 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 119.701 -0.19 . . . . 0.51 110.597 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.463 ' HA ' ' H ' ' A' ' 13' ' ' THR . 0.2 OUTLIER -160.36 27.03 0.16 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.886 1.439 . . . . 1.98 114.886 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.682 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 12.3 mt-10 -151.1 -174.4 4.79 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.56 -0.533 . . . . 1.28 109.56 177.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.616 ' HB3' ' HA ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -153.08 -72.55 0.14 Allowed 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 118.815 2.894 . . . . 4.88 118.815 -177.185 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.642 ' C ' HG22 ' A' ' 9' ' ' ILE . 33.7 mt -82.92 143.09 30.96 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 114.749 1.389 . . . . 4.63 114.749 -172.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.015 HG21 ' N ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER 17.37 -148.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 111.522 -2.581 . . . . 2.72 113.751 -179.297 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER 83.15 -5.88 1.23 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.902 -0.407 . . . . 2.6 109.902 -178.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 1.119 ' CH2' HG13 ' A' ' 34' ' ' VAL . 1.3 p90 -121.98 28.57 7.49 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 120.861 -0.336 . . . . 1.71 111.023 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.8 tttt 29.18 62.93 0.14 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.223 0.823 . . . . 3.35 113.223 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.453 ' HB3' ' CG ' ' A' ' 4' ' ' GLU . 3.9 p30 45.61 27.4 0.42 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.753 0.311 . . . . 2.14 111.631 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -49.48 -65.9 2.54 Favored Glycine 0 CA--C 1.508 -0.356 0 N-CA-C 110.776 -0.929 . . . . 0.86 110.776 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.566 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -132.56 100.72 5.05 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 108.752 -0.833 . . . . 2.9 108.752 177.374 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.487 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 70.2 m 37.08 109.53 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 N-CA-C 116.24 1.941 . . . . 1.46 116.24 176.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.487 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 2.8 Cg_exo -34.92 102.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.938 2.425 . . . . 0.79 110.027 174.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.582 ' HB2' ' CD2' ' A' ' 38' ' ' TYR . 28.7 t -124.2 -177.54 3.81 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 114.166 1.173 . . . . 0.95 114.166 -174.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.754 ' CD1' HG23 ' A' ' 13' ' ' THR . 3.7 t-105 -109.33 100.13 9.28 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 103.235 -2.876 . . . . 1.24 103.235 173.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 1.119 HG13 ' CH2' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -153.07 154.79 31.4 Favored Pre-proline 0 N--CA 1.444 -0.761 0 CA-C-N 115.267 -0.879 . . . . 1.74 112.63 -171.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.688 ' HD2' HG23 ' A' ' 34' ' ' VAL . 21.2 Cg_endo -59.45 -13.74 22.15 Favored 'Trans proline' 0 N--CA 1.491 1.344 1 C-N-CA 126.35 4.7 . . . . 1.52 117.817 -176.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.423 ' H ' HG22 ' A' ' 34' ' ' VAL . 18.6 p 178.51 -23.59 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 119.572 1.078 . . . . 1.75 113.764 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.521 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 48.2 t -141.21 -73.23 0.33 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.514 0.673 . . . . 1.49 110.663 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.983 ' OH ' ' HB3' ' A' ' 40' ' ' ALA . 11.7 t80 177.8 131.84 0.06 Allowed 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 115.536 -0.756 . . . . 5.43 109.84 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.489 ' O ' HG12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -146.67 26.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.503 -0.879 . . . . 2.1 110.852 -179.216 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.983 ' HB3' ' OH ' ' A' ' 38' ' ' TYR . . . -64.81 88.7 0.07 Allowed 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.144 -1.022 . . . . 1.64 109.955 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 151.8 37.84 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.538 -1.21 . . . . 2.5 110.522 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 61.19 88.72 0.08 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.057 0.391 . . . . 4.56 112.057 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.481 HG23 ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -162.99 -169.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 110.25 -0.278 . . . . 3.73 110.25 178.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.783 HG12 ' HA2' ' A' ' 17' ' ' GLY . 11.4 m -144.59 124.1 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 113.216 0.821 . . . . 2.57 113.216 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.469 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 28.9 t 53.8 16.25 0.99 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.249 -0.887 . . . . 1.34 113.084 178.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 179.84 148.01 0.27 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.724 -0.39 . . . . 1.6 111.925 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.546 ' N ' ' O ' ' A' ' 38' ' ' TYR . 14.4 t80 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.211 -0.899 . . . . 4.12 111.094 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.544 -0.222 . . . . 6.11 112.544 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.2 m 56.0 54.24 8.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.908 0.385 . . . . 4.17 110.852 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.75 144.59 8.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.782 -0.723 . . . . 2.16 112.412 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.462 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 15.0 tt0 61.67 14.05 5.78 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.163 0.506 . . . . 2.17 111.665 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.546 ' N ' HG21 ' A' ' 23' ' ' ILE . 58.0 t -79.67 -42.62 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 O-C-N 121.986 -0.446 . . . . 0.87 111.138 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.633 ' H ' HG21 ' A' ' 23' ' ' ILE . 20.1 t-20 82.06 44.51 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.697 -0.683 . . . . 1.86 111.999 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.501 ' O ' HG23 ' A' ' 9' ' ' ILE . 22.9 ptmt -119.76 -143.2 0.35 Allowed 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.179 -1.045 . . . . 2.42 108.179 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.447 HG22 ' HG3' ' A' ' 7' ' ' LYS . 3.1 tp -45.44 139.26 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 122.219 0.208 . . . . 2.03 111.009 178.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.63 HG22 HG12 ' A' ' 23' ' ' ILE . 27.6 pt -133.94 129.28 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 114.641 1.349 . . . . 3.89 114.641 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.06 144.41 16.0 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 106.865 -2.494 . . . . 1.14 106.865 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.506 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -152.36 105.42 3.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 118.855 1.328 . . . . 1.69 113.471 -175.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -156.85 102.87 2.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.847 -0.615 . . . . 3.7 110.874 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.638 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -116.67 -80.82 0.61 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.625 -0.83 . . . . 0.48 113.082 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.41 ' C ' ' HG2' ' A' ' 19' ' ' MET . . . -150.3 -58.79 0.19 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.631 0.604 . . . . 0.45 112.631 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.9 -36.37 3.36 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.577 -0.82 . . . . 0.72 111.757 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.19 -31.21 68.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.39 -0.596 . . . . 2.82 109.39 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.414 ' HA2' HG23 ' A' ' 44' ' ' VAL . . . -147.35 -58.45 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.029 -0.987 . . . . 0.8 110.847 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.487 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . . . -106.21 151.45 24.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.523 -0.338 . . . . 0.51 110.662 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.421 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -165.47 26.01 0.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.07 0.767 . . . . 1.98 113.07 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 5.2 mt-10 -146.54 -171.45 3.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.718 -0.845 . . . . 1.28 108.718 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.603 ' CD2' ' CZ3' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -155.17 -53.96 0.09 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 117.965 2.58 . . . . 4.88 117.965 -177.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.536 ' HB3' HG22 ' A' ' 9' ' ' ILE . 8.7 mt -88.27 151.69 22.47 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 116.324 1.972 . . . . 4.63 116.324 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.633 HG21 ' H ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -7.54 -117.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 111.584 -2.553 . . . . 2.72 114.402 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.452 ' CG ' HD13 ' A' ' 9' ' ' ILE . 0.9 OUTLIER 48.88 24.0 0.78 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.623 0.647 . . . . 2.6 110.221 -177.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.576 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -145.81 31.13 1.06 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 113.45 0.907 . . . . 1.71 113.45 -179.302 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.6 mttp 33.54 33.98 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.556 0.576 . . . . 3.35 112.556 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.453 ' HB3' ' CG ' ' A' ' 4' ' ' GLU . 4.1 p-10 46.64 47.81 14.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.886 -0.597 . . . . 2.14 112.194 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.445 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -52.95 -56.11 20.38 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.073 -1.06 . . . . 0.86 111.531 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.487 ' O ' ' O ' ' A' ' 30' ' ' SER . 85.8 m-70 -131.1 94.21 3.54 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 109.337 -0.616 . . . . 2.9 109.337 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 29' ' ' HIS . 13.9 m 40.43 106.68 0.01 OUTLIER Pre-proline 0 C--O 1.223 -0.29 0 N-CA-C 113.468 0.914 . . . . 1.46 113.468 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 8.2 Cg_exo -33.53 130.63 0.14 Allowed 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 122.479 2.12 . . . . 0.79 110.037 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.556 ' CB ' ' CG2' ' A' ' 34' ' ' VAL . 64.7 m -150.94 156.36 41.02 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 113.94 1.089 . . . . 0.95 113.94 -173.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.638 ' CD1' HG23 ' A' ' 13' ' ' THR . 3.7 t-105 -86.1 92.26 8.67 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 103.663 -2.717 . . . . 1.24 103.663 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.926 HG12 ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -154.99 -177.8 0.79 Allowed Pre-proline 0 CA--C 1.547 0.855 0 CA-C-N 114.706 -1.133 . . . . 1.74 110.414 -174.607 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.926 ' HD3' HG12 ' A' ' 34' ' ' VAL . 30.4 Cg_endo -86.33 103.22 0.66 Allowed 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 124.185 3.257 . . . . 1.52 116.32 -174.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 t 41.2 28.08 0.06 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.108 0.48 . . . . 1.75 111.251 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.502 ' O ' ' CE3' ' A' ' 25' ' ' TRP . 1.5 m -166.23 -131.85 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.444 -0.798 . . . . 1.49 109.913 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -170.45 98.92 0.26 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 105.004 -2.221 . . . . 5.43 105.004 -177.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.861 ' HB ' HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -116.59 37.64 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.823 -1.08 . . . . 2.1 111.624 -173.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -69.82 89.98 0.59 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.188 -0.915 . . . . 1.64 110.904 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 152.96 42.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.272 -0.876 . . . . 2.5 110.504 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 t70 54.76 88.67 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.72 0.295 . . . . 4.56 110.778 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.861 HG13 ' HB ' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -169.75 170.6 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.306 -0.628 . . . . 3.73 109.306 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.588 ' HA ' HD12 ' A' ' 39' ' ' ILE . 7.6 p -128.63 132.99 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 114.079 1.14 . . . . 2.57 114.079 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.502 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 16.6 t 61.83 7.59 2.07 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.669 1.359 . . . . 1.34 114.669 176.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' O ' ' CG2' ' A' ' 43' ' ' VAL . 3.5 tt0 177.8 -173.04 0.12 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.136 -0.626 . . . . 1.6 112.42 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.504 ' HB2' ' HA ' ' A' ' 39' ' ' ILE . 45.5 t80 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.222 -0.894 . . . . 4.12 110.675 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.503 -0.239 . . . . 6.11 112.503 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.5 t 63.16 45.18 5.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.851 0.358 . . . . 4.17 111.055 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.454 ' HA2' HG12 ' A' ' 23' ' ' ILE . . . -168.91 146.75 10.54 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.678 -0.772 . . . . 2.16 112.616 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.566 ' N ' HG23 ' A' ' 23' ' ' ILE . 0.0 OUTLIER 58.29 12.98 2.16 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.021 0.378 . . . . 2.17 112.021 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 5' ' ' VAL . 23.2 t -89.42 -4.22 10.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 112.274 0.472 . . . . 0.87 112.274 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.599 ' H ' HG22 ' A' ' 23' ' ' ILE . 29.4 t-20 39.09 71.66 0.16 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.007 0.432 . . . . 1.86 111.236 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.587 ' HD3' HG22 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -150.77 -141.98 0.11 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.874 -0.603 . . . . 2.42 109.389 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -56.49 106.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.596 0.712 . . . . 2.03 111.537 179.48 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.755 HD11 ' CZ ' ' A' ' 21' ' ' TYR . 3.0 tp -153.55 171.06 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.845 -0.616 . . . . 3.89 110.763 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.03 169.37 20.45 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 111.824 -0.511 . . . . 1.14 111.824 -175.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.516 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 14.1 p -150.29 103.99 3.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 113.312 0.856 . . . . 1.69 113.312 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.422 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 32.2 ttm180 -159.46 101.36 1.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.481 -0.327 . . . . 3.7 111.845 177.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.582 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -115.69 -85.42 0.62 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.857 1.058 . . . . 0.48 113.857 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.425 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -146.03 -51.57 0.24 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.421 0.555 . . . . 0.45 112.493 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.06 -35.57 4.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.625 -0.798 . . . . 0.72 112.193 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -59.73 -41.99 92.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.224 0.535 . . . . 2.82 110.01 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -136.03 -40.61 0.14 Allowed Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.397 -0.819 . . . . 0.8 111.697 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.513 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . . . -130.59 150.7 51.67 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.439 -0.578 . . . . 0.51 109.439 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.425 ' HG3' ' C ' ' A' ' 14' ' ' ALA . 2.9 ttt -162.74 24.58 0.1 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.1 0.778 . . . . 1.98 113.1 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.56 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 18.5 mt-10 -150.65 178.81 8.74 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.183 -0.673 . . . . 1.28 109.183 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.755 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 2.3 t80 -157.61 9.66 0.18 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.515 0.931 . . . . 4.88 113.515 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.799 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.8 pp -83.6 130.3 34.98 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 116.522 2.045 . . . . 4.63 116.522 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 6' ' ' ASN . 1.4 mp -72.5 10.14 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 CA-C-N 110.016 -3.266 . . . . 2.72 111.1 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.415 ' OE1' ' N ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -78.64 10.86 2.88 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.232 -0.44 . . . . 2.6 110.702 177.411 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.646 ' HZ2' ' H ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -86.98 32.57 0.67 Allowed 'General case' 0 C--N 1.347 0.458 0 CA-C-O 120.627 0.251 . . . . 1.71 111.411 178.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 74.6 tttt 48.85 36.3 7.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.626 -0.261 . . . . 3.35 111.212 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.446 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 16.4 t0 57.09 23.08 8.07 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.114 -0.634 . . . . 2.14 109.746 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -43.45 -64.39 1.82 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 120.764 -0.731 . . . . 0.86 111.328 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.528 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -135.16 98.87 4.1 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 109.553 -0.536 . . . . 2.9 109.553 177.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 29' ' ' HIS . 40.6 m 32.43 117.23 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 117.096 2.258 . . . . 1.46 117.096 176.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.479 ' HB3' ' CG1' ' A' ' 23' ' ' ILE . 14.8 Cg_exo -31.5 118.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 123.75 2.967 . . . . 0.79 108.427 172.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.646 ' H ' ' HZ2' ' A' ' 25' ' ' TRP . 7.3 t -152.21 154.35 35.62 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.379 1.252 . . . . 0.95 114.379 -172.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.61 ' CE3' ' CD2' ' A' ' 21' ' ' TYR . 8.4 t-105 -91.52 91.23 7.97 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 104.187 -2.523 . . . . 1.24 104.187 175.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.886 HG12 ' CD ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -156.77 173.97 4.47 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 114.65 -1.159 . . . . 1.74 110.928 -175.066 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.886 ' CD ' HG12 ' A' ' 34' ' ' VAL . 7.3 Cg_endo -92.38 122.24 0.57 Allowed 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.512 2.808 . . . . 1.52 116.447 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.6 m 79.9 -51.72 0.38 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.833 -1.076 . . . . 1.75 113.736 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.561 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 57.9 m -144.16 -65.49 0.36 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.538 0.685 . . . . 1.49 111.272 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.702 ' OH ' ' HB3' ' A' ' 40' ' ' ALA . 10.0 t80 178.7 140.88 0.1 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.251 -0.648 . . . . 5.43 109.251 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.791 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -161.1 30.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 122.801 1.286 . . . . 2.1 109.137 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.702 ' HB3' ' OH ' ' A' ' 38' ' ' TYR . . . -66.23 89.85 0.14 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.748 -1.114 . . . . 1.64 110.507 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 156.62 41.1 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.438 -0.801 . . . . 2.5 110.573 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.414 ' O ' HG22 ' A' ' 43' ' ' VAL . 7.6 m-20 58.18 84.09 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.77 0.319 . . . . 4.56 111.18 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 0.6 OUTLIER -157.21 -151.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.43 -0.582 . . . . 3.73 109.43 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.42 ' N ' HG13 ' A' ' 39' ' ' ILE . 7.6 p -169.05 120.72 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 113.448 0.907 . . . . 2.57 113.448 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.3 t 65.74 7.02 4.23 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 114.089 1.144 . . . . 1.34 114.089 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 179.05 147.01 0.18 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.571 0.582 . . . . 1.6 112.571 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 38' ' ' TYR . 28.6 p90 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.19 -0.91 . . . . 4.12 111.07 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.567 -0.213 . . . . 6.11 112.567 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.6 t -110.18 -30.89 7.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 4.17 110.857 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.551 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . -127.55 -116.59 2.0 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.657 -0.782 . . . . 2.16 113.034 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.51 ' CG ' ' HB3' ' A' ' 27' ' ' ASP . 1.8 tm-20 61.39 26.57 16.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 122.274 1.035 . . . . 2.17 109.275 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -104.32 -19.73 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.129 -0.941 . . . . 0.87 111.505 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.455 ' ND2' ' HA ' ' A' ' 24' ' ' GLU . 7.1 m120 47.5 79.1 0.07 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.946 -0.39 . . . . 1.86 109.946 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HE3' HG21 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -135.68 -98.61 0.23 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.887 0.699 . . . . 2.42 112.887 -177.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 8' ' ' ILE . 2.1 tp -135.97 111.63 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 109.839 -0.43 . . . . 2.03 109.839 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 1.178 HG23 ' CE2' ' A' ' 21' ' ' TYR . 6.9 tp -150.97 162.73 3.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 112.622 0.601 . . . . 3.89 112.622 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.501 ' N ' HG13 ' A' ' 9' ' ' ILE . . . -109.85 121.15 5.93 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 110.634 -0.986 . . . . 1.14 110.634 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.83 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -102.55 107.85 18.94 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.698 1.237 . . . . 1.69 113.174 -176.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -157.68 112.73 2.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 112.433 -2.167 . . . . 3.7 112.311 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.508 ' CB ' ' HA ' ' A' ' 19' ' ' MET . 1.6 m -116.36 -78.21 0.58 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.408 0.521 . . . . 0.48 112.408 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.96 -54.94 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.731 0.301 . . . . 0.45 111.647 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.12 -35.67 4.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.352 -0.928 . . . . 0.72 112.653 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.3 -27.0 65.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.056 0.455 . . . . 2.82 110.342 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -150.38 -43.64 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.694 -0.685 . . . . 0.8 111.582 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.515 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -129.98 151.47 50.5 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.862 -0.421 . . . . 0.51 109.862 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.508 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 4.0 ttp -164.23 51.88 0.13 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.618 1.34 . . . . 1.98 114.618 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.748 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 6.7 mt-10 -151.01 -124.39 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 114.886 1.439 . . . . 1.28 114.886 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 1.178 ' CE2' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -155.72 -126.78 0.03 OUTLIER 'General case' 0 C--O 1.199 -1.556 0 N-CA-C 117.787 2.514 . . . . 4.88 117.787 -173.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.94 ' O ' HG21 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -151.53 165.19 34.98 Favored 'General case' 0 N--CA 1.432 -1.358 0 O-C-N 121.409 -0.807 . . . . 4.63 111.128 178.517 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.76 HD13 ' C ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER 56.29 63.04 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 124.505 1.122 . . . . 2.72 113.678 179.193 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.86 ' HB3' ' OH ' ' A' ' 21' ' ' TYR . 5.0 tt0 178.88 38.67 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.861 0.689 . . . . 2.6 112.861 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.546 ' CZ2' ' HA ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -153.15 32.92 0.47 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.682 0.623 . . . . 1.71 112.682 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp 56.17 20.12 4.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.843 0.354 . . . . 3.35 111.425 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.51 ' HB3' ' CG ' ' A' ' 4' ' ' GLU . 2.6 p-10 47.34 40.16 10.19 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.135 0.791 . . . . 2.14 113.135 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.84 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -48.23 -54.89 11.31 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.082 -1.056 . . . . 0.86 112.344 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.591 ' CE1' ' CE2' ' A' ' 47' ' ' TYR . 69.8 t60 -131.69 95.44 3.72 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 117.244 0.522 . . . . 2.9 110.546 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.511 ' O ' ' O ' ' A' ' 29' ' ' HIS . 14.6 m 37.63 107.48 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.402 0 N-CA-C 113.471 0.915 . . . . 1.46 113.471 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.451 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 7.1 Cg_exo -33.85 125.67 0.16 Allowed 'Trans proline' 0 C--N 1.366 1.45 0 C-N-CA 122.768 2.312 . . . . 0.79 110.275 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.558 ' O ' ' O ' ' A' ' 21' ' ' TYR . 67.3 m -152.24 143.96 23.58 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 119.422 -0.911 . . . . 0.95 112.879 -173.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.583 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 31.5 t-105 -78.59 92.42 4.7 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 104.051 -2.574 . . . . 1.24 104.051 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.892 HG12 ' CD ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -152.67 173.04 4.88 Favored Pre-proline 0 N--CA 1.442 -0.829 0 CA-C-N 112.308 -2.223 . . . . 1.74 108.533 -176.183 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.892 ' CD ' HG12 ' A' ' 34' ' ' VAL . 85.5 Cg_endo -77.46 105.82 2.11 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 123.726 2.95 . . . . 1.52 117.432 -173.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.8 t 43.5 27.25 0.14 Allowed 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.33 -1.305 . . . . 1.75 111.997 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.547 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 12.2 m -166.65 -120.16 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.494 -0.775 . . . . 1.49 109.668 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.84 ' OH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -175.49 101.21 0.08 Allowed 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 106.45 -1.685 . . . . 5.43 106.45 -177.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.677 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -127.04 33.16 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 114.745 -1.116 . . . . 2.1 109.154 -176.082 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -58.28 92.79 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.424 -1.262 . . . . 1.64 111.905 -177.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 168.49 -61.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.184 -0.916 . . . . 2.5 110.059 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 9.2 t70 163.29 79.73 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.321 -0.854 . . . . 4.56 109.683 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.557 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -148.91 -157.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.959 -0.296 . . . . 3.73 110.401 -179.361 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.562 ' N ' HD12 ' A' ' 39' ' ' ILE . 4.8 p -155.16 105.9 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.421 0.629 . . . . 2.57 112.531 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.46 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 6.3 p 80.16 2.36 1.98 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.762 -1.108 . . . . 1.34 113.335 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 179.15 140.74 0.11 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.597 0.237 . . . . 1.6 111.311 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.591 ' CE2' ' CE1' ' A' ' 29' ' ' HIS . 11.0 t80 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.195 -0.907 . . . . 4.12 110.069 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.519 -0.232 . . . . 6.11 112.519 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.6 p -87.97 94.7 9.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 4.17 110.917 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.565 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . -151.25 -143.66 3.76 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.791 -0.718 . . . . 2.16 112.464 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.496 ' N ' ' HG3' ' A' ' 31' ' ' PRO . 2.1 tm-20 64.36 47.19 3.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.953 0.883 . . . . 2.17 110.137 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.411 HG11 ' HD3' ' A' ' 7' ' ' LYS . 12.0 t -119.94 -16.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.243 -0.89 . . . . 0.87 111.301 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 24.8 t-20 50.37 38.59 18.35 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 108.529 -0.915 . . . . 1.86 108.529 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.9 ' HE3' HG21 ' A' ' 23' ' ' ILE . 21.7 pttp -93.48 -129.6 0.12 Allowed 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.291 -1.322 . . . . 2.42 111.268 -176.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -117.02 117.14 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.048 0.452 . . . . 2.03 111.965 -178.402 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.555 ' HB ' HD11 ' A' ' 23' ' ' ILE . 9.7 tp -149.59 161.88 4.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.958 -0.564 . . . . 3.89 110.849 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -109.34 130.41 9.97 Favored Glycine 0 CA--C 1.505 -0.589 0 N-CA-C 110.363 -1.095 . . . . 1.14 110.363 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.621 ' HB3' ' CG ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -102.16 107.8 19.0 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.562 1.172 . . . . 1.69 113.188 -177.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.34 104.4 2.03 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.547 -2.115 . . . . 3.7 111.285 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.488 ' CB ' ' HA ' ' A' ' 19' ' ' MET . 1.3 m -109.59 -81.51 0.57 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 119.953 -0.699 . . . . 0.48 112.562 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.404 ' C ' ' HG2' ' A' ' 19' ' ' MET . . . -149.84 -54.23 0.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.717 0.294 . . . . 0.45 111.417 -178.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.415 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . 117.05 -28.37 7.32 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.313 -0.946 . . . . 0.72 112.893 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.28 -33.43 71.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.336 0.589 . . . . 2.82 109.75 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.643 ' HA2' HG12 ' A' ' 44' ' ' VAL . . . -150.32 -46.9 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.785 -0.926 . . . . 0.8 110.785 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.577 ' HB1' ' HA ' ' A' ' 34' ' ' VAL . . . -115.17 152.17 33.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.263 -0.468 . . . . 0.51 110.027 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.488 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -165.94 46.84 0.08 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.105 0.78 . . . . 1.98 113.105 -179.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.755 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 53.3 mt-10 -149.54 -139.77 0.1 Allowed 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 114.621 1.341 . . . . 1.28 114.621 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.621 ' CG ' ' HB3' ' A' ' 11' ' ' SER . 0.1 OUTLIER -123.45 -172.65 2.56 Favored 'General case' 0 C--O 1.191 -2.008 0 N-CA-C 114.728 1.381 . . . . 4.88 114.728 -173.112 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.838 ' O ' HG23 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -137.88 104.74 5.36 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 114.181 1.178 . . . . 4.63 114.181 173.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.9 HG21 ' HE3' ' A' ' 7' ' ' LYS . 2.7 pp 136.57 24.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 126.886 2.075 . . . . 2.72 112.436 176.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.581 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 8.9 tp10 -130.57 53.4 1.96 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.786 0.721 . . . . 2.6 111.925 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.576 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -153.83 -169.4 3.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.108 -0.496 . . . . 1.71 109.782 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.59 36.69 1.6 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.08 0.467 . . . . 3.35 109.791 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.443 ' HB2' ' HG3' ' A' ' 4' ' ' GLU . 24.9 t70 53.31 44.82 29.6 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.809 -0.632 . . . . 2.14 110.862 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.513 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -54.04 -64.27 4.41 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.231 -0.985 . . . . 0.86 112.312 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.464 ' O ' ' CB ' ' A' ' 38' ' ' TYR . 47.5 t-80 -134.41 95.94 3.49 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 117.099 0.449 . . . . 2.9 110.386 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 31' ' ' PRO . 17.4 m 39.12 98.01 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 112.573 0.583 . . . . 1.46 112.573 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.496 ' HG3' ' N ' ' A' ' 4' ' ' GLU . 18.0 Cg_exo -27.24 126.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.365 1.395 0 C-N-CA 123.558 2.839 . . . . 0.79 110.407 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.495 ' O ' ' CH2' ' A' ' 25' ' ' TRP . 8.5 t -152.41 144.64 23.93 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 119.038 -1.065 . . . . 0.95 112.959 -171.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.525 ' N ' ' HB3' ' A' ' 22' ' ' LEU . 9.1 t-105 -83.31 96.07 8.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 104.335 -2.469 . . . . 1.24 104.335 175.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.94 HG12 ' HD3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -151.51 -172.24 0.31 Allowed Pre-proline 0 N--CA 1.434 -1.229 0 CA-C-N 112.548 -2.115 . . . . 1.74 106.659 -175.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.94 ' HD3' HG12 ' A' ' 34' ' ' VAL . 44.9 Cg_endo -88.13 102.69 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.676 2.251 . . . . 1.52 116.142 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.42 ' N ' ' OE1' ' A' ' 20' ' ' GLU . 41.9 t 45.41 23.93 0.15 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.725 -0.671 . . . . 1.75 111.989 177.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.548 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 5.4 m -163.59 -122.93 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 116.476 -0.329 . . . . 1.49 110.22 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -174.47 102.15 0.1 Allowed 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 106.282 -1.747 . . . . 5.43 106.282 -177.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.749 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -124.17 34.98 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 114.683 -1.144 . . . . 2.1 110.329 -174.223 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -59.4 91.92 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.346 -1.297 . . . . 1.64 111.695 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 166.72 -60.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.307 -0.86 . . . . 2.5 110.022 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 41' ' ' ALA . 1.6 p30 160.49 78.66 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.567 -0.742 . . . . 4.56 110.398 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.628 HG11 ' O ' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -151.44 -166.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 110.067 -0.346 . . . . 3.73 110.067 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.643 HG12 ' HA2' ' A' ' 17' ' ' GLY . 3.1 m -147.22 121.68 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 112.848 0.684 . . . . 2.57 112.848 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.455 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 22.8 t 69.5 5.01 4.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.207 -0.906 . . . . 1.34 113.199 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 45' ' ' SER . 39.1 tt0 179.02 158.62 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.089 0.471 . . . . 1.6 111.863 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.628 ' O ' HG11 ' A' ' 43' ' ' VAL . 37.4 p90 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.176 -0.916 . . . . 4.12 110.997 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.529 -0.229 . . . . 6.11 112.529 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.1 p -94.05 173.6 7.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.765 0.317 . . . . 4.17 110.908 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.641 ' O ' HG23 ' A' ' 5' ' ' VAL . . . 81.56 144.84 4.57 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.724 -0.751 . . . . 2.16 112.647 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 48.74 26.82 1.36 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.785 0.803 . . . . 2.17 110.348 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 3' ' ' GLY . 5.1 t -105.4 -8.65 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.391 -0.822 . . . . 0.87 112.488 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.545 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 2.0 p30 41.34 74.38 0.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.714 0.293 . . . . 1.86 111.396 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.551 ' HD2' HG22 ' A' ' 8' ' ' ILE . 3.6 pttp -151.44 -107.93 0.06 Allowed 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.963 0.357 . . . . 2.42 111.963 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.678 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -82.77 101.46 7.52 Favored 'Isoleucine or valine' 0 C--N 1.345 0.408 0 N-CA-C 109.485 -0.561 . . . . 2.03 109.485 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.822 HD11 ' CZ ' ' A' ' 21' ' ' TYR . 2.4 tp -153.29 171.38 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 120.031 -0.667 . . . . 3.89 112.371 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.94 169.74 22.77 Favored Glycine 0 CA--C 1.508 -0.374 0 CA-C-N 116.16 -0.473 . . . . 1.14 111.987 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.495 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 2.5 p -150.35 104.48 3.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.128 0.788 . . . . 1.69 113.128 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.444 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 14.9 tpt180 -157.56 102.2 1.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.015 -0.539 . . . . 3.7 110.829 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.485 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -117.08 -84.09 0.64 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 114.008 1.114 . . . . 0.48 114.008 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.43 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -150.34 -56.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.428 -0.509 . . . . 0.45 112.305 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.472 ' N ' ' HG3' ' A' ' 19' ' ' MET . . . 119.4 -29.49 6.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.142 -1.028 . . . . 0.72 112.53 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -58.81 -33.7 70.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.471 0.653 . . . . 2.82 109.245 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 43' ' ' VAL . . . -150.83 -46.0 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 114.777 -1.102 . . . . 0.8 111.068 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.566 ' HA ' ' HG3' ' A' ' 35' ' ' PRO . . . -116.19 151.21 36.15 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.208 -0.293 . . . . 0.51 110.208 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.472 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 2.8 ttp -162.61 24.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.433 0.531 . . . . 1.98 112.433 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 5.7 mt-10 -150.47 -179.91 7.62 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.823 -0.436 . . . . 1.28 109.823 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.822 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -155.52 14.09 0.36 Allowed 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 113.702 1.001 . . . . 4.88 113.702 -179.274 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.681 ' HB3' HG23 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -84.78 135.45 34.11 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 116.003 1.853 . . . . 4.63 116.003 -177.038 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.626 HD13 ' H ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -74.2 16.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 111.505 -2.588 . . . . 2.72 111.126 177.641 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.545 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . 24.6 tt0 -80.09 17.25 1.03 Allowed 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.058 0.543 . . . . 2.6 111.082 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.591 ' HZ2' ' H ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -91.58 32.28 1.1 Allowed 'General case' 0 C--N 1.342 0.272 0 N-CA-C 109.851 -0.426 . . . . 1.71 109.851 177.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 25' ' ' TRP . 64.4 pttt 46.78 34.44 2.59 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.142 -0.481 . . . . 3.35 111.154 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 0.3 OUTLIER 65.24 23.89 12.23 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.704 -0.399 . . . . 2.14 110.246 179.424 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -44.32 -68.93 0.79 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.848 -0.691 . . . . 0.86 111.798 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.579 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -133.29 99.46 4.54 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.815 -0.439 . . . . 2.9 109.815 178.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.507 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 27.6 t 33.28 113.07 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 116.825 2.157 . . . . 1.46 116.825 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.507 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 13.5 Cg_exo -29.2 116.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.982 3.121 . . . . 0.79 110.053 173.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.591 ' H ' ' HZ2' ' A' ' 25' ' ' TRP . 22.8 t -152.72 -177.6 6.35 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 114.093 1.145 . . . . 0.95 114.093 -174.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.6 ' CE3' ' CG ' ' A' ' 21' ' ' TYR . 11.7 t-105 -106.21 92.19 4.03 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.584 -1.189 . . . . 1.24 108.935 178.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.018 HG21 HG23 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -159.76 -179.75 1.16 Allowed Pre-proline 0 C--O 1.214 -0.775 0 CA-C-N 115.822 -0.627 . . . . 1.74 110.815 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.716 ' CD ' HG22 ' A' ' 34' ' ' VAL . 11.7 Cg_endo -98.53 115.74 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 123.605 2.87 . . . . 1.52 115.778 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t 70.63 -8.75 0.87 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 115.37 1.619 . . . . 1.75 115.37 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.553 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 49.4 m -160.86 -90.27 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 118.707 -1.197 . . . . 1.49 114.102 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.784 ' CA ' HG11 ' A' ' 34' ' ' VAL . 12.8 t80 176.75 140.42 0.07 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 110.062 -0.347 . . . . 5.43 110.062 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.018 HG23 HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -165.62 31.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 123.182 1.468 . . . . 2.1 108.365 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -65.85 91.69 0.15 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.359 -1.292 . . . . 1.64 110.93 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 160.2 -26.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.367 -0.833 . . . . 2.5 110.421 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 5.8 m-20 -120.84 -92.04 0.55 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.41 0.522 . . . . 4.56 112.41 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.531 ' CA ' HD11 ' A' ' 39' ' ' ILE . 7.1 p 174.98 -30.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.276 0.472 . . . . 3.73 112.276 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.489 HG23 ' H ' ' A' ' 46' ' ' GLU . 32.6 m -54.51 -170.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 112.495 0.554 . . . . 2.57 112.495 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.477 ' CB ' ' HG2' ' A' ' 35' ' ' PRO . 11.7 t -107.58 21.8 16.92 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.1 0.778 . . . . 1.34 113.1 -177.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.489 ' H ' HG23 ' A' ' 44' ' ' VAL . 41.4 tt0 -172.86 139.18 0.85 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.565 0.58 . . . . 1.6 112.565 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' A' ' 38' ' ' TYR . 4.1 t80 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.273 -0.87 . . . . 4.12 110.989 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.511 -0.236 . . . . 6.11 112.511 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.3 m -153.96 144.08 22.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 4.17 110.919 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 70.18 162.67 4.0 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.704 -0.76 . . . . 2.16 112.503 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.567 ' H ' HG22 ' A' ' 23' ' ' ILE . 9.8 tt0 61.46 14.78 6.11 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.303 0.573 . . . . 2.17 111.588 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.641 ' H ' HG21 ' A' ' 23' ' ' ILE . 4.9 t -79.87 -35.39 16.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 122.134 -0.354 . . . . 0.87 111.428 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.458 ' H ' HG21 ' A' ' 23' ' ' ILE . 42.8 t-20 58.61 88.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 1.86 110.632 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.476 ' HD2' ' CG1' ' A' ' 5' ' ' VAL . 2.5 ptmm? -150.94 -67.24 0.19 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.176 -0.466 . . . . 2.42 111.73 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.624 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -138.76 128.96 33.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.966 -0.561 . . . . 2.03 109.782 -179.22 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.624 ' N ' HD13 ' A' ' 8' ' ' ILE . 13.5 pt -122.1 131.46 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 113.949 1.092 . . . . 3.89 113.949 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.69 102.77 0.23 Allowed Glycine 0 N--CA 1.453 -0.216 0 N-CA-C 109.419 -1.472 . . . . 1.14 109.419 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.615 ' HB2' ' N ' ' A' ' 21' ' ' TYR . 7.0 m -148.99 169.96 19.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.334 1.235 . . . . 1.69 114.334 -176.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -159.89 102.74 1.49 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.522 -1.672 . . . . 3.7 109.91 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.848 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -87.85 -76.97 0.36 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.022 -0.671 . . . . 0.48 112.043 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -150.95 -63.54 0.19 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.683 0.623 . . . . 0.45 112.683 -178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.481 ' N ' ' HG3' ' A' ' 19' ' ' MET . . . 125.86 -42.05 1.56 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.773 -0.931 . . . . 0.72 110.773 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.408 ' OE2' ' N ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -59.3 -28.16 66.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.576 -0.898 . . . . 2.82 108.576 178.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.822 ' HA2' HG12 ' A' ' 44' ' ' VAL . . . -142.1 -65.17 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.958 -1.019 . . . . 0.8 111.179 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.88 ' HB2' HD11 ' A' ' 39' ' ' ILE . . . -109.19 154.0 22.99 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 119.564 -0.255 . . . . 0.51 111.367 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.558 ' HA ' ' H ' ' A' ' 13' ' ' THR . 1.6 ttm -157.05 25.09 0.31 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.49 1.293 . . . . 1.98 114.49 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.702 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 18.1 mt-10 -157.73 175.44 13.89 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 107.668 -1.234 . . . . 1.28 107.668 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.638 ' HB2' ' HA ' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -155.79 -26.69 0.1 Allowed 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 116.047 1.869 . . . . 4.88 116.047 -178.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.619 HD21 ' CZ ' ' A' ' 21' ' ' TYR . 2.0 mm? -89.66 138.21 31.67 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 115.308 1.595 . . . . 4.63 115.308 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.641 HG21 ' H ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -8.17 -119.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 111.363 -2.653 . . . . 2.72 114.969 177.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.564 ' HB2' HG21 ' A' ' 9' ' ' ILE . 33.9 tt0 48.23 25.03 0.76 Allowed 'General case' 0 C--N 1.344 0.365 0 O-C-N 121.777 -0.577 . . . . 2.6 109.939 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.927 ' CZ3' HG13 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -138.57 32.17 2.28 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 112.764 0.653 . . . . 1.71 112.764 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.2 tptt 37.3 30.41 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.326 0.491 . . . . 3.35 112.326 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HB3' ' CB ' ' A' ' 4' ' ' GLU . 4.1 p-10 44.15 35.82 1.32 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.09 0.404 . . . . 2.14 112.09 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.744 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -46.69 -53.86 9.63 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.302 -0.952 . . . . 0.86 111.72 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.543 ' CE1' ' CE2' ' A' ' 47' ' ' TYR . 9.6 t60 -132.04 94.57 3.5 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.581 -0.526 . . . . 2.9 109.581 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 29' ' ' HIS . 16.0 t 37.75 112.15 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 115.266 1.58 . . . . 1.46 115.266 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.448 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 17.9 Cg_exo -33.14 122.27 0.11 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.801 2.334 . . . . 0.79 108.768 174.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.492 ' O ' ' CZ2' ' A' ' 25' ' ' TRP . 40.4 m -143.38 174.98 10.26 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 114.201 1.186 . . . . 0.95 114.201 -172.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.848 ' CD1' HG23 ' A' ' 13' ' ' THR . 2.1 t90 -97.96 100.97 12.34 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 104.602 -2.37 . . . . 1.24 104.602 174.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.998 HG21 ' N ' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -151.83 151.62 28.6 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 114.226 -1.352 . . . . 1.74 111.37 -171.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.711 ' HD2' HG23 ' A' ' 34' ' ' VAL . 40.9 Cg_exo -56.37 -14.15 11.78 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 125.127 3.885 . . . . 1.52 116.588 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.771 ' H ' HG22 ' A' ' 34' ' ' VAL . 28.1 t 176.54 -28.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.96 0.726 . . . . 1.75 112.96 -177.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.567 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 49.7 m -114.61 -90.18 0.54 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.0 0.37 . . . . 1.49 112.0 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.998 ' N ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -178.94 123.3 0.09 Allowed 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 106.655 -1.609 . . . . 5.43 106.655 -179.349 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.88 HD11 ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -135.62 27.89 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.746 0.784 . . . . 2.1 110.305 -175.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -59.58 92.04 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.022 -0.99 . . . . 1.64 111.59 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 160.83 -60.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.232 -0.895 . . . . 2.5 109.948 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 6.7 t70 163.13 80.72 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.435 -0.802 . . . . 4.56 110.13 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.656 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -148.42 -163.34 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.961 -0.296 . . . . 3.73 110.336 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.822 HG12 ' HA2' ' A' ' 17' ' ' GLY . 15.9 m -141.14 101.74 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 113.073 0.768 . . . . 2.57 113.073 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.503 ' N ' ' HG2' ' A' ' 35' ' ' PRO . 46.9 t 64.39 14.68 8.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.281 -0.872 . . . . 1.34 112.414 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -178.6 133.61 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.487 -0.485 . . . . 1.6 111.822 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.543 ' CE2' ' CE1' ' A' ' 29' ' ' HIS . 90.4 t80 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.228 -0.891 . . . . 4.12 110.927 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 112.545 -0.222 . . . . 6.11 112.545 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 81.3 p 51.27 -173.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.938 0.399 . . . . 4.17 110.945 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.457 ' HA2' HD11 ' A' ' 23' ' ' ILE . . . 146.32 158.5 7.79 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.882 -0.675 . . . . 2.16 112.184 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.476 ' CB ' ' HB3' ' A' ' 27' ' ' ASP . 6.9 tt0 67.52 7.27 5.48 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.771 0.286 . . . . 2.17 111.771 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 6' ' ' ASN . 54.9 t -82.53 -43.42 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.035 0.445 . . . . 0.87 110.353 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.658 ' N ' HG21 ' A' ' 23' ' ' ILE . 27.8 t-20 83.56 74.07 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.915 -1.038 . . . . 1.86 110.739 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.752 ' HG3' HG22 ' A' ' 8' ' ' ILE . 36.4 pttt -151.56 -140.36 0.1 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.302 -1.772 . . . . 2.42 108.093 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.958 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -38.95 143.54 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 122.565 0.346 . . . . 2.03 110.884 177.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.958 ' N ' HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -147.48 126.88 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 114.32 1.23 . . . . 3.89 114.32 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.03 146.71 16.66 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 107.767 -2.133 . . . . 1.14 107.767 175.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.509 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -154.24 104.43 2.61 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 118.51 1.155 . . . . 1.69 112.917 -176.046 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -157.86 102.65 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.822 -0.627 . . . . 3.7 109.849 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.463 ' H ' ' HA ' ' A' ' 19' ' ' MET . 1.0 OUTLIER -113.86 -82.98 0.6 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.894 1.072 . . . . 0.48 113.894 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.421 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -145.32 -54.52 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.576 -0.45 . . . . 0.45 112.157 -177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.435 ' N ' ' HG3' ' A' ' 19' ' ' MET . . . 116.63 -37.27 3.43 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 119.903 -1.142 . . . . 0.72 112.801 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.18 -27.74 64.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.251 0.548 . . . . 2.82 109.522 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -150.02 -53.98 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.33 -0.85 . . . . 0.8 111.123 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.565 ' HB1' ' HD3' ' A' ' 35' ' ' PRO . . . -115.67 146.58 41.72 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 110.034 -0.358 . . . . 0.51 110.034 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.463 ' HA ' ' H ' ' A' ' 13' ' ' THR . 2.6 ttp -155.68 31.81 0.36 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 111.925 0.343 . . . . 1.98 111.925 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.645 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 9.3 mt-10 -147.29 -176.39 5.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 119.155 -0.45 . . . . 1.28 109.88 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.675 ' HB2' ' CD2' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -154.28 -62.85 0.13 Allowed 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 119.919 3.303 . . . . 4.88 119.919 -174.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.945 ' HG ' HD12 ' A' ' 23' ' ' ILE . 10.6 tp -84.18 155.65 22.44 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 114.864 1.431 . . . . 4.63 114.864 -170.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.945 HD12 ' HG ' ' A' ' 22' ' ' LEU . 3.4 mp -9.86 -112.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 112.462 -2.154 . . . . 2.72 114.85 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.558 ' N ' HG22 ' A' ' 23' ' ' ILE . 5.9 tt0 70.69 -61.35 0.48 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.728 -1.582 . . . . 2.6 106.728 -175.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.566 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 1.1 p90 -57.76 -173.18 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.021 -0.99 . . . . 1.71 111.033 176.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.46 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 3.2 mptp? -116.37 55.2 0.82 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.122 0.487 . . . . 3.35 109.941 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.476 ' HB3' ' CB ' ' A' ' 4' ' ' GLU . 4.0 p30 42.85 33.94 0.55 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.563 -0.744 . . . . 2.14 111.874 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.743 ' N ' ' OH ' ' A' ' 38' ' ' TYR . . . -49.48 -57.54 9.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.534 -0.841 . . . . 0.86 112.722 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.542 ' NE2' ' CE2' ' A' ' 47' ' ' TYR . 54.5 t-80 -131.97 96.29 3.88 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 117.383 0.591 . . . . 2.9 110.694 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 29' ' ' HIS . 23.3 t 39.71 103.24 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 113.761 1.022 . . . . 1.46 113.761 177.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.446 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 15.1 Cg_exo -31.6 114.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.371 1.723 0 C-N-CA 122.816 2.344 . . . . 0.79 109.699 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 21' ' ' TYR . 10.0 t -133.62 -163.31 1.34 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.712 0.634 . . . . 0.95 112.712 -172.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.675 ' CD2' ' HB2' ' A' ' 21' ' ' TYR . 6.4 t-105 -120.41 91.98 3.66 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.15 -1.796 . . . . 1.24 106.15 175.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.699 HG13 ' CD ' ' A' ' 35' ' ' PRO . 1.2 t -158.7 170.65 8.58 Favored Pre-proline 0 N--CA 1.444 -0.751 0 CA-C-N 114.993 -1.003 . . . . 1.74 112.186 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.699 ' CD ' HG13 ' A' ' 34' ' ' VAL . 59.1 Cg_endo -70.39 108.41 2.19 Favored 'Trans proline' 0 N--CA 1.485 1.003 1 C-N-CA 125.484 4.123 . . . . 1.52 116.253 175.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 t 37.55 30.35 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.813 -0.63 . . . . 1.75 112.13 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.544 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -163.11 -136.14 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 116.024 -0.535 . . . . 1.49 110.464 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.743 ' OH ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -174.34 100.68 0.1 Allowed 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.444 -1.688 . . . . 5.43 106.444 -177.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.679 HG23 HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -126.14 31.44 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 122.92 1.343 . . . . 2.1 109.477 -175.106 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -60.91 92.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.51 -1.223 . . . . 1.64 111.055 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 164.38 -29.46 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.432 -0.804 . . . . 2.5 110.024 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.574 ' OD2' HG12 ' A' ' 43' ' ' VAL . 23.8 t70 -123.95 -91.46 0.54 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.989 -0.55 . . . . 4.56 112.008 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.574 HG12 ' OD2' ' A' ' 42' ' ' ASP . 14.7 p 175.55 -30.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 112.382 0.512 . . . . 3.73 112.382 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.473 HG23 ' H ' ' A' ' 46' ' ' GLU . 17.1 m -55.45 -169.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.005 0.372 . . . . 2.57 112.005 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.598 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 26.3 t -106.47 35.09 3.08 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.857 0.688 . . . . 1.34 112.857 -177.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.608 ' N ' HG21 ' A' ' 39' ' ' ILE . 34.8 tt0 -179.01 149.21 0.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.81 0.338 . . . . 1.6 110.815 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.542 ' CE2' ' NE2' ' A' ' 29' ' ' HIS . 9.4 t80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.239 -0.886 . . . . 4.12 110.803 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.501 -0.24 . . . . 6.11 112.501 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.5 p -72.41 -177.72 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.747 0.308 . . . . 4.17 110.73 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.564 ' HA3' ' HB3' ' A' ' 31' ' ' PRO . . . 148.25 -158.47 27.7 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.482 -0.866 . . . . 2.16 112.603 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.418 ' CA ' HG23 ' A' ' 23' ' ' ILE . 0.0 OUTLIER 62.0 7.92 2.32 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.42 0.526 . . . . 2.17 112.42 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.541 HG11 ' HD3' ' A' ' 7' ' ' LYS . 13.9 t -85.31 -50.37 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 120.897 0.379 . . . . 0.87 110.721 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 5' ' ' VAL . 34.5 t-20 93.25 69.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.55 -1.205 . . . . 1.86 108.553 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.541 ' HD3' HG11 ' A' ' 5' ' ' VAL . 17.0 pttp -150.41 -141.58 0.11 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.002 -0.999 . . . . 2.42 109.932 -177.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.708 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -48.1 102.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 121.486 0.66 . . . . 2.03 111.98 178.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.876 HD11 ' CZ ' ' A' ' 21' ' ' TYR . 5.1 tp -154.06 169.08 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.228 -0.589 . . . . 3.89 111.506 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.91 169.93 20.21 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.542 -0.361 . . . . 1.14 112.524 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.535 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 3.0 p -150.62 104.68 3.22 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 113.264 0.839 . . . . 1.69 113.264 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.428 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 12.6 mmt180 -157.93 103.38 1.87 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.295 -0.411 . . . . 3.7 111.723 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.591 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -125.28 -85.2 0.63 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.207 -0.933 . . . . 0.48 113.488 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.462 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -143.7 -61.36 0.4 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.094 0.405 . . . . 0.45 112.094 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 19' ' ' MET . . . 124.26 -46.98 1.05 Allowed Glycine 0 C--N 1.329 0.166 0 C-N-CA 120.434 -0.889 . . . . 0.72 112.522 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -59.26 -25.59 64.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.015 0.436 . . . . 2.82 110.517 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -141.43 -54.94 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.802 -0.919 . . . . 0.8 110.802 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.525 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . . . -128.76 150.98 50.06 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.454 -0.573 . . . . 0.51 109.454 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.462 ' HG2' ' N ' ' A' ' 14' ' ' ALA . 2.9 tmm? -162.49 22.61 0.1 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.351 0.871 . . . . 1.98 113.351 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.601 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 9.3 mm-40 -148.01 179.75 7.51 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.709 -0.848 . . . . 1.28 108.709 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.876 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -156.2 11.72 0.28 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.513 0.931 . . . . 4.88 113.513 -179.394 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.718 ' HB3' HG23 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -84.99 133.9 34.24 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 117.242 2.312 . . . . 4.63 117.242 -175.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.56 HD13 HG12 ' A' ' 9' ' ' ILE . 1.9 mp -64.4 -6.39 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-N 110.248 -3.16 . . . . 2.72 110.151 176.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.544 ' HB3' HD13 ' A' ' 22' ' ' LEU . 30.8 tt0 -47.83 -12.61 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.92 -0.582 . . . . 2.6 112.172 177.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.606 ' HZ2' ' H ' ' A' ' 32' ' ' SER . 0.2 OUTLIER -72.56 30.41 0.06 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.776 1.028 . . . . 1.71 113.776 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 53.6 mttm 46.18 35.57 2.68 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 118.048 0.385 . . . . 3.35 111.916 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.4 ' HB2' ' HG2' ' A' ' 4' ' ' GLU . 56.4 t0 62.68 25.34 15.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.955 0.407 . . . . 2.14 110.332 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -46.21 -66.57 1.64 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.408 -0.901 . . . . 0.86 111.393 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.546 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -135.35 99.57 4.27 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.934 -0.307 . . . . 2.9 110.612 178.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.485 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 20.1 m 37.18 111.8 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.495 0 N-CA-C 116.469 2.025 . . . . 1.46 116.469 176.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.564 ' HB3' ' HA3' ' A' ' 3' ' ' GLY . 7.3 Cg_exo -33.1 117.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 123.268 2.645 . . . . 0.79 108.935 173.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.606 ' H ' ' HZ2' ' A' ' 25' ' ' TRP . 18.6 t -150.1 176.16 11.07 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.496 0.924 . . . . 0.95 113.496 -173.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.614 ' CG ' ' HB2' ' A' ' 21' ' ' TYR . 12.0 t-105 -104.76 91.3 3.78 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.902 -0.777 . . . . 1.24 108.902 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.018 HG21 HG23 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -159.72 175.05 3.43 Favored Pre-proline 0 C--O 1.217 -0.616 0 CA-C-N 115.468 -0.787 . . . . 1.74 111.124 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.597 ' CD ' HG22 ' A' ' 34' ' ' VAL . 26.0 Cg_endo -92.02 142.45 2.59 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.756 2.971 . . . . 1.52 113.118 175.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 27.8 t 72.91 -57.56 0.63 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.965 -1.016 . . . . 1.75 113.65 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.579 ' HA ' ' CE3' ' A' ' 25' ' ' TRP . 42.9 m -148.72 -64.32 0.24 Allowed 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 114.937 1.458 . . . . 1.49 114.937 -177.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.679 ' CA ' HG11 ' A' ' 34' ' ' VAL . 7.9 t80 178.12 149.3 0.19 Allowed 'General case' 0 C--N 1.318 -0.771 0 O-C-N 121.759 -0.588 . . . . 5.43 110.407 -176.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.018 HG23 HG21 ' A' ' 34' ' ' VAL . 0.5 OUTLIER 176.45 74.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.61 0.719 . . . . 2.1 110.019 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.32 92.66 0.06 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.206 -0.906 . . . . 1.64 110.974 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 178.62 -31.9 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.5 -0.773 . . . . 2.5 111.182 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 77.26 25.88 0.74 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.089 -0.505 . . . . 4.56 110.661 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.583 HG23 ' CG2' ' A' ' 44' ' ' VAL . 29.8 m -121.31 0.5 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 3.73 112.106 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.798 ' O ' HG21 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -159.76 169.23 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-O 120.791 0.329 . . . . 2.57 110.947 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.47 ' CB ' ' HG2' ' A' ' 35' ' ' PRO . 47.4 t -105.32 26.03 9.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.971 -0.559 . . . . 1.34 111.281 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -178.8 148.62 0.42 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.028 0.381 . . . . 1.6 112.028 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' TYR . 9.3 t80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.224 -0.893 . . . . 4.12 110.8 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 112.612 -0.195 . . . . 6.11 112.612 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m -121.12 -57.07 1.89 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.321 . . . . 4.17 110.85 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.517 ' O ' HG23 ' A' ' 5' ' ' VAL . . . -121.07 -102.47 1.82 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.678 -0.773 . . . . 2.16 112.555 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.456 ' HB2' ' CA ' ' A' ' 27' ' ' ASP . 9.4 pt-20 44.6 27.78 0.27 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.888 0.375 . . . . 2.17 111.006 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 3' ' ' GLY . 41.1 t -90.07 -8.97 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.16 -0.473 . . . . 0.87 111.846 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.577 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 3.2 t-20 49.14 73.06 0.25 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 110.313 -0.255 . . . . 1.86 110.313 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.618 ' N ' HD13 ' A' ' 23' ' ' ILE . 1.6 ptmm? -140.61 -98.92 0.15 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.298 0.481 . . . . 2.42 112.298 -178.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 8' ' ' ILE . 1.4 tp -137.4 105.34 3.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 CA-C-O 121.034 0.445 . . . . 2.03 110.902 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.946 HG22 ' CG1' ' A' ' 23' ' ' ILE . 3.4 tt -151.85 173.77 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.783 -0.644 . . . . 3.89 110.579 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -100.66 167.59 20.05 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.214 -0.517 . . . . 1.14 113.176 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.771 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 13.6 p -153.63 103.9 2.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 1.69 111.896 -177.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -158.99 102.88 1.65 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.608 -0.724 . . . . 3.7 110.043 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.47 ' H ' ' HA ' ' A' ' 19' ' ' MET . 1.0 OUTLIER -108.7 -85.2 0.53 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.815 1.043 . . . . 0.48 113.815 -178.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.448 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -145.38 -54.16 0.29 Allowed 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.163 0.431 . . . . 0.45 112.163 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.83 -34.84 4.68 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.291 -0.957 . . . . 0.72 112.268 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.0 -32.82 70.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.532 0.682 . . . . 2.82 109.183 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.581 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -141.09 -55.72 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.807 -1.088 . . . . 0.8 110.554 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.599 ' CA ' ' HD3' ' A' ' 35' ' ' PRO . . . -120.28 150.0 41.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.816 -0.192 . . . . 0.51 111.001 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.523 ' H ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -155.46 37.36 0.38 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.032 0.752 . . . . 1.98 113.032 178.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.636 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 27.8 mt-10 -151.81 -169.45 3.37 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 119.43 -0.319 . . . . 1.28 110.466 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.835 ' O ' ' CH2' ' A' ' 25' ' ' TRP 0.269 2.5 t80 -152.76 -130.77 0.04 OUTLIER 'General case' 0 C--O 1.209 -1.029 0 N-CA-C 116.057 1.873 . . . . 4.88 116.057 -177.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.598 ' N ' ' CD1' ' A' ' 21' ' ' TYR . 4.4 mt -78.94 166.67 22.12 Favored 'General case' 0 CA--C 1.491 -1.326 0 O-C-N 120.402 -1.437 . . . . 4.63 114.651 -166.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.946 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.9 OUTLIER 45.5 -166.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 112.848 -1.978 . . . . 2.72 109.679 -179.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.773 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.6 OUTLIER 71.08 9.85 6.77 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.721 -0.844 . . . . 2.6 108.721 -177.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.835 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -143.48 -173.55 3.98 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 108.694 -0.854 . . . . 1.71 108.694 178.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 4.0 mppt? -122.29 65.2 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.604 -0.439 . . . . 3.35 111.99 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.456 ' CA ' ' HB2' ' A' ' 4' ' ' GLU . 3.5 p30 40.63 29.01 0.06 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.283 -0.417 . . . . 2.14 112.105 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.736 ' N ' ' OH ' ' A' ' 38' ' ' TYR . . . -46.7 -62.92 3.4 Favored Glycine 0 C--N 1.329 0.16 0 C-N-CA 120.601 -0.809 . . . . 0.86 113.248 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.571 ' CE1' ' CE2' ' A' ' 47' ' ' TYR . 68.4 t60 -133.09 96.3 3.73 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 117.724 0.762 . . . . 2.9 111.153 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 31' ' ' PRO . 13.8 m 40.47 99.98 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 118.575 -0.726 . . . . 1.46 112.874 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.447 ' C ' ' O ' ' A' ' 30' ' ' SER . 17.9 Cg_exo -27.51 124.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.368 2.712 . . . . 0.79 110.789 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.8 t -148.93 -168.81 3.2 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.525 0.935 . . . . 0.95 113.525 -173.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.646 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 3.7 t-105 -116.08 95.56 5.15 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.254 -1.387 . . . . 1.24 107.254 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.728 HG13 ' CD ' ' A' ' 35' ' ' PRO . 1.0 OUTLIER -157.87 166.3 16.85 Favored Pre-proline 0 C--O 1.221 -0.401 0 CA-C-N 115.872 -0.604 . . . . 1.74 112.469 -178.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.728 ' CD ' HG13 ' A' ' 34' ' ' VAL . 12.1 Cg_endo -56.03 69.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.475 0.438 1 C-N-CA 125.44 4.094 . . . . 1.52 116.129 177.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.4 m 60.94 31.21 19.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.436 0.636 . . . . 1.75 110.794 176.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.577 ' O ' ' CZ3' ' A' ' 25' ' ' TRP . 1.5 m -150.79 -131.57 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.859 -1.064 . . . . 1.49 108.445 177.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.736 ' OH ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -174.59 99.91 0.09 Allowed 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 106.374 -1.713 . . . . 5.43 106.374 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.758 HD11 ' H ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -155.2 83.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.184 -1.371 . . . . 2.1 107.691 -175.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.67 91.05 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.585 -1.189 . . . . 1.64 111.504 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 46.41 59.3 3.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.08 -0.964 . . . . 2.5 111.772 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.819 ' O ' HG13 ' A' ' 43' ' ' VAL . 25.2 t70 -122.58 -20.95 5.84 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.788 0.662 . . . . 4.56 112.788 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.819 HG13 ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -179.03 -95.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 112.089 0.403 . . . . 3.73 112.089 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 17' ' ' GLY . 4.8 p -179.74 124.93 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 113.159 0.8 . . . . 2.57 113.159 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.501 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 28.8 t 65.87 10.38 6.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.92 -1.037 . . . . 1.34 113.72 176.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.475 ' H ' HG21 ' A' ' 39' ' ' ILE . 2.6 mt-10 176.98 166.38 0.53 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.773 0.657 . . . . 1.6 112.773 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.571 ' CE2' ' CE1' ' A' ' 29' ' ' HIS . 43.6 t80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.22 -0.895 . . . . 4.12 110.344 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 112.589 -0.204 . . . . 6.11 112.589 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.0 m 61.57 170.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.796 0.331 . . . . 4.17 110.873 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 4' ' ' GLU . . . 106.39 134.73 7.81 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 2.16 112.484 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 27' ' ' ASP . 6.5 pt-20 51.37 21.48 1.19 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.861 0.362 . . . . 2.17 111.6 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.657 ' N ' HG22 ' A' ' 23' ' ' ILE . 18.6 t -78.62 -6.05 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 113.271 0.841 . . . . 0.87 113.271 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.665 ' H ' HG22 ' A' ' 23' ' ' ILE . 26.0 t-20 38.28 85.79 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.843 0.292 . . . . 1.86 110.594 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.447 ' HD3' ' CG1' ' A' ' 5' ' ' VAL . 22.2 pttp -150.99 -135.04 0.06 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 121.098 -0.241 . . . . 2.42 110.563 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.653 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.9 OUTLIER -105.49 97.92 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 112.874 0.694 . . . . 2.03 112.874 -178.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.896 ' HB ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -133.46 172.93 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 116.171 -0.468 . . . . 3.89 111.925 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.623 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -99.86 165.38 19.9 Favored Glycine 0 C--O 1.219 -0.815 0 N-CA-C 110.138 -1.185 . . . . 1.14 110.138 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.552 ' HA ' ' HB2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -155.55 109.37 2.82 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 117.916 0.858 . . . . 1.69 113.077 -176.466 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 11' ' ' SER . 2.1 mpt_? -154.63 103.21 2.44 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.38 -0.373 . . . . 3.7 111.196 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.766 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -106.24 -82.72 0.53 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.397 0.888 . . . . 0.48 113.397 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.41 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -146.31 -53.25 0.25 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.072 0.397 . . . . 0.45 112.072 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.49 -35.91 4.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.291 -0.957 . . . . 0.72 112.839 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -58.69 -30.09 67.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.325 0.583 . . . . 2.82 109.762 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.514 ' HA3' ' CG2' ' A' ' 43' ' ' VAL . . . -150.39 -46.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.236 -0.893 . . . . 0.8 110.899 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.62 ' CA ' ' HD3' ' A' ' 35' ' ' PRO . . . -121.53 142.12 50.38 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 121.034 -0.266 . . . . 0.51 111.045 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.55 ' HA ' ' H ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -153.49 39.14 0.49 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.66 0.615 . . . . 1.98 112.66 178.38 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.63 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 27.9 mt-10 -145.79 -151.4 0.37 Allowed 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 118.371 -0.823 . . . . 1.28 111.378 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.851 ' CE2' HD11 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -153.24 -97.19 0.05 OUTLIER 'General case' 0 C--O 1.203 -1.345 0 N-CA-C 119.725 3.231 . . . . 4.88 119.725 -174.228 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.802 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 13.2 tp -120.57 168.6 11.19 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 113.035 0.754 . . . . 4.63 113.035 -174.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.896 HD11 ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER 38.5 -142.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.579 -1.191 . . . . 2.72 110.435 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 53.29 19.32 1.51 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.609 1.095 . . . . 2.6 109.464 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.637 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -152.77 -173.19 4.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.731 -0.668 . . . . 1.71 109.756 -179.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -122.52 62.75 0.97 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.792 0.664 . . . . 3.35 112.792 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . 31.2 t70 46.22 26.11 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.187 0.44 . . . . 2.14 112.187 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.579 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -47.52 -61.04 4.9 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 119.707 -1.235 . . . . 0.86 111.884 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.49 ' O ' ' HB2' ' A' ' 38' ' ' TYR . 58.3 t-80 -134.05 95.8 3.5 Favored 'General case' 0 C--O 1.215 -0.721 0 C-N-CA 119.966 -0.694 . . . . 2.9 111.575 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 29' ' ' HIS . 14.8 m 37.88 105.63 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 114.215 1.191 . . . . 1.46 114.215 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.553 ' HB3' HD11 ' A' ' 22' ' ' LEU . 23.7 Cg_exo -30.55 116.86 0.06 OUTLIER 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 123.038 2.492 . . . . 0.79 110.31 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 21' ' ' TYR . 8.5 t -135.94 -150.44 0.37 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.36 0.874 . . . . 0.95 113.36 -173.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.766 ' CD1' HG23 ' A' ' 13' ' ' THR . 6.8 t-105 -135.0 95.08 3.24 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 106.141 -1.8 . . . . 1.24 106.141 174.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.864 HG11 HG22 ' A' ' 39' ' ' ILE . 1.4 t -156.75 162.04 28.36 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 115.132 -0.94 . . . . 1.74 113.092 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.815 ' CD ' HG13 ' A' ' 34' ' ' VAL . 18.6 Cg_endo -55.31 72.5 0.03 OUTLIER 'Trans proline' 0 N--CA 1.477 0.502 1 C-N-CA 126.784 4.989 . . . . 1.52 115.488 177.24 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 35.3 t 65.04 23.7 12.5 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.748 -0.381 . . . . 1.75 111.742 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.547 ' O ' ' CZ3' ' A' ' 25' ' ' TRP . 7.3 m -149.06 -123.06 0.05 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.23 -0.441 . . . . 1.49 110.262 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.579 ' CZ ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -176.83 107.79 0.07 Allowed 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.81 -1.552 . . . . 5.43 106.81 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.864 HG22 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -174.9 39.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 122.937 1.351 . . . . 2.1 108.51 -175.426 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 33' ' ' TRP . . . -77.04 90.14 3.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.862 -1.517 . . . . 1.64 110.596 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.41 -34.87 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.391 -1.277 . . . . 2.5 109.923 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.445 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 32.0 t70 -102.03 -99.48 0.27 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.889 -0.596 . . . . 4.56 111.895 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.2 p 174.09 68.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 119.841 -0.123 . . . . 3.73 110.971 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.484 ' CG2' HG12 ' A' ' 39' ' ' ILE . 25.2 m -156.81 169.99 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 113.995 1.109 . . . . 2.57 113.995 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.638 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 28.2 t -83.44 10.8 7.99 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.607 -1.178 . . . . 1.34 112.487 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.45 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 36.8 tt0 179.16 161.13 0.74 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.113 0.483 . . . . 1.6 111.963 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.481 ' CD2' ' OXT' ' A' ' 47' ' ' TYR . 38.1 p90 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.265 -0.874 . . . . 4.12 110.917 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.463 -0.255 . . . . 6.11 112.463 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.2 p -155.63 60.57 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.738 0.304 . . . . 4.17 110.824 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.625 ' O ' HG23 ' A' ' 5' ' ' VAL . . . 129.47 176.91 14.61 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.6 -0.81 . . . . 2.16 112.657 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.475 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.0 OUTLIER 56.11 18.09 3.03 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.863 0.363 . . . . 2.17 111.072 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 3' ' ' GLY . 12.7 t -106.79 -4.14 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.33 . . . . 0.87 111.429 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.557 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 9.7 p30 45.28 79.73 0.05 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.33 0.586 . . . . 1.86 110.886 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.426 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 6.2 pttp -143.99 -104.71 0.12 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.138 -0.937 . . . . 2.42 110.442 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.635 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -87.06 103.67 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 108.354 -0.98 . . . . 2.03 108.354 178.458 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.764 HG21 ' HB2' ' A' ' 22' ' ' LEU . 21.9 pt -104.2 165.73 3.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.917 0.865 . . . . 3.89 113.082 -177.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.4 138.83 9.29 Favored Glycine 0 CA--C 1.498 -0.983 0 N-CA-C 107.454 -2.258 . . . . 1.14 107.454 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.49 ' HB2' ' CB ' ' A' ' 20' ' ' GLU . 12.4 p -144.59 104.45 4.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 119.062 1.431 . . . . 1.69 113.415 -176.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.418 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 31.2 ttm180 -159.94 101.09 1.44 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.452 -1.249 . . . . 3.7 111.091 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.536 ' HB ' ' C ' ' A' ' 18' ' ' ALA . 2.9 m -116.68 -87.99 0.6 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 113.981 1.104 . . . . 0.48 113.981 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.41 ' C ' ' HG3' ' A' ' 19' ' ' MET . . . -148.63 -60.0 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.218 -0.593 . . . . 0.45 112.581 -177.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.458 ' N ' ' HG3' ' A' ' 19' ' ' MET . . . 125.24 -34.98 3.22 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.327 -0.94 . . . . 0.72 112.13 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -30.28 66.74 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.256 -0.646 . . . . 2.82 109.256 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -146.43 -47.38 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.137 -0.938 . . . . 0.8 110.931 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.566 ' CA ' ' HD3' ' A' ' 35' ' ' PRO . . . -127.02 151.78 48.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 111.488 0.181 . . . . 0.51 111.488 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.458 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 1.6 ttm -151.66 22.0 0.7 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.891 0.33 . . . . 1.98 111.891 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.615 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 18.9 mt-10 -148.36 177.85 9.09 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 122.287 -0.258 . . . . 1.28 111.407 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.67 ' CG ' ' O ' ' A' ' 21' ' ' TYR . 1.0 OUTLIER -159.09 50.91 0.37 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.514 0.673 . . . . 4.88 111.701 -179.413 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.764 ' HB2' HG21 ' A' ' 9' ' ' ILE . 2.0 pp -110.15 114.05 27.24 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 116.266 1.95 . . . . 4.63 116.266 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.656 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 8.2 pt -53.89 -16.92 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 113.195 -1.821 . . . . 2.72 112.376 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.557 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . 35.1 tt0 -67.3 65.51 0.07 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.242 0.544 . . . . 2.6 111.212 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.656 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -142.97 31.69 1.4 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.568 -0.742 . . . . 1.71 110.225 178.439 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 60.06 34.17 21.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.288 -0.869 . . . . 3.35 111.908 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.464 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 4.2 p30 44.77 29.17 0.41 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.88 0.371 . . . . 2.14 111.282 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.467 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -47.63 -61.95 4.37 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.676 -0.774 . . . . 0.86 112.338 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.57 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 35.8 t60 -135.26 93.71 3.02 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 110.01 -0.367 . . . . 2.9 110.01 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 32' ' ' SER . 28.9 m 39.57 116.39 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 116.3 1.963 . . . . 1.46 116.3 177.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.592 ' HB3' HG22 ' A' ' 23' ' ' ILE . 14.2 Cg_exo -32.08 92.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 124.138 3.226 . . . . 0.79 107.749 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 30' ' ' SER . 33.8 t -111.72 166.32 11.28 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.334 -1.303 . . . . 0.95 113.849 -172.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.626 ' CZ3' ' CD2' ' A' ' 21' ' ' TYR . 15.0 t-105 -97.87 91.23 5.24 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 105.656 -1.979 . . . . 1.24 105.656 176.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.715 HG21 HG23 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -156.36 165.55 18.39 Favored Pre-proline 0 N--CA 1.441 -0.882 0 N-CA-C 113.887 1.069 . . . . 1.74 113.887 -178.376 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.674 ' HD2' HG22 ' A' ' 34' ' ' VAL . 38.2 Cg_endo -67.58 78.05 0.51 Allowed 'Trans proline' 0 C--N 1.352 0.728 1 C-N-CA 125.791 4.327 . . . . 1.52 117.609 177.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.8 m 76.09 14.5 2.52 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.641 0.978 . . . . 1.75 113.641 173.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.547 ' O ' ' CE3' ' A' ' 25' ' ' TRP . 1.8 m -162.54 -110.6 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 120.571 -0.451 . . . . 1.49 112.029 176.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.57 ' CG ' ' HB3' ' A' ' 29' ' ' HIS . 0.1 OUTLIER -174.49 132.82 0.37 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.997 -1.853 . . . . 5.43 105.997 -176.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.715 HG23 HG21 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -149.68 28.98 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 119.377 -0.929 . . . . 2.1 111.118 -174.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.566 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -60.86 89.43 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.574 -0.739 . . . . 1.64 110.25 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.566 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 153.69 38.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.839 -1.073 . . . . 2.5 110.705 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 55.83 87.51 0.05 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.429 0.529 . . . . 4.56 112.429 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.592 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -151.59 -156.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 110.05 -0.352 . . . . 3.73 110.05 178.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 44' ' ' VAL . 8.3 p -159.29 120.59 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 113.702 1.001 . . . . 2.57 113.702 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.549 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 28.8 t 63.44 8.71 3.68 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.202 0.816 . . . . 1.34 113.202 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 45' ' ' SER . 38.0 tt0 179.23 154.99 0.47 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.912 0.387 . . . . 1.6 111.931 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 39' ' ' ILE . 35.4 t80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.2 -0.905 . . . . 4.12 110.833 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 112.501 -0.24 . . . . 6.11 112.501 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.2 t -139.44 135.76 33.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.783 0.325 . . . . 4.17 110.878 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.437 ' C ' ' HG3' ' A' ' 31' ' ' PRO . . . 143.53 154.03 6.03 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.686 -0.769 . . . . 2.16 112.495 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.485 ' H ' HG23 ' A' ' 23' ' ' ILE . 0.0 OUTLIER 64.97 3.78 2.23 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 112.179 0.437 . . . . 2.17 112.179 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.497 ' HB ' ' HG2' ' A' ' 7' ' ' LYS . 24.1 t -79.74 -41.21 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 CA-C-O 121.317 0.579 . . . . 0.87 110.807 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.473 ' H ' ' CG2' ' A' ' 23' ' ' ILE . 0.3 OUTLIER 81.68 71.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.821 -1.081 . . . . 1.86 108.421 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.846 ' HD3' HG22 ' A' ' 8' ' ' ILE . 5.3 ptpt -152.41 -107.12 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 112.986 0.736 . . . . 2.42 112.986 -176.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.846 HG22 ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -79.49 97.95 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 C-N-CA 123.217 0.607 . . . . 2.03 110.105 -179.22 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.902 HD11 ' CZ ' ' A' ' 21' ' ' TYR . 3.2 tp -153.42 170.49 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 C-N-CA 120.008 -0.677 . . . . 3.89 111.615 -178.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.24 169.18 20.63 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 121.276 -0.487 . . . . 1.14 111.982 -175.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.534 ' HB2' ' CB ' ' A' ' 20' ' ' GLU . 11.8 p -151.14 102.41 2.94 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 113.403 0.89 . . . . 1.69 113.403 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -163.3 97.32 0.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 119.176 -0.44 . . . . 3.7 111.255 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.761 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -105.02 -81.12 0.54 Allowed 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 119.022 -1.071 . . . . 0.48 113.742 177.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.414 ' C ' ' HG2' ' A' ' 19' ' ' MET . . . -150.81 -55.85 0.16 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.824 0.675 . . . . 0.45 112.824 -177.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.486 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . 122.49 -45.35 1.21 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.483 -0.865 . . . . 0.72 111.656 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -59.17 -32.17 69.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.036 -0.727 . . . . 2.82 109.036 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.703 ' HA2' HG12 ' A' ' 44' ' ' VAL . . . -132.46 -68.52 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.03 -0.986 . . . . 0.8 110.948 178.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 1.031 ' HB2' HD11 ' A' ' 39' ' ' ILE . . . -111.48 155.65 22.9 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 119.774 -0.155 . . . . 0.51 110.845 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.504 ' HA ' ' H ' ' A' ' 13' ' ' THR . 0.9 OUTLIER -153.85 16.07 0.5 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.75 1.018 . . . . 1.98 113.75 179.209 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.69 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 18.2 mt-10 -152.69 178.91 9.11 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 119.367 -0.349 . . . . 1.28 110.131 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.902 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 1.1 t80 -160.05 12.94 0.12 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.445 1.276 . . . . 4.88 114.445 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.694 ' HB3' HG23 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -85.43 125.64 33.17 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 117.916 2.561 . . . . 4.63 117.916 -175.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.684 HD12 ' HB ' ' A' ' 9' ' ' ILE . 5.7 mt -48.56 -22.48 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-N 111.266 -2.697 . . . . 2.72 110.868 174.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.54 ' HB3' HD13 ' A' ' 22' ' ' LEU . 23.6 tt0 -29.34 -32.19 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.839 0.856 . . . . 2.6 112.517 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.676 ' CZ3' ' CG1' ' A' ' 34' ' ' VAL . 0.4 OUTLIER -55.96 -163.4 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.26 -0.645 . . . . 1.71 109.26 177.014 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.431 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -114.62 54.61 0.77 Allowed 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.513 -0.742 . . . . 3.35 111.104 -178.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.423 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 4.2 p30 44.36 28.41 0.29 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.918 -0.583 . . . . 2.14 111.256 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.512 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -49.54 -65.63 2.69 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.471 -0.871 . . . . 0.86 112.087 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.447 ' O ' ' O ' ' A' ' 30' ' ' SER . 41.5 m-70 -134.56 94.85 3.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.706 -0.398 . . . . 2.9 110.432 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 29' ' ' HIS . 29.5 t 41.26 114.47 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 116.058 1.873 . . . . 1.46 116.058 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.501 ' HB3' HG12 ' A' ' 23' ' ' ILE . 8.0 Cg_exo -30.96 95.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 124.022 3.148 . . . . 0.79 108.167 172.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.565 ' OG ' ' HB2' ' A' ' 40' ' ' ALA . 33.5 t -119.43 176.67 5.24 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-N 114.462 -1.245 . . . . 0.95 113.782 -172.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.761 ' CD1' HG23 ' A' ' 13' ' ' THR . 4.3 t-105 -104.79 99.83 9.47 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.326 -1.761 . . . . 1.24 107.18 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.948 HG11 ' C ' ' A' ' 37' ' ' SER . 7.4 p -152.42 155.44 32.92 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-N 115.166 -0.925 . . . . 1.74 111.591 -175.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.757 ' HD2' HG23 ' A' ' 34' ' ' VAL . 53.5 Cg_exo -55.03 -12.75 5.41 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 124.17 3.247 . . . . 1.52 115.789 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 19.4 p 174.07 -19.32 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.328 0.862 . . . . 1.75 113.328 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.948 ' C ' HG11 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -115.32 -95.39 0.47 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.179 0.445 . . . . 1.49 111.7 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.743 ' N ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -178.44 122.98 0.1 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.296 -1.372 . . . . 5.43 107.296 -178.336 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.031 HD11 ' HB2' ' A' ' 18' ' ' ALA . 5.1 pt -145.64 32.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 119.904 -0.718 . . . . 2.1 111.139 -176.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.565 ' HB2' ' OG ' ' A' ' 32' ' ' SER . . . -60.22 90.57 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.944 -1.026 . . . . 1.64 110.489 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 162.5 -61.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.888 -1.051 . . . . 2.5 109.736 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 13.5 t70 165.71 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.918 -0.583 . . . . 4.56 111.406 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.677 HG11 ' O ' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -147.58 -159.51 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 110.083 -0.34 . . . . 3.73 110.083 178.708 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.703 HG12 ' HA2' ' A' ' 17' ' ' GLY . 13.0 m -146.91 109.78 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 113.426 0.898 . . . . 2.57 113.426 -178.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.475 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . 47.2 t 54.26 16.17 1.14 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.816 -0.629 . . . . 1.34 112.481 178.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.417 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 3.0 tt0 178.36 132.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.566 -0.453 . . . . 1.6 111.703 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.677 ' O ' HG11 ' A' ' 43' ' ' VAL . 91.7 t80 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.244 -0.884 . . . . 4.12 110.67 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.557 -0.217 . . . . 6.11 112.557 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.8 t -122.36 -52.14 1.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.766 0.317 . . . . 4.17 110.921 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 31' ' ' PRO . . . 175.55 -151.38 11.86 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.692 -0.766 . . . . 2.16 112.487 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.462 ' CB ' ' HB3' ' A' ' 27' ' ' ASP . 1.2 pp20? 44.88 26.15 0.19 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.925 0.393 . . . . 2.17 111.996 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.53 HG11 ' HD3' ' A' ' 7' ' ' LYS . 38.8 t -79.8 -11.91 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.042 -0.527 . . . . 0.87 112.357 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.578 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 10.3 t-20 43.22 81.53 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.496 0.665 . . . . 1.86 109.871 -178.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.53 ' HD3' HG11 ' A' ' 5' ' ' VAL . 62.3 pttt -150.95 -134.02 0.06 Allowed 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.667 -1.151 . . . . 2.42 109.499 -177.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.66 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -96.52 113.69 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 120.989 0.423 . . . . 2.03 110.512 179.257 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.793 HD12 ' HB2' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -151.06 167.92 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 119.524 -0.87 . . . . 3.89 112.221 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.716 ' H ' HD13 ' A' ' 9' ' ' ILE . . . -104.12 168.21 16.59 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.75 -0.659 . . . . 1.14 112.703 -178.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.66 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 1.2 p -153.94 103.96 2.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 1.69 111.589 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -157.8 102.15 1.83 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.239 -0.437 . . . . 3.7 110.956 178.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.707 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -110.76 -82.66 0.58 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 119.243 -0.983 . . . . 0.48 113.642 179.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.05 -56.72 0.2 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.194 0.442 . . . . 0.45 112.194 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.51 -40.72 2.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.408 -0.901 . . . . 0.72 112.422 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.53 -25.25 64.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.975 0.417 . . . . 2.82 110.301 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 43' ' ' VAL . . . -149.12 -45.92 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.511 -0.636 . . . . 0.8 111.511 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.537 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -131.07 152.59 50.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.767 -0.457 . . . . 0.51 109.767 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.5 ' HA ' ' H ' ' A' ' 13' ' ' THR . 2.8 ttt -163.01 31.68 0.1 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.202 1.186 . . . . 1.98 114.202 -178.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.628 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 35.5 mt-10 -150.64 -160.55 1.18 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 117.508 -1.234 . . . . 1.28 108.618 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 1.146 ' CE1' HD13 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -153.45 -79.35 0.1 Allowed 'General case' 0 C--O 1.204 -1.327 1 N-CA-C 122.151 4.13 . . . . 4.88 122.151 -175.797 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.146 HD13 ' CE1' ' A' ' 21' ' ' TYR . 3.9 tp -114.22 166.59 11.49 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 115.401 1.63 . . . . 4.63 115.401 -173.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.578 ' HB ' ' HA ' ' A' ' 6' ' ' ASN . 1.3 pp 23.75 -150.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 111.956 -2.383 . . . . 2.72 113.03 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.495 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER 63.07 16.56 9.42 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.038 -0.727 . . . . 2.6 109.038 -178.722 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.614 ' CH2' ' O ' ' A' ' 21' ' ' TYR . 0.3 OUTLIER -152.24 31.14 0.54 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.154 0.502 . . . . 1.71 111.401 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt 17.08 74.55 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.332 1.605 . . . . 3.35 115.332 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.462 ' HB3' ' CB ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 39.16 67.58 0.43 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.6 0.963 . . . . 2.14 113.6 176.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.577 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -88.18 -62.24 1.44 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.524 -1.322 . . . . 0.86 109.953 177.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.549 ' CD2' ' CD2' ' A' ' 47' ' ' TYR . 48.3 t-80 -133.2 94.78 3.4 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 109.544 -0.539 . . . . 2.9 109.544 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 31' ' ' PRO . 18.1 t 37.52 98.14 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 113.873 1.064 . . . . 1.46 113.873 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.432 ' C ' ' O ' ' A' ' 30' ' ' SER . 52.9 Cg_exo -27.08 106.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.349 2.7 . . . . 0.79 110.896 176.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 21' ' ' TYR . 8.7 t -122.18 -149.85 0.44 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.421 -0.809 . . . . 0.95 112.309 -173.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.707 ' CD1' HG23 ' A' ' 13' ' ' THR . 6.9 t-105 -137.87 94.48 2.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.069 -1.826 . . . . 1.24 106.069 174.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.078 HG13 ' HD2' ' A' ' 35' ' ' PRO . 1.4 t -156.26 165.25 19.02 Favored Pre-proline 0 C--O 1.218 -0.553 0 CA-C-N 116.053 -0.521 . . . . 1.74 111.759 -176.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 1.078 ' HD2' HG13 ' A' ' 34' ' ' VAL . 14.5 Cg_exo -63.81 81.3 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.286 2.657 . . . . 1.52 116.039 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.3 t 63.73 28.27 14.86 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.019 0.438 . . . . 1.75 111.365 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.592 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 5.6 t -151.78 -127.31 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.802 -0.635 . . . . 1.49 110.563 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.592 ' CG ' ' C ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -175.8 102.34 0.07 Allowed 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.317 -1.364 . . . . 5.43 107.317 -177.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.804 HG22 HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -158.98 72.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.978 1.371 . . . . 2.1 108.679 -176.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.96 91.31 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.461 -1.7 . . . . 1.64 110.821 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 42' ' ' ASP . . . -166.36 -35.19 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.551 -1.204 . . . . 2.5 110.921 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 15.2 t70 80.86 30.19 0.17 Allowed 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.183 -0.462 . . . . 4.56 110.31 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.8 HG13 HG23 ' A' ' 44' ' ' VAL . 8.9 p -127.85 -3.53 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 112.885 0.698 . . . . 3.73 112.885 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.8 HG23 HG13 ' A' ' 43' ' ' VAL . 3.6 t -158.32 153.38 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.253 0.549 . . . . 2.57 111.787 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.502 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 18.6 p -93.57 21.67 6.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.343 -0.844 . . . . 1.34 111.179 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.484 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 12.4 tt0 -178.99 141.15 0.17 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 120.424 -0.51 . . . . 1.6 112.153 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.549 ' CD2' ' CD2' ' A' ' 29' ' ' HIS . 75.4 t80 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.268 -0.873 . . . . 4.12 110.762 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.448 -0.261 . . . . 6.11 112.448 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.1 t -120.21 -57.27 1.94 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.715 0.293 . . . . 4.17 110.934 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.961 ' HA2' HD12 ' A' ' 23' ' ' ILE . . . -103.26 -125.56 5.66 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.531 -0.842 . . . . 2.16 112.557 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 61.48 18.66 9.61 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.431 0.634 . . . . 2.17 111.583 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.748 ' HB ' HD11 ' A' ' 23' ' ' ILE . 23.2 t -107.08 -9.51 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.046 -0.524 . . . . 0.87 111.621 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 44.1 t-20 50.72 88.33 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.021 0.439 . . . . 1.86 110.177 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.446 ' O ' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -138.36 -147.77 0.24 Allowed 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.876 -0.787 . . . . 2.42 108.876 -178.295 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.3 OUTLIER -65.08 117.44 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 109.824 -0.435 . . . . 2.03 109.824 178.347 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.78 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -129.25 136.25 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 114.096 1.147 . . . . 3.89 114.096 -178.125 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -116.51 106.97 1.55 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 107.693 -2.163 . . . . 1.14 107.693 176.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.667 ' CB ' ' CD2' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -102.76 108.34 19.53 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 114.736 1.384 . . . . 1.69 114.736 -174.722 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -158.18 102.69 1.79 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 112.91 -1.95 . . . . 3.7 112.39 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.515 ' CB ' ' HA ' ' A' ' 19' ' ' MET . 0.2 OUTLIER -111.74 -82.29 0.58 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.25 -0.906 . . . . 0.48 112.478 178.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.429 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -140.61 -50.82 0.46 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.689 0.281 . . . . 0.45 111.416 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.455 ' CA ' ' HG3' ' A' ' 19' ' ' MET . . . 110.74 -44.41 1.51 Allowed Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.312 -0.947 . . . . 0.72 112.732 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -58.62 -24.98 62.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.229 0.538 . . . . 2.82 109.811 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.517 ' HA3' ' CB ' ' A' ' 43' ' ' VAL . . . -145.14 -69.32 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.519 -1.032 . . . . 0.8 110.519 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.656 ' HB1' ' HA ' ' A' ' 34' ' ' VAL . . . -105.18 150.46 25.06 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.407 -0.59 . . . . 0.51 109.407 178.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.515 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 2.4 tmm? -165.01 42.48 0.08 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 114.218 1.192 . . . . 1.98 114.218 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.614 ' HA ' ' OG ' ' A' ' 11' ' ' SER . 32.0 mt-10 -143.47 -147.8 0.22 Allowed 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 114.398 1.259 . . . . 1.28 114.398 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.724 ' CE2' ' CG1' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -113.27 -174.41 2.45 Favored 'General case' 0 CA--C 1.456 -2.659 0 C-N-CA 124.837 1.255 . . . . 4.88 112.097 -173.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.583 ' HB3' ' N ' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -127.39 78.64 1.83 Allowed 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 115.823 1.786 . . . . 4.63 115.823 175.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.961 HD12 ' HA2' ' A' ' 3' ' ' GLY . 4.6 tt 152.41 71.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.136 0 N-CA-C 113.75 1.019 . . . . 2.72 113.75 171.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.74 ' HB2' HG21 ' A' ' 9' ' ' ILE . 14.2 tt0 178.58 59.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.154 -0.475 . . . . 2.6 111.96 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.539 ' CD1' ' N ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -154.22 29.86 0.44 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.854 0.359 . . . . 1.71 110.898 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.465 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 9.6 mptt 55.17 22.54 4.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.217 -0.447 . . . . 3.35 110.816 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.43 ' HB2' ' HG3' ' A' ' 4' ' ' GLU . 16.1 t70 59.29 109.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.588 0.709 . . . . 2.14 111.617 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.568 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -121.08 -62.52 0.24 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 109.857 -1.297 . . . . 0.86 109.857 178.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.473 ' O ' ' CB ' ' A' ' 38' ' ' TYR . 39.7 m80 -135.17 94.45 3.13 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.605 -0.517 . . . . 2.9 109.605 177.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.46 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 15.5 m 39.99 102.69 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 113.338 0.866 . . . . 1.46 113.338 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 14.8 Cg_exo -25.69 125.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.877 3.052 . . . . 0.79 109.705 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.549 ' C ' ' HB3' ' A' ' 22' ' ' LEU . 3.8 t -154.19 138.95 17.05 Favored 'General case' 0 C--O 1.21 -0.989 0 N-CA-C 114.62 1.341 . . . . 0.95 114.62 -171.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.583 ' N ' ' HB3' ' A' ' 22' ' ' LEU . 5.5 t-105 -83.6 96.58 8.69 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.593 -2.373 . . . . 1.24 104.593 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.016 HG12 ' HD3' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -150.88 -159.73 0.04 OUTLIER Pre-proline 0 N--CA 1.441 -0.902 0 CA-C-N 113.271 -1.786 . . . . 1.74 107.631 -175.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 1.016 ' HD3' HG12 ' A' ' 34' ' ' VAL . 60.5 Cg_endo -95.25 99.01 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 122.708 2.003 . . . . 1.52 116.683 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.45 ' H ' ' CG ' ' A' ' 20' ' ' GLU . 47.0 t 55.18 16.79 1.74 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.709 -0.678 . . . . 1.75 112.223 176.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.557 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 50.4 m -162.76 -109.65 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 120.402 -0.519 . . . . 1.49 111.48 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.568 ' OH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -177.71 102.07 0.05 OUTLIER 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 106.645 -1.613 . . . . 5.43 106.645 -176.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.71 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -159.05 71.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.418 -0.81 . . . . 2.1 110.199 -176.078 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.65 91.6 5.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.974 -1.012 . . . . 1.64 110.676 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.8 -43.74 0.15 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.999 -1.001 . . . . 2.5 109.964 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.799 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.8 m-20 -142.53 -74.14 0.29 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.841 -0.618 . . . . 4.56 111.242 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 175.46 74.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.234 -0.439 . . . . 3.73 111.354 -178.375 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 35' ' ' PRO . 24.0 t -133.84 150.33 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 120.957 -0.297 . . . . 2.57 111.757 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.552 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 45.4 t -68.07 1.79 2.53 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.372 1.249 . . . . 1.34 114.372 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.477 ' N ' HG21 ' A' ' 39' ' ' ILE . 38.0 tt0 -179.59 155.67 0.67 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.607 0.242 . . . . 1.6 110.695 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.425 ' N ' ' HB ' ' A' ' 39' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.186 -0.911 . . . . 4.12 110.47 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 112.487 -0.245 . . . . 6.11 112.487 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m -101.36 -62.15 1.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.756 0.312 . . . . 4.17 110.731 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.55 ' HA2' HG23 ' A' ' 23' ' ' ILE . . . 93.97 155.14 31.56 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.634 -0.793 . . . . 2.16 112.671 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.522 ' CG ' ' HB3' ' A' ' 27' ' ' ASP . 1.1 tm-20 51.16 54.27 11.48 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 122.549 1.166 . . . . 2.17 109.268 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 3' ' ' GLY . 12.0 t -131.42 -24.25 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.033 -0.985 . . . . 0.87 112.49 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 50.96 78.26 0.11 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.188 -0.671 . . . . 1.86 109.188 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.463 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -138.39 -98.16 0.18 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.844 0.683 . . . . 2.42 112.844 -176.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 8' ' ' ILE . 2.3 tp -137.69 114.03 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 109.765 -0.457 . . . . 2.03 109.765 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 1.036 HG23 ' CE2' ' A' ' 21' ' ' TYR . 6.4 tp -150.03 165.06 3.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.315 -0.402 . . . . 3.89 111.987 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.496 ' N ' HG13 ' A' ' 9' ' ' ILE . . . -111.57 115.99 4.05 Favored Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.0 -1.24 . . . . 1.14 110.0 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.823 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -101.11 106.36 17.61 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 123.063 1.411 . . . . 1.69 112.819 -174.497 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -157.93 109.02 2.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 111.723 -2.49 . . . . 3.7 111.987 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.524 ' HB ' ' HA ' ' A' ' 19' ' ' MET . 3.2 m -115.24 -80.92 0.6 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.703 0.631 . . . . 0.48 112.703 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.69 -59.92 0.33 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.341 0.497 . . . . 0.45 112.341 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.11 -41.53 1.77 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.64 -0.791 . . . . 0.72 112.472 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.19 -26.67 65.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.025 0.44 . . . . 2.82 110.138 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -150.77 -50.75 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.75 -0.659 . . . . 0.8 111.577 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.66 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -117.52 152.33 35.3 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.153 -0.684 . . . . 0.51 109.153 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.557 ' N ' ' HG3' ' A' ' 35' ' ' PRO . 3.4 ttt -169.74 34.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 115.387 1.625 . . . . 1.98 115.387 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.816 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 7.2 mt-10 -141.09 -122.25 0.1 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 119.198 -1.001 . . . . 1.28 111.982 176.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 1.036 ' CE2' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -154.74 -117.47 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 117.996 2.591 . . . . 4.88 117.996 -175.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.935 ' O ' HG21 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -152.67 168.89 24.15 Favored 'General case' 0 N--CA 1.424 -1.774 0 O-C-N 121.398 -0.814 . . . . 4.63 110.497 -178.591 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.801 HD11 ' HB ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER 47.43 58.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.874 -0.603 . . . . 2.72 111.38 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.515 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 0.3 OUTLIER -168.03 28.72 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.088 -0.506 . . . . 2.6 112.23 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.874 ' CH2' HG13 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -142.86 31.24 1.43 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.862 0.363 . . . . 1.71 110.245 177.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.406 ' O ' ' OD2' ' A' ' 27' ' ' ASP . 7.4 mtpm? 47.85 38.8 9.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 3.35 110.183 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.522 ' HB3' ' CG ' ' A' ' 4' ' ' GLU . 1.3 p30 53.88 38.83 29.56 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.554 -0.748 . . . . 2.14 110.985 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -43.41 -70.13 0.57 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.838 -0.696 . . . . 0.86 111.659 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.497 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -132.9 100.23 4.84 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 120.877 -0.329 . . . . 2.9 110.349 178.175 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.475 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 19.5 m 38.83 103.32 0.02 OUTLIER Pre-proline 0 C--O 1.218 -0.562 0 N-CA-C 114.095 1.146 . . . . 1.46 114.095 176.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.482 ' HB3' ' CA ' ' A' ' 3' ' ' GLY . 25.6 Cg_exo -25.21 138.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.966 3.111 . . . . 0.79 112.518 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.655 ' HB2' ' CD2' ' A' ' 38' ' ' TYR . 43.7 t -152.36 -155.85 0.65 Allowed 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 113.362 0.875 . . . . 0.95 113.362 -175.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.516 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 48.6 t-105 -139.3 95.0 2.86 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 101.524 -3.51 . . . . 1.24 101.524 172.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.05 HG11 ' HA ' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -154.42 163.73 23.22 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 114.086 -1.415 . . . . 1.74 109.745 -171.336 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.912 ' HD2' HG23 ' A' ' 34' ' ' VAL . 24.0 Cg_exo -62.81 -11.12 22.57 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.542 2.828 . . . . 1.52 118.379 -175.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 35' ' ' PRO . 1.9 m 157.98 31.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 114.051 1.13 . . . . 1.75 114.051 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.524 ' N ' ' CE3' ' A' ' 25' ' ' TRP . 37.8 m -176.55 -85.86 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.02 0.438 . . . . 1.49 110.126 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 1.05 ' HA ' HG11 ' A' ' 34' ' ' VAL . 29.4 t80 -177.96 152.75 0.77 Allowed 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.757 -0.656 . . . . 5.43 110.602 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.854 HG21 ' O ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER 175.55 73.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.869 0.366 . . . . 2.1 110.197 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.553 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . . . -66.46 91.94 0.19 Allowed 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.98 -0.688 . . . . 1.64 110.618 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 172.06 -31.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.51 -0.768 . . . . 2.5 110.95 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 17.7 t70 75.9 28.92 0.84 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.043 -0.526 . . . . 4.56 110.963 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.486 ' O ' HG12 ' A' ' 43' ' ' VAL . 47.0 t -119.71 -9.15 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.222 -0.444 . . . . 3.73 112.142 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.854 ' O ' HG21 ' A' ' 39' ' ' ILE . 11.2 t -145.41 162.97 12.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.389 0.138 . . . . 2.57 110.899 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.567 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 78.1 p -97.64 17.39 17.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.397 -0.365 . . . . 1.34 111.761 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' TYR . 0.7 OUTLIER 178.39 140.46 0.09 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 120.696 -0.402 . . . . 1.6 111.632 -179.276 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 38' ' ' TYR . 7.5 t80 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.234 -0.888 . . . . 4.12 111.052 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.491 -0.244 . . . . 6.11 112.491 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.7 p 50.48 45.83 26.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.864 0.364 . . . . 4.17 110.922 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.22 163.24 29.4 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.756 -0.735 . . . . 2.16 112.489 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.545 ' HA ' ' CD1' ' A' ' 23' ' ' ILE . 1.6 tt0 60.27 14.71 4.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.281 0.562 . . . . 2.17 111.404 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -91.18 -21.77 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.648 -0.501 . . . . 0.87 109.648 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.478 ' ND2' ' HA ' ' A' ' 24' ' ' GLU . 34.5 t-20 58.45 80.23 0.19 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.881 -0.6 . . . . 1.86 109.476 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.453 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 17.8 pttp -147.75 -140.39 0.1 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.037 -0.983 . . . . 2.42 108.423 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.643 HD13 ' N ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -67.79 132.34 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.467 -0.938 . . . . 2.03 108.467 177.195 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.643 ' N ' HD13 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -148.7 173.19 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 113.965 1.098 . . . . 3.89 113.965 -176.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.68 159.51 21.55 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 113.545 -1.661 . . . . 1.14 110.388 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.547 ' HB2' ' CB ' ' A' ' 20' ' ' GLU . 2.8 p -154.79 103.71 2.45 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.319 0.859 . . . . 1.69 113.319 -177.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.1 ttp-105 -161.68 98.41 1.1 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.504 0.928 . . . . 3.7 113.504 176.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.71 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -110.54 -81.3 0.58 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 119.031 -1.068 . . . . 0.48 113.521 176.005 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -151.16 -57.44 0.16 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.645 0.609 . . . . 0.45 112.645 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . 125.14 -41.6 1.66 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.0 -0.619 . . . . 0.72 111.771 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -72.76 -9.39 58.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.767 0.318 . . . . 2.82 111.26 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 43' ' ' VAL . . . -151.55 -55.47 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.216 -1.154 . . . . 0.8 110.216 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.792 ' HB2' HD11 ' A' ' 39' ' ' ILE . . . -131.52 153.04 50.22 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 108.774 -0.825 . . . . 0.51 108.774 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.527 ' N ' ' HG3' ' A' ' 35' ' ' PRO . 2.6 ttt -154.33 11.06 0.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.969 1.1 . . . . 1.98 113.969 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.745 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 14.8 mt-10 -151.55 -177.82 6.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.484 -0.932 . . . . 1.28 108.484 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.718 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -157.87 9.35 0.17 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.258 0.836 . . . . 4.88 113.258 178.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.643 ' HA ' HG21 ' A' ' 9' ' ' ILE . 3.6 pp -87.23 128.5 35.15 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 115.343 1.609 . . . . 4.63 115.343 -175.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.763 HD12 ' CD1' ' A' ' 25' ' ' TRP . 0.4 OUTLIER -42.02 -104.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 112.508 -2.133 . . . . 2.72 108.522 173.704 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.522 ' H ' HG23 ' A' ' 23' ' ' ILE . 7.4 tp10 34.72 30.15 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.609 1.095 . . . . 2.6 112.561 177.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.763 ' CD1' HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -134.53 32.29 3.35 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.068 -0.515 . . . . 1.71 111.052 -178.284 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 50.95 29.4 4.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.873 -0.603 . . . . 3.35 111.167 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.415 ' HB3' ' CB ' ' A' ' 4' ' ' GLU . 4.2 p30 43.64 38.07 1.79 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.524 . . . . 2.14 111.696 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.685 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -47.94 -57.4 7.83 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.547 -0.835 . . . . 0.86 112.287 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.576 ' HB2' ' CD1' ' A' ' 38' ' ' TYR . 76.2 m80 -133.65 92.17 2.94 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.245 -0.65 . . . . 2.9 109.245 178.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 29' ' ' HIS . 22.7 t 39.62 117.71 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 116.082 1.882 . . . . 1.46 116.082 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 4' ' ' GLU . 11.1 Cg_exo -32.88 95.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.95 3.1 . . . . 0.79 107.953 172.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 30' ' ' SER . 18.3 m -117.21 173.34 6.74 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 114.463 1.283 . . . . 0.95 114.463 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.71 ' CD1' HG23 ' A' ' 13' ' ' THR . 7.4 t-105 -104.08 100.49 10.24 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 105.314 -2.106 . . . . 1.24 105.314 176.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.945 ' CG2' HG23 ' A' ' 39' ' ' ILE . 4.4 p -151.39 158.98 34.15 Favored Pre-proline 0 C--O 1.204 -1.309 0 CA-C-N 114.19 -1.368 . . . . 1.74 111.417 -173.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.738 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 50.3 Cg_exo -61.48 -6.43 7.0 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 124.07 3.18 . . . . 1.52 115.712 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m 172.2 -12.91 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.182 1.179 . . . . 1.75 114.182 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.945 ' C ' HG11 ' A' ' 34' ' ' VAL . 73.9 m -138.75 -87.49 0.23 Allowed 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 118.816 0.734 . . . . 1.49 112.138 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.685 ' OH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -177.05 102.47 0.05 Allowed 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.223 -1.029 . . . . 5.43 108.223 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.945 HG23 ' CG2' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -127.68 59.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 122.746 1.26 . . . . 2.1 110.583 -174.578 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -55.0 92.63 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 113.852 -1.522 . . . . 1.64 110.934 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 164.95 -29.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 113.966 -1.47 . . . . 2.5 109.177 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 77.15 54.82 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.434 -0.803 . . . . 4.56 111.856 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 43' ' ' VAL . 3.4 t -154.76 23.77 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 112.643 0.608 . . . . 3.73 112.643 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 39' ' ' ILE . 2.4 t -157.88 152.32 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 113.083 0.771 . . . . 2.57 113.083 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.633 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 39.0 t -82.44 -2.71 54.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.747 -0.66 . . . . 1.34 111.409 177.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.474 ' HG2' ' CB ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 176.51 153.71 0.2 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.233 0.457 . . . . 1.6 112.233 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.487 ' CB ' ' O ' ' A' ' 38' ' ' TYR . 36.6 t80 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.26 -0.876 . . . . 4.12 110.754 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.771 -0.132 . . . . 6.11 112.771 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.5 p -101.26 -77.49 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.976 0.417 . . . . 4.17 110.691 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.565 ' O ' HG23 ' A' ' 5' ' ' VAL . . . 131.95 -116.68 1.91 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.834 -0.698 . . . . 2.16 112.554 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.478 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.0 OUTLIER 53.66 20.57 2.24 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.66 0.743 . . . . 2.17 109.536 -178.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 3' ' ' GLY . 17.4 t -98.61 -19.55 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.656 -0.702 . . . . 0.87 111.0 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.575 ' ND2' ' HA ' ' A' ' 24' ' ' GLU . 30.7 t-20 62.88 62.35 1.06 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.929 0.871 . . . . 1.86 108.851 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.449 ' HG3' HG22 ' A' ' 8' ' ' ILE . 18.1 ptmt -134.99 -133.34 0.16 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.13 -1.395 . . . . 2.42 108.272 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 8' ' ' ILE . 6.8 tp -45.45 105.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.341 0 N-CA-C 109.213 -0.662 . . . . 2.03 109.213 177.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.894 ' CG2' HD23 ' A' ' 22' ' ' LEU . 1.4 pt -104.03 109.63 27.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 113.757 1.021 . . . . 3.89 113.757 -176.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 22' ' ' LEU . . . -107.61 139.01 14.85 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 108.685 -1.766 . . . . 1.14 108.685 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.648 ' HA ' ' H ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -153.53 109.34 3.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 114.66 1.356 . . . . 1.69 114.66 -175.07 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.47 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 15.0 tpt180 -158.61 100.0 1.6 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.029 -0.668 . . . . 3.7 112.361 177.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.556 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -117.24 -79.48 0.59 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 119.406 -0.918 . . . . 0.48 113.326 178.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.45 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -149.15 -59.35 0.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.721 -0.392 . . . . 0.45 112.022 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 19' ' ' MET . . . 118.33 -50.55 0.8 Allowed Glycine 0 C--N 1.329 0.162 0 C-N-CA 119.906 -1.14 . . . . 0.72 112.617 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -58.38 -21.1 49.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.047 0.451 . . . . 2.82 109.971 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.454 ' HA3' ' CG2' ' A' ' 43' ' ' VAL . . . -143.71 -57.2 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.862 -0.608 . . . . 0.8 111.875 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.671 ' HA ' ' HB3' ' A' ' 35' ' ' PRO . . . -129.21 149.82 50.85 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.616 -0.883 . . . . 0.51 108.616 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.546 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -167.51 20.7 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 116.629 2.085 . . . . 1.98 116.629 -178.277 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 34' ' ' VAL . 2.8 mt-10 -154.68 98.67 2.09 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 118.928 0.786 . . . . 1.28 112.044 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.674 ' HB2' ' CG ' ' A' ' 33' ' ' TRP . 3.0 t80 -79.13 8.1 6.38 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 113.486 0.921 . . . . 4.88 113.486 -177.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.894 HD23 ' CG2' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -89.16 130.37 35.6 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 116.095 1.887 . . . . 4.63 116.095 -176.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.73 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -47.77 -137.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 111.758 -2.473 . . . . 2.72 112.118 174.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.575 ' HA ' ' ND2' ' A' ' 6' ' ' ASN . 33.1 tt0 60.27 16.5 6.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 120.934 -1.104 . . . . 2.6 109.698 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.73 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -112.15 31.26 6.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.287 0.565 . . . . 1.71 110.423 179.486 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 0.5 OUTLIER 57.95 28.38 16.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.384 -0.826 . . . . 3.35 111.941 177.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.471 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 4.6 p-10 44.87 32.15 0.78 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.751 0.31 . . . . 2.14 111.346 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.775 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -47.82 -59.94 5.78 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.498 -0.858 . . . . 0.86 112.285 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.592 ' HB2' ' CD1' ' A' ' 38' ' ' TYR . 99.2 m-70 -134.89 91.3 2.74 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 119.897 -0.721 . . . . 2.9 109.618 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 29' ' ' HIS . 24.2 t 42.22 120.16 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 115.68 1.733 . . . . 1.46 115.68 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.478 ' HD3' ' CB ' ' A' ' 4' ' ' GLU . 2.9 Cg_exo -38.05 101.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 122.86 2.374 . . . . 0.79 107.425 172.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.57 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 68.7 m -124.0 155.82 37.56 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-N 115.176 -0.92 . . . . 0.95 112.81 -172.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.674 ' CG ' ' HB2' ' A' ' 21' ' ' TYR . 6.8 t-105 -90.29 92.81 9.08 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.43 -2.433 . . . . 1.24 104.43 176.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.041 HG12 ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -155.05 -166.46 0.15 Allowed Pre-proline 0 C--O 1.186 -2.272 0 CA-C-N 115.354 -0.839 . . . . 1.74 112.258 -173.115 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 1.041 ' HD3' HG12 ' A' ' 34' ' ' VAL . 65.6 Cg_endo -95.67 105.78 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.108 0 CA-C-N 122.566 1.952 . . . . 1.52 116.278 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.439 ' H ' ' HB2' ' A' ' 20' ' ' GLU . 29.4 t 37.48 30.08 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.293 0.568 . . . . 1.75 111.359 177.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.539 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 1.3 m -168.4 -130.31 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.059 -0.973 . . . . 1.49 108.922 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.775 ' OH ' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -173.17 100.9 0.12 Allowed 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 106.562 -1.644 . . . . 5.43 106.562 -178.006 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.806 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -121.95 31.8 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.526 -0.761 . . . . 2.1 112.245 -174.137 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -55.69 93.05 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.743 -0.783 . . . . 1.64 111.415 -176.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 163.08 -30.1 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 114.192 -1.367 . . . . 2.5 109.404 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.513 ' O ' HG12 ' A' ' 39' ' ' ILE . 4.8 p-10 -177.3 104.19 0.05 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.863 -0.608 . . . . 4.56 111.009 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.723 ' HA ' HD11 ' A' ' 39' ' ' ILE . 23.0 m -51.05 126.82 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.098 -0.501 . . . . 3.73 112.276 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 44' ' ' VAL . 5.1 p -173.66 34.15 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.519 0 N-CA-C 114.615 1.339 . . . . 2.57 114.615 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.579 ' HA ' ' CG ' ' A' ' 35' ' ' PRO . 30.1 t 68.41 2.9 3.52 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 114.373 1.249 . . . . 1.34 114.373 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 36.4 tt0 179.37 153.01 0.42 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.827 0.677 . . . . 1.6 112.827 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.433 ' CD2' ' CE1' ' A' ' 29' ' ' HIS . 17.3 t80 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.23 -0.89 . . . . 4.12 110.939 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.436 -0.266 . . . . 6.11 112.436 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.0 t -177.33 39.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.918 0.389 . . . . 4.17 110.718 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.587 ' O ' HG23 ' A' ' 5' ' ' VAL . . . 113.32 -176.08 17.07 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.912 -0.661 . . . . 2.16 112.222 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.494 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER 51.65 22.2 1.54 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.638 0.732 . . . . 2.17 110.044 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 3' ' ' GLY . 2.9 t -104.54 -17.14 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.72 -0.673 . . . . 0.87 111.137 -179.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 24' ' ' GLU . 31.4 t-20 61.17 66.17 0.91 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.998 -0.742 . . . . 1.86 108.998 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' HG2' HD11 ' A' ' 23' ' ' ILE . 19.8 pttp -150.72 -146.96 0.21 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.05 -0.523 . . . . 2.42 109.65 -178.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -47.59 98.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 121.956 0.884 . . . . 2.03 111.525 178.669 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.865 HD11 ' CZ ' ' A' ' 21' ' ' TYR . 3.4 tp -152.85 170.07 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.659 -0.701 . . . . 3.89 110.177 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -130.76 168.6 21.76 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.88 -0.676 . . . . 1.14 112.113 -175.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.506 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 35.4 p -148.24 103.57 3.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 113.398 0.888 . . . . 1.69 113.398 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.431 ' O ' ' NE1' ' A' ' 33' ' ' TRP . 51.0 ttp180 -159.96 101.6 1.45 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.003 -0.544 . . . . 3.7 111.254 176.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.612 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -115.45 -84.81 0.62 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.532 0.938 . . . . 0.48 113.532 179.237 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.6 -55.72 0.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.425 -0.51 . . . . 0.45 112.357 -178.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.81 -34.14 4.48 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.342 -0.933 . . . . 0.72 112.489 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.19 -29.38 67.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.206 0.527 . . . . 2.82 109.763 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 35' ' ' PRO . . . -150.44 -41.23 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.422 -0.808 . . . . 0.8 111.879 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.532 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . . . -130.54 151.2 51.27 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.449 -0.575 . . . . 0.51 109.449 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.475 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 4.7 ttp -163.17 27.71 0.09 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.705 1.002 . . . . 1.98 113.705 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 20.4 mt-10 -151.4 -179.71 7.61 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.516 -0.55 . . . . 1.28 109.516 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.865 ' CZ ' HD11 ' A' ' 9' ' ' ILE . 2.8 t80 -159.66 11.09 0.12 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.57 0.952 . . . . 4.88 113.57 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.623 ' HB2' ' CG2' ' A' ' 9' ' ' ILE . 2.4 pt? -86.66 120.76 28.31 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 117.327 2.343 . . . . 4.63 117.327 -176.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.738 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 5.7 pt -55.49 -15.02 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 111.967 -2.379 . . . . 2.72 110.497 174.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.559 ' CB ' HD12 ' A' ' 22' ' ' LEU . 29.4 tp10 -39.14 -27.57 0.02 OUTLIER 'General case' 0 C--N 1.344 0.332 0 CA-C-N 116.065 -0.516 . . . . 2.6 110.682 177.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.738 ' NE1' ' HA ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -57.58 -163.19 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.803 -0.814 . . . . 1.71 108.803 176.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -107.41 44.76 1.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.449 -0.782 . . . . 3.35 111.379 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.455 ' CB ' ' HB2' ' A' ' 4' ' ' GLU . 3.5 p30 42.01 28.51 0.1 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.268 -0.424 . . . . 2.14 111.585 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.779 ' HA3' ' OH ' ' A' ' 38' ' ' TYR . . . -53.57 -55.53 24.59 Favored Glycine 0 CA--C 1.507 -0.422 0 C-N-CA 120.202 -0.999 . . . . 0.86 111.797 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.598 ' HB2' ' CD1' ' A' ' 38' ' ' TYR . 72.8 m80 -134.1 92.8 2.99 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 119.882 -0.727 . . . . 2.9 110.322 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 29' ' ' HIS . 17.0 m 41.62 119.45 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 116.54 2.052 . . . . 1.46 116.54 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.537 ' HB3' HG22 ' A' ' 23' ' ' ILE . 12.5 Cg_exo -34.25 97.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 123.493 2.795 . . . . 0.79 107.856 170.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.611 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 67.2 m -121.06 155.16 35.01 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 114.263 1.209 . . . . 0.95 114.263 -172.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.64 ' CE3' ' CD2' ' A' ' 21' ' ' TYR . 6.7 t-105 -90.75 91.37 8.35 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 104.107 -2.553 . . . . 1.24 104.107 175.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.903 HG12 ' CD ' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -155.76 177.79 1.91 Allowed Pre-proline 0 C--O 1.215 -0.74 0 CA-C-N 114.896 -1.047 . . . . 1.74 110.974 -174.736 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.903 ' CD ' HG12 ' A' ' 34' ' ' VAL . 28.8 Cg_endo -86.34 111.86 1.07 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.879 2.386 . . . . 1.52 116.651 -174.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.7 t 49.69 19.37 0.4 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.555 -1.202 . . . . 1.75 113.079 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.553 ' N ' ' CE3' ' A' ' 25' ' ' TRP . 11.7 t -173.4 -108.15 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.205 -0.598 . . . . 1.49 111.597 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.779 ' OH ' ' HA3' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -176.3 116.59 0.12 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.446 -1.687 . . . . 5.43 106.446 -177.578 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.798 ' H ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -141.51 31.42 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.772 0.796 . . . . 2.1 111.008 -174.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' A' ' 41' ' ' ALA . . . -59.59 89.82 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.069 -0.969 . . . . 1.64 110.636 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 157.02 39.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.138 -0.937 . . . . 2.5 110.763 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 t70 56.67 85.41 0.08 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.816 0.302 . . . . 4.56 111.816 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.605 HG11 ' OXT' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -153.94 -159.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 110.083 -0.34 . . . . 3.73 110.083 179.113 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.639 ' N ' HD12 ' A' ' 39' ' ' ILE . 7.4 p -157.27 118.58 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 113.557 0.947 . . . . 2.57 113.557 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.451 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 54.5 p 65.99 4.77 3.17 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 114.696 -1.138 . . . . 1.34 113.757 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 45' ' ' SER . 39.0 tt0 179.38 154.03 0.46 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.099 0.476 . . . . 1.6 111.671 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.605 ' OXT' HG11 ' A' ' 43' ' ' VAL . 50.9 t80 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.243 -0.884 . . . . 4.12 110.991 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.541 -0.224 . . . . 6.11 112.541 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.9 p -79.71 152.19 30.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.868 0.366 . . . . 4.17 110.757 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 31' ' ' PRO . . . 105.82 152.18 20.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.677 -0.773 . . . . 2.16 112.427 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.603 ' HA ' HD13 ' A' ' 23' ' ' ILE . 2.7 tm-20 65.46 9.03 5.45 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.868 0.366 . . . . 2.17 111.891 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.1 t -91.39 -36.18 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 122.017 0.913 . . . . 0.87 108.85 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.507 ' H ' HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER 68.65 87.45 0.12 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.678 -1.601 . . . . 1.86 111.329 179.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.474 ' O ' HG23 ' A' ' 9' ' ' ILE . 21.4 ptmt -150.31 -144.4 0.15 Allowed 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.995 -1.113 . . . . 2.42 107.995 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.495 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -55.03 118.44 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.006 -0.368 . . . . 2.03 110.006 178.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.8 HG22 ' HB3' ' A' ' 22' ' ' LEU . 36.6 pt -111.27 136.79 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 114.751 1.389 . . . . 3.89 114.751 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.8 146.43 16.67 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 106.86 -2.496 . . . . 1.14 106.86 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.626 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.6 OUTLIER -153.13 105.94 2.95 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 118.781 1.291 . . . . 1.69 113.408 -175.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -156.3 102.82 2.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.995 -0.548 . . . . 3.7 111.104 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.688 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -121.97 -80.74 0.63 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 119.599 -0.84 . . . . 0.48 112.993 179.402 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.442 ' N ' ' HG2' ' A' ' 19' ' ' MET . . . -150.05 -57.75 0.19 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.437 -0.505 . . . . 0.45 112.172 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.405 ' HA2' ' HB2' ' A' ' 19' ' ' MET . . . 119.04 -42.34 1.8 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.538 -0.839 . . . . 0.72 112.158 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -59.38 -33.89 71.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.169 0.509 . . . . 2.82 110.135 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.45 -48.72 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.568 -0.742 . . . . 0.8 111.493 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.537 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . . . -130.55 150.13 51.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.86 -0.422 . . . . 0.51 109.86 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.487 ' HA ' ' CB ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -163.9 30.08 0.08 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.062 1.134 . . . . 1.98 114.062 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.626 ' HA ' ' HB2' ' A' ' 11' ' ' SER . 11.1 mt-10 -148.79 -171.9 3.98 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.287 -1.005 . . . . 1.28 108.287 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.63 ' HB2' ' CD2' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -154.02 -57.5 0.12 Allowed 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 119.217 3.043 . . . . 4.88 119.217 -176.056 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.8 ' HB3' HG22 ' A' ' 9' ' ' ILE . 8.4 mt -81.24 148.04 29.67 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 118.034 -1.466 . . . . 4.63 114.705 -171.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.621 HD12 ' CD1' ' A' ' 25' ' ' TRP . 3.2 tp -13.23 -105.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 110.818 -2.901 . . . . 2.72 114.07 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.643 ' HG3' HD13 ' A' ' 9' ' ' ILE . 8.1 mm-40 42.82 25.85 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 119.39 0.996 . . . . 2.6 111.349 -177.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.621 ' CD1' HD12 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -136.53 29.01 2.98 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 116.133 -0.485 . . . . 1.71 111.289 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 40.35 30.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 3.35 112.133 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.434 ' HB2' ' CG ' ' A' ' 4' ' ' GLU . 23.8 t70 63.51 34.11 12.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.008 0.432 . . . . 2.14 110.312 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 25' ' ' TRP . . . -45.37 -63.76 2.57 Favored Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 111.045 -0.822 . . . . 0.86 111.045 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.522 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -133.44 109.12 9.09 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 109.047 -0.723 . . . . 2.9 109.047 177.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.446 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 48.1 m 31.0 103.3 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 114.994 1.479 . . . . 1.46 114.994 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.441 ' HG3' ' CB ' ' A' ' 4' ' ' GLU . 13.4 Cg_exo -29.87 120.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.257 0 C-N-CA 123.093 2.529 . . . . 0.79 111.372 176.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.652 ' HB2' ' CD2' ' A' ' 38' ' ' TYR . 17.9 t -143.34 -163.72 1.71 Allowed 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 114.345 1.239 . . . . 0.95 114.345 -174.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.688 ' CD1' HG23 ' A' ' 13' ' ' THR . 4.5 t-105 -123.11 93.11 3.85 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 106.349 -1.722 . . . . 1.24 106.349 175.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.956 HG21 HG23 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -159.85 178.27 1.74 Allowed Pre-proline 0 C--O 1.22 -0.47 0 CA-C-N 115.356 -0.838 . . . . 1.74 111.01 -177.72 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.676 ' HD2' HG13 ' A' ' 34' ' ' VAL . 6.4 Cg_endo -95.51 137.27 0.72 Allowed 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.939 3.093 . . . . 1.52 112.444 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 35' ' ' PRO . 10.7 t 79.83 -62.17 0.27 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.454 0.909 . . . . 1.75 113.454 177.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.611 ' HA ' ' CE3' ' A' ' 25' ' ' TRP . 47.5 t -150.54 -56.89 0.17 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.556 1.317 . . . . 1.49 114.556 -177.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.718 ' CA ' HG11 ' A' ' 34' ' ' VAL . 14.4 t80 176.97 152.04 0.19 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.799 -0.445 . . . . 5.43 109.799 -176.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.956 HG23 HG21 ' A' ' 34' ' ' VAL . 0.6 OUTLIER 175.86 67.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.9 0.857 . . . . 2.1 108.851 -179.621 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.557 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . . . -59.66 92.76 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.151 -0.931 . . . . 1.64 111.082 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 174.14 -31.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.337 -0.847 . . . . 2.5 110.983 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 74.08 23.94 2.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.075 -0.511 . . . . 4.56 110.807 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.82 -25.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 3.73 111.211 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.781 ' O ' HG21 ' A' ' 39' ' ' ILE . 3.5 t -136.07 165.02 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.955 0.407 . . . . 2.57 111.118 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.549 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 29.6 t -96.38 25.46 4.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.873 -0.603 . . . . 1.34 110.689 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -179.72 149.05 0.35 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.437 -0.347 . . . . 1.6 110.996 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.522 ' HB3' ' CD2' ' A' ' 29' ' ' HIS . 10.3 t80 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.212 -0.899 . . . . 4.12 110.944 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.368 -0.293 . . . . 6.11 112.368 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.7 t -140.39 108.35 5.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.901 0.381 . . . . 4.17 111.024 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.48 ' CA ' ' CD1' ' A' ' 23' ' ' ILE . . . 146.86 -148.26 19.77 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.795 -0.716 . . . . 2.16 112.424 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.475 ' HB3' ' HG3' ' A' ' 31' ' ' PRO . 0.0 OUTLIER 78.0 -13.49 0.95 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.144 0.794 . . . . 2.17 113.144 179.484 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 6' ' ' ASN . 11.3 t -77.71 -51.29 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 121.454 0.645 . . . . 0.87 111.12 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 1.015 ' N ' HG21 ' A' ' 23' ' ' ILE . 1.1 m-20 99.11 82.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.362 -1.29 . . . . 1.86 109.669 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.427 ' HG3' HG22 ' A' ' 8' ' ' ILE . 12.9 pttp -150.61 -131.23 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.42 -1.264 . . . . 2.42 108.75 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.648 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -47.06 113.83 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 118.306 0.503 . . . . 2.03 109.824 177.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.642 HG22 ' C ' ' A' ' 22' ' ' LEU . 3.1 pt -124.8 116.49 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 114.793 1.405 . . . . 3.89 114.793 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.634 ' H ' HD12 ' A' ' 22' ' ' LEU . . . -101.72 144.54 16.43 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 107.055 -2.418 . . . . 1.14 107.055 174.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.616 ' HA ' ' HB3' ' A' ' 21' ' ' TYR . 15.9 p -155.11 104.38 2.45 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.934 1.087 . . . . 1.69 113.934 -175.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.27 98.22 1.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.944 -0.571 . . . . 3.7 109.881 176.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.754 HG23 ' CD1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -102.89 -82.16 0.49 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 119.385 -0.926 . . . . 0.48 112.901 179.533 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -142.69 -65.78 0.39 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.692 0.627 . . . . 0.45 112.692 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . 126.19 -35.05 3.07 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.099 -0.8 . . . . 0.72 111.099 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -66.78 -30.52 70.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.27 0.557 . . . . 2.82 109.61 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.783 ' HA2' HG12 ' A' ' 44' ' ' VAL . . . -145.47 -49.1 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.272 -0.876 . . . . 0.8 111.686 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.589 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . . . -118.49 151.55 37.62 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 119.701 -0.19 . . . . 0.51 110.597 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.463 ' HA ' ' H ' ' A' ' 13' ' ' THR . 0.2 OUTLIER -160.36 27.03 0.16 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.886 1.439 . . . . 1.98 114.886 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.682 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 12.3 mt-10 -151.1 -174.4 4.79 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.56 -0.533 . . . . 1.28 109.56 177.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.616 ' HB3' ' HA ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -153.08 -72.55 0.14 Allowed 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 118.815 2.894 . . . . 4.88 118.815 -177.185 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.642 ' C ' HG22 ' A' ' 9' ' ' ILE . 33.7 mt -82.92 143.09 30.96 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 114.749 1.389 . . . . 4.63 114.749 -172.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.015 HG21 ' N ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER 17.37 -148.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 111.522 -2.581 . . . . 2.72 113.751 -179.297 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER 83.15 -5.88 1.23 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.902 -0.407 . . . . 2.6 109.902 -178.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 1.119 ' CH2' HG13 ' A' ' 34' ' ' VAL . 1.3 p90 -121.98 28.57 7.49 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 120.861 -0.336 . . . . 1.71 111.023 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.8 tttt 29.18 62.93 0.14 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.223 0.823 . . . . 3.35 113.223 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.453 ' HB3' ' CG ' ' A' ' 4' ' ' GLU . 3.9 p30 45.61 27.4 0.42 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.753 0.311 . . . . 2.14 111.631 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -49.48 -65.9 2.54 Favored Glycine 0 CA--C 1.508 -0.356 0 N-CA-C 110.776 -0.929 . . . . 0.86 110.776 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.566 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -132.56 100.72 5.05 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 108.752 -0.833 . . . . 2.9 108.752 177.374 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.487 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 70.2 m 37.08 109.53 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 N-CA-C 116.24 1.941 . . . . 1.46 116.24 176.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.487 ' HD2' ' HA ' ' A' ' 30' ' ' SER . 2.8 Cg_exo -34.92 102.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.938 2.425 . . . . 0.79 110.027 174.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.582 ' HB2' ' CD2' ' A' ' 38' ' ' TYR . 28.7 t -124.2 -177.54 3.81 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 114.166 1.173 . . . . 0.95 114.166 -174.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.754 ' CD1' HG23 ' A' ' 13' ' ' THR . 3.7 t-105 -109.33 100.13 9.28 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 103.235 -2.876 . . . . 1.24 103.235 173.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.119 HG13 ' CH2' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -153.07 154.79 31.4 Favored Pre-proline 0 N--CA 1.444 -0.761 0 CA-C-N 115.267 -0.879 . . . . 1.74 112.63 -171.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.688 ' HD2' HG23 ' A' ' 34' ' ' VAL . 21.2 Cg_endo -59.45 -13.74 22.15 Favored 'Trans proline' 0 N--CA 1.491 1.344 1 C-N-CA 126.35 4.7 . . . . 1.52 117.817 -176.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.423 ' H ' HG22 ' A' ' 34' ' ' VAL . 18.6 p 178.51 -23.59 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 119.572 1.078 . . . . 1.75 113.764 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.521 ' O ' ' CD2' ' A' ' 25' ' ' TRP . 48.2 t -141.21 -73.23 0.33 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.514 0.673 . . . . 1.49 110.663 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.983 ' OH ' ' HB3' ' A' ' 40' ' ' ALA . 11.7 t80 177.8 131.84 0.06 Allowed 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 115.536 -0.756 . . . . 5.43 109.84 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.489 ' O ' HG12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -146.67 26.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.503 -0.879 . . . . 2.1 110.852 -179.216 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.983 ' HB3' ' OH ' ' A' ' 38' ' ' TYR . . . -64.81 88.7 0.07 Allowed 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.144 -1.022 . . . . 1.64 109.955 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 151.8 37.84 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.538 -1.21 . . . . 2.5 110.522 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 61.19 88.72 0.08 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.057 0.391 . . . . 4.56 112.057 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.481 HG23 ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -162.99 -169.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 110.25 -0.278 . . . . 3.73 110.25 178.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.783 HG12 ' HA2' ' A' ' 17' ' ' GLY . 11.4 m -144.59 124.1 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 113.216 0.821 . . . . 2.57 113.216 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.469 ' HA ' ' HG2' ' A' ' 35' ' ' PRO . 28.9 t 53.8 16.25 0.99 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.249 -0.887 . . . . 1.34 113.084 178.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 179.84 148.01 0.27 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.724 -0.39 . . . . 1.6 111.925 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.546 ' N ' ' O ' ' A' ' 38' ' ' TYR . 14.4 t80 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.211 -0.899 . . . . 4.12 111.094 -179.781 . . . . . . . . 1 1 . 1 stop_ save_